id	sid	tid	token	lemma	pos
admet-2013	1	1	supremacy	supremacy	NOUN
admet-2013	1	2	of	of	ADP
admet-2013	1	3	nanoparticles	nanoparticle	NOUN
admet-2013	1	4	in	in	ADP
admet-2013	1	5	the	the	DET
admet-2013	1	6	therapy	therapy	NOUN
admet-2013	1	7	of	of	ADP
admet-2013	1	8	chronic	chronic	ADJ
admet-2013	1	9	myelogenous	myelogenous	ADJ
admet-2013	1	10	leukemia	leukemia	PROPN
admet-2013	1	11	doi	doi	PROPN
admet-2013	1	12	:	:	PUNCT
admet-2013	1	13	https://doi.org/10.5599/adme	https://doi.org/10.5599/adme	NOUN
admet-2013	1	14	t.2013	t.2013	PROPN
admet-2013	1	15	499	499	NUM
admet-2013	1	16	admet	admet	PROPN
admet-2013	1	17	&	&	CCONJ
admet-2013	1	18	dmpk	dmpk	PROPN
admet-2013	1	19	11(4	11(4	NUM
admet-2013	1	20	)	)	PUNCT
admet-2013	1	21	(	(	PUNCT
admet-2013	1	22	2023	2023	NUM
admet-2013	1	23	)	)	PUNCT
admet-2013	1	24	499	499	NUM
admet-2013	1	25	-	-	SYM
admet-2013	1	26	511	511	NUM
admet-2013	1	27	;	;	PUNCT
admet-2013	1	28	doi	doi	NOUN
admet-2013	1	29	:	:	PUNCT
admet-2013	1	30	https://doi.org/10.5599/admet.2013	https://doi.org/10.5599/admet.2013	NOUN
admet-2013	1	31	open	open	ADJ
admet-2013	1	32	access	access	NOUN
admet-2013	1	33	:	:	PUNCT
admet-2013	1	34	issn	issn	PROPN
admet-2013	1	35	:	:	PUNCT
admet-2013	1	36	1848	1848	NUM
admet-2013	1	37	-	-	SYM
admet-2013	1	38	7718	7718	NUM
admet-2013	1	39	http://www.pub.iapchem.org/ojs/index.php/admet/index	http://www.pub.iapchem.org/ojs/index.php/admet/index	NOUN
admet-2013	1	40	review	review	NOUN
admet-2013	1	41	supremacy	supremacy	NOUN
admet-2013	1	42	of	of	ADP
admet-2013	1	43	nanoparticles	nanoparticle	NOUN
admet-2013	1	44	in	in	ADP
admet-2013	1	45	the	the	DET
admet-2013	1	46	therapy	therapy	NOUN
admet-2013	1	47	of	of	ADP
admet-2013	1	48	chronic	chronic	ADJ
admet-2013	1	49	myelogenous	myelogenous	ADJ
admet-2013	1	50	leukemia	leukemia	NOUN
admet-2013	1	51	gopalarethinam	gopalarethinam	PROPN
admet-2013	1	52	janani	janani	PROPN
admet-2013	1	53	,	,	PUNCT
admet-2013	1	54	agnishwar	agnishwar	PROPN
admet-2013	1	55	girigoswami	girigoswami	PROPN
admet-2013	1	56	and	and	CCONJ
admet-2013	1	57	koyeli	koyeli	PROPN
admet-2013	1	58	girigoswami	girigoswami	PROPN
admet-2013	1	59	*	*	PROPN
admet-2013	1	60	medical	medical	ADJ
admet-2013	1	61	bionanotechnology	bionanotechnology	NOUN
admet-2013	1	62	,	,	PUNCT
admet-2013	1	63	faculty	faculty	NOUN
admet-2013	1	64	of	of	ADP
admet-2013	1	65	allied	ally	VERB
admet-2013	1	66	health	health	NOUN
admet-2013	1	67	sciences	science	NOUN
admet-2013	1	68	,	,	PUNCT
admet-2013	1	69	chettinad	chettinad	PROPN
admet-2013	1	70	hospital	hospital	PROPN
admet-2013	1	71	and	and	CCONJ
admet-2013	1	72	research	research	PROPN
admet-2013	1	73	institute	institute	PROPN
admet-2013	1	74	,	,	PUNCT
admet-2013	1	75	chettina	chettina	PROPN
admet-2013	1	76	d	d	PROPN
admet-2013	1	77	academy	academy	PROPN
admet-2013	1	78	of	of	ADP
admet-2013	1	79	research	research	NOUN
admet-2013	1	80	and	and	CCONJ
admet-2013	1	81	education	education	NOUN
admet-2013	1	82	,	,	PUNCT
admet-2013	1	83	chettinad	chettinad	PROPN
admet-2013	1	84	health	health	PROPN
admet-2013	1	85	city	city	PROPN
admet-2013	1	86	,	,	PUNCT
admet-2013	1	87	kelambakkam	kelambakkam	PROPN
admet-2013	1	88	,	,	PUNCT
admet-2013	1	89	chennai-603103	chennai-603103	NOUN
admet-2013	1	90	,	,	PUNCT
admet-2013	1	91	india	india	PROPN
admet-2013	1	92	*	*	PUNCT
admet-2013	1	93	corresponding	correspond	VERB
admet-2013	1	94	author	author	NOUN
admet-2013	1	95	:	:	PUNCT
admet-2013	1	96	e	e	NOUN
admet-2013	1	97	-	-	NOUN
admet-2013	1	98	mail	mail	NOUN
admet-2013	1	99	:	:	PUNCT
admet-2013	1	100	koyelig@gmail.com	koyelig@gmail.com	X
admet-2013	1	101	;	;	PUNCT
admet-2013	2	1	tel	tel	PROPN
admet-2013	2	2	.	.	PROPN
admet-2013	2	3	+91	+91	PROPN
admet-2013	2	4	-	-	PUNCT
admet-2013	2	5	9600060358	9600060358	NUM
admet-2013	2	6	received	receive	VERB
admet-2013	2	7	:	:	PUNCT
admet-2013	2	8	august	august	PROPN
admet-2013	2	9	2	2	NUM
admet-2013	2	10	,	,	PUNCT
admet-2013	2	11	2023	2023	NUM
admet-2013	2	12	;	;	PUNCT
admet-2013	2	13	revised	revise	VERB
admet-2013	2	14	:	:	PUNCT
admet-2013	2	15	september	september	PROPN
admet-2013	2	16	25	25	NUM
admet-2013	2	17	,	,	PUNCT
admet-2013	2	18	2023	2023	NUM
admet-2013	2	19	;	;	PUNCT
admet-2013	2	20	published	publish	VERB
admet-2013	2	21	:	:	PUNCT
admet-2013	2	22	september	september	PROPN
admet-2013	2	23	26	26	NUM
admet-2013	2	24	,	,	PUNCT
admet-2013	2	25	2023	2023	NUM
admet-2013	2	26	abstract	abstract	ADJ
admet-2013	2	27	background	background	NOUN
admet-2013	2	28	and	and	CCONJ
admet-2013	2	29	purpose	purpose	NOUN
admet-2013	2	30	:	:	PUNCT
admet-2013	2	31	the	the	DET
admet-2013	2	32	reciprocal	reciprocal	ADJ
admet-2013	2	33	translocation	translocation	NOUN
admet-2013	2	34	of	of	ADP
admet-2013	2	35	the	the	DET
admet-2013	2	36	abl	abl	PROPN
admet-2013	2	37	gene	gene	NOUN
admet-2013	2	38	from	from	ADP
admet-2013	2	39	chromosome	chromosome	NOUN
admet-2013	2	40	9	9	NUM
admet-2013	2	41	to	to	PART
admet-2013	2	42	chromosome	chromosome	VERB
admet-2013	2	43	22	22	NUM
admet-2013	2	44	near	near	ADP
admet-2013	2	45	the	the	DET
admet-2013	2	46	bcr	bcr	NOUN
admet-2013	2	47	gene	gene	NOUN
admet-2013	2	48	gives	give	VERB
admet-2013	2	49	rise	rise	NOUN
admet-2013	2	50	to	to	ADP
admet-2013	2	51	chronic	chronic	ADJ
admet-2013	2	52	myelogenous	myelogenous	ADJ
admet-2013	2	53	leukemia	leukemia	NOUN
admet-2013	2	54	(	(	PUNCT
admet-2013	2	55	cml	cml	PROPN
admet-2013	2	56	)	)	PUNCT
admet-2013	2	57	.	.	PUNCT
admet-2013	3	1	the	the	DET
admet-2013	3	2	translocation	translocation	NOUN
admet-2013	3	3	results	result	NOUN
admet-2013	3	4	in	in	ADP
admet-2013	3	5	forming	form	VERB
admet-2013	3	6	the	the	DET
admet-2013	3	7	philadelphia	philadelphia	PROPN
admet-2013	3	8	chromosome	chromosome	NOUN
admet-2013	3	9	(	(	PUNCT
admet-2013	3	10	bcr	bcr	NOUN
admet-2013	3	11	-	-	PUNCT
admet-2013	3	12	abl	abl	NOUN
admet-2013	3	13	)	)	PUNCT
admet-2013	3	14	tyrosine	tyrosine	PROPN
admet-2013	3	15	kinase	kinase	PROPN
admet-2013	3	16	.	.	PUNCT
admet-2013	4	1	cml	cml	PROPN
admet-2013	4	2	results	result	NOUN
admet-2013	4	3	in	in	ADP
admet-2013	4	4	an	an	DET
admet-2013	4	5	increase	increase	NOUN
admet-2013	4	6	in	in	ADP
admet-2013	4	7	the	the	DET
admet-2013	4	8	number	number	NOUN
admet-2013	4	9	of	of	ADP
admet-2013	4	10	white	white	ADJ
admet-2013	4	11	blood	blood	NOUN
admet-2013	4	12	cells	cell	NOUN
admet-2013	4	13	and	and	CCONJ
admet-2013	4	14	alteration	alteration	NOUN
admet-2013	4	15	in	in	ADP
admet-2013	4	16	tyrosine	tyrosine	PROPN
admet-2013	4	17	kinase	kinase	PROPN
admet-2013	4	18	expression	expression	NOUN
admet-2013	4	19	.	.	PUNCT
admet-2013	5	1	cml	cml	PROPN
admet-2013	5	2	prognosis	prognosis	NOUN
admet-2013	5	3	includes	include	VERB
admet-2013	5	4	three	three	NUM
admet-2013	5	5	stages	stage	NOUN
admet-2013	5	6	,	,	PUNCT
admet-2013	5	7	namely	namely	ADV
admet-2013	5	8	chronic	chronic	ADJ
admet-2013	5	9	,	,	PUNCT
admet-2013	5	10	accelerated	accelerate	VERB
admet-2013	5	11	,	,	PUNCT
admet-2013	5	12	and	and	CCONJ
admet-2013	5	13	blast	blast	NOUN
admet-2013	5	14	.	.	PUNCT
admet-2013	6	1	the	the	DET
admet-2013	6	2	diagnosis	diagnosis	NOUN
admet-2013	6	3	method	method	NOUN
admet-2013	6	4	involves	involve	VERB
admet-2013	6	5	a	a	DET
admet-2013	6	6	ct	ct	PROPN
admet-2013	6	7	scan	scan	NOUN
admet-2013	6	8	,	,	PUNCT
admet-2013	6	9	biopsy	biopsy	VERB
admet-2013	6	10	,	,	PUNCT
admet-2013	6	11	and	and	CCONJ
admet-2013	6	12	complete	complete	ADJ
admet-2013	6	13	blood	blood	NOUN
admet-2013	6	14	count	count	NOUN
admet-2013	6	15	.	.	PUNCT
admet-2013	7	1	however	however	ADV
admet-2013	7	2	,	,	PUNCT
admet-2013	7	3	due	due	ADP
admet-2013	7	4	to	to	ADP
admet-2013	7	5	certain	certain	ADJ
admet-2013	7	6	disadvantages	disadvantage	NOUN
admet-2013	7	7	,	,	PUNCT
admet-2013	7	8	early	early	ADJ
admet-2013	7	9	diagnosis	diagnosis	NOUN
admet-2013	7	10	of	of	ADP
admet-2013	7	11	cml	cml	PROPN
admet-2013	7	12	is	be	AUX
admet-2013	7	13	not	not	PART
admet-2013	7	14	possible	possible	ADJ
admet-2013	7	15	by	by	ADP
admet-2013	7	16	traditional	traditional	ADJ
admet-2013	7	17	methods	method	NOUN
admet-2013	7	18	.	.	PUNCT
admet-2013	8	1	nano	nano	NOUN
admet-2013	8	2	technology	technology	NOUN
admet-2013	8	3	offers	offer	VERB
admet-2013	8	4	many	many	ADJ
admet-2013	8	5	advantages	advantage	NOUN
admet-2013	8	6	in	in	ADP
admet-2013	8	7	diagnosing	diagnose	VERB
admet-2013	8	8	and	and	CCONJ
admet-2013	8	9	treating	treat	VERB
admet-2013	8	10	cancer	cancer	NOUN
admet-2013	8	11	.	.	PUNCT
admet-2013	9	1	experimental	experimental	ADJ
admet-2013	9	2	approach	approach	NOUN
admet-2013	9	3	:	:	PUNCT
admet-2013	9	4	we	we	PRON
admet-2013	9	5	searched	search	VERB
admet-2013	9	6	pubmed	pubmed	PROPN
admet-2013	9	7	,	,	PUNCT
admet-2013	9	8	scopus	scopus	PROPN
admet-2013	9	9	and	and	CCONJ
admet-2013	9	10	google	google	PROPN
admet-2013	9	11	scholar	scholar	NOUN
admet-2013	9	12	using	use	VERB
admet-2013	9	13	the	the	DET
admet-2013	9	14	keywords	keyword	NOUN
admet-2013	9	15	philadelphia	philadelphia	PROPN
admet-2013	9	16	chromosome	chromosome	NOUN
admet-2013	9	17	,	,	PUNCT
admet-2013	9	18	bionano	bionano	ADJ
admet-2013	9	19	technology	technology	NOUN
admet-2013	9	20	,	,	PUNCT
admet-2013	9	21	tyrosine	tyrosine	NOUN
admet-2013	9	22	kinase	kinase	PROPN
admet-2013	9	23	pathway	pathway	NOUN
admet-2013	9	24	,	,	PUNCT
admet-2013	9	25	half	half	ADJ
admet-2013	9	26	-	-	PUNCT
admet-2013	9	27	life	life	NOUN
admet-2013	9	28	,	,	PUNCT
admet-2013	9	29	passive	passive	ADJ
admet-2013	9	30	targeting	targeting	NOUN
admet-2013	9	31	,	,	PUNCT
admet-2013	9	32	and	and	CCONJ
admet-2013	9	33	organic	organic	ADJ
admet-2013	9	34	and	and	CCONJ
admet-2013	9	35	inorganic	inorganic	ADJ
admet-2013	9	36	nanoparticles	nanoparticle	NOUN
admet-2013	9	37	.	.	PUNCT
admet-2013	10	1	the	the	DET
admet-2013	10	2	relevant	relevant	ADJ
admet-2013	10	3	papers	paper	NOUN
admet-2013	10	4	and	and	CCONJ
admet-2013	10	5	the	the	DET
admet-2013	10	6	classical	classical	ADJ
admet-2013	10	7	papers	paper	NOUN
admet-2013	10	8	in	in	ADP
admet-2013	10	9	this	this	DET
admet-2013	10	10	field	field	NOUN
admet-2013	10	11	were	be	AUX
admet-2013	10	12	selected	select	VERB
admet-2013	10	13	to	to	PART
admet-2013	10	14	write	write	VERB
admet-2013	10	15	about	about	ADP
admet-2013	10	16	in	in	ADP
admet-2013	10	17	this	this	DET
admet-2013	10	18	review	review	NOUN
admet-2013	10	19	.	.	PUNCT
admet-2013	11	1	key	key	ADJ
admet-2013	11	2	results	result	NOUN
admet-2013	11	3	:	:	PUNCT
admet-2013	11	4	the	the	DET
admet-2013	11	5	sensitivity	sensitivity	NOUN
admet-2013	11	6	and	and	CCONJ
admet-2013	11	7	specificity	specificity	NOUN
admet-2013	11	8	of	of	ADP
admet-2013	11	9	an	an	DET
admet-2013	11	10	assay	assay	NOUN
admet-2013	11	11	can	can	AUX
admet-2013	11	12	be	be	AUX
admet-2013	11	13	improved	improve	VERB
admet-2013	11	14	by	by	ADP
admet-2013	11	15	nanoparticles	nanoparticle	NOUN
admet-2013	11	16	.	.	PUNCT
admet-2013	12	1	utilizing	utilize	VERB
admet-2013	12	2	this	this	DET
admet-2013	12	3	property	property	NOUN
admet-2013	12	4	,	,	PUNCT
admet-2013	12	5	pe	pe	PROPN
admet-2013	12	6	ptides	ptide	NOUN
admet-2013	12	7	,	,	PUNCT
admet-2013	12	8	antibodies	antibodie	VERB
admet-2013	12	9	,	,	PUNCT
admet-2013	12	10	aptamers	aptamer	NOUN
admet-2013	12	11	,	,	PUNCT
admet-2013	12	12	etc	etc	X
admet-2013	12	13	.	.	X
admet-2013	12	14	,	,	PUNCT
admet-2013	12	15	in	in	ADP
admet-2013	12	16	the	the	DET
admet-2013	12	17	form	form	NOUN
admet-2013	12	18	of	of	ADP
admet-2013	12	19	nanoparticles	nanoparticle	NOUN
admet-2013	12	20	,	,	PUNCT
admet-2013	12	21	can	can	AUX
admet-2013	12	22	be	be	AUX
admet-2013	12	23	used	use	VERB
admet-2013	12	24	to	to	PART
admet-2013	12	25	detect	detect	VERB
admet-2013	12	26	cancer	cancer	NOUN
admet-2013	12	27	at	at	ADP
admet-2013	12	28	a	a	DET
admet-2013	12	29	much	much	ADV
admet-2013	12	30	earlier	early	ADJ
admet-2013	12	31	stage	stage	NOUN
admet-2013	12	32	.	.	PUNCT
admet-2013	13	1	the	the	DET
admet-2013	13	2	half	half	ADJ
admet-2013	13	3	-	-	PUNCT
admet-2013	13	4	life	life	NOUN
admet-2013	13	5	of	of	ADP
admet-2013	13	6	the	the	DET
admet-2013	13	7	drug	drug	NOUN
admet-2013	13	8	is	be	AUX
admet-2013	13	9	also	also	ADV
admet-2013	13	10	increased	increase	VERB
admet-2013	13	11	by	by	ADP
admet-2013	13	12	nanoformulation	nanoformulation	NOUN
admet-2013	13	13	.	.	PUNCT
admet-2013	14	1	the	the	DET
admet-2013	14	2	nanoparticle	nanoparticle	NOUN
admet-2013	14	3	-coated	-coated	ADJ
admet-2013	14	4	drugs	drug	NOUN
admet-2013	14	5	can	can	AUX
admet-2013	14	6	easily	easily	ADV
admet-2013	14	7	escape	escape	VERB
admet-2013	14	8	from	from	ADP
admet-2013	14	9	the	the	DET
admet-2013	14	10	immune	immune	ADJ
admet-2013	14	11	system	system	NOUN
admet-2013	14	12	.	.	PUNCT
admet-2013	15	1	conclusion	conclusion	NOUN
admet-2013	15	2	:	:	PUNCT
admet-2013	15	3	depending	depend	VERB
admet-2013	15	4	on	on	ADP
admet-2013	15	5	their	their	PRON
admet-2013	15	6	type	type	NOUN
admet-2013	15	7	,	,	PUNCT
admet-2013	15	8	nanoparticles	nanoparticle	NOUN
admet-2013	15	9	can	can	AUX
admet-2013	15	10	be	be	AUX
admet-2013	15	11	categorized	categorize	VERB
admet-2013	15	12	into	into	ADP
admet-2013	15	13	organic	organic	ADJ
admet-2013	15	14	,	,	PUNCT
admet-2013	15	15	inorganic	inorganic	ADJ
admet-2013	15	16	and	and	CCONJ
admet-2013	15	17	hybrid	hybrid	NOUN
admet-2013	15	18	.	.	PUNCT
admet-2013	16	1	each	each	DET
admet-2013	16	2	type	type	NOUN
admet-2013	16	3	has	have	VERB
admet-2013	16	4	its	its	PRON
admet-2013	16	5	advantage	advantage	NOUN
admet-2013	16	6	s.	s.	PROPN
admet-2013	16	7	organic	organic	ADJ
admet-2013	16	8	nanoparticles	nanoparticle	NOUN
admet-2013	16	9	have	have	VERB
admet-2013	16	10	good	good	ADJ
admet-2013	16	11	biocompatibility	biocompatibility	NOUN
admet-2013	16	12	,	,	PUNCT
admet-2013	16	13	inorganic	inorganic	ADJ
admet-2013	16	14	nanoparticles	nanoparticle	NOUN
admet-2013	16	15	increase	increase	VERB
admet-2013	16	16	the	the	DET
admet-2013	16	17	half	half	ADJ
admet-2013	16	18	-	-	PUNCT
admet-2013	16	19	life	life	NOUN
admet-2013	16	20	of	of	ADP
admet-2013	16	21	the	the	DET
admet-2013	16	22	drugs	drug	NOUN
admet-2013	16	23	.	.	PUNCT
admet-2013	17	1	in	in	ADP
admet-2013	17	2	this	this	DET
admet-2013	17	3	review	review	NOUN
admet-2013	17	4	,	,	PUNCT
admet-2013	17	5	we	we	PRON
admet-2013	17	6	highlight	highlight	VERB
admet-2013	17	7	the	the	DET
admet-2013	17	8	nanoparticles	nanoparticle	NOUN
admet-2013	17	9	involved	involve	VERB
admet-2013	17	10	in	in	ADP
admet-2013	17	11	treating	treat	VERB
admet-2013	17	12	cml	cml	PROPN
admet-2013	17	13	.	.	PUNCT
admet-2013	18	1	©	©	PROPN
admet-2013	18	2	2023	2023	NUM
admet-2013	18	3	by	by	ADP
admet-2013	18	4	the	the	DET
admet-2013	18	5	authors	author	NOUN
admet-2013	18	6	.	.	PUNCT
admet-2013	19	1	this	this	DET
admet-2013	19	2	article	article	NOUN
admet-2013	19	3	is	be	AUX
admet-2013	19	4	an	an	DET
admet-2013	19	5	open	open	ADJ
admet-2013	19	6	-	-	PUNCT
admet-2013	19	7	access	access	NOUN
admet-2013	19	8	article	article	NOUN
admet-2013	19	9	distributed	distribute	VERB
admet-2013	19	10	under	under	ADP
admet-2013	19	11	the	the	DET
admet-2013	19	12	terms	term	NOUN
admet-2013	19	13	and	and	CCONJ
admet-2013	19	14	conditions	condition	NOUN
admet-2013	19	15	of	of	ADP
admet-2013	19	16	the	the	DET
admet-2013	19	17	creative	creative	ADJ
admet-2013	19	18	commons	common	NOUN
admet-2013	19	19	attribution	attribution	NOUN
admet-2013	19	20	license	license	NOUN
admet-2013	19	21	(	(	PUNCT
admet-2013	19	22	http://creativecommons.org/licenses/by/4.0/	http://creativecommons.org/licenses/by/4.0/	PROPN
admet-2013	19	23	)	)	PUNCT
admet-2013	19	24	.	.	PUNCT
admet-2013	20	1	keywords	keyword	VERB
admet-2013	20	2	philadelphia	philadelphia	PROPN
admet-2013	20	3	chromosome	chromosome	NOUN
admet-2013	20	4	;	;	PUNCT
admet-2013	20	5	bionanotechnology	bionanotechnology	NOUN
admet-2013	20	6	;	;	PUNCT
admet-2013	20	7	tyrosine	tyrosine	NOUN
admet-2013	20	8	kinase	kinase	PROPN
admet-2013	20	9	pathway	pathway	NOUN
admet-2013	20	10	;	;	PUNCT
admet-2013	21	1	halflife	halflife	NOUN
admet-2013	21	2	;	;	PUNCT
admet-2013	21	3	passive	passive	ADJ
admet-2013	21	4	targeting	targeting	NOUN
admet-2013	21	5	introduction	introduction	NOUN
admet-2013	21	6	hematopoietic	hematopoietic	ADJ
admet-2013	21	7	stem	stem	NOUN
admet-2013	21	8	cells	cell	NOUN
admet-2013	21	9	(	(	PUNCT
admet-2013	21	10	hscs	hsc	NOUN
admet-2013	21	11	)	)	PUNCT
admet-2013	21	12	are	be	AUX
admet-2013	21	13	self	self	NOUN
admet-2013	21	14	-	-	PUNCT
admet-2013	21	15	regenerating	regenerate	VERB
admet-2013	21	16	cells	cell	NOUN
admet-2013	21	17	and	and	CCONJ
admet-2013	21	18	can	can	AUX
admet-2013	21	19	develop	develop	VERB
admet-2013	21	20	into	into	ADP
admet-2013	21	21	different	different	ADJ
admet-2013	21	22	hematopoietic	hematopoietic	ADJ
admet-2013	21	23	cells	cell	NOUN
admet-2013	21	24	throughout	throughout	ADP
admet-2013	21	25	a	a	DET
admet-2013	21	26	solitary	solitary	ADJ
admet-2013	21	27	life	life	NOUN
admet-2013	21	28	cycle	cycle	NOUN
admet-2013	21	29	and	and	CCONJ
admet-2013	21	30	the	the	DET
admet-2013	21	31	process	process	NOUN
admet-2013	21	32	is	be	AUX
admet-2013	21	33	termed	term	VERB
admet-2013	21	34	hematopoiesis	hematopoiesis	NOUN
admet-2013	21	35	.	.	PUNCT
admet-2013	22	1	blood	blood	NOUN
admet-2013	22	2	tumors	tumor	NOUN
admet-2013	22	3	can	can	AUX
admet-2013	22	4	have	have	VERB
admet-2013	22	5	various	various	ADJ
admet-2013	22	6	causes	cause	NOUN
admet-2013	22	7	,	,	PUNCT
admet-2013	22	8	one	one	NUM
admet-2013	22	9	of	of	ADP
admet-2013	22	10	which	which	PRON
admet-2013	22	11	is	be	AUX
admet-2013	22	12	hematopoiesis	hematopoiesis	NOUN
admet-2013	22	13	dysregulation	dysregulation	NOUN
admet-2013	22	14	.	.	PUNCT
admet-2013	23	1	at	at	ADP
admet-2013	23	2	various	various	ADJ
admet-2013	23	3	stages	stage	NOUN
admet-2013	23	4	of	of	ADP
admet-2013	23	5	hematopoietic	hematopoietic	ADJ
admet-2013	23	6	development	development	NOUN
admet-2013	23	7	,	,	PUNCT
admet-2013	23	8	mutations	mutation	NOUN
admet-2013	23	9	or	or	CCONJ
admet-2013	23	10	other	other	ADJ
admet-2013	23	11	adverse	adverse	ADJ
admet-2013	23	12	occurrences	occurrence	NOUN
admet-2013	23	13	may	may	AUX
admet-2013	23	14	occur	occur	VERB
admet-2013	23	15	,	,	PUNCT
admet-2013	23	16	leading	lead	VERB
admet-2013	23	17	to	to	ADP
admet-2013	23	18	various	various	ADJ
admet-2013	23	19	tumor	tumor	NOUN
admet-2013	23	20	subtypes	subtype	NOUN
admet-2013	23	21	with	with	ADP
admet-2013	23	22	various	various	ADJ
admet-2013	23	23	clinical	clinical	ADJ
admet-2013	23	24	signs	sign	NOUN
admet-2013	23	25	.	.	PUNCT
admet-2013	24	1	hematological	hematological	ADJ
admet-2013	24	2	cancers	cancer	NOUN
admet-2013	24	3	can	can	AUX
admet-2013	24	4	largely	largely	ADV
admet-2013	24	5	be	be	AUX
admet-2013	24	6	divided	divide	VERB
admet-2013	24	7	into	into	ADP
admet-2013	24	8	two	two	NUM
admet-2013	24	9	categories	category	NOUN
admet-2013	24	10	,	,	PUNCT
admet-2013	24	11	namely	namely	ADV
admet-2013	24	12	myeloid	myeloid	NOUN
admet-2013	24	13	and	and	CCONJ
admet-2013	24	14	lymphoid	lymphoid	ADJ
admet-2013	24	15	,	,	PUNCT
admet-2013	24	16	depending	depend	VERB
admet-2013	24	17	on	on	ADP
admet-2013	24	18	the	the	DET
admet-2013	24	19	origin	origin	NOUN
admet-2013	24	20	of	of	ADP
admet-2013	24	21	stem	stem	NOUN
admet-2013	24	22	cells	cell	NOUN
admet-2013	24	23	.	.	PUNCT
admet-2013	25	1	polycythemia	polycythemia	NOUN
admet-2013	25	2	,	,	PUNCT
admet-2013	25	3	acute	acute	ADJ
admet-2013	25	4	myeloid	myeloid	NOUN
admet-2013	25	5	leukemia	leukemia	NOUN
admet-2013	25	6	(	(	PUNCT
admet-2013	25	7	aml	aml	PROPN
admet-2013	25	8	)	)	PUNCT
admet-2013	25	9	,	,	PUNCT
admet-2013	25	10	idiopathic	idiopathic	ADJ
admet-2013	25	11	thrombocytosis	thrombocytosis	NOUN
admet-2013	25	12	,	,	PUNCT
admet-2013	25	13	chronic	chronic	ADJ
admet-2013	25	14	myeloid	myeloid	NOUN
admet-2013	25	15	leukemia	leukemia	NOUN
admet-2013	25	16	(	(	PUNCT
admet-2013	25	17	cml	cml	PROPN
admet-2013	25	18	)	)	PUNCT
admet-2013	25	19	,	,	PUNCT
admet-2013	25	20	primary	primary	ADJ
admet-2013	25	21	myelofibrosis	myelofibrosis	NOUN
admet-2013	25	22	,	,	PUNCT
admet-2013	25	23	and	and	CCONJ
admet-2013	25	24	myelodysplastic	myelodysplastic	ADJ
admet-2013	25	25	syndrome	syndrome	NOUN
admet-2013	25	26	are	be	AUX
admet-2013	25	27	examples	example	NOUN
admet-2013	25	28	of	of	ADP
admet-2013	25	29	myeloid	myeloid	ADJ
admet-2013	25	30	https://doi.org/10.5599/admet.2013	https://doi.org/10.5599/admet.2013	NOUN
admet-2013	25	31	https://doi.org/10.5599/admet.2013	https://doi.org/10.5599/admet.2013	PROPN
admet-2013	25	32	http://www.pub.iapchem.org/ojs/index.php/admet/index	http://www.pub.iapchem.org/ojs/index.php/admet/index	PROPN
admet-2013	25	33	mailto:koyelig@gmail.com	mailto:koyelig@gmail.com	PROPN
admet-2013	26	1	http://creativecommons.org/licenses/by/4.0/	http://creativecommons.org/licenses/by/4.0/	PROPN
admet-2013	26	2	g.	g.	PROPN
admet-2013	26	3	janani	janani	PROPN
admet-2013	26	4	et	et	PROPN
admet-2013	26	5	al	al	PROPN
admet-2013	26	6	.	.	PROPN
admet-2013	26	7	admet	admet	PROPN
admet-2013	26	8	&	&	CCONJ
admet-2013	26	9	dmpk	dmpk	PROPN
admet-2013	26	10	11(4	11(4	NUM
admet-2013	26	11	)	)	PUNCT
admet-2013	26	12	(	(	PUNCT
admet-2013	26	13	2023	2023	NUM
admet-2013	26	14	)	)	PUNCT
admet-2013	26	15	499	499	NUM
admet-2013	26	16	-	-	SYM
admet-2013	26	17	511	511	NUM
admet-2013	26	18	500	500	NUM
admet-2013	26	19	tumors	tumor	NOUN
admet-2013	26	20	that	that	PRON
admet-2013	26	21	largely	largely	ADV
admet-2013	26	22	grow	grow	VERB
admet-2013	26	23	in	in	ADP
admet-2013	26	24	the	the	DET
admet-2013	26	25	bone	bone	NOUN
admet-2013	26	26	marrow	marrow	NOUN
admet-2013	27	1	[	[	X
admet-2013	27	2	1	1	NUM
admet-2013	27	3	]	]	PUNCT
admet-2013	27	4	.	.	PUNCT
admet-2013	28	1	with	with	ADP
admet-2013	28	2	acute	acute	ADJ
admet-2013	28	3	lymphocytic	lymphocytic	ADJ
admet-2013	28	4	or	or	CCONJ
admet-2013	28	5	lymphoblastic	lymphoblastic	ADJ
admet-2013	28	6	leukemia	leukemia	NOUN
admet-2013	29	1	[	[	X
admet-2013	29	2	all	all	PRON
admet-2013	29	3	]	]	X
admet-2013	29	4	being	be	AUX
admet-2013	29	5	the	the	DET
admet-2013	29	6	most	most	ADV
admet-2013	29	7	prevalent	prevalent	ADJ
admet-2013	29	8	leukemia	leukemia	NOUN
admet-2013	29	9	in	in	ADP
admet-2013	29	10	juvenile	juvenile	ADJ
admet-2013	29	11	,	,	PUNCT
admet-2013	29	12	acute	acute	ADJ
admet-2013	29	13	leukemia	leukemia	NOUN
admet-2013	29	14	advance	advance	NOUN
admet-2013	29	15	quickly	quickly	ADV
admet-2013	29	16	in	in	ADP
admet-2013	29	17	the	the	DET
admet-2013	29	18	creation	creation	NOUN
admet-2013	29	19	of	of	ADP
admet-2013	29	20	these	these	DET
admet-2013	29	21	immature	immature	ADJ
admet-2013	29	22	blood	blood	NOUN
admet-2013	29	23	cells	cell	NOUN
admet-2013	29	24	.	.	PUNCT
admet-2013	30	1	as	as	SCONJ
admet-2013	30	2	opposed	oppose	VERB
admet-2013	30	3	to	to	ADP
admet-2013	30	4	acute	acute	ADJ
admet-2013	30	5	leukemia	leukemia	NOUN
admet-2013	30	6	,	,	PUNCT
admet-2013	30	7	chronic	chronic	ADJ
admet-2013	30	8	leukemia	leukemia	NOUN
admet-2013	30	9	advance	advance	NOUN
admet-2013	30	10	s	s	VERB
admet-2013	30	11	more	more	ADV
admet-2013	30	12	gradually	gradually	ADV
admet-2013	30	13	and	and	CCONJ
admet-2013	30	14	mainly	mainly	ADV
admet-2013	30	15	affects	affect	VERB
admet-2013	30	16	adults	adult	NOUN
admet-2013	30	17	.	.	PUNCT
admet-2013	31	1	chronic	chronic	ADJ
admet-2013	31	2	myeloid	myeloid	NOUN
admet-2013	31	3	leukemia	leukemia	NOUN
admet-2013	31	4	(	(	PUNCT
admet-2013	31	5	cml	cml	PROPN
admet-2013	31	6	)	)	PUNCT
admet-2013	31	7	affects	affect	VERB
admet-2013	31	8	stem	stem	NOUN
admet-2013	31	9	cells	cell	NOUN
admet-2013	31	10	that	that	PRON
admet-2013	31	11	differentiate	differentiate	VERB
admet-2013	31	12	into	into	ADP
admet-2013	31	13	myeloid	myeloid	ADJ
admet-2013	31	14	cells	cell	NOUN
admet-2013	31	15	,	,	PUNCT
admet-2013	31	16	which	which	PRON
admet-2013	31	17	produce	produce	VERB
admet-2013	31	18	platelets	platelet	NOUN
admet-2013	31	19	,	,	PUNCT
admet-2013	31	20	red	red	ADJ
admet-2013	31	21	blood	blood	NOUN
admet-2013	31	22	cells	cell	NOUN
admet-2013	31	23	(	(	PUNCT
admet-2013	31	24	rbcs	rbc	NOUN
admet-2013	31	25	)	)	PUNCT
admet-2013	31	26	,	,	PUNCT
admet-2013	31	27	and	and	CCONJ
admet-2013	31	28	some	some	DET
admet-2013	31	29	types	type	NOUN
admet-2013	31	30	of	of	ADP
admet-2013	31	31	white	white	ADJ
admet-2013	31	32	blood	blood	NOUN
admet-2013	31	33	cells	cell	NOUN
admet-2013	31	34	[	[	X
admet-2013	31	35	2	2	NUM
admet-2013	31	36	]	]	PUNCT
admet-2013	31	37	.	.	PUNCT
admet-2013	32	1	cml	cml	PROPN
admet-2013	32	2	results	result	NOUN
admet-2013	32	3	from	from	ADP
admet-2013	32	4	overactive	overactive	ADJ
admet-2013	32	5	tyrosine	tyrosine	NOUN
admet-2013	32	6	kinase	kinase	NOUN
admet-2013	32	7	that	that	PRON
admet-2013	32	8	phosphorylates	phosphorylate	VERB
admet-2013	32	9	proteins	protein	NOUN
admet-2013	32	10	and	and	CCONJ
admet-2013	32	11	inhibits	inhibit	VERB
admet-2013	32	12	apoptosis	apoptosis	NOUN
admet-2013	32	13	and	and	CCONJ
admet-2013	32	14	rapid	rapid	ADJ
admet-2013	32	15	cell	cell	NOUN
admet-2013	32	16	growth	growth	NOUN
admet-2013	33	1	[	[	X
admet-2013	33	2	3	3	NUM
admet-2013	33	3	]	]	PUNCT
admet-2013	33	4	.	.	PUNCT
admet-2013	34	1	in	in	ADP
admet-2013	34	2	cml	cml	PROPN
admet-2013	34	3	,	,	PUNCT
admet-2013	34	4	reciprocal	reciprocal	ADJ
admet-2013	34	5	translocation	translocation	NOUN
admet-2013	34	6	occurs	occur	VERB
admet-2013	34	7	involving	involve	VERB
admet-2013	34	8	the	the	DET
admet-2013	34	9	fusion	fusion	NOUN
admet-2013	34	10	of	of	ADP
admet-2013	34	11	the	the	DET
admet-2013	34	12	abelson	abelson	NOUN
admet-2013	34	13	oncogene	oncogene	NOUN
admet-2013	34	14	(	(	PUNCT
admet-2013	34	15	abl	abl	PROPN
admet-2013	34	16	)	)	PUNCT
admet-2013	34	17	on	on	ADP
admet-2013	34	18	chromosome	chromosome	NOUN
admet-2013	34	19	9q34	9q34	NOUN
admet-2013	34	20	with	with	ADP
admet-2013	34	21	the	the	DET
admet-2013	34	22	breakage	breakage	NOUN
admet-2013	34	23	cluster	cluster	NOUN
admet-2013	34	24	area	area	NOUN
admet-2013	34	25	(	(	PUNCT
admet-2013	34	26	bcr	bcr	PROPN
admet-2013	34	27	)	)	PUNCT
admet-2013	34	28	on	on	ADP
admet-2013	34	29	chromosome	chromosome	NOUN
admet-2013	34	30	22q11.2	22q11.2	NUM
admet-2013	34	31	(	(	PUNCT
admet-2013	34	32	the	the	DET
admet-2013	34	33	philadelphia	philadelphia	PROPN
admet-2013	34	34	(	(	PUNCT
admet-2013	34	35	ph	ph	ADJ
admet-2013	34	36	)	)	PUNCT
admet-2013	34	37	chromosome	chromosome	NOUN
admet-2013	34	38	)	)	PUNCT
admet-2013	35	1	[	[	X
admet-2013	35	2	4	4	NUM
admet-2013	35	3	]	]	PUNCT
admet-2013	35	4	.	.	PUNCT
admet-2013	36	1	tyrosine	tyrosine	NOUN
admet-2013	36	2	residues	residue	NOUN
admet-2013	36	3	found	find	VERB
admet-2013	36	4	on	on	ADP
admet-2013	36	5	the	the	DET
admet-2013	36	6	structure	structure	NOUN
admet-2013	36	7	of	of	ADP
admet-2013	36	8	abl	abl	PROPN
admet-2013	36	9	kinase	kinase	PROPN
admet-2013	36	10	serve	serve	VERB
admet-2013	36	11	as	as	ADP
admet-2013	36	12	substrates	substrate	NOUN
admet-2013	36	13	for	for	ADP
admet-2013	36	14	phosphorylation	phosphorylation	NOUN
admet-2013	36	15	reactions	reaction	NOUN
admet-2013	36	16	that	that	PRON
admet-2013	36	17	maintain	maintain	VERB
admet-2013	36	18	the	the	DET
admet-2013	36	19	enzyme	enzyme	NOUN
admet-2013	36	20	's	's	PART
admet-2013	36	21	functional	functional	ADJ
admet-2013	36	22	conformity	conformity	NOUN
admet-2013	36	23	.	.	PUNCT
admet-2013	37	1	bcr	bcr	ADJ
admet-2013	37	2	coiled	coil	VERB
admet-2013	37	3	-	-	PUNCT
admet-2013	37	4	coil	coil	NOUN
admet-2013	37	5	domains	domain	NOUN
admet-2013	37	6	encourage	encourage	VERB
admet-2013	37	7	intermolecular	intermolecular	ADJ
admet-2013	37	8	crossphosphorylation	crossphosphorylation	NOUN
admet-2013	37	9	upon	upon	SCONJ
admet-2013	37	10	abl	abl	PROPN
admet-2013	37	11	kinase	kinase	PROPN
admet-2013	37	12	in	in	ADP
admet-2013	37	13	the	the	DET
admet-2013	37	14	fused	fuse	VERB
admet-2013	37	15	conformity	conformity	NOUN
admet-2013	37	16	,	,	PUNCT
admet-2013	37	17	increasing	increase	VERB
admet-2013	37	18	its	its	PRON
admet-2013	37	19	kinase	kinase	NOUN
admet-2013	37	20	activity	activity	NOUN
admet-2013	37	21	and	and	CCONJ
admet-2013	37	22	encouraging	encourage	VERB
admet-2013	37	23	a	a	DET
admet-2013	37	24	continuous	continuous	ADJ
admet-2013	37	25	active	active	ADJ
admet-2013	37	26	tyrosine	tyrosine	NOUN
admet-2013	37	27	kinase	kinase	NOUN
admet-2013	38	1	[	[	X
admet-2013	38	2	3,5	3,5	NUM
admet-2013	38	3	]	]	PUNCT
admet-2013	38	4	.	.	PUNCT
admet-2013	39	1	the	the	DET
admet-2013	39	2	antiapoptotic	antiapoptotic	ADJ
admet-2013	39	3	sequels	sequel	NOUN
admet-2013	39	4	result	result	VERB
admet-2013	39	5	from	from	ADP
admet-2013	39	6	the	the	DET
admet-2013	39	7	p38	p38	NOUN
admet-2013	39	8	and	and	CCONJ
admet-2013	39	9	jnk	jnk	PROPN
admet-2013	39	10	pathway	pathway	NOUN
admet-2013	39	11	suppression	suppression	NOUN
admet-2013	39	12	,	,	PUNCT
admet-2013	39	13	p53	p53	NOUN
admet-2013	39	14	and	and	CCONJ
admet-2013	39	15	apaf-1	apaf-1	NUM
admet-2013	39	16	mutations	mutation	NOUN
admet-2013	39	17	,	,	PUNCT
admet-2013	39	18	and	and	CCONJ
admet-2013	39	19	an	an	DET
admet-2013	39	20	insufficiency	insufficiency	NOUN
admet-2013	39	21	in	in	ADP
admet-2013	39	22	fasr	fasr	PROPN
admet-2013	39	23	.	.	PUNCT
admet-2013	40	1	the	the	DET
admet-2013	40	2	proteins	protein	NOUN
admet-2013	40	3	that	that	PRON
admet-2013	40	4	promote	promote	VERB
admet-2013	40	5	cellular	cellular	ADJ
admet-2013	40	6	proliferation	proliferation	NOUN
admet-2013	40	7	activate	activate	VERB
admet-2013	40	8	the	the	DET
admet-2013	40	9	ras	ras	PROPN
admet-2013	40	10	,	,	PUNCT
admet-2013	40	11	mek	mek	PROPN
admet-2013	40	12	,	,	PUNCT
admet-2013	40	13	erk	erk	PROPN
admet-2013	40	14	,	,	PUNCT
admet-2013	40	15	stat5	stat5	NOUN
admet-2013	40	16	,	,	PUNCT
admet-2013	40	17	and	and	CCONJ
admet-2013	40	18	pi3k	pi3k	PROPN
admet-2013	40	19	/	/	SYM
admet-2013	40	20	akt	akt	PROPN
admet-2013	40	21	signaling	signal	VERB
admet-2013	40	22	pathways	pathway	NOUN
admet-2013	41	1	[	[	X
admet-2013	41	2	3	3	NUM
admet-2013	41	3	]	]	PUNCT
admet-2013	41	4	.	.	PUNCT
admet-2013	42	1	in	in	ADP
admet-2013	42	2	cml	cml	PROPN
admet-2013	42	3	,	,	PUNCT
admet-2013	42	4	the	the	DET
admet-2013	42	5	percentage	percentage	NOUN
admet-2013	42	6	of	of	ADP
admet-2013	42	7	white	white	ADJ
admet-2013	42	8	blood	blood	NOUN
admet-2013	42	9	cells	cell	NOUN
admet-2013	42	10	increases	increase	NOUN
admet-2013	42	11	.	.	PUNCT
admet-2013	43	1	depending	depend	VERB
admet-2013	43	2	on	on	ADP
admet-2013	43	3	the	the	DET
admet-2013	43	4	characteristics	characteristic	NOUN
admet-2013	43	5	,	,	PUNCT
admet-2013	43	6	chronic	chronic	ADJ
admet-2013	43	7	myeloid	myeloid	NOUN
admet-2013	43	8	leukemia	leukemia	NOUN
admet-2013	43	9	can	can	AUX
admet-2013	43	10	be	be	AUX
admet-2013	43	11	divided	divide	VERB
admet-2013	43	12	into	into	ADP
admet-2013	43	13	three	three	NUM
admet-2013	43	14	stages	stage	NOUN
admet-2013	43	15	:	:	PUNCT
admet-2013	43	16	chronic	chronic	ADJ
admet-2013	43	17	,	,	PUNCT
admet-2013	43	18	accelerated	accelerate	VERB
admet-2013	43	19	,	,	PUNCT
admet-2013	43	20	and	and	CCONJ
admet-2013	43	21	blast	blast	VERB
admet-2013	43	22	[	[	X
admet-2013	43	23	4,6	4,6	X
admet-2013	43	24	]	]	PUNCT
admet-2013	43	25	.	.	PUNCT
admet-2013	44	1	the	the	DET
admet-2013	44	2	majority	majority	NOUN
admet-2013	44	3	of	of	ADP
admet-2013	44	4	cml	cml	PROPN
admet-2013	44	5	patients	patient	NOUN
admet-2013	44	6	initially	initially	ADV
admet-2013	44	7	show	show	VERB
admet-2013	44	8	up	up	ADP
admet-2013	44	9	in	in	ADP
admet-2013	44	10	the	the	DET
admet-2013	44	11	benign	benign	ADJ
admet-2013	44	12	chronic	chronic	ADJ
admet-2013	44	13	phase	phase	NOUN
admet-2013	44	14	(	(	PUNCT
admet-2013	44	15	cp	cp	NOUN
admet-2013	44	16	)	)	PUNCT
admet-2013	44	17	.	.	PUNCT
admet-2013	45	1	if	if	SCONJ
admet-2013	45	2	ignored	ignore	VERB
admet-2013	45	3	,	,	PUNCT
admet-2013	45	4	the	the	DET
admet-2013	45	5	disease	disease	NOUN
admet-2013	45	6	will	will	AUX
admet-2013	45	7	advance	advance	VERB
admet-2013	45	8	toward	toward	ADP
admet-2013	45	9	the	the	DET
admet-2013	45	10	myeloid	myeloid	NOUN
admet-2013	45	11	or	or	CCONJ
admet-2013	45	12	lymphoid	lymphoid	ADJ
admet-2013	45	13	blast	blast	NOUN
admet-2013	45	14	phase	phase	NOUN
admet-2013	45	15	(	(	PUNCT
admet-2013	45	16	bp	bp	PROPN
admet-2013	45	17	)	)	PUNCT
admet-2013	45	18	where	where	SCONJ
admet-2013	45	19	acute	acute	NOUN
admet-2013	45	20	leukemia	leukemia	NOUN
admet-2013	45	21	is	be	AUX
admet-2013	45	22	reflected	reflect	VERB
admet-2013	45	23	[	[	PUNCT
admet-2013	45	24	4	4	NUM
admet-2013	45	25	]	]	PUNCT
admet-2013	45	26	.	.	PUNCT
admet-2013	46	1	diagnosis	diagnosis	NOUN
admet-2013	46	2	of	of	ADP
admet-2013	46	3	cml	cml	PROPN
admet-2013	46	4	includes	include	VERB
admet-2013	46	5	complete	complete	ADJ
admet-2013	46	6	blood	blood	NOUN
admet-2013	46	7	count	count	NOUN
admet-2013	46	8	,	,	PUNCT
admet-2013	46	9	ct	ct	PROPN
admet-2013	46	10	scan	scan	NOUN
admet-2013	46	11	,	,	PUNCT
admet-2013	46	12	and	and	CCONJ
admet-2013	46	13	biopsy	biopsy	NOUN
admet-2013	46	14	.	.	PUNCT
admet-2013	47	1	however	however	ADV
admet-2013	47	2	,	,	PUNCT
admet-2013	47	3	due	due	ADP
admet-2013	47	4	to	to	ADP
admet-2013	47	5	certain	certain	ADJ
admet-2013	47	6	limits	limit	NOUN
admet-2013	47	7	,	,	PUNCT
admet-2013	47	8	early	early	ADJ
admet-2013	47	9	cancer	cancer	NOUN
admet-2013	47	10	detection	detection	NOUN
admet-2013	47	11	is	be	AUX
admet-2013	47	12	not	not	PART
admet-2013	47	13	possible	possible	ADJ
admet-2013	47	14	by	by	ADP
admet-2013	47	15	traditional	traditional	ADJ
admet-2013	47	16	methods	method	NOUN
admet-2013	47	17	.	.	PUNCT
admet-2013	48	1	the	the	DET
admet-2013	48	2	sensitivity	sensitivity	NOUN
admet-2013	48	3	and	and	CCONJ
admet-2013	48	4	specificity	specificity	NOUN
admet-2013	48	5	of	of	ADP
admet-2013	48	6	an	an	DET
admet-2013	48	7	assay	assay	NOUN
admet-2013	48	8	can	can	AUX
admet-2013	48	9	be	be	AUX
admet-2013	48	10	achieved	achieve	VERB
admet-2013	48	11	by	by	ADP
admet-2013	48	12	nanoparticles	nanoparticle	NOUN
admet-2013	48	13	because	because	SCONJ
admet-2013	48	14	of	of	ADP
admet-2013	48	15	their	their	PRON
admet-2013	48	16	large	large	ADJ
admet-2013	48	17	surface	surface	NOUN
admet-2013	48	18	area	area	NOUN
admet-2013	48	19	.	.	PUNCT
admet-2013	49	1	utilizing	utilize	VERB
admet-2013	49	2	this	this	DET
admet-2013	49	3	property	property	NOUN
admet-2013	49	4	,	,	PUNCT
admet-2013	49	5	the	the	DET
admet-2013	49	6	nanoparticles	nanoparticle	NOUN
admet-2013	49	7	are	be	AUX
admet-2013	49	8	covered	cover	VERB
admet-2013	49	9	with	with	ADP
admet-2013	49	10	peptides	peptide	NOUN
admet-2013	49	11	,	,	PUNCT
admet-2013	49	12	antibodies	antibodie	VERB
admet-2013	49	13	,	,	PUNCT
admet-2013	49	14	aptamers	aptamer	NOUN
admet-2013	49	15	,	,	PUNCT
admet-2013	49	16	etc	etc	X
admet-2013	49	17	.	.	X
admet-2013	49	18	,	,	PUNCT
admet-2013	49	19	enabling	enable	VERB
admet-2013	49	20	cancer	cancer	NOUN
admet-2013	49	21	detection	detection	NOUN
admet-2013	49	22	at	at	ADP
admet-2013	49	23	a	a	DET
admet-2013	49	24	much	much	ADV
admet-2013	49	25	earlier	early	ADJ
admet-2013	49	26	stage	stage	NOUN
admet-2013	49	27	[	[	X
admet-2013	49	28	7,8	7,8	NUM
admet-2013	49	29	]	]	PUNCT
admet-2013	49	30	.	.	PUNCT
admet-2013	50	1	nanoparticles	nanoparticle	NOUN
admet-2013	50	2	are	be	AUX
admet-2013	50	3	also	also	ADV
admet-2013	50	4	employed	employ	VERB
admet-2013	50	5	in	in	ADP
admet-2013	50	6	various	various	ADJ
admet-2013	50	7	fields	field	NOUN
admet-2013	50	8	of	of	ADP
admet-2013	50	9	biomedicine	biomedicine	NOUN
admet-2013	50	10	,	,	PUNCT
admet-2013	50	11	such	such	ADJ
admet-2013	50	12	as	as	ADP
admet-2013	50	13	biosensing	biosense	VERB
admet-2013	50	14	[	[	X
admet-2013	50	15	9	9	NUM
admet-2013	50	16	-	-	SYM
admet-2013	50	17	12	12	NUM
admet-2013	50	18	]	]	PUNCT
admet-2013	50	19	,	,	PUNCT
admet-2013	50	20	targeted	target	VERB
admet-2013	50	21	drug	drug	NOUN
admet-2013	50	22	delivery	delivery	NOUN
admet-2013	50	23	[	[	X
admet-2013	50	24	13	13	NUM
admet-2013	50	25	-	-	SYM
admet-2013	50	26	15	15	NUM
admet-2013	50	27	]	]	PUNCT
admet-2013	50	28	,	,	PUNCT
admet-2013	50	29	theranostics	theranostic	VERB
admet-2013	51	1	[	[	X
admet-2013	51	2	16,17	16,17	NUM
admet-2013	51	3	]	]	PUNCT
admet-2013	51	4	,	,	PUNCT
admet-2013	51	5	photodynamic	photodynamic	ADJ
admet-2013	51	6	therapy	therapy	NOUN
admet-2013	51	7	[	[	X
admet-2013	51	8	18	18	NUM
admet-2013	51	9	]	]	PUNCT
admet-2013	51	10	,	,	PUNCT
admet-2013	51	11	nanoformulation	nanoformulation	NOUN
admet-2013	51	12	of	of	ADP
admet-2013	51	13	nutraceuticals	nutraceutical	NOUN
admet-2013	51	14	[	[	X
admet-2013	51	15	19	19	NUM
admet-2013	51	16	-	-	SYM
admet-2013	51	17	21	21	NUM
admet-2013	51	18	]	]	PUNCT
admet-2013	51	19	,	,	PUNCT
admet-2013	51	20	tissue	tissue	NOUN
admet-2013	51	21	engineering	engineering	NOUN
admet-2013	52	1	[	[	X
admet-2013	52	2	22,23	22,23	NOUN
admet-2013	52	3	]	]	X
admet-2013	52	4	,	,	PUNCT
admet-2013	52	5	multimodal	multimodal	ADJ
admet-2013	52	6	imaging	imaging	NOUN
admet-2013	52	7	[	[	X
admet-2013	52	8	24,25	24,25	NUM
admet-2013	52	9	]	]	PUNCT
admet-2013	52	10	,	,	PUNCT
admet-2013	52	11	and	and	CCONJ
admet-2013	52	12	also	also	ADV
admet-2013	52	13	treating	treat	VERB
admet-2013	52	14	cancer	cancer	NOUN
admet-2013	52	15	[	[	X
admet-2013	52	16	26	26	NUM
admet-2013	52	17	]	]	PUNCT
admet-2013	52	18	.	.	PUNCT
admet-2013	53	1	they	they	PRON
admet-2013	53	2	specifically	specifically	ADV
admet-2013	53	3	target	target	VERB
admet-2013	53	4	cancer	cancer	NOUN
admet-2013	53	5	because	because	SCONJ
admet-2013	53	6	of	of	ADP
admet-2013	53	7	their	their	PRON
admet-2013	53	8	size	size	NOUN
admet-2013	53	9	,	,	PUNCT
admet-2013	53	10	optical	optical	ADJ
admet-2013	53	11	and	and	CCONJ
admet-2013	53	12	catalytic	catalytic	ADJ
admet-2013	53	13	properties	property	NOUN
admet-2013	53	14	[	[	X
admet-2013	53	15	27,28	27,28	NUM
admet-2013	53	16	]	]	X
admet-2013	53	17	.	.	PUNCT
admet-2013	54	1	the	the	DET
admet-2013	54	2	nanoparticles	nanoparticle	NOUN
admet-2013	54	3	which	which	PRON
admet-2013	54	4	are	be	AUX
admet-2013	54	5	employed	employ	VERB
admet-2013	54	6	in	in	ADP
admet-2013	54	7	treating	treat	VERB
admet-2013	54	8	cml	cml	PROPN
admet-2013	54	9	are	be	AUX
admet-2013	54	10	majorly	majorly	ADV
admet-2013	54	11	discussed	discuss	VERB
admet-2013	54	12	here	here	ADV
admet-2013	54	13	.	.	PUNCT
admet-2013	55	1	clinical	clinical	ADJ
admet-2013	55	2	features	feature	NOUN
admet-2013	55	3	,	,	PUNCT
admet-2013	55	4	conventional	conventional	ADJ
admet-2013	55	5	and	and	CCONJ
admet-2013	55	6	nano	nano	NOUN
admet-2013	55	7	-	-	PUNCT
admet-2013	55	8	enabled	enable	VERB
admet-2013	55	9	cml	cml	PROPN
admet-2013	55	10	diagnosis	diagnosis	NOUN
admet-2013	55	11	fifty	fifty	NUM
admet-2013	55	12	percent	percent	NOUN
admet-2013	55	13	of	of	ADP
admet-2013	55	14	cml	cml	PROPN
admet-2013	55	15	patients	patient	NOUN
admet-2013	55	16	do	do	AUX
admet-2013	55	17	not	not	PART
admet-2013	55	18	show	show	VERB
admet-2013	55	19	symptoms	symptom	NOUN
admet-2013	55	20	and	and	CCONJ
admet-2013	55	21	are	be	AUX
admet-2013	55	22	discovered	discover	VERB
admet-2013	55	23	by	by	ADP
admet-2013	55	24	chance	chance	NOUN
admet-2013	55	25	during	during	ADP
admet-2013	55	26	standard	standard	ADJ
admet-2013	55	27	checkups	checkup	NOUN
admet-2013	55	28	.	.	PUNCT
admet-2013	56	1	even	even	ADV
admet-2013	56	2	when	when	SCONJ
admet-2013	56	3	they	they	PRON
admet-2013	56	4	have	have	VERB
admet-2013	56	5	symptoms	symptom	NOUN
admet-2013	56	6	,	,	PUNCT
admet-2013	56	7	they	they	PRON
admet-2013	56	8	are	be	AUX
admet-2013	56	9	not	not	PART
admet-2013	56	10	always	always	ADV
admet-2013	56	11	identifiable	identifiable	ADJ
admet-2013	56	12	[	[	X
admet-2013	56	13	6	6	NUM
admet-2013	56	14	]	]	PUNCT
admet-2013	56	15	.	.	PUNCT
admet-2013	57	1	the	the	DET
admet-2013	57	2	symptoms	symptom	NOUN
admet-2013	57	3	are	be	AUX
admet-2013	57	4	early	early	ADJ
admet-2013	57	5	satiety	satiety	NOUN
admet-2013	57	6	,	,	PUNCT
admet-2013	57	7	pain	pain	NOUN
admet-2013	57	8	in	in	ADP
admet-2013	57	9	the	the	DET
admet-2013	57	10	left	left	ADJ
admet-2013	57	11	upper	upper	ADJ
admet-2013	57	12	quadrant	quadrant	NOUN
admet-2013	57	13	,	,	PUNCT
admet-2013	57	14	splenomegaly	splenomegaly	ADJ
admet-2013	57	15	,	,	PUNCT
admet-2013	57	16	dyspnoea	dyspnoea	NOUN
admet-2013	57	17	,	,	PUNCT
admet-2013	57	18	strain	strain	NOUN
admet-2013	57	19	,	,	PUNCT
admet-2013	57	20	or	or	CCONJ
admet-2013	57	21	weariness	weariness	NOUN
admet-2013	57	22	caused	cause	VERB
admet-2013	57	23	by	by	ADP
admet-2013	57	24	anemia	anemia	NOUN
admet-2013	57	25	[	[	X
admet-2013	57	26	29	29	NUM
admet-2013	57	27	]	]	PUNCT
admet-2013	57	28	.	.	PUNCT
admet-2013	58	1	in	in	ADP
admet-2013	58	2	cml	cml	PROPN
admet-2013	58	3	,	,	PUNCT
admet-2013	58	4	there	there	PRON
admet-2013	58	5	is	be	VERB
admet-2013	58	6	surplus	surplus	ADJ
admet-2013	58	7	production	production	NOUN
admet-2013	58	8	of	of	ADP
admet-2013	58	9	white	white	ADJ
admet-2013	58	10	blood	blood	NOUN
admet-2013	58	11	cells	cell	NOUN
admet-2013	58	12	due	due	ADJ
admet-2013	58	13	to	to	ADP
admet-2013	58	14	the	the	DET
admet-2013	58	15	unrestricted	unrestricted	ADJ
admet-2013	58	16	multiplication	multiplication	NOUN
admet-2013	58	17	of	of	ADP
admet-2013	58	18	mature	mature	ADJ
admet-2013	58	19	granulocytes	granulocyte	NOUN
admet-2013	58	20	and	and	CCONJ
admet-2013	58	21	their	their	PRON
admet-2013	58	22	precursors	precursor	NOUN
admet-2013	58	23	.	.	PUNCT
admet-2013	59	1	it	it	PRON
admet-2013	59	2	is	be	AUX
admet-2013	59	3	a	a	DET
admet-2013	59	4	bi	bi	ADJ
admet-2013	59	5	or	or	CCONJ
admet-2013	59	6	tri	tri	ADJ
admet-2013	59	7	-	-	ADJ
admet-2013	59	8	phasic	phasic	ADJ
admet-2013	59	9	disease	disease	NOUN
admet-2013	59	10	and	and	CCONJ
admet-2013	59	11	20	20	NUM
admet-2013	59	12	%	%	NOUN
admet-2013	59	13	of	of	ADP
admet-2013	59	14	patients	patient	NOUN
admet-2013	59	15	usually	usually	ADV
admet-2013	59	16	die	die	VERB
admet-2013	59	17	in	in	ADP
admet-2013	59	18	the	the	DET
admet-2013	59	19	chronic	chronic	ADJ
admet-2013	59	20	phase	phase	NOUN
admet-2013	59	21	.	.	PUNCT
admet-2013	60	1	in	in	ADP
admet-2013	60	2	the	the	DET
admet-2013	60	3	chronic	chronic	ADJ
admet-2013	60	4	phase	phase	NOUN
admet-2013	60	5	of	of	ADP
admet-2013	60	6	cml	cml	PROPN
admet-2013	60	7	,	,	PUNCT
admet-2013	60	8	the	the	DET
admet-2013	60	9	proliferation	proliferation	NOUN
admet-2013	60	10	is	be	AUX
admet-2013	60	11	under	under	ADP
admet-2013	60	12	the	the	DET
admet-2013	60	13	control	control	NOUN
admet-2013	60	14	of	of	ADP
admet-2013	60	15	the	the	DET
admet-2013	60	16	growth	growth	NOUN
admet-2013	60	17	factor	factor	NOUN
admet-2013	60	18	.	.	PUNCT
admet-2013	61	1	in	in	ADP
admet-2013	61	2	80	80	NUM
admet-2013	61	3	%	%	NOUN
admet-2013	61	4	of	of	ADP
admet-2013	61	5	cases	case	NOUN
admet-2013	61	6	,	,	PUNCT
admet-2013	61	7	it	it	PRON
admet-2013	61	8	proceeds	proceed	VERB
admet-2013	61	9	to	to	ADP
admet-2013	61	10	the	the	DET
admet-2013	61	11	accelerated	accelerate	VERB
admet-2013	61	12	and	and	CCONJ
admet-2013	61	13	blast	blast	NOUN
admet-2013	61	14	transformation	transformation	NOUN
admet-2013	61	15	phase	phase	NOUN
admet-2013	61	16	[	[	X
admet-2013	61	17	1	1	NUM
admet-2013	61	18	]	]	PUNCT
admet-2013	61	19	.	.	PUNCT
admet-2013	62	1	multidrug	multidrug	NOUN
admet-2013	62	2	-	-	PUNCT
admet-2013	62	3	resistant	resistant	ADJ
admet-2013	62	4	cml	cml	PROPN
admet-2013	62	5	is	be	AUX
admet-2013	62	6	encoded	encode	VERB
admet-2013	62	7	by	by	ADP
admet-2013	62	8	the	the	DET
admet-2013	62	9	mdr1	mdr1	PROPN
admet-2013	62	10	gene	gene	NOUN
admet-2013	62	11	,	,	PUNCT
admet-2013	62	12	which	which	PRON
admet-2013	62	13	works	work	VERB
admet-2013	62	14	to	to	PART
admet-2013	62	15	actively	actively	ADV
admet-2013	62	16	transport	transport	VERB
admet-2013	62	17	medications	medication	NOUN
admet-2013	62	18	out	out	ADP
admet-2013	62	19	of	of	ADP
admet-2013	62	20	cells	cell	NOUN
admet-2013	62	21	to	to	PART
admet-2013	62	22	reduce	reduce	VERB
admet-2013	62	23	intracellular	intracellular	ADJ
admet-2013	62	24	drug	drug	NOUN
admet-2013	62	25	concentration	concentration	NOUN
admet-2013	62	26	.	.	PUNCT
admet-2013	63	1	this	this	DET
admet-2013	63	2	upregulation	upregulation	NOUN
admet-2013	63	3	of	of	ADP
admet-2013	63	4	mdr1	mdr1	PROPN
admet-2013	63	5	worsens	worsen	VERB
admet-2013	63	6	treatment	treatment	NOUN
admet-2013	63	7	resistance	resistance	NOUN
admet-2013	63	8	,	,	PUNCT
admet-2013	63	9	which	which	PRON
admet-2013	63	10	raises	raise	VERB
admet-2013	63	11	the	the	DET
admet-2013	63	12	risk	risk	NOUN
admet-2013	63	13	of	of	ADP
admet-2013	63	14	cancer	cancer	NOUN
admet-2013	63	15	recurrence	recurrence	NOUN
admet-2013	63	16	,	,	PUNCT
admet-2013	63	17	indicating	indicate	VERB
admet-2013	63	18	a	a	DET
admet-2013	63	19	poorer	poor	ADJ
admet-2013	63	20	prognosis	prognosis	NOUN
admet-2013	63	21	[	[	X
admet-2013	63	22	30	30	NUM
admet-2013	63	23	]	]	SYM
admet-2013	63	24	.	.	PUNCT
admet-2013	64	1	atypical	atypical	ADJ
admet-2013	64	2	chronic	chronic	ADJ
admet-2013	64	3	myeloid	myeloid	NOUN
admet-2013	64	4	leukaemia	leukaemia	NOUN
admet-2013	64	5	(	(	PUNCT
admet-2013	64	6	acml	acml	PROPN
admet-2013	64	7	)	)	PUNCT
admet-2013	64	8	is	be	AUX
admet-2013	64	9	an	an	DET
admet-2013	64	10	uncommon	uncommon	ADJ
admet-2013	64	11	form	form	NOUN
admet-2013	64	12	of	of	ADP
admet-2013	64	13	myelodysplastic	myelodysplastic	ADJ
admet-2013	64	14	syndrome	syndrome	NOUN
admet-2013	64	15	(	(	PUNCT
admet-2013	64	16	mds)/myeloproliferative	mds)/myeloproliferative	ADJ
admet-2013	64	17	neoplasm	neoplasm	NOUN
admet-2013	64	18	(	(	PUNCT
admet-2013	64	19	mpn	mpn	NOUN
admet-2013	64	20	)	)	PUNCT
admet-2013	64	21	that	that	PRON
admet-2013	64	22	is	be	AUX
admet-2013	64	23	bcr	bcr	ADJ
admet-2013	64	24	-	-	ADJ
admet-2013	64	25	abl1	abl1	ADJ
admet-2013	64	26	negative	negative	NOUN
admet-2013	64	27	.	.	PUNCT
admet-2013	65	1	it	it	PRON
admet-2013	65	2	is	be	AUX
admet-2013	65	3	historically	historically	ADV
admet-2013	65	4	known	know	VERB
admet-2013	65	5	for	for	ADP
admet-2013	65	6	having	have	VERB
admet-2013	65	7	a	a	DET
admet-2013	65	8	poor	poor	ADJ
admet-2013	65	9	prognosis	prognosis	NOUN
admet-2013	65	10	.	.	PUNCT
admet-2013	66	1	the	the	DET
admet-2013	66	2	difficulties	difficulty	NOUN
admet-2013	66	3	in	in	ADP
admet-2013	66	4	managing	manage	VERB
admet-2013	66	5	acml	acml	NOUN
admet-2013	66	6	affect	affect	VERB
admet-2013	66	7	both	both	DET
admet-2013	66	8	diagnosis	diagnosis	NOUN
admet-2013	66	9	and	and	CCONJ
admet-2013	66	10	treatment	treatment	NOUN
admet-2013	66	11	options	option	NOUN
admet-2013	66	12	because	because	SCONJ
admet-2013	66	13	there	there	PRON
admet-2013	66	14	are	be	VERB
admet-2013	66	15	no	no	DET
admet-2013	66	16	current	current	ADJ
admet-2013	66	17	guidelines	guideline	NOUN
admet-2013	66	18	for	for	ADP
admet-2013	66	19	care	care	NOUN
admet-2013	66	20	and	and	CCONJ
admet-2013	66	21	the	the	DET
admet-2013	66	22	disease	disease	NOUN
admet-2013	66	23	's	's	PART
admet-2013	66	24	clinical	clinical	ADJ
admet-2013	66	25	characteristics	characteristic	NOUN
admet-2013	66	26	are	be	AUX
admet-2013	66	27	heterogeneous	heterogeneous	ADJ
admet-2013	67	1	[	[	X
admet-2013	67	2	1	1	NUM
admet-2013	67	3	]	]	PUNCT
admet-2013	67	4	.	.	PUNCT
admet-2013	68	1	mostly	mostly	ADV
admet-2013	68	2	cml	cml	PROPN
admet-2013	68	3	is	be	AUX
admet-2013	68	4	diagnosed	diagnose	VERB
admet-2013	68	5	from	from	ADP
admet-2013	68	6	the	the	DET
admet-2013	68	7	complete	complete	ADJ
admet-2013	68	8	blood	blood	NOUN
admet-2013	68	9	count	count	NOUN
admet-2013	68	10	.	.	PUNCT
admet-2013	69	1	other	other	ADJ
admet-2013	69	2	diagnostic	diagnostic	ADJ
admet-2013	69	3	methods	method	NOUN
admet-2013	69	4	include	include	VERB
admet-2013	69	5	fluorescent	fluorescent	NOUN
admet-2013	69	6	in	in	ADP
admet-2013	69	7	situ	situ	ADJ
admet-2013	69	8	hybridization	hybridization	NOUN
admet-2013	69	9	,	,	PUNCT
admet-2013	69	10	ct	ct	PROPN
admet-2013	69	11	scan	scan	NOUN
admet-2013	69	12	,	,	PUNCT
admet-2013	69	13	biopsy	biopsy	ADJ
admet-2013	69	14	,	,	PUNCT
admet-2013	69	15	bone	bone	NOUN
admet-2013	69	16	marrow	marrow	NOUN
admet-2013	69	17	aspiration	aspiration	NOUN
admet-2013	69	18	,	,	PUNCT
admet-2013	69	19	and	and	CCONJ
admet-2013	69	20	quantitative	quantitative	ADJ
admet-2013	69	21	rt	rt	NOUN
admet-2013	69	22	-	-	PUNCT
admet-2013	69	23	pcr	pcr	NOUN
admet-2013	69	24	.	.	PUNCT
admet-2013	70	1	atypical	atypical	PROPN
admet-2013	70	2	cml	cml	PROPN
admet-2013	70	3	is	be	AUX
admet-2013	70	4	admet	admet	PROPN
admet-2013	70	5	&	&	CCONJ
admet-2013	70	6	dmpk	dmpk	PROPN
admet-2013	70	7	11(4	11(4	NUM
admet-2013	70	8	)	)	PUNCT
admet-2013	70	9	(	(	PUNCT
admet-2013	70	10	2023	2023	NUM
admet-2013	70	11	)	)	PUNCT
admet-2013	70	12	499	499	NUM
admet-2013	70	13	-	-	SYM
admet-2013	70	14	511	511	NUM
admet-2013	70	15	nanoparticles	nanoparticle	NOUN
admet-2013	70	16	in	in	ADP
admet-2013	70	17	the	the	DET
admet-2013	70	18	therapy	therapy	NOUN
admet-2013	70	19	of	of	ADP
admet-2013	70	20	chronic	chronic	ADJ
admet-2013	70	21	myelogenous	myelogenous	ADJ
admet-2013	70	22	leukemia	leukemia	PROPN
admet-2013	70	23	doi	doi	PROPN
admet-2013	70	24	:	:	PUNCT
admet-2013	70	25	https://doi.org/10.5599/adme	https://doi.org/10.5599/adme	NOUN
admet-2013	70	26	t.2013	t.2013	PROPN
admet-2013	70	27	501	501	NUM
admet-2013	70	28	diagnosed	diagnose	VERB
admet-2013	70	29	by	by	ADP
admet-2013	70	30	neutrophilic	neutrophilic	ADJ
admet-2013	70	31	leukocytosis	leukocytosis	NOUN
admet-2013	70	32	and	and	CCONJ
admet-2013	70	33	pronounced	pronounce	VERB
admet-2013	70	34	dysgranulopoiesis	dysgranulopoiesis	NOUN
admet-2013	70	35	.	.	PUNCT
admet-2013	71	1	additionally	additionally	ADV
admet-2013	71	2	,	,	PUNCT
admet-2013	71	3	the	the	DET
admet-2013	71	4	wbc	wbc	NOUN
admet-2013	71	5	should	should	AUX
admet-2013	71	6	be	be	AUX
admet-2013	71	7	more	more	ADJ
admet-2013	71	8	than	than	ADP
admet-2013	71	9	13×109	13×109	NUM
admet-2013	71	10	l-1	l-1	NOUN
admet-2013	71	11	with	with	ADP
admet-2013	71	12	more	more	ADJ
admet-2013	71	13	than	than	ADP
admet-2013	71	14	10	10	NUM
admet-2013	71	15	percent	percent	NOUN
admet-2013	71	16	immature	immature	ADJ
admet-2013	71	17	granulocytes	granulocyte	NOUN
admet-2013	71	18	and	and	CCONJ
admet-2013	71	19	20	20	NUM
admet-2013	71	20	percent	percent	NOUN
admet-2013	71	21	blasts	blast	NOUN
admet-2013	71	22	in	in	ADP
admet-2013	71	23	the	the	DET
admet-2013	71	24	bone	bone	NOUN
admet-2013	71	25	marrow	marrow	NOUN
admet-2013	71	26	and	and	CCONJ
admet-2013	71	27	blood	blood	NOUN
admet-2013	71	28	to	to	PART
admet-2013	71	29	meet	meet	VERB
admet-2013	71	30	the	the	DET
admet-2013	71	31	diagnostic	diagnostic	ADJ
admet-2013	71	32	criteria	criterion	NOUN
admet-2013	71	33	[	[	X
admet-2013	71	34	1	1	NUM
admet-2013	71	35	]	]	PUNCT
admet-2013	71	36	.	.	PUNCT
admet-2013	72	1	diagnostic	diagnostic	ADJ
admet-2013	72	2	nanoparticles	nanoparticle	NOUN
admet-2013	72	3	are	be	AUX
admet-2013	72	4	intended	intend	VERB
admet-2013	72	5	to	to	PART
admet-2013	72	6	highlight	highlight	VERB
admet-2013	72	7	irregularities	irregularity	NOUN
admet-2013	72	8	and	and	CCONJ
admet-2013	72	9	advance	advance	NOUN
admet-2013	72	10	understanding	understanding	NOUN
admet-2013	72	11	of	of	ADP
admet-2013	72	12	the	the	DET
admet-2013	72	13	fundamental	fundamental	ADJ
admet-2013	72	14	physiological	physiological	ADJ
admet-2013	72	15	principles	principle	NOUN
admet-2013	72	16	that	that	PRON
admet-2013	72	17	underlie	underlie	VERB
admet-2013	72	18	various	various	ADJ
admet-2013	72	19	diseases	disease	NOUN
admet-2013	72	20	and	and	CCONJ
admet-2013	72	21	treatment	treatment	NOUN
admet-2013	72	22	options	option	NOUN
admet-2013	72	23	[	[	X
admet-2013	72	24	3	3	NUM
admet-2013	72	25	]	]	PUNCT
admet-2013	72	26	.	.	PUNCT
admet-2013	73	1	in	in	ADP
admet-2013	73	2	cml	cml	PROPN
admet-2013	73	3	diagnosis	diagnosis	NOUN
admet-2013	73	4	,	,	PUNCT
admet-2013	73	5	various	various	ADJ
admet-2013	73	6	inorganic	inorganic	ADJ
admet-2013	73	7	nanoparticles	nanoparticle	NOUN
admet-2013	73	8	are	be	AUX
admet-2013	73	9	employed	employ	VERB
admet-2013	73	10	.	.	PUNCT
admet-2013	74	1	a	a	DET
admet-2013	74	2	localized	localize	VERB
admet-2013	74	3	surface	surface	NOUN
admet-2013	74	4	plasmon	plasmon	NOUN
admet-2013	74	5	resonance	resonance	NOUN
admet-2013	74	6	layer	layer	NOUN
admet-2013	74	7	made	make	VERB
admet-2013	74	8	of	of	ADP
admet-2013	74	9	polydimethylsiloxane	polydimethylsiloxane	NOUN
admet-2013	74	10	(	(	PUNCT
admet-2013	74	11	pdms	pdms	NOUN
admet-2013	74	12	)	)	PUNCT
admet-2013	74	13	supporting	support	VERB
admet-2013	74	14	layer	layer	NOUN
admet-2013	74	15	and	and	CCONJ
admet-2013	74	16	gold	gold	NOUN
admet-2013	74	17	nanoparticles	nanoparticle	NOUN
admet-2013	74	18	(	(	PUNCT
admet-2013	74	19	au	au	PROPN
admet-2013	74	20	nps	nps	PROPN
admet-2013	74	21	)	)	PUNCT
admet-2013	74	22	coupled	couple	VERB
admet-2013	74	23	to	to	ADP
admet-2013	74	24	tumor	tumor	NOUN
admet-2013	74	25	necrosis	necrosis	NOUN
admet-2013	74	26	factor	factor	NOUN
admet-2013	74	27	(	(	PUNCT
admet-2013	74	28	tnf	tnf	PROPN
admet-2013	74	29	)	)	PUNCT
admet-2013	74	30	for	for	ADP
admet-2013	74	31	cytokine	cytokine	ADJ
admet-2013	74	32	detection	detection	NOUN
admet-2013	74	33	is	be	AUX
admet-2013	74	34	a	a	DET
admet-2013	74	35	microfluidic	microfluidic	ADJ
admet-2013	74	36	layer	layer	NOUN
admet-2013	74	37	that	that	PRON
admet-2013	74	38	traps	trap	VERB
admet-2013	74	39	and	and	CCONJ
admet-2013	74	40	incubates	incubate	VERB
admet-2013	74	41	cells	cell	NOUN
admet-2013	74	42	.	.	PUNCT
admet-2013	75	1	when	when	SCONJ
admet-2013	75	2	compared	compare	VERB
admet-2013	75	3	to	to	ADP
admet-2013	75	4	elisa	elisa	VERB
admet-2013	75	5	,	,	PUNCT
admet-2013	75	6	pdms	pdms	NOUN
admet-2013	75	7	uses	use	VERB
admet-2013	75	8	a	a	DET
admet-2013	75	9	100	100	NUM
admet-2013	75	10	times	time	NOUN
admet-2013	75	11	smaller	small	ADJ
admet-2013	75	12	volume	volume	NOUN
admet-2013	75	13	of	of	ADP
admet-2013	75	14	sample	sample	NOUN
admet-2013	75	15	and	and	CCONJ
admet-2013	75	16	the	the	DET
admet-2013	75	17	detection	detection	NOUN
admet-2013	75	18	time	time	NOUN
admet-2013	75	19	also	also	ADV
admet-2013	75	20	was	be	AUX
admet-2013	75	21	3x	3x	PRON
admet-2013	75	22	faster	fast	ADV
admet-2013	75	23	.	.	PUNCT
admet-2013	76	1	therefore	therefore	ADV
admet-2013	76	2	,	,	PUNCT
admet-2013	76	3	this	this	DET
admet-2013	76	4	novel	novel	ADJ
admet-2013	76	5	optofluidic	optofluidic	ADJ
admet-2013	76	6	method	method	NOUN
admet-2013	76	7	was	be	AUX
admet-2013	76	8	first	first	ADV
admet-2013	76	9	used	use	VERB
admet-2013	76	10	to	to	PART
admet-2013	76	11	detect	detect	VERB
admet-2013	76	12	thp-1	thp-1	ADP
admet-2013	76	13	cells	cell	NOUN
admet-2013	76	14	(	(	PUNCT
admet-2013	76	15	human	human	NOUN
admet-2013	76	16	myeloid	myeloid	NOUN
admet-2013	76	17	leukemia	leukemia	NOUN
admet-2013	76	18	mononuclear	mononuclear	ADJ
admet-2013	76	19	cells	cell	NOUN
admet-2013	76	20	)	)	PUNCT
admet-2013	77	1	[	[	X
admet-2013	77	2	31	31	NUM
admet-2013	77	3	]	]	PUNCT
admet-2013	77	4	.	.	PUNCT
admet-2013	78	1	size	size	NOUN
admet-2013	78	2	-	-	PUNCT
admet-2013	78	3	dependent	dependent	ADJ
admet-2013	78	4	fluorescence	fluorescence	NOUN
admet-2013	78	5	raman	raman	NOUN
admet-2013	78	6	scattering	scattering	NOUN
admet-2013	78	7	was	be	AUX
admet-2013	78	8	noticeably	noticeably	ADV
admet-2013	78	9	improved	improve	VERB
admet-2013	78	10	in	in	ADP
admet-2013	78	11	surface	surface	NOUN
admet-2013	78	12	-	-	PUNCT
admet-2013	78	13	enhanced	enhance	VERB
admet-2013	78	14	raman	raman	NOUN
admet-2013	78	15	scattering	scattering	NOUN
admet-2013	78	16	(	(	PUNCT
admet-2013	78	17	sers	ser	NOUN
admet-2013	78	18	)	)	PUNCT
admet-2013	78	19	.	.	PUNCT
admet-2013	79	1	ag	ag	PROPN
admet-2013	79	2	nps	nps	PROPN
admet-2013	79	3	-	-	PUNCT
admet-2013	79	4	eiii1	eiii1	NOUN
admet-2013	79	5	network	network	NOUN
admet-2013	79	6	was	be	AUX
admet-2013	79	7	created	create	VERB
admet-2013	79	8	as	as	ADP
admet-2013	79	9	an	an	DET
admet-2013	79	10	sers	ser	NOUN
admet-2013	79	11	probe	probe	NOUN
admet-2013	79	12	using	use	VERB
admet-2013	79	13	an	an	DET
admet-2013	79	14	ag	ag	PROPN
admet-2013	79	15	nps	nps	PROPN
admet-2013	79	16	assembled	assemble	VERB
admet-2013	79	17	phage	phage	NOUN
admet-2013	79	18	clone	clone	NOUN
admet-2013	79	19	to	to	PART
admet-2013	79	20	recognize	recognize	VERB
admet-2013	79	21	the	the	DET
admet-2013	79	22	cancerous	cancerous	ADJ
admet-2013	79	23	cells	cell	NOUN
admet-2013	79	24	[	[	X
admet-2013	79	25	32	32	NUM
admet-2013	79	26	]	]	PUNCT
admet-2013	79	27	.	.	PUNCT
admet-2013	80	1	the	the	DET
admet-2013	80	2	use	use	NOUN
admet-2013	80	3	of	of	ADP
admet-2013	80	4	fluorescent	fluorescent	ADJ
admet-2013	80	5	platinum	platinum	NOUN
admet-2013	80	6	nanoclusters	nanocluster	NOUN
admet-2013	80	7	(	(	PUNCT
admet-2013	80	8	pt	pt	X
admet-2013	80	9	ncs	nc	NOUN
admet-2013	80	10	)	)	PUNCT
admet-2013	80	11	instead	instead	ADV
admet-2013	80	12	of	of	ADP
admet-2013	80	13	additional	additional	ADJ
admet-2013	80	14	fluorescent	fluorescent	NOUN
admet-2013	80	15	biomarkers	biomarker	NOUN
admet-2013	80	16	has	have	AUX
admet-2013	80	17	shown	show	VERB
admet-2013	80	18	considerable	considerable	ADJ
admet-2013	80	19	promise	promise	NOUN
admet-2013	80	20	in	in	ADP
admet-2013	80	21	the	the	DET
admet-2013	80	22	diagnosis	diagnosis	NOUN
admet-2013	80	23	of	of	ADP
admet-2013	80	24	hematological	hematological	ADJ
admet-2013	80	25	disorders	disorder	NOUN
admet-2013	80	26	such	such	ADJ
admet-2013	80	27	as	as	ADP
admet-2013	80	28	leukemia	leukemia	NOUN
admet-2013	80	29	,	,	PUNCT
admet-2013	80	30	lymphoma	lymphoma	NOUN
admet-2013	80	31	,	,	PUNCT
admet-2013	80	32	and	and	CCONJ
admet-2013	80	33	myeloma	myeloma	NOUN
admet-2013	80	34	.	.	PUNCT
admet-2013	81	1	k562	k562	PROPN
admet-2013	81	2	leukemia	leukemia	NOUN
admet-2013	81	3	cell	cell	NOUN
admet-2013	81	4	lines	line	NOUN
admet-2013	81	5	were	be	AUX
admet-2013	81	6	co	co	ADJ
admet-2013	81	7	-	-	VERB
admet-2013	81	8	cultured	cultured	ADJ
admet-2013	81	9	with	with	ADP
admet-2013	81	10	bifunctional	bifunctional	ADJ
admet-2013	81	11	polyethyleneimine	polyethyleneimine	NOUN
admet-2013	81	12	(	(	PUNCT
admet-2013	81	13	pei)-encased	pei)-encase	VERB
admet-2013	81	14	pt	pt	NOUN
admet-2013	81	15	ncs	ncs	NOUN
admet-2013	81	16	to	to	PART
admet-2013	81	17	show	show	VERB
admet-2013	81	18	that	that	SCONJ
admet-2013	81	19	pt	pt	NOUN
admet-2013	81	20	ncs	ncs	NOUN
admet-2013	81	21	smaller	small	ADJ
admet-2013	81	22	than	than	ADP
admet-2013	81	23	2	2	NUM
admet-2013	81	24	nm	nm	NOUN
admet-2013	81	25	could	could	AUX
admet-2013	81	26	specifically	specifically	ADV
admet-2013	81	27	identify	identify	VERB
admet-2013	81	28	k562	k562	PROPN
admet-2013	81	29	cells	cell	NOUN
admet-2013	81	30	with	with	ADP
admet-2013	81	31	the	the	DET
admet-2013	81	32	internalized	internalize	VERB
admet-2013	81	33	proportion	proportion	NOUN
admet-2013	81	34	at	at	ADP
admet-2013	81	35	97±4	97±4	NUM
admet-2013	81	36	%	%	NOUN
admet-2013	81	37	as	as	ADP
admet-2013	81	38	opposed	oppose	VERB
admet-2013	81	39	to	to	ADP
admet-2013	81	40	peripheral	peripheral	ADJ
admet-2013	81	41	blood	blood	NOUN
admet-2013	81	42	mononucleated	mononucleate	VERB
admet-2013	81	43	cells	cell	NOUN
admet-2013	81	44	(	(	PUNCT
admet-2013	81	45	pbmcs	pbmcs	NOUN
admet-2013	81	46	)	)	PUNCT
admet-2013	81	47	at	at	ADP
admet-2013	81	48	20±8	20±8	NUM
admet-2013	81	49	%	%	NOUN
admet-2013	82	1	[	[	X
admet-2013	82	2	33	33	NUM
admet-2013	82	3	]	]	PUNCT
admet-2013	82	4	.	.	PUNCT
admet-2013	83	1	the	the	DET
admet-2013	83	2	biocodeaunanobeacon	biocodeaunanobeacon	NOUN
admet-2013	83	3	,	,	PUNCT
admet-2013	83	4	made	make	VERB
admet-2013	83	5	up	up	ADP
admet-2013	83	6	of	of	ADP
admet-2013	83	7	aunps	aunps	NOUN
admet-2013	83	8	functionalized	functionalize	VERB
admet-2013	83	9	with	with	ADP
admet-2013	83	10	hairpin	hairpin	NOUN
admet-2013	83	11	-	-	PUNCT
admet-2013	83	12	shaped	shape	VERB
admet-2013	83	13	string	string	NOUN
admet-2013	83	14	dnas	dna	NOUN
admet-2013	83	15	with	with	ADP
admet-2013	83	16	a	a	DET
admet-2013	83	17	fluorophore	fluorophore	NOUN
admet-2013	83	18	on	on	ADP
admet-2013	83	19	the	the	DET
admet-2013	83	20	extremes	extreme	NOUN
admet-2013	83	21	,	,	PUNCT
admet-2013	83	22	is	be	AUX
admet-2013	83	23	another	another	DET
admet-2013	83	24	sensor	sensor	NOUN
admet-2013	83	25	for	for	ADP
admet-2013	83	26	identifying	identify	VERB
admet-2013	83	27	bcr	bcr	PROPN
admet-2013	83	28	-	-	PUNCT
admet-2013	83	29	abl	abl	PROPN
admet-2013	83	30	.	.	PROPN
admet-2013	83	31	aunps	aunps	PROPN
admet-2013	83	32	may	may	AUX
admet-2013	83	33	operate	operate	VERB
admet-2013	83	34	as	as	ADP
admet-2013	83	35	a	a	DET
admet-2013	83	36	dark	dark	ADJ
admet-2013	83	37	quencher	quencher	NOUN
admet-2013	83	38	on	on	ADP
admet-2013	83	39	the	the	DET
admet-2013	83	40	single	single	ADJ
admet-2013	83	41	-	-	PUNCT
admet-2013	83	42	strand	strand	NOUN
admet-2013	83	43	fluorophores	fluorophore	NOUN
admet-2013	83	44	because	because	SCONJ
admet-2013	83	45	of	of	ADP
admet-2013	83	46	their	their	PRON
admet-2013	83	47	lspr	lspr	NOUN
admet-2013	83	48	.	.	PUNCT
admet-2013	84	1	when	when	SCONJ
admet-2013	84	2	no	no	DET
admet-2013	84	3	target	target	NOUN
admet-2013	84	4	was	be	AUX
admet-2013	84	5	present	present	ADJ
admet-2013	84	6	,	,	PUNCT
admet-2013	84	7	the	the	DET
admet-2013	84	8	hairpin	hairpin	NOUN
admet-2013	84	9	maintained	maintain	VERB
admet-2013	84	10	its	its	PRON
admet-2013	84	11	tight	tight	ADJ
admet-2013	84	12	conformation	conformation	NOUN
admet-2013	84	13	,	,	PUNCT
admet-2013	84	14	keeping	keep	VERB
admet-2013	84	15	the	the	DET
admet-2013	84	16	fluorophore	fluorophore	NOUN
admet-2013	84	17	close	close	ADJ
admet-2013	84	18	to	to	ADP
admet-2013	84	19	the	the	DET
admet-2013	84	20	aunp	aunp	NOUN
admet-2013	84	21	,	,	PUNCT
admet-2013	84	22	quenching	quench	VERB
admet-2013	84	23	the	the	DET
admet-2013	84	24	fluorescence	fluorescence	NOUN
admet-2013	84	25	.	.	PUNCT
admet-2013	85	1	instead	instead	ADV
admet-2013	85	2	,	,	PUNCT
admet-2013	85	3	when	when	SCONJ
admet-2013	85	4	there	there	PRON
admet-2013	85	5	was	be	VERB
admet-2013	85	6	a	a	DET
admet-2013	85	7	binding	binding	NOUN
admet-2013	85	8	between	between	ADP
admet-2013	85	9	the	the	DET
admet-2013	85	10	hairpin	hairpin	NOUN
admet-2013	85	11	and	and	CCONJ
admet-2013	85	12	its	its	PRON
admet-2013	85	13	target	target	NOUN
admet-2013	85	14	,	,	PUNCT
admet-2013	85	15	the	the	DET
admet-2013	85	16	hairpin	hairpin	NOUN
admet-2013	85	17	opened	open	VERB
admet-2013	85	18	,	,	PUNCT
admet-2013	85	19	and	and	CCONJ
admet-2013	85	20	the	the	DET
admet-2013	85	21	separation	separation	NOUN
admet-2013	85	22	from	from	ADP
admet-2013	85	23	the	the	DET
admet-2013	85	24	aunp	aunp	NOUN
admet-2013	85	25	enabled	enable	VERB
admet-2013	85	26	the	the	DET
admet-2013	85	27	fluorescence	fluorescence	NOUN
admet-2013	85	28	to	to	PART
admet-2013	85	29	be	be	AUX
admet-2013	85	30	detected	detect	VERB
admet-2013	86	1	[	[	X
admet-2013	86	2	34	34	NUM
admet-2013	86	3	]	]	PUNCT
admet-2013	86	4	.	.	PUNCT
admet-2013	87	1	upper	upper	ADJ
admet-2013	87	2	hand	hand	NOUN
admet-2013	87	3	of	of	ADP
admet-2013	87	4	nanotechnology	nanotechnology	NOUN
admet-2013	87	5	in	in	ADP
admet-2013	87	6	cml	cml	PROPN
admet-2013	87	7	treatment	treatment	PROPN
admet-2013	87	8	traditional	traditional	PROPN
admet-2013	87	9	cml	cml	PROPN
admet-2013	87	10	treatment	treatment	NOUN
admet-2013	87	11	involves	involve	VERB
admet-2013	87	12	chemotherapy	chemotherapy	NOUN
admet-2013	87	13	,	,	PUNCT
admet-2013	87	14	radiotherapy	radiotherapy	NOUN
admet-2013	87	15	,	,	PUNCT
admet-2013	87	16	phototherapy	phototherapy	NOUN
admet-2013	87	17	,	,	PUNCT
admet-2013	87	18	immunotherapy	immunotherapy	NOUN
admet-2013	87	19	,	,	PUNCT
admet-2013	87	20	e	e	PROPN
admet-2013	87	21	tc	tc	X
admet-2013	87	22	.	.	PUNCT
admet-2013	88	1	chemotherapy	chemotherapy	NOUN
admet-2013	88	2	drugs	drug	NOUN
admet-2013	88	3	like	like	ADP
admet-2013	88	4	cisplatin	cisplatin	NOUN
admet-2013	88	5	and	and	CCONJ
admet-2013	88	6	carboplatin	carboplatin	NOUN
admet-2013	88	7	have	have	VERB
admet-2013	88	8	side	side	NOUN
admet-2013	88	9	effects	effect	NOUN
admet-2013	88	10	because	because	SCONJ
admet-2013	88	11	of	of	ADP
admet-2013	88	12	their	their	PRON
admet-2013	88	13	neurology	neurology	NOUN
admet-2013	88	14	and	and	CCONJ
admet-2013	88	15	nephrology	nephrology	NOUN
admet-2013	88	16	-	-	PUNCT
admet-2013	88	17	related	relate	VERB
admet-2013	88	18	toxicity	toxicity	NOUN
admet-2013	88	19	[	[	X
admet-2013	88	20	35	35	NUM
admet-2013	88	21	]	]	PUNCT
admet-2013	88	22	.	.	PUNCT
admet-2013	89	1	in	in	ADP
admet-2013	89	2	targeted	target	VERB
admet-2013	89	3	therapy	therapy	NOUN
admet-2013	89	4	,	,	PUNCT
admet-2013	89	5	ligands	ligand	NOUN
admet-2013	89	6	were	be	AUX
admet-2013	89	7	combined	combine	VERB
admet-2013	89	8	with	with	ADP
admet-2013	89	9	chemotherapy	chemotherapy	NOUN
admet-2013	89	10	drugs	drug	NOUN
admet-2013	89	11	to	to	PART
admet-2013	89	12	treat	treat	VERB
admet-2013	89	13	the	the	DET
admet-2013	89	14	disease	disease	NOUN
admet-2013	89	15	.	.	PUNCT
admet-2013	90	1	in	in	ADP
admet-2013	90	2	photothermal	photothermal	ADJ
admet-2013	90	3	therapy	therapy	NOUN
admet-2013	90	4	,	,	PUNCT
admet-2013	90	5	electromagnetic	electromagnetic	ADJ
admet-2013	90	6	radiation	radiation	NOUN
admet-2013	90	7	was	be	AUX
admet-2013	90	8	used	use	VERB
admet-2013	90	9	.	.	PUNCT
admet-2013	91	1	they	they	PRON
admet-2013	91	2	excite	excite	VERB
admet-2013	91	3	the	the	DET
admet-2013	91	4	non	non	ADJ
admet-2013	91	5	-	-	ADJ
admet-2013	91	6	toxic	toxic	ADJ
admet-2013	91	7	material	material	NOUN
admet-2013	91	8	known	know	VERB
admet-2013	91	9	as	as	ADP
admet-2013	91	10	photosensitizer	photosensitizer	NOUN
admet-2013	91	11	to	to	PART
admet-2013	91	12	generate	generate	VERB
admet-2013	91	13	ros	ros	PROPN
admet-2013	91	14	,	,	PUNCT
admet-2013	91	15	which	which	PRON
admet-2013	91	16	targets	target	VERB
admet-2013	91	17	and	and	CCONJ
admet-2013	91	18	kills	kill	VERB
admet-2013	91	19	the	the	DET
admet-2013	91	20	cancer	cancer	NOUN
admet-2013	91	21	cells	cell	NOUN
admet-2013	91	22	[	[	X
admet-2013	91	23	36	36	NUM
admet-2013	91	24	]	]	PUNCT
admet-2013	91	25	.	.	PUNCT
admet-2013	92	1	despite	despite	SCONJ
admet-2013	92	2	the	the	DET
admet-2013	92	3	availability	availability	NOUN
admet-2013	92	4	of	of	ADP
admet-2013	92	5	different	different	ADJ
admet-2013	92	6	types	type	NOUN
admet-2013	92	7	of	of	ADP
admet-2013	92	8	treatment	treatment	NOUN
admet-2013	92	9	for	for	ADP
admet-2013	92	10	cml	cml	PROPN
admet-2013	92	11	,	,	PUNCT
admet-2013	92	12	nanomedicine	nanomedicine	PROPN
admet-2013	92	13	has	have	VERB
admet-2013	92	14	an	an	DET
admet-2013	92	15	added	add	VERB
admet-2013	92	16	advantage	advantage	NOUN
admet-2013	92	17	because	because	SCONJ
admet-2013	92	18	of	of	ADP
admet-2013	92	19	the	the	DET
admet-2013	92	20	size	size	NOUN
admet-2013	92	21	of	of	ADP
admet-2013	92	22	nanoparticles	nanoparticle	NOUN
admet-2013	92	23	and	and	CCONJ
admet-2013	92	24	the	the	DET
admet-2013	92	25	ability	ability	NOUN
admet-2013	92	26	to	to	PART
admet-2013	92	27	target	target	VERB
admet-2013	92	28	cancer	cancer	NOUN
admet-2013	92	29	cells	cell	NOUN
admet-2013	92	30	alone	alone	ADV
admet-2013	92	31	[	[	X
admet-2013	92	32	37	37	NUM
admet-2013	92	33	]	]	PUNCT
admet-2013	92	34	.	.	PUNCT
admet-2013	93	1	nanotechnology	nanotechnology	PROPN
admet-2013	93	2	successfully	successfully	ADV
admet-2013	93	3	ameliorates	ameliorate	VERB
admet-2013	93	4	drug	drug	NOUN
admet-2013	93	5	uptake	uptake	ADJ
admet-2013	93	6	issues	issue	NOUN
admet-2013	93	7	and	and	CCONJ
admet-2013	93	8	helps	help	VERB
admet-2013	93	9	maintain	maintain	VERB
admet-2013	93	10	the	the	DET
admet-2013	93	11	drug	drug	NOUN
admet-2013	93	12	release	release	NOUN
admet-2013	93	13	by	by	ADP
admet-2013	93	14	increasing	increase	VERB
admet-2013	93	15	its	its	PRON
admet-2013	93	16	half	half	ADJ
admet-2013	93	17	-life	-life	NOUN
admet-2013	93	18	.	.	PUNCT
admet-2013	94	1	the	the	DET
admet-2013	94	2	half	half	ADJ
admet-2013	94	3	-	-	PUNCT
admet-2013	94	4	life	life	NOUN
admet-2013	94	5	is	be	AUX
admet-2013	94	6	usually	usually	ADV
admet-2013	94	7	arbitrated	arbitrate	VERB
admet-2013	94	8	by	by	ADP
admet-2013	94	9	the	the	DET
admet-2013	94	10	macrophage	macrophage	NOUN
admet-2013	94	11	.	.	PUNCT
admet-2013	95	1	they	they	PRON
admet-2013	95	2	carefully	carefully	ADV
admet-2013	95	3	acknowledge	acknowledge	VERB
admet-2013	95	4	the	the	DET
admet-2013	95	5	cancer	cancer	NOUN
admet-2013	95	6	cells	cell	NOUN
admet-2013	95	7	and	and	CCONJ
admet-2013	95	8	deliver	deliver	VERB
admet-2013	95	9	the	the	DET
admet-2013	95	10	drugs	drug	NOUN
admet-2013	95	11	to	to	ADP
admet-2013	95	12	the	the	DET
admet-2013	95	13	target	target	NOUN
admet-2013	95	14	location	location	NOUN
admet-2013	95	15	accurately	accurately	ADV
admet-2013	95	16	,	,	PUNCT
admet-2013	95	17	minimising	minimise	VERB
admet-2013	95	18	the	the	DET
admet-2013	95	19	faulty	faulty	ADJ
admet-2013	95	20	site	site	NOUN
admet-2013	95	21	of	of	ADP
admet-2013	95	22	action	action	NOUN
admet-2013	95	23	in	in	ADP
admet-2013	95	24	the	the	DET
admet-2013	95	25	cells	cell	NOUN
admet-2013	95	26	.	.	PUNCT
admet-2013	96	1	thus	thus	ADV
admet-2013	96	2	,	,	PUNCT
admet-2013	96	3	nanotechnology	nanotechnology	NOUN
admet-2013	96	4	helps	help	VERB
admet-2013	96	5	battle	battle	VERB
admet-2013	96	6	the	the	DET
admet-2013	96	7	shortcomings	shortcoming	NOUN
admet-2013	96	8	of	of	ADP
admet-2013	96	9	conventional	conventional	ADJ
admet-2013	96	10	treatment	treatment	NOUN
admet-2013	96	11	procedures	procedure	NOUN
admet-2013	96	12	[	[	X
admet-2013	96	13	38	38	NUM
admet-2013	96	14	]	]	PUNCT
admet-2013	96	15	.	.	PUNCT
admet-2013	97	1	nanoparticles	nanoparticle	NOUN
admet-2013	97	2	are	be	AUX
admet-2013	97	3	good	good	ADJ
admet-2013	97	4	in	in	ADP
admet-2013	97	5	treating	treat	VERB
admet-2013	97	6	cancer	cancer	NOUN
admet-2013	97	7	due	due	ADP
admet-2013	97	8	to	to	ADP
admet-2013	97	9	their	their	PRON
admet-2013	97	10	distinctive	distinctive	ADJ
admet-2013	97	11	characteristics	characteristic	NOUN
admet-2013	97	12	.	.	PUNCT
admet-2013	98	1	different	different	ADJ
admet-2013	98	2	types	type	NOUN
admet-2013	98	3	of	of	ADP
admet-2013	98	4	nanoparticles	nanoparticle	NOUN
admet-2013	98	5	have	have	VERB
admet-2013	98	6	their	their	PRON
admet-2013	98	7	advantage	advantage	NOUN
admet-2013	98	8	.	.	PUNCT
admet-2013	99	1	organic	organic	ADJ
admet-2013	99	2	nanoparticles	nanoparticle	NOUN
admet-2013	99	3	have	have	VERB
admet-2013	99	4	excessive	excessive	ADJ
admet-2013	99	5	biocompatibility	biocompatibility	NOUN
admet-2013	99	6	in	in	ADP
admet-2013	99	7	delivering	deliver	VERB
admet-2013	99	8	drugs	drug	NOUN
admet-2013	99	9	.	.	PUNCT
admet-2013	100	1	inorganic	inorganic	ADJ
admet-2013	100	2	nanoparticles	nanoparticle	NOUN
admet-2013	100	3	increase	increase	VERB
admet-2013	100	4	the	the	DET
admet-2013	100	5	half	half	ADJ
admet-2013	100	6	-	-	PUNCT
admet-2013	100	7	life	life	NOUN
admet-2013	100	8	more	more	ADV
admet-2013	100	9	when	when	SCONJ
admet-2013	100	10	compared	compare	VERB
admet-2013	100	11	to	to	ADP
admet-2013	100	12	other	other	ADJ
admet-2013	100	13	types	type	NOUN
admet-2013	100	14	of	of	ADP
admet-2013	100	15	nanoparticles	nanoparticle	NOUN
admet-2013	100	16	[	[	X
admet-2013	100	17	36	36	NUM
admet-2013	100	18	]	]	PUNCT
admet-2013	100	19	.	.	PUNCT
admet-2013	101	1	nanoparticles	nanoparticle	NOUN
admet-2013	101	2	coated	coat	VERB
admet-2013	101	3	with	with	ADP
admet-2013	101	4	hydrophilic	hydrophilic	ADJ
admet-2013	101	5	polymer	polymer	NOUN
admet-2013	101	6	curtail	curtail	NOUN
admet-2013	101	7	opsonisation	opsonisation	NOUN
admet-2013	101	8	and	and	CCONJ
admet-2013	101	9	escape	escape	NOUN
admet-2013	101	10	from	from	ADP
admet-2013	101	11	the	the	DET
admet-2013	101	12	immune	immune	ADJ
admet-2013	101	13	system	system	NOUN
admet-2013	101	14	.	.	PUNCT
admet-2013	102	1	passive	passive	ADJ
admet-2013	102	2	targeting	targeting	NOUN
admet-2013	102	3	is	be	AUX
admet-2013	102	4	the	the	DET
admet-2013	102	5	mechanism	mechanism	NOUN
admet-2013	102	6	by	by	ADP
admet-2013	102	7	which	which	PRON
admet-2013	102	8	drugs	drug	NOUN
admet-2013	102	9	are	be	AUX
admet-2013	102	10	delivered	deliver	VERB
admet-2013	102	11	through	through	ADP
admet-2013	102	12	blood	blood	NOUN
admet-2013	102	13	vessels	vessel	NOUN
admet-2013	102	14	.	.	PUNCT
admet-2013	103	1	thus	thus	ADV
admet-2013	103	2	,	,	PUNCT
admet-2013	103	3	negatively	negatively	ADV
admet-2013	103	4	charged	charge	VERB
admet-2013	103	5	liposomes	liposome	NOUN
admet-2013	103	6	ranging	range	VERB
admet-2013	103	7	between	between	ADP
admet-2013	103	8	50	50	NUM
admet-2013	103	9	to	to	PART
admet-2013	103	10	100	100	NUM
admet-2013	103	11	nm	nm	NOUN
admet-2013	103	12	in	in	ADP
admet-2013	103	13	size	size	NOUN
admet-2013	103	14	increase	increase	VERB
admet-2013	103	15	the	the	DET
admet-2013	103	16	drug	drug	NOUN
admet-2013	103	17	uptake	uptake	ADJ
admet-2013	103	18	by	by	ADP
admet-2013	103	19	flowing	flow	VERB
admet-2013	103	20	freely	freely	ADV
admet-2013	103	21	and	and	CCONJ
admet-2013	103	22	by	by	ADP
admet-2013	103	23	having	have	VERB
admet-2013	103	24	high	high	ADJ
admet-2013	103	25	surface	surface	NOUN
admet-2013	103	26	energy	energy	NOUN
admet-2013	103	27	[	[	X
admet-2013	103	28	3	3	NUM
admet-2013	103	29	]	]	PUNCT
admet-2013	103	30	.	.	PUNCT
admet-2013	104	1	thus	thus	ADV
admet-2013	104	2	,	,	PUNCT
admet-2013	104	3	nanomedicine	nanomedicine	NOUN
admet-2013	104	4	serves	serve	VERB
admet-2013	104	5	as	as	ADP
admet-2013	104	6	one	one	NUM
admet-2013	104	7	of	of	ADP
admet-2013	104	8	the	the	DET
admet-2013	104	9	effective	effective	ADJ
admet-2013	104	10	treatments	treatment	NOUN
admet-2013	104	11	in	in	ADP
admet-2013	104	12	treating	treat	VERB
admet-2013	104	13	cancer	cancer	NOUN
admet-2013	104	14	.	.	PUNCT
admet-2013	105	1	figure	figure	NOUN
admet-2013	105	2	1	1	NUM
admet-2013	105	3	depicts	depict	VERB
admet-2013	105	4	the	the	DET
admet-2013	105	5	various	various	ADJ
admet-2013	105	6	treatments	treatment	NOUN
admet-2013	105	7	for	for	ADP
admet-2013	105	8	treating	treat	VERB
admet-2013	105	9	chronic	chronic	ADJ
admet-2013	105	10	myelogenous	myelogenous	ADJ
admet-2013	105	11	leukemia	leukemia	NOUN
admet-2013	105	12	.	.	PUNCT
admet-2013	106	1	https://doi.org/10.5599/admet.2013	https://doi.org/10.5599/admet.2013	PROPN
admet-2013	106	2	g.	g.	PROPN
admet-2013	106	3	janani	janani	PROPN
admet-2013	106	4	et	et	PROPN
admet-2013	106	5	al	al	PROPN
admet-2013	106	6	.	.	PROPN
admet-2013	106	7	admet	admet	PROPN
admet-2013	106	8	&	&	CCONJ
admet-2013	106	9	dmpk	dmpk	PROPN
admet-2013	106	10	11(4	11(4	NUM
admet-2013	106	11	)	)	PUNCT
admet-2013	106	12	(	(	PUNCT
admet-2013	106	13	2023	2023	NUM
admet-2013	106	14	)	)	PUNCT
admet-2013	106	15	499	499	NUM
admet-2013	106	16	-	-	SYM
admet-2013	106	17	511	511	NUM
admet-2013	106	18	502	502	NUM
admet-2013	106	19	figure	figure	NOUN
admet-2013	106	20	1	1	NUM
admet-2013	106	21	.	.	PUNCT
admet-2013	107	1	the	the	DET
admet-2013	107	2	various	various	ADJ
admet-2013	107	3	treatments	treatment	NOUN
admet-2013	107	4	involved	involve	VERB
admet-2013	107	5	in	in	ADP
admet-2013	107	6	treating	treat	VERB
admet-2013	107	7	chronic	chronic	ADJ
admet-2013	107	8	myelogenous	myelogenous	ADJ
admet-2013	107	9	leukemia	leukemia	NOUN
admet-2013	107	10	inorganic	inorganic	ADJ
admet-2013	107	11	nanoparticles	nanoparticle	NOUN
admet-2013	107	12	in	in	ADP
admet-2013	107	13	cml	cml	PROPN
admet-2013	107	14	therapy	therapy	NOUN
admet-2013	107	15	only	only	ADV
admet-2013	107	16	six	six	NUM
admet-2013	107	17	different	different	ADJ
admet-2013	107	18	types	type	NOUN
admet-2013	107	19	of	of	ADP
admet-2013	107	20	inorganic	inorganic	ADJ
admet-2013	107	21	nanoparticles	nanoparticle	NOUN
admet-2013	107	22	—	—	PUNCT
admet-2013	107	23	zinc	zinc	NOUN
admet-2013	107	24	oxide	oxide	NOUN
admet-2013	107	25	,	,	PUNCT
admet-2013	107	26	copper	copper	NOUN
admet-2013	107	27	,	,	PUNCT
admet-2013	107	28	gold	gold	NOUN
admet-2013	107	29	,	,	PUNCT
admet-2013	107	30	silver	silver	NOUN
admet-2013	107	31	,	,	PUNCT
admet-2013	107	32	ferrous	ferrous	ADJ
admet-2013	107	33	oxide	oxide	NOUN
admet-2013	107	34	,	,	PUNCT
admet-2013	107	35	and	and	CCONJ
admet-2013	107	36	carbon	carbon	NOUN
admet-2013	107	37	nanotubes	nanotube	NOUN
admet-2013	107	38	(	(	PUNCT
admet-2013	107	39	cnts)—have	cnts)—have	AUX
admet-2013	107	40	been	be	AUX
admet-2013	107	41	investigated	investigate	VERB
admet-2013	107	42	as	as	ADP
admet-2013	107	43	potential	potential	ADJ
admet-2013	107	44	ways	way	NOUN
admet-2013	107	45	to	to	PART
admet-2013	107	46	deliver	deliver	VERB
admet-2013	107	47	drugs	drug	NOUN
admet-2013	107	48	to	to	ADP
admet-2013	107	49	cml	cml	PROPN
admet-2013	107	50	.	.	PUNCT
admet-2013	108	1	silver	silver	ADJ
admet-2013	108	2	nanoparticles	nanoparticle	NOUN
admet-2013	108	3	bring	bring	VERB
admet-2013	108	4	about	about	ADP
admet-2013	108	5	cytotoxicity	cytotoxicity	NOUN
admet-2013	108	6	effect	effect	NOUN
admet-2013	108	7	in	in	ADP
admet-2013	108	8	cml	cml	PROPN
admet-2013	108	9	cells	cell	NOUN
admet-2013	108	10	[	[	X
admet-2013	108	11	6	6	NUM
admet-2013	108	12	]	]	PUNCT
admet-2013	108	13	.	.	PUNCT
admet-2013	109	1	gold	gold	ADJ
admet-2013	109	2	nanoparticles	nanoparticle	NOUN
admet-2013	109	3	(	(	PUNCT
admet-2013	109	4	gnps	gnps	ADV
admet-2013	109	5	)	)	PUNCT
admet-2013	109	6	have	have	AUX
admet-2013	109	7	been	be	AUX
admet-2013	109	8	proven	prove	VERB
admet-2013	109	9	to	to	PART
admet-2013	109	10	be	be	AUX
admet-2013	109	11	ideal	ideal	ADJ
admet-2013	109	12	drug	drug	NOUN
admet-2013	109	13	nanocarriers	nanocarrier	NOUN
admet-2013	109	14	for	for	ADP
admet-2013	109	15	anticancer	anticancer	NOUN
admet-2013	109	16	medications	medication	NOUN
admet-2013	109	17	because	because	SCONJ
admet-2013	109	18	they	they	PRON
admet-2013	109	19	can	can	AUX
admet-2013	109	20	safely	safely	ADV
admet-2013	109	21	transport	transport	VERB
admet-2013	109	22	and	and	CCONJ
admet-2013	109	23	protect	protect	VERB
admet-2013	109	24	a	a	DET
admet-2013	109	25	large	large	ADJ
admet-2013	109	26	therapeutic	therapeutic	ADJ
admet-2013	109	27	payload	payload	NOUN
admet-2013	109	28	and	and	CCONJ
admet-2013	109	29	deliver	deliver	VERB
admet-2013	109	30	the	the	DET
admet-2013	109	31	medication	medication	NOUN
admet-2013	109	32	just	just	ADV
admet-2013	109	33	to	to	ADP
admet-2013	109	34	the	the	DET
admet-2013	109	35	tumor	tumor	NOUN
admet-2013	109	36	site	site	NOUN
admet-2013	109	37	using	use	VERB
admet-2013	109	38	active	active	ADJ
admet-2013	109	39	/	/	SYM
admet-2013	109	40	passive	passive	ADJ
admet-2013	109	41	targeting	targeting	NOUN
admet-2013	109	42	techniques	technique	NOUN
admet-2013	109	43	,	,	PUNCT
admet-2013	109	44	increasing	increase	VERB
admet-2013	109	45	the	the	DET
admet-2013	109	46	therapeutic	therapeutic	ADJ
admet-2013	109	47	index	index	NOUN
admet-2013	109	48	[	[	X
admet-2013	109	49	39	39	NUM
admet-2013	109	50	]	]	PUNCT
admet-2013	109	51	.	.	PUNCT
admet-2013	110	1	a	a	DET
admet-2013	110	2	class	class	NOUN
admet-2013	110	3	of	of	ADP
admet-2013	110	4	magnetic	magnetic	ADJ
admet-2013	110	5	nanoparticles	nanoparticle	NOUN
admet-2013	110	6	(	(	PUNCT
admet-2013	110	7	magnetic	magnetic	PROPN
admet-2013	110	8	nps	nps	PROPN
admet-2013	110	9	)	)	PUNCT
admet-2013	110	10	that	that	PRON
admet-2013	110	11	exhibit	exhibit	VERB
admet-2013	110	12	small	small	ADJ
admet-2013	110	13	size	size	NOUN
admet-2013	110	14	,	,	PUNCT
admet-2013	110	15	quantum	quantum	NOUN
admet-2013	110	16	size	size	NOUN
admet-2013	110	17	,	,	PUNCT
admet-2013	110	18	increased	increase	VERB
admet-2013	110	19	surface	surface	NOUN
admet-2013	110	20	area	area	NOUN
admet-2013	110	21	,	,	PUNCT
admet-2013	110	22	and	and	CCONJ
admet-2013	110	23	macroscopic	macroscopic	ADJ
admet-2013	110	24	quantum	quantum	ADJ
admet-2013	110	25	tunneling	tunneling	NOUN
admet-2013	110	26	phenomena	phenomenon	NOUN
admet-2013	110	27	are	be	AUX
admet-2013	110	28	predominantly	predominantly	ADV
admet-2013	110	29	made	make	VERB
admet-2013	110	30	of	of	ADP
admet-2013	110	31	fe	fe	NOUN
admet-2013	110	32	oxide	oxide	NOUN
admet-2013	110	33	at	at	ADP
admet-2013	110	34	the	the	DET
admet-2013	110	35	nanoscale	nanoscale	NOUN
admet-2013	110	36	.	.	PUNCT
admet-2013	111	1	the	the	DET
admet-2013	111	2	inherent	inherent	ADJ
admet-2013	111	3	biological	biological	ADJ
admet-2013	111	4	functional	functional	ADJ
admet-2013	111	5	components	component	NOUN
admet-2013	111	6	make	make	VERB
admet-2013	111	7	them	they	PRON
admet-2013	111	8	suitable	suitable	ADJ
admet-2013	111	9	for	for	ADP
admet-2013	111	10	disease	disease	NOUN
admet-2013	111	11	monitoring	monitoring	NOUN
admet-2013	111	12	and	and	CCONJ
admet-2013	111	13	diagnosis	diagnosis	NOUN
admet-2013	111	14	[	[	X
admet-2013	111	15	40,41	40,41	NOUN
admet-2013	111	16	]	]	PUNCT
admet-2013	111	17	.	.	PUNCT
admet-2013	112	1	leukemia	leukemia	NOUN
admet-2013	112	2	cells	cell	NOUN
admet-2013	112	3	’	'	PUNCT
admet-2013	112	4	proliferation	proliferation	NOUN
admet-2013	112	5	was	be	AUX
admet-2013	112	6	inhibited	inhibit	VERB
admet-2013	112	7	by	by	ADP
admet-2013	112	8	carbon	carbon	NOUN
admet-2013	112	9	-	-	PUNCT
admet-2013	112	10	nanostructured	nanostructure	VERB
admet-2013	112	11	c60	c60	NOUN
admet-2013	112	12	fullerene	fullerene	NOUN
admet-2013	112	13	,	,	PUNCT
admet-2013	112	14	which	which	PRON
admet-2013	112	15	showed	show	VERB
admet-2013	112	16	strong	strong	ADJ
admet-2013	112	17	anticancer	anticancer	NOUN
admet-2013	112	18	properties	property	NOUN
admet-2013	112	19	.	.	PUNCT
admet-2013	113	1	it	it	PRON
admet-2013	113	2	got	get	AUX
admet-2013	113	3	activated	activate	VERB
admet-2013	113	4	by	by	ADP
admet-2013	113	5	violet	violet	ADJ
admet-2013	113	6	light	light	NOUN
admet-2013	113	7	to	to	PART
admet-2013	113	8	produce	produce	VERB
admet-2013	113	9	a	a	DET
admet-2013	113	10	lot	lot	NOUN
admet-2013	113	11	of	of	ADP
admet-2013	113	12	ros	ros	PROPN
admet-2013	113	13	and	and	CCONJ
admet-2013	113	14	apoptosis	apoptosis	NOUN
admet-2013	113	15	[	[	X
admet-2013	113	16	42	42	NUM
admet-2013	113	17	]	]	PUNCT
admet-2013	113	18	.	.	PUNCT
admet-2013	114	1	over	over	ADP
admet-2013	114	2	the	the	DET
admet-2013	114	3	past	past	ADJ
admet-2013	114	4	ten	ten	NUM
admet-2013	114	5	years	year	NOUN
admet-2013	114	6	,	,	PUNCT
admet-2013	114	7	there	there	PRON
admet-2013	114	8	has	have	AUX
admet-2013	114	9	been	be	AUX
admet-2013	114	10	a	a	DET
admet-2013	114	11	lot	lot	NOUN
admet-2013	114	12	of	of	ADP
admet-2013	114	13	curiosity	curiosity	NOUN
admet-2013	114	14	about	about	ADP
admet-2013	114	15	the	the	DET
admet-2013	114	16	prospective	prospective	ADJ
admet-2013	114	17	uses	use	NOUN
admet-2013	114	18	of	of	ADP
admet-2013	114	19	hybrid	hybrid	ADJ
admet-2013	114	20	nanocomposites	nanocomposite	NOUN
admet-2013	114	21	.	.	PUNCT
admet-2013	115	1	due	due	ADP
admet-2013	115	2	to	to	ADP
admet-2013	115	3	the	the	DET
admet-2013	115	4	additive	additive	NOUN
admet-2013	115	5	and	and	CCONJ
admet-2013	115	6	mixing	mix	VERB
admet-2013	115	7	qualities	quality	NOUN
admet-2013	115	8	of	of	ADP
admet-2013	115	9	inorganic	inorganic	ADJ
admet-2013	115	10	and	and	CCONJ
admet-2013	115	11	organic	organic	ADJ
admet-2013	115	12	components	component	NOUN
admet-2013	115	13	,	,	PUNCT
admet-2013	115	14	these	these	DET
admet-2013	115	15	composites	composite	NOUN
admet-2013	115	16	have	have	VERB
admet-2013	115	17	intriguing	intriguing	ADJ
admet-2013	115	18	features	feature	NOUN
admet-2013	115	19	.	.	PUNCT
admet-2013	116	1	various	various	ADJ
admet-2013	116	2	nanoformulations	nanoformulation	NOUN
admet-2013	116	3	of	of	ADP
admet-2013	116	4	inorganic	inorganic	ADJ
admet-2013	116	5	nanoparticles	nanoparticle	NOUN
admet-2013	116	6	in	in	ADP
admet-2013	116	7	treating	treat	VERB
admet-2013	116	8	cml	cml	PROPN
admet-2013	116	9	are	be	AUX
admet-2013	116	10	discussed	discuss	VERB
admet-2013	116	11	here	here	ADV
admet-2013	116	12	.	.	PUNCT
admet-2013	117	1	exosomes	exosome	NOUN
admet-2013	117	2	released	release	VERB
admet-2013	117	3	by	by	ADP
admet-2013	117	4	cml	cml	PROPN
admet-2013	117	5	cells	cell	NOUN
admet-2013	117	6	have	have	AUX
admet-2013	117	7	been	be	AUX
admet-2013	117	8	shown	show	VERB
admet-2013	117	9	in	in	ADP
admet-2013	117	10	numerous	numerous	ADJ
admet-2013	117	11	publications	publication	NOUN
admet-2013	117	12	to	to	PART
admet-2013	117	13	be	be	AUX
admet-2013	117	14	able	able	ADJ
admet-2013	117	15	to	to	PART
admet-2013	117	16	stimulate	stimulate	VERB
admet-2013	117	17	the	the	DET
admet-2013	117	18	growth	growth	NOUN
admet-2013	117	19	of	of	ADP
admet-2013	117	20	new	new	ADJ
admet-2013	117	21	blood	blood	NOUN
admet-2013	117	22	vessels	vessel	NOUN
admet-2013	117	23	,	,	PUNCT
admet-2013	117	24	pointing	point	VERB
admet-2013	117	25	to	to	ADP
admet-2013	117	26	a	a	DET
admet-2013	117	27	potential	potential	ADJ
admet-2013	117	28	function	function	NOUN
admet-2013	117	29	in	in	ADP
admet-2013	117	30	neo	neo	NOUN
admet-2013	117	31	-	-	NOUN
admet-2013	117	32	angiogenesis	angiogenesis	NOUN
admet-2013	117	33	[	[	X
admet-2013	117	34	43	43	NUM
admet-2013	117	35	]	]	PUNCT
admet-2013	117	36	.	.	PUNCT
admet-2013	118	1	exosomes	exosome	NOUN
admet-2013	118	2	purified	purify	VERB
admet-2013	118	3	from	from	ADP
admet-2013	118	4	k562	k562	PROPN
admet-2013	118	5	cells	cell	NOUN
admet-2013	118	6	encouraged	encourage	VERB
admet-2013	118	7	the	the	DET
admet-2013	118	8	expansion	expansion	NOUN
admet-2013	118	9	of	of	ADP
admet-2013	118	10	newly	newly	ADV
admet-2013	118	11	created	create	VERB
admet-2013	118	12	vasculature	vasculature	NOUN
admet-2013	118	13	,	,	PUNCT
admet-2013	118	14	accompanied	accompany	VERB
admet-2013	118	15	by	by	ADP
admet-2013	118	16	an	an	DET
admet-2013	118	17	uptick	uptick	NOUN
admet-2013	118	18	in	in	ADP
admet-2013	118	19	vegfr1	vegfr1	NOUN
admet-2013	118	20	expression	expression	NOUN
admet-2013	118	21	.	.	PUNCT
admet-2013	119	1	in	in	ADP
admet-2013	119	2	a	a	DET
admet-2013	119	3	chorioallantoic	chorioallantoic	ADJ
admet-2013	119	4	membrane	membrane	NOUN
admet-2013	119	5	(	(	PUNCT
admet-2013	119	6	cam	cam	NOUN
admet-2013	119	7	)	)	PUNCT
admet-2013	119	8	model	model	NOUN
admet-2013	119	9	,	,	PUNCT
admet-2013	119	10	it	it	PRON
admet-2013	119	11	has	have	AUX
admet-2013	119	12	been	be	AUX
admet-2013	119	13	shown	show	VERB
admet-2013	119	14	that	that	SCONJ
admet-2013	119	15	gold	gold	ADJ
admet-2013	119	16	nanoparticles	nanoparticle	NOUN
admet-2013	119	17	(	(	PUNCT
admet-2013	119	18	aunps	aunps	ADJ
admet-2013	119	19	)	)	PUNCT
admet-2013	119	20	enriched	enrich	VERB
admet-2013	119	21	with	with	ADP
admet-2013	119	22	antiangiogenic	antiangiogenic	ADJ
admet-2013	119	23	peptides	peptide	NOUN
admet-2013	119	24	can	can	AUX
admet-2013	119	25	prevent	prevent	VERB
admet-2013	119	26	angiogenesis	angiogenesis	NOUN
admet-2013	119	27	by	by	ADP
admet-2013	119	28	having	have	VERB
admet-2013	119	29	an	an	DET
admet-2013	119	30	impact	impact	NOUN
admet-2013	119	31	on	on	ADP
admet-2013	119	32	the	the	DET
admet-2013	119	33	intrinsic	intrinsic	ADJ
admet-2013	119	34	vegfr	vegfr	NOUN
admet-2013	119	35	pathway	pathway	NOUN
admet-2013	120	1	[	[	X
admet-2013	120	2	44	44	NUM
admet-2013	120	3	]	]	PUNCT
admet-2013	120	4	.	.	PUNCT
admet-2013	121	1	in	in	ADP
admet-2013	121	2	cml	cml	PROPN
admet-2013	121	3	k562	k562	PROPN
admet-2013	121	4	cells	cell	NOUN
admet-2013	121	5	,	,	PUNCT
admet-2013	121	6	cuo	cuo	PROPN
admet-2013	121	7	-	-	PUNCT
admet-2013	121	8	tio2	tio2	NOUN
admet-2013	121	9	-	-	PUNCT
admet-2013	121	10	chitosan	chitosan	NOUN
admet-2013	121	11	-	-	PUNCT
admet-2013	121	12	berbamine	berbamine	NOUN
admet-2013	121	13	nanocomposites	nanocomposite	NOUN
admet-2013	121	14	led	lead	VERB
admet-2013	121	15	to	to	ADP
admet-2013	121	16	the	the	DET
admet-2013	121	17	death	death	NOUN
admet-2013	121	18	of	of	ADP
admet-2013	121	19	cells	cell	NOUN
admet-2013	121	20	in	in	ADP
admet-2013	121	21	a	a	DET
admet-2013	121	22	dose	dose	NOUN
admet-2013	121	23	-	-	PUNCT
admet-2013	121	24	dependent	dependent	ADJ
admet-2013	121	25	way	way	NOUN
admet-2013	121	26	with	with	ADP
admet-2013	121	27	an	an	DET
admet-2013	121	28	ic50	ic50	PROPN
admet-2013	121	29	of	of	ADP
admet-2013	121	30	113.54	113.54	NUM
admet-2013	121	31	g	g	NOUN
admet-2013	121	32	/	/	SYM
admet-2013	121	33	ml	ml	NOUN
admet-2013	121	34	.	.	PUNCT
admet-2013	122	1	by	by	ADP
admet-2013	122	2	targeting	target	VERB
admet-2013	122	3	members	member	NOUN
admet-2013	122	4	of	of	ADP
admet-2013	122	5	the	the	DET
admet-2013	122	6	bcl-2	bcl-2	ADJ
admet-2013	122	7	family	family	NOUN
admet-2013	122	8	(	(	PUNCT
admet-2013	122	9	bax	bax	NOUN
admet-2013	122	10	and	and	CCONJ
admet-2013	122	11	bcl-2	bcl-2	NOUN
admet-2013	122	12	)	)	PUNCT
admet-2013	122	13	and	and	CCONJ
admet-2013	122	14	raising	raise	VERB
admet-2013	122	15	the	the	DET
admet-2013	122	16	level	level	NOUN
admet-2013	122	17	of	of	ADP
admet-2013	122	18	p53	p53	NOUN
admet-2013	122	19	,	,	PUNCT
admet-2013	122	20	they	they	PRON
admet-2013	122	21	cause	cause	VERB
admet-2013	122	22	mitochondrial	mitochondrial	ADJ
admet-2013	122	23	apoptosis	apoptosis	NOUN
admet-2013	122	24	[	[	X
admet-2013	122	25	45	45	NUM
admet-2013	122	26	]	]	PUNCT
admet-2013	122	27	.	.	PUNCT
admet-2013	123	1	dasatinib	dasatinib	NOUN
admet-2013	123	2	-	-	PUNCT
admet-2013	123	3	loaded	load	VERB
admet-2013	123	4	gold	gold	NOUN
admet-2013	123	5	nanoparticles	nanoparticle	NOUN
admet-2013	123	6	(	(	PUNCT
admet-2013	123	7	dsbgnps	dsbgnps	PROPN
admet-2013	123	8	)	)	PUNCT
admet-2013	123	9	are	be	AUX
admet-2013	123	10	a	a	DET
admet-2013	123	11	reliable	reliable	ADJ
admet-2013	123	12	method	method	NOUN
admet-2013	123	13	for	for	ADP
admet-2013	123	14	dsb	dsb	PROPN
admet-2013	123	15	administration	administration	NOUN
admet-2013	123	16	in	in	ADP
admet-2013	123	17	the	the	DET
admet-2013	123	18	therapy	therapy	NOUN
admet-2013	123	19	of	of	ADP
admet-2013	123	20	cml	cml	PROPN
admet-2013	123	21	due	due	ADP
admet-2013	123	22	to	to	ADP
admet-2013	123	23	their	their	PRON
admet-2013	123	24	claimed	claim	VERB
admet-2013	123	25	cytotoxic	cytotoxic	ADJ
admet-2013	123	26	effect	effect	NOUN
admet-2013	123	27	,	,	PUNCT
admet-2013	123	28	systemic	systemic	ADJ
admet-2013	123	29	bioavailability	bioavailability	NOUN
admet-2013	123	30	,	,	PUNCT
admet-2013	123	31	and	and	CCONJ
admet-2013	123	32	sustained	sustain	VERB
admet-2013	123	33	release	release	NOUN
admet-2013	123	34	[	[	X
admet-2013	123	35	46	46	NUM
admet-2013	123	36	]	]	PUNCT
admet-2013	123	37	.	.	PUNCT
admet-2013	124	1	after	after	ADP
admet-2013	124	2	treating	treat	VERB
admet-2013	124	3	k562	k562	PROPN
admet-2013	124	4	cells	cell	NOUN
admet-2013	124	5	with	with	ADP
admet-2013	124	6	zinc	zinc	NOUN
admet-2013	124	7	oxide	oxide	NOUN
admet-2013	124	8	nps	nps	PROPN
admet-2013	124	9	(	(	PUNCT
admet-2013	124	10	zno	zno	PROPN
admet-2013	124	11	nps	nps	PROPN
admet-2013	124	12	)	)	PUNCT
admet-2013	124	13	,	,	PUNCT
admet-2013	124	14	admet	admet	PROPN
admet-2013	124	15	&	&	CCONJ
admet-2013	124	16	dmpk	dmpk	PROPN
admet-2013	124	17	11(4	11(4	NUM
admet-2013	124	18	)	)	PUNCT
admet-2013	124	19	(	(	PUNCT
admet-2013	124	20	2023	2023	NUM
admet-2013	124	21	)	)	PUNCT
admet-2013	124	22	499	499	NUM
admet-2013	124	23	-	-	SYM
admet-2013	124	24	511	511	NUM
admet-2013	124	25	nanoparticles	nanoparticle	NOUN
admet-2013	124	26	in	in	ADP
admet-2013	124	27	the	the	DET
admet-2013	124	28	therapy	therapy	NOUN
admet-2013	124	29	of	of	ADP
admet-2013	124	30	chronic	chronic	ADJ
admet-2013	124	31	myelogenous	myelogenous	ADJ
admet-2013	124	32	leukemia	leukemia	PROPN
admet-2013	124	33	doi	doi	PROPN
admet-2013	124	34	:	:	PUNCT
admet-2013	124	35	https://doi.org/10.5599/adme	https://doi.org/10.5599/adme	NOUN
admet-2013	124	36	t.2013	t.2013	PROPN
admet-2013	124	37	503	503	NUM
admet-2013	124	38	researchers	researcher	NOUN
admet-2013	124	39	could	could	AUX
admet-2013	124	40	detect	detect	VERB
admet-2013	124	41	changes	change	NOUN
admet-2013	124	42	in	in	ADP
admet-2013	124	43	the	the	DET
admet-2013	124	44	transcriptome	transcriptome	NOUN
admet-2013	124	45	using	use	VERB
admet-2013	124	46	a	a	DET
admet-2013	124	47	dna	dna	NOUN
admet-2013	124	48	microarray	microarray	NOUN
admet-2013	124	49	-	-	PUNCT
admet-2013	124	50	based	base	VERB
admet-2013	124	51	transcriptomic	transcriptomic	ADJ
admet-2013	124	52	method	method	NOUN
admet-2013	124	53	.	.	PUNCT
admet-2013	125	1	the	the	DET
admet-2013	125	2	transcriptomics	transcriptomic	NOUN
admet-2013	125	3	results	result	NOUN
admet-2013	125	4	supported	support	VERB
admet-2013	125	5	the	the	DET
admet-2013	125	6	zno	zno	PROPN
admet-2013	125	7	nps	nps	PROPN
admet-2013	125	8	'	'	PART
admet-2013	125	9	induction	induction	NOUN
admet-2013	125	10	of	of	ADP
admet-2013	125	11	apoptosis	apoptosis	NOUN
admet-2013	125	12	in	in	ADP
admet-2013	125	13	k562	k562	PROPN
admet-2013	125	14	cells	cell	NOUN
admet-2013	125	15	and	and	CCONJ
admet-2013	125	16	suggested	suggest	VERB
admet-2013	125	17	potential	potential	ADJ
admet-2013	125	18	molecular	molecular	ADJ
admet-2013	125	19	pathways	pathway	NOUN
admet-2013	125	20	by	by	ADP
admet-2013	125	21	which	which	PRON
admet-2013	125	22	the	the	DET
admet-2013	125	23	nps	nps	PROPN
admet-2013	125	24	caused	cause	VERB
admet-2013	125	25	toxicity	toxicity	NOUN
admet-2013	125	26	in	in	ADP
admet-2013	125	27	the	the	DET
admet-2013	125	28	leukemic	leukemic	ADJ
admet-2013	125	29	cells	cell	NOUN
admet-2013	125	30	[	[	X
admet-2013	125	31	47	47	NUM
admet-2013	125	32	]	]	PUNCT
admet-2013	125	33	.	.	PUNCT
admet-2013	126	1	various	various	ADJ
admet-2013	126	2	inorganic	inorganic	ADJ
admet-2013	126	3	nanoparticles	nanoparticle	NOUN
admet-2013	126	4	involved	involve	VERB
admet-2013	126	5	in	in	ADP
admet-2013	126	6	nanoformulation	nanoformulation	NOUN
admet-2013	126	7	for	for	ADP
admet-2013	126	8	treating	treat	VERB
admet-2013	126	9	cml	cml	PROPN
admet-2013	126	10	have	have	AUX
admet-2013	126	11	been	be	AUX
admet-2013	126	12	summarized	summarize	VERB
admet-2013	126	13	in	in	ADP
admet-2013	126	14	table	table	NOUN
admet-2013	126	15	1	1	NUM
admet-2013	126	16	.	.	PUNCT
admet-2013	126	17	table	table	NOUN
admet-2013	126	18	1	1	NUM
admet-2013	126	19	.	.	PUNCT
admet-2013	126	20	explanations	explanation	NOUN
admet-2013	126	21	of	of	ADP
admet-2013	126	22	the	the	DET
admet-2013	126	23	various	various	ADJ
admet-2013	126	24	nanoformulations	nanoformulation	NOUN
admet-2013	126	25	of	of	ADP
admet-2013	126	26	inorganic	inorganic	ADJ
admet-2013	126	27	nanoparticles	nanoparticle	NOUN
admet-2013	126	28	that	that	PRON
admet-2013	126	29	have	have	AUX
admet-2013	126	30	been	be	AUX
admet-2013	126	31	employed	employ	VERB
admet-2013	126	32	in	in	ADP
admet-2013	126	33	cml	cml	PROPN
admet-2013	126	34	treatment	treatment	NOUN
admet-2013	126	35	so	so	ADV
admet-2013	126	36	far	far	ADV
admet-2013	126	37	no	no	NOUN
admet-2013	126	38	.	.	PUNCT
admet-2013	126	39	nanoparticle	nanoparticle	NOUN
admet-2013	126	40	type	type	NOUN
admet-2013	126	41	conjugated	conjugate	VERB
admet-2013	126	42	to	to	ADP
admet-2013	126	43	mechanism	mechanism	NOUN
admet-2013	126	44	of	of	ADP
admet-2013	126	45	action	action	NOUN
admet-2013	126	46	experiment	experiment	NOUN
admet-2013	126	47	ref	ref	NOUN
admet-2013	126	48	.	.	PUNCT
admet-2013	127	1	1	1	NUM
admet-2013	127	2	mesoporous	mesoporous	ADJ
admet-2013	127	3	silica	silica	NOUN
admet-2013	127	4	nanoparticle	nanoparticle	NOUN
admet-2013	127	5	glycine	glycine	NOUN
admet-2013	127	6	and	and	CCONJ
admet-2013	127	7	doxorubicin	doxorubicin	VERB
admet-2013	127	8	59	59	NUM
admet-2013	127	9	%	%	NOUN
admet-2013	127	10	of	of	ADP
admet-2013	127	11	doxorubicin	doxorubicin	PROPN
admet-2013	127	12	drug	drug	NOUN
admet-2013	127	13	is	be	AUX
admet-2013	127	14	released	release	VERB
admet-2013	127	15	from	from	ADP
admet-2013	127	16	the	the	DET
admet-2013	127	17	aggregate	aggregate	NOUN
admet-2013	127	18	inhibiting	inhibit	VERB
admet-2013	127	19	the	the	DET
admet-2013	127	20	k562	k562	PROPN
admet-2013	127	21	cells	cell	NOUN
admet-2013	127	22	.	.	PUNCT
admet-2013	128	1	in	in	ADP
admet-2013	128	2	vitro	vitro	X
admet-2013	128	3	[	[	PUNCT
admet-2013	128	4	48	48	NUM
admet-2013	128	5	]	]	SYM
admet-2013	128	6	2	2	NUM
admet-2013	128	7	thioxanthone	thioxanthone	NOUN
admet-2013	128	8	derived	derive	VERB
admet-2013	128	9	gold	gold	NOUN
admet-2013	128	10	nanoparticle	nanoparticle	NOUN
admet-2013	128	11	doxorubicin	doxorubicin	PROPN
admet-2013	128	12	5µl	5µl	NOUN
admet-2013	128	13	of	of	ADP
admet-2013	128	14	conjugated	conjugate	VERB
admet-2013	128	15	doxorubicin	doxorubicin	PROPN
admet-2013	128	16	killedk562	killedk562	PROPN
admet-2013	128	17	cells	cell	NOUN
admet-2013	128	18	with	with	ADP
admet-2013	128	19	7.3	7.3	NUM
admet-2013	128	20	%	%	NOUN
admet-2013	128	21	cytotoxicity	cytotoxicity	NOUN
admet-2013	128	22	.	.	PUNCT
admet-2013	129	1	in	in	ADP
admet-2013	129	2	vitro	vitro	X
admet-2013	129	3	[	[	X
admet-2013	129	4	49	49	NUM
admet-2013	129	5	]	]	SYM
admet-2013	129	6	3	3	NUM
admet-2013	129	7	gold	gold	NOUN
admet-2013	129	8	nanoparticle	nanoparticle	NOUN
admet-2013	129	9	as1411	as1411	PROPN
admet-2013	129	10	,	,	PUNCT
admet-2013	129	11	doxorubicin	doxorubicin	PROPN
admet-2013	129	12	,	,	PUNCT
admet-2013	129	13	anti-221	anti-221	NOUN
admet-2013	129	14	they	they	PRON
admet-2013	129	15	triggered	trigger	VERB
admet-2013	129	16	apoptosis	apoptosis	NOUN
admet-2013	129	17	of	of	ADP
admet-2013	129	18	drug	drug	NOUN
admet-2013	129	19	-	-	PUNCT
admet-2013	129	20	resistant	resistant	ADJ
admet-2013	129	21	cml	cml	PROPN
admet-2013	129	22	cells	cell	NOUN
admet-2013	129	23	by	by	ADP
admet-2013	129	24	down	down	ADV
admet-2013	129	25	-	-	PUNCT
admet-2013	129	26	regulating	regulate	VERB
admet-2013	129	27	dnmt1	dnmt1	NOUN
admet-2013	129	28	and	and	CCONJ
admet-2013	129	29	mir-221.this	mir-221.this	PRON
admet-2013	129	30	downregulation	downregulation	NOUN
admet-2013	129	31	restored	restore	VERB
admet-2013	129	32	p15ink4b	p15ink4b	NOUN
admet-2013	129	33	andp27kip1	andp27kip1	PROPN
admet-2013	129	34	tumor	tumor	NOUN
admet-2013	129	35	suppressor	suppressor	NOUN
admet-2013	129	36	expression	expression	NOUN
admet-2013	129	37	.	.	PUNCT
admet-2013	130	1	they	they	PRON
admet-2013	130	2	also	also	ADV
admet-2013	130	3	restored	restore	VERB
admet-2013	130	4	p	p	NOUN
admet-2013	130	5	-	-	PUNCT
admet-2013	130	6	gp	gp	NOUN
admet-2013	130	7	expression	expression	NOUN
admet-2013	130	8	which	which	PRON
admet-2013	130	9	was	be	AUX
admet-2013	130	10	downregulated	downregulate	VERB
admet-2013	130	11	by	by	ADP
admet-2013	130	12	mir-221	mir-221	NOUN
admet-2013	130	13	.	.	PUNCT
admet-2013	131	1	in	in	ADP
admet-2013	131	2	vitro	vitro	X
admet-2013	131	3	[	[	X
admet-2013	131	4	50	50	NUM
admet-2013	131	5	]	]	SYM
admet-2013	131	6	4	4	NUM
admet-2013	131	7	cobalt	cobalt	NOUN
admet-2013	131	8	ferrite	ferrite	NOUN
admet-2013	131	9	nanoparticle	nanoparticle	NOUN
admet-2013	131	10	45	45	NUM
admet-2013	131	11	%	%	NOUN
admet-2013	131	12	oleic	oleic	ADJ
admet-2013	131	13	acid	acid	PROPN
admet-2013	131	14	9	9	NUM
admet-2013	131	15	µm	µm	NOUN
admet-2013	131	16	of	of	ADP
admet-2013	131	17	coated	coated	ADJ
admet-2013	131	18	cofe2o4	cofe2o4	NOUN
admet-2013	131	19	showed	show	VERB
admet-2013	131	20	strong	strong	ADJ
admet-2013	131	21	apoptotic	apoptotic	ADJ
admet-2013	131	22	effects	effect	NOUN
admet-2013	131	23	on	on	ADP
admet-2013	131	24	k562	k562	PROPN
admet-2013	131	25	cells	cell	NOUN
admet-2013	131	26	when	when	SCONJ
admet-2013	131	27	they	they	PRON
admet-2013	131	28	aretreatedfor72	aretreatedfor72	VERB
admet-2013	131	29	h.	h.	PROPN
admet-2013	131	30	in	in	ADP
admet-2013	131	31	vitro	vitro	X
admet-2013	131	32	[	[	X
admet-2013	131	33	51	51	NUM
admet-2013	131	34	]	]	SYM
admet-2013	131	35	5	5	NUM
admet-2013	131	36	arsenic	arsenic	ADJ
admet-2013	131	37	trioxide	trioxide	NOUN
admet-2013	131	38	nanoparticle	nanoparticle	NOUN
admet-2013	131	39	dss6	dss6	PROPN
admet-2013	131	40	and	and	CCONJ
admet-2013	131	41	f56	f56	NOUN
admet-2013	131	42	20	20	NUM
admet-2013	131	43	percent	percent	NOUN
admet-2013	131	44	f56	f56	NOUN
admet-2013	131	45	and	and	CCONJ
admet-2013	131	46	50	50	NUM
admet-2013	131	47	percent	percent	NOUN
admet-2013	131	48	dss6	dss6	PROPN
admet-2013	131	49	oligopeptide	oligopeptide	NOUN
admet-2013	131	50	target	target	VERB
admet-2013	131	51	the	the	DET
admet-2013	131	52	vascular	vascular	NOUN
admet-2013	131	53	and	and	CCONJ
admet-2013	131	54	endothelia	endothelia	NOUN
admet-2013	131	55	niches	niche	NOUN
admet-2013	131	56	.	.	PUNCT
admet-2013	132	1	they	they	PRON
admet-2013	132	2	suppress	suppress	VERB
admet-2013	132	3	the	the	DET
admet-2013	132	4	colony	colony	NOUN
admet-2013	132	5	-	-	PUNCT
admet-2013	132	6	forming	form	VERB
admet-2013	132	7	function	function	NOUN
admet-2013	132	8	and	and	CCONJ
admet-2013	132	9	proliferation	proliferation	NOUN
admet-2013	132	10	of	of	ADP
admet-2013	132	11	k562	k562	PROPN
admet-2013	132	12	cells	cell	NOUN
admet-2013	132	13	with	with	ADP
admet-2013	132	14	the	the	DET
admet-2013	132	15	ic50	ic50	PROPN
admet-2013	132	16	value	value	NOUN
admet-2013	132	17	of	of	ADP
admet-2013	132	18	3.29	3.29	NUM
admet-2013	132	19	µm	µm	NOUN
admet-2013	132	20	.	.	PUNCT
admet-2013	133	1	in	in	ADP
admet-2013	133	2	vitro	vitro	X
admet-2013	133	3	[	[	X
admet-2013	133	4	52	52	NUM
admet-2013	133	5	]	]	SYM
admet-2013	133	6	6	6	NUM
admet-2013	133	7	realgar	realgar	NOUN
admet-2013	133	8	imatinib	imatinib	NOUN
admet-2013	133	9	they	they	PRON
admet-2013	133	10	suppressed	suppress	VERB
admet-2013	133	11	the	the	DET
admet-2013	133	12	tyrosine	tyrosine	NOUN
admet-2013	133	13	kinase	kinase	NOUN
admet-2013	133	14	activity	activity	NOUN
admet-2013	133	15	via	via	ADP
admet-2013	133	16	apoptotic	apoptotic	ADJ
admet-2013	133	17	mechanism	mechanism	NOUN
admet-2013	133	18	.	.	PUNCT
admet-2013	134	1	in	in	ADP
admet-2013	134	2	vitro	vitro	X
admet-2013	134	3	[	[	PUNCT
admet-2013	134	4	53	53	NUM
admet-2013	134	5	]	]	SYM
admet-2013	134	6	7	7	NUM
admet-2013	134	7	arsenic	arsenic	ADJ
admet-2013	134	8	sulfide	sulfide	NOUN
admet-2013	134	9	nanoparticle	nanoparticle	NOUN
admet-2013	134	10	water	water	NOUN
admet-2013	134	11	dissolved	dissolve	VERB
admet-2013	134	12	they	they	PRON
admet-2013	134	13	directly	directly	ADV
admet-2013	134	14	degraded	degrade	VERB
admet-2013	134	15	the	the	DET
admet-2013	134	16	bcr	bcr	NOUN
admet-2013	134	17	-	-	NOUN
admet-2013	134	18	abl	abl	NOUN
admet-2013	134	19	by	by	ADP
admet-2013	134	20	down	down	ADV
admet-2013	134	21	-	-	PUNCT
admet-2013	134	22	regulating	regulate	VERB
admet-2013	134	23	hypoxia	hypoxia	NOUN
admet-2013	134	24	-	-	PUNCT
admet-2013	134	25	inducible	inducible	ADJ
admet-2013	134	26	factor	factor	NOUN
admet-2013	134	27	1α	1α	NOUN
admet-2013	134	28	and	and	CCONJ
admet-2013	134	29	ros	ros	PROPN
admet-2013	134	30	.	.	PUNCT
admet-2013	135	1	in	in	ADP
admet-2013	135	2	vitro	vitro	X
admet-2013	135	3	[	[	X
admet-2013	135	4	54	54	NUM
admet-2013	135	5	]	]	SYM
admet-2013	135	6	8	8	NUM
admet-2013	135	7	ferrous	ferrous	ADJ
admet-2013	135	8	oxide	oxide	NOUN
admet-2013	135	9	and	and	CCONJ
admet-2013	135	10	zinc	zinc	NOUN
admet-2013	135	11	oxide	oxide	NOUN
admet-2013	135	12	nanoparticle	nanoparticle	NOUN
admet-2013	135	13	hydroxylated	hydroxylate	VERB
admet-2013	135	14	carbon	carbon	NOUN
admet-2013	135	15	nanotube	nanotube	VERB
admet-2013	135	16	the	the	DET
admet-2013	135	17	proliferation	proliferation	NOUN
admet-2013	135	18	activity	activity	NOUN
admet-2013	135	19	of	of	ADP
admet-2013	135	20	k562	k562	PROPN
admet-2013	135	21	cells	cell	NOUN
admet-2013	135	22	is	be	AUX
admet-2013	135	23	decreased	decrease	VERB
admet-2013	135	24	through	through	ADP
admet-2013	135	25	activation	activation	NOUN
admet-2013	135	26	of	of	ADP
admet-2013	135	27	apoptosis	apoptosis	NOUN
admet-2013	135	28	and	and	CCONJ
admet-2013	135	29	g1	g1	PROPN
admet-2013	135	30	arrest	arrest	NOUN
admet-2013	135	31	.	.	PUNCT
admet-2013	136	1	it	it	PRON
admet-2013	136	2	is	be	AUX
admet-2013	136	3	carried	carry	VERB
admet-2013	136	4	out	out	ADP
admet-2013	136	5	by	by	ADP
admet-2013	136	6	upregulating	upregulate	VERB
admet-2013	136	7	the	the	DET
admet-2013	136	8	foxo3a	foxo3a	NOUN
admet-2013	136	9	and	and	CCONJ
admet-2013	136	10	sirt1.they	sirt1.they	PROPN
admet-2013	136	11	also	also	ADV
admet-2013	136	12	inhibit	inhibit	VERB
admet-2013	136	13	the	the	DET
admet-2013	136	14	nf	nf	ADJ
admet-2013	136	15	-	-	PUNCT
admet-2013	136	16	kβ	kβ	ADJ
admet-2013	136	17	signaling	signal	VERB
admet-2013	136	18	pathway	pathway	NOUN
admet-2013	136	19	.	.	PUNCT
admet-2013	137	1	in	in	ADP
admet-2013	137	2	vitro	vitro	X
admet-2013	137	3	[	[	X
admet-2013	137	4	55	55	NUM
admet-2013	137	5	]	]	SYM
admet-2013	137	6	9	9	NUM
admet-2013	137	7	silver	silver	NOUN
admet-2013	137	8	nanoparticle	nanoparticle	NOUN
admet-2013	137	9	sophora	sophora	PROPN
admet-2013	137	10	pachycarpa	pachycarpa	PROPN
admet-2013	137	11	extract	extract	NOUN
admet-2013	137	12	it	it	PRON
admet-2013	137	13	showed	show	VERB
admet-2013	137	14	anticancer	anticancer	NOUN
admet-2013	137	15	activity	activity	NOUN
admet-2013	137	16	in	in	ADP
admet-2013	137	17	k562	k562	PROPN
admet-2013	137	18	cells	cell	NOUN
admet-2013	137	19	with	with	ADP
admet-2013	137	20	an	an	DET
admet-2013	137	21	ic50	ic50	PROPN
admet-2013	137	22	value	value	NOUN
admet-2013	137	23	of	of	ADP
admet-2013	137	24	19.5	19.5	NUM
admet-2013	137	25	mg	mg	NUM
admet-2013	137	26	/	/	SYM
admet-2013	137	27	ml	ml	NOUN
admet-2013	137	28	.	.	PUNCT
admet-2013	138	1	in	in	ADP
admet-2013	138	2	vitro	vitro	X
admet-2013	138	3	[	[	X
admet-2013	138	4	56	56	NUM
admet-2013	138	5	]	]	SYM
admet-2013	138	6	10	10	NUM
admet-2013	138	7	.	.	PUNCT
admet-2013	139	1	ultra	ultra	ADJ
admet-2013	139	2	small	small	ADJ
admet-2013	139	3	platinum	platinum	NOUN
admet-2013	139	4	nanoparticles	nanoparticle	NOUN
admet-2013	139	5	gold	gold	NOUN
admet-2013	139	6	nanorods	nanorod	NOUN
admet-2013	139	7	it	it	PRON
admet-2013	139	8	facilitated	facilitate	VERB
admet-2013	139	9	ros	ros	PROPN
admet-2013	139	10	fluctuation	fluctuation	NOUN
admet-2013	139	11	and	and	CCONJ
admet-2013	139	12	triggered	trigger	VERB
admet-2013	139	13	cellular	cellular	ADJ
admet-2013	139	14	autophagy	autophagy	NOUN
admet-2013	139	15	by	by	ADP
admet-2013	139	16	increasing	increase	VERB
admet-2013	139	17	the	the	DET
admet-2013	139	18	level	level	NOUN
admet-2013	139	19	of	of	ADP
admet-2013	139	20	beclin-1	beclin-1	PROPN
admet-2013	139	21	,	,	PUNCT
admet-2013	139	22	which	which	PRON
admet-2013	139	23	degraded	degrade	VERB
admet-2013	139	24	the	the	DET
admet-2013	139	25	bcr	bcr	NOUN
admet-2013	139	26	-	-	NOUN
admet-2013	139	27	abl	abl	NOUN
admet-2013	139	28	.	.	PUNCT
admet-2013	140	1	it	it	PRON
admet-2013	140	2	also	also	ADV
admet-2013	140	3	downregulated	downregulate	VERB
admet-2013	140	4	the	the	DET
admet-2013	140	5	phosphorylation	phosphorylation	NOUN
admet-2013	140	6	of	of	ADP
admet-2013	140	7	pi3k	pi3k	PROPN
admet-2013	140	8	and	and	CCONJ
admet-2013	140	9	akt	akt	PROPN
admet-2013	140	10	.	.	PUNCT
admet-2013	141	1	in	in	ADP
admet-2013	141	2	vitro	vitro	X
admet-2013	141	3	[	[	PUNCT
admet-2013	141	4	57	57	NUM
admet-2013	141	5	]	]	PUNCT
admet-2013	141	6	nanoparticles	nanoparticle	NOUN
admet-2013	141	7	targeting	target	VERB
admet-2013	141	8	tyrosine	tyrosine	PROPN
admet-2013	141	9	kinase	kinase	PROPN
admet-2013	141	10	pathway	pathway	PROPN
admet-2013	141	11	tyrosine	tyrosine	PROPN
admet-2013	141	12	kinases	kinases	PROPN
admet-2013	141	13	(	(	PUNCT
admet-2013	141	14	egfr	egfr	ADJ
admet-2013	141	15	,	,	PUNCT
admet-2013	141	16	fgfr	fgfr	ADJ
admet-2013	141	17	,	,	PUNCT
admet-2013	141	18	pdgfr	pdgfr	ADJ
admet-2013	141	19	,	,	PUNCT
admet-2013	141	20	and	and	CCONJ
admet-2013	141	21	vegfr	vegfr	VERB
admet-2013	141	22	,	,	PUNCT
admet-2013	141	23	for	for	ADP
admet-2013	141	24	example	example	NOUN
admet-2013	141	25	)	)	PUNCT
admet-2013	141	26	are	be	AUX
admet-2013	141	27	commonly	commonly	ADV
admet-2013	141	28	abnormally	abnormally	ADV
admet-2013	141	29	triggered	trigger	VERB
admet-2013	141	30	in	in	ADP
admet-2013	141	31	tumors	tumor	NOUN
admet-2013	141	32	and	and	CCONJ
admet-2013	141	33	numerous	numerous	ADJ
admet-2013	141	34	publications	publication	NOUN
admet-2013	141	35	have	have	AUX
admet-2013	141	36	seen	see	VERB
admet-2013	141	37	encouraging	encourage	VERB
admet-2013	141	38	therapeutic	therapeutic	ADJ
admet-2013	141	39	benefits	benefit	NOUN
admet-2013	141	40	by	by	ADP
admet-2013	141	41	employing	employ	VERB
admet-2013	141	42	very	very	ADV
admet-2013	141	43	smallmolecule	smallmolecule	NOUN
admet-2013	141	44	that	that	PRON
admet-2013	141	45	block	block	VERB
admet-2013	141	46	the	the	DET
admet-2013	141	47	tyrosine	tyrosine	NOUN
admet-2013	141	48	kinase	kinase	PROPN
admet-2013	141	49	key	key	PROPN
admet-2013	141	50	pathways	pathway	NOUN
admet-2013	141	51	associated	associate	VERB
admet-2013	141	52	with	with	ADP
admet-2013	141	53	the	the	DET
admet-2013	141	54	growth	growth	NOUN
admet-2013	141	55	and	and	CCONJ
admet-2013	141	56	progression	progression	NOUN
admet-2013	141	57	of	of	ADP
admet-2013	141	58	tumor	tumor	NOUN
admet-2013	141	59	cells	cell	NOUN
admet-2013	141	60	[	[	X
admet-2013	141	61	58	58	NUM
admet-2013	141	62	]	]	PUNCT
admet-2013	141	63	.	.	PUNCT
admet-2013	142	1	an	an	DET
admet-2013	142	2	actively	actively	ADV
admet-2013	142	3	functioning	function	VERB
admet-2013	142	4	non	non	ADJ
admet-2013	142	5	-	-	ADJ
admet-2013	142	6	receptor	receptor	ADJ
admet-2013	142	7	tyrosine	tyrosine	NOUN
admet-2013	142	8	kinase	kinase	PROPN
admet-2013	142	9	enzyme	enzyme	NOUN
admet-2013	142	10	called	call	VERB
admet-2013	142	11	bcr	bcr	NOUN
admet-2013	142	12	-	-	PUNCT
admet-2013	142	13	abl	abl	NOUN
admet-2013	142	14	can	can	AUX
admet-2013	142	15	be	be	AUX
admet-2013	142	16	identified	identify	VERB
admet-2013	142	17	in	in	ADP
admet-2013	142	18	the	the	DET
admet-2013	142	19	cytoplasm	cytoplasm	NOUN
admet-2013	142	20	of	of	ADP
admet-2013	142	21	leukemia	leukemia	NOUN
admet-2013	142	22	cells	cell	NOUN
admet-2013	142	23	that	that	PRON
admet-2013	142	24	have	have	VERB
admet-2013	142	25	the	the	DET
admet-2013	142	26	philadelphia	philadelphia	PROPN
admet-2013	142	27	chromosome	chromosome	NOUN
admet-2013	142	28	[	[	X
admet-2013	142	29	59	59	NUM
admet-2013	142	30	]	]	PUNCT
admet-2013	142	31	.	.	PUNCT
admet-2013	143	1	tyrosine	tyrosine	PROPN
admet-2013	143	2	kinase	kinase	PROPN
admet-2013	143	3	inhibitor	inhibitor	PROPN
admet-2013	143	4	(	(	PUNCT
admet-2013	143	5	tki	tki	PROPN
admet-2013	143	6	)	)	PUNCT
admet-2013	143	7	based	base	VERB
admet-2013	143	8	therapy	therapy	NOUN
admet-2013	143	9	is	be	AUX
admet-2013	143	10	regarded	regard	VERB
admet-2013	143	11	as	as	ADP
admet-2013	143	12	the	the	DET
admet-2013	143	13	most	most	ADV
admet-2013	143	14	effective	effective	ADJ
admet-2013	143	15	form	form	NOUN
admet-2013	143	16	of	of	ADP
admet-2013	143	17	management	management	NOUN
admet-2013	143	18	for	for	ADP
admet-2013	143	19	cml	cml	PROPN
admet-2013	143	20	.	.	PUNCT
admet-2013	144	1	in	in	ADP
admet-2013	144	2	cml	cml	PROPN
admet-2013	144	3	,	,	PUNCT
admet-2013	144	4	the	the	DET
admet-2013	144	5	ras	ras	PROPN
admet-2013	144	6	mitogenactivated	mitogenactivated	ADJ
admet-2013	144	7	protein	protein	NOUN
admet-2013	144	8	kinase	kinase	PROPN
admet-2013	144	9	family	family	PROPN
admet-2013	144	10	(	(	PUNCT
admet-2013	144	11	mapks	mapks	NOUN
admet-2013	144	12	)	)	PUNCT
admet-2013	144	13	,	,	PUNCT
admet-2013	144	14	including	include	VERB
admet-2013	144	15	the	the	DET
admet-2013	144	16	erk1/2	erk1/2	PROPN
admet-2013	144	17	,	,	PUNCT
admet-2013	144	18	mek	mek	PROPN
admet-2013	144	19	,	,	PUNCT
admet-2013	144	20	jnk	jnk	PROPN
admet-2013	144	21	,	,	PUNCT
admet-2013	144	22	and	and	CCONJ
admet-2013	144	23	p38	p38	NOUN
admet-2013	144	24	families	family	NOUN
admet-2013	144	25	,	,	PUNCT
admet-2013	144	26	is	be	AUX
admet-2013	144	27	a	a	DET
admet-2013	144	28	key	key	ADJ
admet-2013	144	29	signaling	signal	VERB
admet-2013	144	30	cascade	cascade	NOUN
admet-2013	144	31	that	that	PRON
admet-2013	144	32	undergoes	undergo	VERB
admet-2013	144	33	modifications	modification	NOUN
admet-2013	144	34	[	[	X
admet-2013	144	35	60	60	NUM
admet-2013	144	36	]	]	PUNCT
admet-2013	144	37	.	.	PUNCT
admet-2013	145	1	tyrosine	tyrosine	NOUN
admet-2013	145	2	locations	location	NOUN
admet-2013	145	3	in	in	ADP
admet-2013	145	4	bcr	bcr	PROPN
admet-2013	145	5	-	-	PUNCT
admet-2013	145	6	abl1	abl1	PROPN
admet-2013	145	7	's	's	PART
admet-2013	145	8	active	active	ADJ
admet-2013	145	9	conformation	conformation	NOUN
admet-2013	145	10	,	,	PUNCT
admet-2013	145	11	like	like	ADP
admet-2013	145	12	y412	y412	PROPN
admet-2013	145	13	in	in	ADP
admet-2013	145	14	the	the	DET
admet-2013	145	15	activation	activation	NOUN
admet-2013	145	16	loop	loop	NOUN
admet-2013	145	17	and	and	CCONJ
admet-2013	145	18	y245	y245	PROPN
admet-2013	145	19	in	in	ADP
admet-2013	145	20	the	the	DET
admet-2013	145	21	sh2	sh2	PROPN
admet-2013	145	22	-	-	PUNCT
admet-2013	145	23	kinase	kinase	PROPN
admet-2013	145	24	linker	linker	NOUN
admet-2013	145	25	,	,	PUNCT
admet-2013	145	26	are	be	AUX
admet-2013	145	27	known	know	VERB
admet-2013	145	28	to	to	PART
admet-2013	145	29	control	control	VERB
admet-2013	145	30	the	the	DET
admet-2013	145	31	activity	activity	NOUN
admet-2013	145	32	and	and	CCONJ
admet-2013	145	33	function	function	NOUN
admet-2013	145	34	of	of	ADP
admet-2013	145	35	https://doi.org/10.5599/admet.2013	https://doi.org/10.5599/admet.2013	NOUN
admet-2013	145	36	g.	g.	PROPN
admet-2013	145	37	janani	janani	PROPN
admet-2013	145	38	et	et	PROPN
admet-2013	145	39	al	al	PROPN
admet-2013	145	40	.	.	PROPN
admet-2013	145	41	admet	admet	PROPN
admet-2013	145	42	&	&	CCONJ
admet-2013	145	43	dmpk	dmpk	PROPN
admet-2013	145	44	11(4	11(4	NUM
admet-2013	145	45	)	)	PUNCT
admet-2013	145	46	(	(	PUNCT
admet-2013	145	47	2023	2023	NUM
admet-2013	145	48	)	)	PUNCT
admet-2013	145	49	499	499	NUM
admet-2013	145	50	-	-	SYM
admet-2013	145	51	511	511	NUM
admet-2013	145	52	504	504	NUM
admet-2013	145	53	tyrosine	tyrosine	NOUN
admet-2013	145	54	kinase	kinase	NOUN
admet-2013	145	55	.	.	PUNCT
admet-2013	146	1	the	the	DET
admet-2013	146	2	y177	y177	PROPN
admet-2013	146	3	binding	bind	VERB
admet-2013	146	4	site	site	NOUN
admet-2013	146	5	on	on	ADP
admet-2013	146	6	the	the	DET
admet-2013	146	7	bcr	bcr	ADJ
admet-2013	146	8	domain	domain	NOUN
admet-2013	146	9	is	be	AUX
admet-2013	146	10	recognized	recognize	VERB
admet-2013	146	11	by	by	ADP
admet-2013	146	12	the	the	DET
admet-2013	146	13	sh2	sh2	NOUN
admet-2013	146	14	-	-	PUNCT
admet-2013	146	15	domain	domain	NOUN
admet-2013	146	16	protein	protein	NOUN
admet-2013	146	17	growth	growth	NOUN
admet-2013	146	18	factor	factor	NOUN
admet-2013	146	19	receptor	receptor	NOUN
admet-2013	146	20	bound	bind	VERB
admet-2013	146	21	protein-2	protein-2	NOUN
admet-2013	146	22	(	(	PUNCT
admet-2013	146	23	grb2	grb2	PROPN
admet-2013	146	24	)	)	PUNCT
admet-2013	146	25	,	,	PUNCT
admet-2013	146	26	which	which	PRON
admet-2013	146	27	supports	support	VERB
admet-2013	146	28	ras	ras	NOUN
admet-2013	146	29	activation	activation	NOUN
admet-2013	146	30	through	through	ADP
admet-2013	146	31	son	son	NOUN
admet-2013	146	32	of	of	ADP
admet-2013	146	33	sevenless	sevenless	NOUN
admet-2013	146	34	(	(	PUNCT
admet-2013	146	35	sos	sos	PROPN
admet-2013	146	36	)	)	PUNCT
admet-2013	146	37	,	,	PUNCT
admet-2013	146	38	a	a	DET
admet-2013	146	39	guanine	guanine	NOUN
admet-2013	146	40	nucleotide	nucleotide	NOUN
admet-2013	146	41	exchange	exchange	NOUN
admet-2013	146	42	factor	factor	NOUN
admet-2013	146	43	protein	protein	NOUN
admet-2013	146	44	and	and	CCONJ
admet-2013	146	45	the	the	DET
admet-2013	146	46	scaffolding	scaffold	VERB
admet-2013	146	47	adapter	adapter	NOUN
admet-2013	146	48	gab2	gab2	NOUN
admet-2013	146	49	(	(	PUNCT
admet-2013	146	50	grb2	grb2	PROPN
admet-2013	146	51	-	-	PUNCT
admet-2013	146	52	associated	associate	VERB
admet-2013	146	53	binding	bind	VERB
admet-2013	146	54	protein	protein	NOUN
admet-2013	146	55	2	2	NUM
admet-2013	146	56	)	)	PUNCT
admet-2013	146	57	.	.	PUNCT
admet-2013	147	1	these	these	DET
admet-2013	147	2	three	three	NUM
admet-2013	147	3	factors	factor	NOUN
admet-2013	147	4	work	work	VERB
admet-2013	147	5	in	in	ADP
admet-2013	147	6	concert	concert	NOUN
admet-2013	147	7	to	to	PART
admet-2013	147	8	facilitate	facilitate	VERB
admet-2013	147	9	cml	cml	PROPN
admet-2013	147	10	[	[	X
admet-2013	147	11	61	61	NUM
admet-2013	147	12	]	]	PUNCT
admet-2013	147	13	.	.	PUNCT
admet-2013	148	1	two	two	NUM
admet-2013	148	2	isoforms	isoform	NOUN
admet-2013	148	3	of	of	ADP
admet-2013	148	4	akt	akt	PROPN
admet-2013	148	5	,	,	PUNCT
admet-2013	148	6	a	a	DET
admet-2013	148	7	serine	serine	NOUN
admet-2013	148	8	/	/	SYM
admet-2013	148	9	threonine	threonine	ADJ
admet-2013	148	10	kinase	kinase	NOUN
admet-2013	148	11	from	from	ADP
admet-2013	148	12	the	the	DET
admet-2013	148	13	agc	agc	PROPN
admet-2013	148	14	family	family	NOUN
admet-2013	148	15	of	of	ADP
admet-2013	148	16	kinases	kinase	NOUN
admet-2013	148	17	,	,	PUNCT
admet-2013	148	18	are	be	AUX
admet-2013	148	19	expelled	expel	VERB
admet-2013	148	20	in	in	ADP
admet-2013	148	21	hematopoietic	hematopoietic	ADJ
admet-2013	148	22	stem	stem	NOUN
admet-2013	148	23	cells	cell	NOUN
admet-2013	148	24	.	.	PUNCT
admet-2013	149	1	p	p	X
admet-2013	149	2	-akt	-akt	NOUN
admet-2013	149	3	,	,	PUNCT
admet-2013	149	4	which	which	PRON
admet-2013	149	5	has	have	AUX
admet-2013	149	6	been	be	AUX
admet-2013	149	7	activated	activate	VERB
admet-2013	149	8	,	,	PUNCT
admet-2013	149	9	followed	follow	VERB
admet-2013	149	10	by	by	ADP
admet-2013	149	11	pi3k	pi3k	NOUN
admet-2013	149	12	activation	activation	NOUN
admet-2013	149	13	by	by	ADP
admet-2013	149	14	bcr	bcr	NOUN
admet-2013	149	15	-	-	PUNCT
admet-2013	149	16	abl1	abl1	ADJ
admet-2013	149	17	,	,	PUNCT
admet-2013	149	18	can	can	AUX
admet-2013	149	19	prevent	prevent	VERB
admet-2013	149	20	apoptosis	apoptosis	NOUN
admet-2013	149	21	and	and	CCONJ
admet-2013	149	22	promote	promote	VERB
admet-2013	149	23	cell	cell	NOUN
admet-2013	149	24	growth	growth	NOUN
admet-2013	149	25	[	[	X
admet-2013	149	26	62	62	NUM
admet-2013	149	27	]	]	PUNCT
admet-2013	149	28	.	.	PUNCT
admet-2013	150	1	by	by	ADP
admet-2013	150	2	examining	examine	VERB
admet-2013	150	3	pten	pten	NOUN
admet-2013	150	4	's	's	PART
admet-2013	150	5	role	role	NOUN
admet-2013	150	6	in	in	ADP
admet-2013	150	7	bcr	bcr	PROPN
admet-2013	150	8	-	-	PROPN
admet-2013	150	9	abl	abl	NOUN
admet-2013	150	10	showing	show	VERB
admet-2013	150	11	ba	ba	NOUN
admet-2013	150	12	/	/	SYM
admet-2013	150	13	f3	f3	ADJ
admet-2013	150	14	cells	cell	NOUN
admet-2013	150	15	,	,	PUNCT
admet-2013	150	16	it	it	PRON
admet-2013	150	17	has	have	AUX
admet-2013	150	18	been	be	AUX
admet-2013	150	19	discovered	discover	VERB
admet-2013	150	20	that	that	SCONJ
admet-2013	150	21	it	it	PRON
admet-2013	150	22	causes	cause	VERB
admet-2013	150	23	the	the	DET
admet-2013	150	24	reduced	reduce	VERB
admet-2013	150	25	activity	activity	NOUN
admet-2013	150	26	of	of	ADP
admet-2013	150	27	pten	pten	ADJ
admet-2013	150	28	phosphatase	phosphatase	NOUN
admet-2013	150	29	and	and	CCONJ
admet-2013	150	30	a	a	DET
admet-2013	150	31	decrease	decrease	NOUN
admet-2013	150	32	in	in	ADP
admet-2013	150	33	the	the	DET
admet-2013	150	34	production	production	NOUN
admet-2013	150	35	of	of	ADP
admet-2013	150	36	the	the	DET
admet-2013	150	37	p53	p53	NOUN
admet-2013	150	38	protein	protein	NOUN
admet-2013	150	39	[	[	X
admet-2013	150	40	63	63	NUM
admet-2013	150	41	]	]	PUNCT
admet-2013	150	42	.	.	PUNCT
admet-2013	151	1	various	various	ADJ
admet-2013	151	2	nanoformulations	nanoformulation	NOUN
admet-2013	151	3	of	of	ADP
admet-2013	151	4	drugs	drug	NOUN
admet-2013	151	5	that	that	PRON
admet-2013	151	6	target	target	VERB
admet-2013	151	7	the	the	DET
admet-2013	151	8	tyrosine	tyrosine	NOUN
admet-2013	151	9	kinase	kinase	PROPN
admet-2013	151	10	pathway	pathway	NOUN
admet-2013	151	11	,	,	PUNCT
admet-2013	151	12	which	which	PRON
admet-2013	151	13	plays	play	VERB
admet-2013	151	14	a	a	DET
admet-2013	151	15	role	role	NOUN
admet-2013	151	16	in	in	ADP
admet-2013	151	17	cml	cml	PROPN
admet-2013	151	18	,	,	PUNCT
admet-2013	151	19	have	have	AUX
admet-2013	151	20	been	be	AUX
admet-2013	151	21	discovered	discover	VERB
admet-2013	151	22	.	.	PUNCT
admet-2013	152	1	the	the	DET
admet-2013	152	2	bcr	bcr	PROPN
admet-2013	152	3	-	-	PUNCT
admet-2013	152	4	abl	abl	PROPN
admet-2013	152	5	tyrosine	tyrosine	PROPN
admet-2013	152	6	kinase	kinase	PROPN
admet-2013	152	7	protein	protein	NOUN
admet-2013	152	8	is	be	AUX
admet-2013	152	9	the	the	DET
admet-2013	152	10	principal	principal	ADJ
admet-2013	152	11	biological	biological	ADJ
admet-2013	152	12	target	target	NOUN
admet-2013	152	13	of	of	ADP
admet-2013	152	14	ponatinib	ponatinib	NOUN
admet-2013	152	15	(	(	PUNCT
admet-2013	152	16	pon	pon	NOUN
admet-2013	152	17	)	)	PUNCT
admet-2013	152	18	.	.	PUNCT
admet-2013	153	1	it	it	PRON
admet-2013	153	2	targets	target	VERB
admet-2013	153	3	the	the	DET
admet-2013	153	4	akt	akt	PROPN
admet-2013	153	5	pathway	pathway	NOUN
admet-2013	153	6	when	when	SCONJ
admet-2013	153	7	encapsulated	encapsulate	VERB
admet-2013	153	8	into	into	ADP
admet-2013	153	9	reproducible	reproducible	ADJ
admet-2013	153	10	biomimetic	biomimetic	ADJ
admet-2013	153	11	lipid	lipid	NOUN
admet-2013	153	12	nanoparticles	nanoparticle	NOUN
admet-2013	153	13	[	[	X
admet-2013	153	14	64	64	NUM
admet-2013	153	15	]	]	PUNCT
admet-2013	153	16	.	.	PUNCT
admet-2013	154	1	gold	gold	NOUN
admet-2013	154	2	nanoparticle	nanoparticle	NOUN
admet-2013	154	3	-	-	PUNCT
admet-2013	154	4	encapsulated	encapsulate	VERB
admet-2013	154	5	dasatinib	dasatinib	NOUN
admet-2013	154	6	competitively	competitively	ADV
admet-2013	154	7	inhibits	inhibit	VERB
admet-2013	154	8	the	the	DET
admet-2013	154	9	atp	atp	NOUN
admet-2013	154	10	site	site	NOUN
admet-2013	154	11	of	of	ADP
admet-2013	154	12	src	src	PROPN
admet-2013	154	13	.	.	PUNCT
admet-2013	155	1	high	high	ADJ
admet-2013	155	2	-	-	PUNCT
admet-2013	155	3	density	density	NOUN
admet-2013	155	4	lipoprotein	lipoprotein	ADJ
admet-2013	155	5	nano	nano	NOUN
admet-2013	155	6	-	-	PUNCT
admet-2013	155	7	formulated	formulate	VERB
admet-2013	155	8	bosutinib	bosutinib	NOUN
admet-2013	155	9	inhibits	inhibit	VERB
admet-2013	155	10	bcr	bcr	NOUN
admet-2013	155	11	-	-	ADJ
admet-2013	155	12	abl	abl	PROPN
admet-2013	155	13	and	and	CCONJ
admet-2013	155	14	src	src	PROPN
admet-2013	155	15	kinase	kinase	PROPN
admet-2013	156	1	[	[	X
admet-2013	156	2	65	65	NUM
admet-2013	156	3	]	]	PUNCT
admet-2013	156	4	.	.	PUNCT
admet-2013	157	1	imatinib	imatinib	NOUN
admet-2013	157	2	encapsulated	encapsulate	VERB
admet-2013	157	3	by	by	ADP
admet-2013	157	4	polymeric	polymeric	ADJ
admet-2013	157	5	nanoparticles	nanoparticle	NOUN
admet-2013	157	6	inhibits	inhibit	VERB
admet-2013	157	7	the	the	DET
admet-2013	157	8	phosphate	phosphate	ADJ
admet-2013	157	9	group	group	NOUN
admet-2013	157	10	transfer	transfer	NOUN
admet-2013	157	11	to	to	ADP
admet-2013	157	12	tyrosine	tyrosine	NOUN
admet-2013	157	13	and	and	CCONJ
admet-2013	157	14	subsequently	subsequently	ADV
admet-2013	157	15	inhibits	inhibit	VERB
admet-2013	157	16	its	its	PRON
admet-2013	157	17	activation	activation	NOUN
admet-2013	157	18	[	[	X
admet-2013	157	19	66	66	NUM
admet-2013	157	20	]	]	PUNCT
admet-2013	157	21	.	.	PUNCT
admet-2013	158	1	figure	figure	NOUN
admet-2013	158	2	2	2	NUM
admet-2013	158	3	.	.	X
admet-2013	158	4	schematically	schematically	NOUN
admet-2013	158	5	represents	represent	VERB
admet-2013	158	6	the	the	DET
admet-2013	158	7	nanoformulated	nanoformulate	VERB
admet-2013	158	8	chronic	chronic	ADJ
admet-2013	158	9	myelogenous	myelogenous	ADJ
admet-2013	158	10	leukemia	leukemia	NOUN
admet-2013	158	11	drugs	drug	NOUN
admet-2013	158	12	inhibiting	inhibit	VERB
admet-2013	158	13	bcr	bcr	PROPN
admet-2013	158	14	-	-	PUNCT
admet-2013	158	15	abl	abl	PROPN
admet-2013	158	16	tyrosine	tyrosine	PROPN
admet-2013	158	17	kinase	kinase	PROPN
admet-2013	158	18	.	.	PUNCT
admet-2013	159	1	figure	figure	NOUN
admet-2013	159	2	2	2	NUM
admet-2013	159	3	.	.	PUNCT
admet-2013	160	1	schematic	schematic	ADJ
admet-2013	160	2	representation	representation	NOUN
admet-2013	160	3	of	of	ADP
admet-2013	160	4	the	the	DET
admet-2013	160	5	nanoformulated	nanoformulate	VERB
admet-2013	160	6	chronic	chronic	ADJ
admet-2013	160	7	myelogenous	myelogenous	ADJ
admet-2013	160	8	leukemia	leukemia	NOUN
admet-2013	160	9	drugs	drug	NOUN
admet-2013	160	10	inhibiting	inhibit	VERB
admet-2013	160	11	bcr	bcr	PROPN
admet-2013	160	12	-	-	PUNCT
admet-2013	160	13	abl	abl	PROPN
admet-2013	160	14	tyrosine	tyrosine	PROPN
admet-2013	160	15	kinase	kinase	PROPN
admet-2013	160	16	organic	organic	ADJ
admet-2013	160	17	nanoparticles	nanoparticle	NOUN
admet-2013	160	18	in	in	ADP
admet-2013	160	19	cml	cml	PROPN
admet-2013	160	20	therapy	therapy	NOUN
admet-2013	160	21	organic	organic	ADJ
admet-2013	160	22	nanoparticles	nanoparticle	NOUN
admet-2013	160	23	include	include	VERB
admet-2013	160	24	lipid	lipid	NOUN
admet-2013	160	25	-	-	PUNCT
admet-2013	160	26	based	base	VERB
admet-2013	160	27	,	,	PUNCT
admet-2013	160	28	polymer	polymer	NOUN
admet-2013	160	29	-	-	PUNCT
admet-2013	160	30	based	base	VERB
admet-2013	160	31	,	,	PUNCT
admet-2013	160	32	dendrimers	dendrimer	NOUN
admet-2013	160	33	,	,	PUNCT
admet-2013	160	34	etc	etc	X
admet-2013	160	35	.	.	X
admet-2013	161	1	the	the	DET
admet-2013	161	2	superiority	superiority	NOUN
admet-2013	161	3	of	of	ADP
admet-2013	161	4	liposomes	liposome	NOUN
admet-2013	161	5	over	over	ADP
admet-2013	161	6	free	free	ADJ
admet-2013	161	7	pharmaceuticals	pharmaceutical	NOUN
admet-2013	161	8	in	in	ADP
admet-2013	161	9	drug	drug	NOUN
admet-2013	161	10	delivery	delivery	NOUN
admet-2013	161	11	can	can	AUX
admet-2013	161	12	be	be	AUX
admet-2013	161	13	due	due	ADJ
admet-2013	161	14	to	to	ADP
admet-2013	161	15	their	their	PRON
admet-2013	161	16	lower	low	ADJ
admet-2013	161	17	toxicity	toxicity	NOUN
admet-2013	161	18	,	,	PUNCT
admet-2013	161	19	the	the	DET
admet-2013	161	20	potential	potential	NOUN
admet-2013	161	21	to	to	PART
admet-2013	161	22	couple	couple	VERB
admet-2013	161	23	them	they	PRON
admet-2013	161	24	with	with	ADP
admet-2013	161	25	antibodies	antibody	NOUN
admet-2013	161	26	,	,	PUNCT
admet-2013	161	27	additional	additional	ADJ
admet-2013	161	28	signalling	signal	VERB
admet-2013	161	29	molecules	molecule	NOUN
admet-2013	161	30	for	for	ADP
admet-2013	161	31	more	more	ADV
admet-2013	161	32	focused	focused	ADJ
admet-2013	161	33	distribution	distribution	NOUN
admet-2013	161	34	,	,	PUNCT
admet-2013	161	35	and	and	CCONJ
admet-2013	161	36	enhanced	enhance	VERB
admet-2013	161	37	altered	alter	VERB
admet-2013	161	38	pharmacokinetics	pharmacokinetic	NOUN
admet-2013	161	39	and	and	CCONJ
admet-2013	161	40	bioavailability	bioavailability	NOUN
admet-2013	161	41	[	[	X
admet-2013	161	42	67	67	NUM
admet-2013	161	43	]	]	PUNCT
admet-2013	161	44	.	.	PUNCT
admet-2013	162	1	therapeutic	therapeutic	ADJ
admet-2013	162	2	medicines	medicine	NOUN
admet-2013	162	3	can	can	AUX
admet-2013	162	4	be	be	AUX
admet-2013	162	5	incorporated	incorporate	VERB
admet-2013	162	6	into	into	ADP
admet-2013	162	7	polylactic	polylactic	ADJ
admet-2013	162	8	-	-	PUNCT
admet-2013	162	9	coglycolic	coglycolic	NOUN
admet-2013	162	10	acid	acid	NOUN
admet-2013	162	11	(	(	PUNCT
admet-2013	162	12	plga	plga	NOUN
admet-2013	162	13	)	)	PUNCT
admet-2013	162	14	,	,	PUNCT
admet-2013	162	15	which	which	PRON
admet-2013	162	16	has	have	VERB
admet-2013	162	17	various	various	ADJ
admet-2013	162	18	benefits	benefit	NOUN
admet-2013	162	19	,	,	PUNCT
admet-2013	162	20	including	include	VERB
admet-2013	162	21	long	long	ADJ
admet-2013	162	22	-	-	PUNCT
admet-2013	162	23	term	term	NOUN
admet-2013	162	24	release	release	NOUN
admet-2013	162	25	and	and	CCONJ
admet-2013	162	26	enzymatic	enzymatic	ADJ
admet-2013	162	27	degradation	degradation	NOUN
admet-2013	162	28	resistance	resistance	NOUN
admet-2013	162	29	,	,	PUNCT
admet-2013	162	30	and	and	CCONJ
admet-2013	162	31	can	can	AUX
admet-2013	162	32	be	be	AUX
admet-2013	162	33	used	use	VERB
admet-2013	162	34	to	to	PART
admet-2013	162	35	deliver	deliver	VERB
admet-2013	162	36	pharmaceuticals	pharmaceutical	NOUN
admet-2013	162	37	effectively	effectively	ADV
admet-2013	162	38	and	and	CCONJ
admet-2013	162	39	with	with	ADP
admet-2013	162	40	less	less	ADJ
admet-2013	162	41	toxicity	toxicity	NOUN
admet-2013	162	42	to	to	ADP
admet-2013	162	43	normal	normal	ADJ
admet-2013	162	44	cells	cell	NOUN
admet-2013	162	45	[	[	X
admet-2013	162	46	68	68	NUM
admet-2013	162	47	]	]	PUNCT
admet-2013	162	48	.	.	PUNCT
admet-2013	163	1	polymer	polymer	NOUN
admet-2013	163	2	micelles	micelle	NOUN
admet-2013	163	3	are	be	AUX
admet-2013	163	4	created	create	VERB
admet-2013	163	5	using	use	VERB
admet-2013	163	6	the	the	DET
admet-2013	163	7	water	water	NOUN
admet-2013	163	8	-	-	PUNCT
admet-2013	163	9	soluble	soluble	ADJ
admet-2013	163	10	building	building	NOUN
admet-2013	163	11	block	block	NOUN
admet-2013	163	12	polyethylene	polyethylene	NOUN
admet-2013	163	13	glycol	glycol	NOUN
admet-2013	163	14	(	(	PUNCT
admet-2013	163	15	peg	peg	NOUN
admet-2013	163	16	)	)	PUNCT
admet-2013	163	17	.	.	PUNCT
admet-2013	164	1	peg	peg	NOUN
admet-2013	164	2	has	have	VERB
admet-2013	164	3	the	the	DET
admet-2013	164	4	benefits	benefit	NOUN
admet-2013	164	5	of	of	ADP
admet-2013	164	6	making	make	VERB
admet-2013	164	7	micelles	micelle	NOUN
admet-2013	164	8	biocompatible	biocompatible	ADJ
admet-2013	164	9	and	and	CCONJ
admet-2013	164	10	increasing	increase	VERB
admet-2013	164	11	the	the	DET
admet-2013	164	12	bioavailability	bioavailability	NOUN
admet-2013	164	13	of	of	ADP
admet-2013	164	14	some	some	DET
admet-2013	164	15	medications	medication	NOUN
admet-2013	164	16	[	[	X
admet-2013	164	17	69	69	NUM
admet-2013	164	18	]	]	PUNCT
admet-2013	164	19	.	.	PUNCT
admet-2013	165	1	small	small	ADJ
admet-2013	165	2	admet	admet	PROPN
admet-2013	165	3	&	&	CCONJ
admet-2013	165	4	dmpk	dmpk	PROPN
admet-2013	165	5	11(4	11(4	NUM
admet-2013	165	6	)	)	PUNCT
admet-2013	165	7	(	(	PUNCT
admet-2013	165	8	2023	2023	NUM
admet-2013	165	9	)	)	PUNCT
admet-2013	165	10	499	499	NUM
admet-2013	165	11	-	-	SYM
admet-2013	165	12	511	511	NUM
admet-2013	165	13	nanoparticles	nanoparticle	NOUN
admet-2013	165	14	in	in	ADP
admet-2013	165	15	the	the	DET
admet-2013	165	16	therapy	therapy	NOUN
admet-2013	165	17	of	of	ADP
admet-2013	165	18	chronic	chronic	ADJ
admet-2013	165	19	myelogenous	myelogenous	ADJ
admet-2013	165	20	leukemia	leukemia	PROPN
admet-2013	165	21	doi	doi	PROPN
admet-2013	165	22	:	:	PUNCT
admet-2013	165	23	https://doi.org/10.5599/adme	https://doi.org/10.5599/adme	NOUN
admet-2013	165	24	t.2013	t.2013	PROPN
admet-2013	165	25	505	505	NUM
admet-2013	165	26	nps	nps	PROPN
admet-2013	165	27	known	know	VERB
admet-2013	165	28	as	as	ADP
admet-2013	165	29	dendrimers	dendrimer	NOUN
admet-2013	165	30	,	,	PUNCT
admet-2013	165	31	exhibit	exhibit	VERB
admet-2013	165	32	radial	radial	ADJ
admet-2013	165	33	symmetry	symmetry	NOUN
admet-2013	165	34	and	and	CCONJ
admet-2013	165	35	function	function	NOUN
admet-2013	165	36	as	as	ADP
admet-2013	165	37	an	an	DET
admet-2013	165	38	effective	effective	ADJ
admet-2013	165	39	drug	drug	NOUN
admet-2013	165	40	delivery	delivery	NOUN
admet-2013	165	41	vehicle	vehicle	NOUN
admet-2013	165	42	[	[	X
admet-2013	165	43	70	70	NUM
admet-2013	165	44	,	,	PUNCT
admet-2013	165	45	71	71	NUM
admet-2013	165	46	]	]	PUNCT
admet-2013	165	47	.	.	PUNCT
admet-2013	166	1	due	due	ADP
admet-2013	166	2	to	to	ADP
admet-2013	166	3	their	their	PRON
admet-2013	166	4	advantages	advantage	NOUN
admet-2013	166	5	,	,	PUNCT
admet-2013	166	6	organic	organic	ADJ
admet-2013	166	7	nanoparticles	nanoparticle	NOUN
admet-2013	166	8	are	be	AUX
admet-2013	166	9	employed	employ	VERB
admet-2013	166	10	in	in	ADP
admet-2013	166	11	treating	treat	VERB
admet-2013	166	12	various	various	ADJ
admet-2013	166	13	diseases	disease	NOUN
admet-2013	166	14	.	.	PUNCT
admet-2013	167	1	the	the	DET
admet-2013	167	2	nanoparticles	nanoparticle	NOUN
admet-2013	167	3	which	which	PRON
admet-2013	167	4	are	be	AUX
admet-2013	167	5	employed	employ	VERB
admet-2013	167	6	in	in	ADP
admet-2013	167	7	treating	treat	VERB
admet-2013	167	8	cml	cml	PROPN
admet-2013	167	9	are	be	AUX
admet-2013	167	10	discussed	discuss	VERB
admet-2013	167	11	here	here	ADV
admet-2013	167	12	.	.	PUNCT
admet-2013	168	1	to	to	PART
admet-2013	168	2	target	target	VERB
admet-2013	168	3	the	the	DET
admet-2013	168	4	overexpression	overexpression	NOUN
admet-2013	168	5	of	of	ADP
admet-2013	168	6	somatostatin	somatostatin	NOUN
admet-2013	168	7	receptor	receptor	NOUN
admet-2013	168	8	type	type	NOUN
admet-2013	168	9	2	2	NUM
admet-2013	168	10	in	in	ADP
admet-2013	168	11	cml	cml	PROPN
admet-2013	168	12	,	,	PUNCT
admet-2013	168	13	amino	amino	NOUN
admet-2013	168	14	-	-	PUNCT
admet-2013	168	15	pegylated	pegylate	VERB
admet-2013	168	16	quantum	quantum	NOUN
admet-2013	168	17	dots	dot	NOUN
admet-2013	168	18	nanoparticle	nanoparticle	NOUN
admet-2013	168	19	was	be	AUX
admet-2013	168	20	succinylated	succinylate	VERB
admet-2013	168	21	and	and	CCONJ
admet-2013	168	22	coated	coat	VERB
admet-2013	168	23	with	with	ADP
admet-2013	168	24	the	the	DET
admet-2013	168	25	ligand	ligand	ADJ
admet-2013	168	26	octreotide	octreotide	NOUN
admet-2013	169	1	[	[	X
admet-2013	169	2	72	72	NUM
admet-2013	169	3	]	]	PUNCT
admet-2013	169	4	.	.	PUNCT
admet-2013	170	1	k562	k562	PROPN
admet-2013	170	2	cells	cell	NOUN
admet-2013	170	3	treated	treat	VERB
admet-2013	170	4	with	with	ADP
admet-2013	170	5	dendrosomal	dendrosomal	ADJ
admet-2013	170	6	nano	nano	NOUN
admet-2013	170	7	-	-	PUNCT
admet-2013	170	8	formulated	formulate	VERB
admet-2013	170	9	solanine	solanine	NOUN
admet-2013	170	10	(	(	PUNCT
admet-2013	170	11	dns	dns	NOUN
admet-2013	170	12	)	)	PUNCT
admet-2013	170	13	,	,	PUNCT
admet-2013	170	14	dns+	dns+	PROPN
admet-2013	170	15	imatinib	imatinib	NOUN
admet-2013	170	16	showed	show	VERB
admet-2013	170	17	increased	increase	VERB
admet-2013	170	18	apoptosis	apoptosis	NOUN
admet-2013	170	19	and	and	CCONJ
admet-2013	170	20	inhibited	inhibit	VERB
admet-2013	170	21	the	the	DET
admet-2013	170	22	expression	expression	NOUN
admet-2013	170	23	of	of	ADP
admet-2013	170	24	c	c	NOUN
admet-2013	170	25	-	-	PUNCT
admet-2013	170	26	myc	myc	NOUN
admet-2013	170	27	,	,	PUNCT
admet-2013	170	28	htert	htert	NOUN
admet-2013	170	29	,	,	PUNCT
admet-2013	170	30	nf	nf	PROPN
admet-2013	170	31	-	-	PUNCT
admet-2013	170	32	kb	kb	PROPN
admet-2013	170	33	,	,	PUNCT
admet-2013	170	34	mtor	mtor	NOUN
admet-2013	170	35	,	,	PUNCT
admet-2013	170	36	pi3kca	pi3kca	PROPN
admet-2013	170	37	and	and	CCONJ
admet-2013	170	38	also	also	ADV
admet-2013	170	39	dephosphorylated	dephosphorylate	VERB
admet-2013	170	40	the	the	DET
admet-2013	170	41	akt	akt	PROPN
admet-2013	170	42	protein	protein	NOUN
admet-2013	170	43	[	[	X
admet-2013	170	44	73	73	NUM
admet-2013	170	45	]	]	PUNCT
admet-2013	170	46	.	.	PUNCT
admet-2013	171	1	multidrug	multidrug	NOUN
admet-2013	171	2	resistance	resistance	NOUN
admet-2013	171	3	(	(	PUNCT
admet-2013	171	4	mdr	mdr	PROPN
admet-2013	171	5	)	)	PUNCT
admet-2013	171	6	in	in	ADP
admet-2013	171	7	cml	cml	PROPN
admet-2013	171	8	was	be	AUX
admet-2013	171	9	overcome	overcome	VERB
admet-2013	171	10	by	by	ADP
admet-2013	171	11	co	co	NOUN
admet-2013	171	12	-	-	NOUN
admet-2013	171	13	encapsulation	encapsulation	NOUN
admet-2013	171	14	of	of	ADP
admet-2013	171	15	mitoxantrone	mitoxantrone	NOUN
admet-2013	171	16	and	and	CCONJ
admet-2013	171	17	a	a	DET
admet-2013	171	18	pglycoprotein(p	pglycoprotein(p	NOUN
admet-2013	171	19	-	-	PUNCT
admet-2013	171	20	gp	gp	NOUN
admet-2013	171	21	)	)	PUNCT
admet-2013	171	22	inhibitor	inhibitor	NOUN
admet-2013	171	23	in	in	ADP
admet-2013	171	24	β	β	NOUN
admet-2013	171	25	-	-	NOUN
admet-2013	171	26	elemene	elemene	ADJ
admet-2013	171	27	,	,	PUNCT
admet-2013	171	28	the	the	DET
admet-2013	171	29	solid	solid	ADJ
admet-2013	171	30	lipid	lipid	NOUN
admet-2013	171	31	nanoparticles	nanoparticle	NOUN
admet-2013	171	32	.	.	PUNCT
admet-2013	172	1	the	the	DET
admet-2013	172	2	mdr	mdr	PROPN
admet-2013	172	3	was	be	AUX
admet-2013	172	4	overcome	overcome	VERB
admet-2013	172	5	by	by	ADP
admet-2013	172	6	blocking	block	VERB
admet-2013	172	7	intracellular	intracellular	ADJ
admet-2013	172	8	atp	atp	NOUN
admet-2013	172	9	production	production	NOUN
admet-2013	172	10	and	and	CCONJ
admet-2013	172	11	p	p	NOUN
admet-2013	172	12	-	-	PUNCT
admet-2013	172	13	gp	gp	NOUN
admet-2013	172	14	release	release	NOUN
admet-2013	172	15	by	by	ADP
admet-2013	172	16	β	β	NOUN
admet-2013	172	17	-	-	NOUN
admet-2013	172	18	elemene	elemene	NOUN
admet-2013	172	19	[	[	X
admet-2013	172	20	74	74	NUM
admet-2013	172	21	]	]	PUNCT
admet-2013	172	22	.	.	PUNCT
admet-2013	173	1	cml	cml	PROPN
admet-2013	173	2	stem	stem	NOUN
admet-2013	173	3	cells	cell	NOUN
admet-2013	173	4	take	take	VERB
admet-2013	173	5	up	up	ADP
admet-2013	173	6	the	the	DET
admet-2013	173	7	poly(lactide	poly(lactide	PROPN
admet-2013	173	8	coglycolic	coglycolic	ADJ
admet-2013	173	9	acid	acid	NOUN
admet-2013	173	10	)	)	PUNCT
admet-2013	173	11	(	(	PUNCT
admet-2013	173	12	plga	plga	NOUN
admet-2013	173	13	)	)	PUNCT
admet-2013	173	14	nanoparticle	nanoparticle	NOUN
admet-2013	173	15	construct	construct	VERB
admet-2013	173	16	containing	contain	VERB
admet-2013	173	17	polymethine	polymethine	NOUN
admet-2013	173	18	dye	dye	NOUN
admet-2013	173	19	dy-635	dy-635	PROPN
admet-2013	173	20	through	through	ADP
admet-2013	173	21	the	the	DET
admet-2013	173	22	anion	anion	NOUN
admet-2013	173	23	transport	transport	NOUN
admet-2013	173	24	protein	protein	NOUN
admet-2013	173	25	1b3	1b3	NUM
admet-2013	173	26	(	(	PUNCT
admet-2013	173	27	oatp1b3	oatp1b3	NOUN
admet-2013	173	28	)	)	PUNCT
admet-2013	173	29	.	.	PUNCT
admet-2013	174	1	this	this	DET
admet-2013	174	2	transporter	transporter	NOUN
admet-2013	174	3	was	be	AUX
admet-2013	174	4	activated	activate	VERB
admet-2013	174	5	via	via	ADP
admet-2013	174	6	hypoxia	hypoxia	NOUN
admet-2013	174	7	-	-	PUNCT
admet-2013	174	8	inducible	inducible	ADJ
admet-2013	174	9	factor	factor	NOUN
admet-2013	174	10	1α	1α	NOUN
admet-2013	174	11	.	.	PUNCT
admet-2013	175	1	thus	thus	ADV
admet-2013	175	2	,	,	PUNCT
admet-2013	175	3	the	the	DET
admet-2013	175	4	cml	cml	PROPN
admet-2013	175	5	stem	stem	NOUN
admet-2013	175	6	cells	cell	NOUN
admet-2013	175	7	could	could	AUX
admet-2013	175	8	be	be	AUX
admet-2013	175	9	targeted	target	VERB
admet-2013	175	10	via	via	ADP
admet-2013	175	11	this	this	DET
admet-2013	175	12	drug	drug	NOUN
admet-2013	175	13	-	-	PUNCT
admet-2013	175	14	loaded	load	VERB
admet-2013	175	15	nanoparticle	nanoparticle	NOUN
admet-2013	175	16	containing	contain	VERB
admet-2013	175	17	dy-635	dy-635	PROPN
admet-2013	175	18	dye	dye	NOUN
admet-2013	176	1	[	[	X
admet-2013	176	2	75	75	NUM
admet-2013	176	3	]	]	PUNCT
admet-2013	176	4	.	.	PUNCT
admet-2013	177	1	when	when	SCONJ
admet-2013	177	2	given	give	VERB
admet-2013	177	3	a	a	DET
admet-2013	177	4	high	high	ADJ
admet-2013	177	5	dose	dose	NOUN
admet-2013	177	6	of	of	ADP
admet-2013	177	7	amphiphilic	amphiphilic	ADJ
admet-2013	177	8	polymer	polymer	NOUN
admet-2013	177	9	which	which	PRON
admet-2013	177	10	was	be	AUX
admet-2013	177	11	conjugated	conjugate	VERB
admet-2013	177	12	and	and	CCONJ
admet-2013	177	13	self	self	NOUN
admet-2013	177	14	-	-	PUNCT
admet-2013	177	15	assembled	assemble	VERB
admet-2013	177	16	into	into	ADP
admet-2013	177	17	nanoparticles	nanoparticle	NOUN
admet-2013	177	18	,	,	PUNCT
admet-2013	177	19	its	its	PRON
admet-2013	177	20	half	half	ADJ
admet-2013	177	21	-	-	PUNCT
admet-2013	177	22	life	life	NOUN
admet-2013	177	23	increased	increase	VERB
admet-2013	177	24	by	by	ADP
admet-2013	177	25	approximately	approximately	ADV
admet-2013	177	26	20	20	NUM
admet-2013	177	27	fold	fold	ADJ
admet-2013	177	28	and	and	CCONJ
admet-2013	177	29	it	it	PRON
admet-2013	177	30	was	be	AUX
admet-2013	177	31	effective	effective	ADJ
admet-2013	177	32	in	in	ADP
admet-2013	177	33	inhibiting	inhibit	VERB
admet-2013	177	34	bcr	bcr	NOUN
admet-2013	177	35	-	-	PROPN
admet-2013	177	36	abl	abl	NOUN
admet-2013	178	1	[	[	X
admet-2013	178	2	76	76	NUM
admet-2013	178	3	]	]	X
admet-2013	178	4	.	.	PUNCT
admet-2013	179	1	when	when	SCONJ
admet-2013	179	2	k562	k562	PROPN
admet-2013	179	3	cells	cell	NOUN
admet-2013	179	4	were	be	AUX
admet-2013	179	5	administered	administer	VERB
admet-2013	179	6	with	with	ADP
admet-2013	179	7	160	160	NUM
admet-2013	179	8	µm	µm	NOUN
admet-2013	179	9	of	of	ADP
admet-2013	179	10	hydroxylated	hydroxylated	ADJ
admet-2013	179	11	fullerene	fullerene	NOUN
admet-2013	179	12	,	,	PUNCT
admet-2013	179	13	it	it	PRON
admet-2013	179	14	showed	show	VERB
admet-2013	179	15	a	a	DET
admet-2013	179	16	decrease	decrease	NOUN
admet-2013	179	17	in	in	ADP
admet-2013	179	18	the	the	DET
admet-2013	179	19	mitochondrial	mitochondrial	ADJ
admet-2013	179	20	membrane	membrane	NOUN
admet-2013	179	21	potential	potential	NOUN
admet-2013	179	22	,	,	PUNCT
admet-2013	179	23	a	a	DET
admet-2013	179	24	change	change	NOUN
admet-2013	179	25	in	in	ADP
admet-2013	179	26	morphology	morphology	NOUN
admet-2013	179	27	,	,	PUNCT
admet-2013	179	28	and	and	CCONJ
admet-2013	179	29	the	the	DET
admet-2013	179	30	g2	g2	PROPN
admet-2013	179	31	-	-	PUNCT
admet-2013	179	32	phase	phase	NOUN
admet-2013	179	33	arrest	arrest	NOUN
admet-2013	179	34	[	[	X
admet-2013	179	35	77	77	NUM
admet-2013	179	36	]	]	PUNCT
admet-2013	179	37	.	.	PUNCT
admet-2013	180	1	cml	cml	PROPN
admet-2013	180	2	stem	stem	NOUN
admet-2013	180	3	cells	cell	NOUN
admet-2013	180	4	aberrantly	aberrantly	ADV
admet-2013	180	5	express	express	VERB
admet-2013	180	6	cd26	cd26	PROPN
admet-2013	180	7	.	.	PUNCT
admet-2013	181	1	liposomes	liposome	NOUN
admet-2013	181	2	conjugated	conjugate	VERB
admet-2013	181	3	with	with	ADP
admet-2013	181	4	begelomab	begelomab	NOUN
admet-2013	181	5	(	(	PUNCT
admet-2013	181	6	anti	anti	ADJ
admet-2013	181	7	-	-	ADJ
admet-2013	181	8	cd26	cd26	ADJ
admet-2013	181	9	)	)	PUNCT
admet-2013	181	10	loaded	load	VERB
admet-2013	181	11	with	with	ADP
admet-2013	181	12	venetoclax	venetoclax	NOUN
admet-2013	181	13	at	at	ADP
admet-2013	181	14	100	100	NUM
admet-2013	181	15	nm	nm	PRON
admet-2013	181	16	concentration	concentration	NOUN
admet-2013	181	17	significantly	significantly	ADV
admet-2013	181	18	reduced	reduce	VERB
admet-2013	181	19	the	the	DET
admet-2013	181	20	expression	expression	NOUN
admet-2013	181	21	of	of	ADP
admet-2013	181	22	cd26	cd26	PROPN
admet-2013	181	23	in	in	ADP
admet-2013	181	24	both	both	DET
admet-2013	181	25	stem	stem	NOUN
admet-2013	181	26	cells	cell	NOUN
admet-2013	181	27	and	and	CCONJ
admet-2013	181	28	progenitor	progenitor	NOUN
admet-2013	181	29	cells	cell	NOUN
admet-2013	181	30	[	[	X
admet-2013	181	31	78	78	NUM
admet-2013	181	32	]	]	PUNCT
admet-2013	181	33	.	.	PUNCT
admet-2013	182	1	anti	anti	ADJ
admet-2013	182	2	-	-	ADJ
admet-2013	182	3	bcr	bcr	ADJ
admet-2013	182	4	-	-	ADJ
admet-2013	182	5	abl	abl	PROPN
admet-2013	182	6	antibodies	antibody	NOUN
admet-2013	182	7	loaded	load	VERB
admet-2013	182	8	in	in	ADP
admet-2013	182	9	poly(d	poly(d	NOUN
admet-2013	182	10	,	,	PUNCT
admet-2013	182	11	l	l	NOUN
admet-2013	182	12	-	-	ADJ
admet-2013	182	13	lactide	lactide	NOUN
admet-2013	182	14	-	-	PUNCT
admet-2013	182	15	co	co	NOUN
admet-2013	182	16	-	-	ADJ
admet-2013	182	17	glycolide	glycolide	ADJ
admet-2013	182	18	)	)	PUNCT
admet-2013	182	19	nanoparticles	nanoparticle	NOUN
admet-2013	182	20	(	(	PUNCT
admet-2013	182	21	plga	plga	NOUN
admet-2013	182	22	nps	nps	PROPN
admet-2013	182	23	)	)	PUNCT
admet-2013	182	24	effectively	effectively	ADV
admet-2013	182	25	degraded	degrade	VERB
admet-2013	182	26	the	the	DET
admet-2013	182	27	bcr	bcr	PROPN
admet-2013	182	28	-	-	PROPN
admet-2013	182	29	abl	abl	PROPN
admet-2013	182	30	oncoprotein	oncoprotein	PROPN
admet-2013	182	31	in	in	ADP
admet-2013	182	32	cml	cml	PROPN
admet-2013	182	33	cells	cell	NOUN
admet-2013	182	34	[	[	X
admet-2013	182	35	79	79	NUM
admet-2013	182	36	]	]	PUNCT
admet-2013	182	37	.	.	PUNCT
admet-2013	183	1	various	various	ADJ
admet-2013	183	2	organic	organic	ADJ
admet-2013	183	3	nanoparticles	nanoparticle	NOUN
admet-2013	183	4	involved	involve	VERB
admet-2013	183	5	in	in	ADP
admet-2013	183	6	treating	treat	VERB
admet-2013	183	7	cml	cml	PROPN
admet-2013	183	8	have	have	AUX
admet-2013	183	9	been	be	AUX
admet-2013	183	10	summarized	summarize	VERB
admet-2013	183	11	in	in	ADP
admet-2013	183	12	table	table	NOUN
admet-2013	183	13	2	2	NUM
admet-2013	183	14	.	.	PUNCT
admet-2013	183	15	table	table	NOUN
admet-2013	183	16	2	2	NUM
admet-2013	183	17	.	.	PUNCT
admet-2013	184	1	summarises	summarise	VERB
admet-2013	184	2	the	the	DET
admet-2013	184	3	other	other	ADJ
admet-2013	184	4	organic	organic	ADJ
admet-2013	184	5	nanoparticles	nanoparticle	NOUN
admet-2013	184	6	involved	involve	VERB
admet-2013	184	7	in	in	ADP
admet-2013	184	8	cml	cml	PROPN
admet-2013	184	9	treatment	treatment	NOUN
admet-2013	184	10	no	no	PROPN
admet-2013	184	11	.	.	PUNCT
admet-2013	184	12	nanoparticle	nanoparticle	NOUN
admet-2013	184	13	type	type	NOUN
admet-2013	184	14	conjugated	conjugate	VERB
admet-2013	184	15	to	to	ADP
admet-2013	184	16	experiment	experiment	NOUN
admet-2013	184	17	mechanism	mechanism	NOUN
admet-2013	184	18	of	of	ADP
admet-2013	184	19	action	action	NOUN
admet-2013	184	20	ref	ref	NOUN
admet-2013	184	21	.	.	PUNCT
admet-2013	185	1	1	1	NUM
admet-2013	185	2	lipid	lipid	NOUN
admet-2013	185	3	nanoparticle	nanoparticle	NOUN
admet-2013	185	4	sirna	sirna	PROPN
admet-2013	185	5	in	in	SCONJ
admet-2013	185	6	vivo	vivo	VERB
admet-2013	185	7	the	the	DET
admet-2013	185	8	bcr	bcr	PROPN
admet-2013	185	9	-	-	ADJ
admet-2013	185	10	abl	abl	NOUN
admet-2013	185	11	fusion	fusion	NOUN
admet-2013	185	12	oncogenein	oncogenein	NOUN
admet-2013	185	13	mousemyeloid	mousemyeloid	PROPN
admet-2013	185	14	leukaemia	leukaemia	NOUN
admet-2013	185	15	model	model	NOUN
admet-2013	185	16	is	be	AUX
admet-2013	185	17	targeted	target	VERB
admet-2013	185	18	by	by	ADP
admet-2013	185	19	lipidloaded	lipidloade	VERB
admet-2013	185	20	nanoparticle	nanoparticle	NOUN
admet-2013	185	21	containing	contain	VERB
admet-2013	185	22	bcr	bcr	PROPN
admet-2013	185	23	-	-	PUNCT
admet-2013	185	24	abl	abl	PROPN
admet-2013	185	25	sirna	sirna	PROPN
admet-2013	185	26	.	.	PUNCT
admet-2013	186	1	[	[	X
admet-2013	186	2	80	80	NUM
admet-2013	186	3	]	]	SYM
admet-2013	186	4	2	2	NUM
admet-2013	186	5	co	co	NOUN
admet-2013	186	6	-	-	NOUN
admet-2013	186	7	polymer	polymer	ADJ
admet-2013	186	8	,	,	PUNCT
admet-2013	186	9	poly	poly	ADJ
admet-2013	186	10	oligo(ethylene	oligo(ethylene	ADJ
admet-2013	186	11	glycol	glycol	NOUN
admet-2013	186	12	)	)	PUNCT
admet-2013	186	13	methacrylate	methacrylate	NOUN
admet-2013	186	14	-	-	PUNCT
admet-2013	186	15	b	b	NOUN
admet-2013	186	16	-	-	PUNCT
admet-2013	186	17	poly(styrene	poly(styrene	ADJ
admet-2013	186	18	–	–	PUNCT
admet-2013	186	19	co-4	co-4	NOUN
admet-2013	186	20	-	-	PUNCT
admet-2013	186	21	formylphenyl	formylphenyl	ADJ
admet-2013	186	22	methacrylate	methacrylate	NOUN
admet-2013	186	23	)	)	PUNCT
admet-2013	186	24	with	with	ADP
admet-2013	186	25	bottlebrush	bottlebrush	NOUN
admet-2013	186	26	-	-	PUNCT
admet-2013	186	27	like	like	ADJ
admet-2013	186	28	oligo	oligo	NOUN
admet-2013	186	29	(	(	PUNCT
admet-2013	186	30	ethylene	ethylene	NOUN
admet-2013	186	31	glycol	glycol	NOUN
admet-2013	186	32	)	)	PUNCT
admet-2013	186	33	methacrylate	methacrylate	NOUN
admet-2013	186	34	chmfl	chmfl	NOUN
admet-2013	186	35	-	-	PUNCT
admet-2013	186	36	abl-053	abl-053	ADJ
admet-2013	186	37	in	in	ADP
admet-2013	186	38	vivo	vivo	NOUN
admet-2013	186	39	and	and	CCONJ
admet-2013	186	40	in	in	ADP
admet-2013	186	41	vitro	vitro	X
admet-2013	186	42	when	when	SCONJ
admet-2013	186	43	this	this	DET
admet-2013	186	44	micelle	micelle	NOUN
admet-2013	186	45	is	be	AUX
admet-2013	186	46	given	give	VERB
admet-2013	186	47	in	in	ADP
admet-2013	186	48	high	high	ADJ
admet-2013	186	49	doses	dose	NOUN
admet-2013	186	50	it	it	PRON
admet-2013	186	51	enables	enable	VERB
admet-2013	186	52	controlled	control	VERB
admet-2013	186	53	release	release	NOUN
admet-2013	186	54	and	and	CCONJ
admet-2013	186	55	longer	long	ADJ
admet-2013	186	56	circulation	circulation	NOUN
admet-2013	186	57	of	of	ADP
admet-2013	186	58	drugs	drug	NOUN
admet-2013	186	59	and	and	CCONJ
admet-2013	186	60	makes	make	VERB
admet-2013	186	61	it	it	PRON
admet-2013	186	62	a	a	DET
admet-2013	186	63	potential	potential	ADJ
admet-2013	186	64	cml	cml	PROPN
admet-2013	186	65	drug	drug	NOUN
admet-2013	186	66	candidate	candidate	NOUN
admet-2013	186	67	.	.	PUNCT
admet-2013	187	1	[	[	X
admet-2013	187	2	81	81	NUM
admet-2013	187	3	]	]	SYM
admet-2013	187	4	3	3	NUM
admet-2013	187	5	protein	protein	NOUN
admet-2013	187	6	scaffold	scaffold	NOUN
admet-2013	187	7	cterminus	cterminus	NOUN
admet-2013	187	8	of	of	ADP
admet-2013	187	9	bcrabl	bcrabl	NOUN
admet-2013	187	10	is	be	AUX
admet-2013	187	11	attached	attach	VERB
admet-2013	187	12	to	to	PART
admet-2013	187	13	arg	arg	VERB
admet-2013	187	14	-	-	PUNCT
admet-2013	187	15	repeating	repeat	VERB
admet-2013	187	16	hexapeptide	hexapeptide	NOUN
admet-2013	187	17	(	(	PUNCT
admet-2013	187	18	r6	r6	NOUN
admet-2013	187	19	)	)	PUNCT
admet-2013	187	20	in	in	ADP
admet-2013	187	21	vivo	vivo	NOUN
admet-2013	187	22	and	and	CCONJ
admet-2013	187	23	in	in	ADP
admet-2013	187	24	vitro	vitro	X
admet-2013	187	25	a	a	DET
admet-2013	187	26	powerful	powerful	ADJ
admet-2013	187	27	dodecameric	dodecameric	ADJ
admet-2013	187	28	peptide	peptide	NOUN
admet-2013	187	29	antagonist	antagonist	NOUN
admet-2013	187	30	of	of	ADP
admet-2013	187	31	p53	p53	NOUN
admet-2013	187	32	-	-	PUNCT
admet-2013	187	33	mdm2	mdm2	NOUN
admet-2013	187	34	/	/	SYM
admet-2013	187	35	mdmx	mdmx	NOUN
admet-2013	187	36	interaction	interaction	NOUN
admet-2013	187	37	(	(	PUNCT
admet-2013	187	38	pmi	pmi	PROPN
admet-2013	187	39	)	)	PUNCT
admet-2013	187	40	,	,	PUNCT
admet-2013	187	41	found	find	VERB
admet-2013	187	42	at	at	ADP
admet-2013	187	43	the	the	DET
admet-2013	187	44	n	n	CCONJ
admet-2013	187	45	-	-	PUNCT
admet-2013	187	46	terminus	terminus	NOUN
admet-2013	187	47	of	of	ADP
admet-2013	187	48	bcr	bcr	PROPN
admet-2013	187	49	/	/	SYM
admet-2013	187	50	abl	abl	PROPN
admet-2013	187	51	,	,	PUNCT
admet-2013	187	52	with	with	SCONJ
admet-2013	187	53	its	its	PRON
admet-2013	187	54	argrepeating	argrepeate	VERB
admet-2013	187	55	hexapeptide	hexapeptide	NOUN
admet-2013	187	56	inhibits	inhibit	VERB
admet-2013	187	57	the	the	DET
admet-2013	187	58	mdm2	mdm2	PROPN
admet-2013	187	59	/	/	SYM
admet-2013	187	60	mdmx	mdmx	NOUN
admet-2013	187	61	and	and	CCONJ
admet-2013	187	62	activates	activate	VERB
admet-2013	187	63	the	the	DET
admet-2013	187	64	p53	p53	NOUN
admet-2013	187	65	pathway	pathway	NOUN
admet-2013	187	66	.	.	PUNCT
admet-2013	188	1	[	[	X
admet-2013	188	2	82	82	NUM
admet-2013	188	3	]	]	SYM
admet-2013	188	4	4	4	NUM
admet-2013	188	5	ferritin	ferritin	ADJ
admet-2013	188	6	dendrimer	dendrimer	NOUN
admet-2013	188	7	pre	pre	NOUN
admet-2013	188	8	-	-	NOUN
admet-2013	188	9	mirna	mirna	NOUN
admet-2013	188	10	in	in	ADP
admet-2013	188	11	vitro	vitro	X
admet-2013	188	12	the	the	DET
admet-2013	188	13	leukaemia	leukaemia	NOUN
admet-2013	188	14	cells	cell	NOUN
admet-2013	188	15	internalize	internalize	VERB
admet-2013	188	16	the	the	DET
admet-2013	188	17	pre	pre	NOUN
admet-2013	188	18	-	-	NOUN
admet-2013	188	19	mirna	mirna	NOUN
admet-2013	188	20	by	by	ADP
admet-2013	188	21	expressing	express	VERB
admet-2013	188	22	cd71	cd71	PROPN
admet-2013	188	23	receptor	receptor	NOUN
admet-2013	188	24	.	.	PUNCT
admet-2013	189	1	once	once	ADV
admet-2013	189	2	internalised	internalise	VERB
admet-2013	189	3	the	the	DET
admet-2013	189	4	pre	pre	ADJ
admet-2013	189	5	-	-	ADJ
admet-2013	189	6	mirna	mirna	ADJ
admet-2013	189	7	matures	mature	NOUN
admet-2013	189	8	and	and	CCONJ
admet-2013	189	9	brings	bring	VERB
admet-2013	189	10	about	about	ADP
admet-2013	189	11	morphological	morphological	ADJ
admet-2013	189	12	changes	change	NOUN
admet-2013	189	13	.	.	PUNCT
admet-2013	190	1	[	[	X
admet-2013	190	2	83	83	NUM
admet-2013	190	3	]	]	SYM
admet-2013	190	4	5	5	NUM
admet-2013	190	5	polyethyleniminecholestrol	polyethyleniminecholestrol	PROPN
admet-2013	190	6	sirna	sirna	PROPN
admet-2013	190	7	in	in	ADP
admet-2013	190	8	vitro	vitro	X
admet-2013	190	9	the	the	DET
admet-2013	190	10	pei	pei	PROPN
admet-2013	190	11	-	-	PUNCT
admet-2013	190	12	chol	chol	NOUN
admet-2013	190	13	mediated	mediate	VERB
admet-2013	190	14	distribution	distribution	NOUN
admet-2013	190	15	of	of	ADP
admet-2013	190	16	bcr	bcr	PROPN
admet-2013	190	17	-	-	PROPN
admet-2013	190	18	abl	abl	PROPN
admet-2013	190	19	sirna	sirna	PROPN
admet-2013	190	20	resulted	result	VERB
admet-2013	190	21	in	in	ADP
admet-2013	190	22	increased	increased	ADJ
admet-2013	190	23	level	level	NOUN
admet-2013	190	24	of	of	ADP
admet-2013	190	25	apoptosis	apoptosis	NOUN
admet-2013	190	26	of	of	ADP
admet-2013	190	27	k562	k562	PROPN
admet-2013	190	28	cells	cell	NOUN
admet-2013	190	29	.	.	PUNCT
admet-2013	191	1	[	[	X
admet-2013	191	2	84	84	NUM
admet-2013	191	3	]	]	SYM
admet-2013	191	4	6	6	NUM
admet-2013	191	5	lipid	lipid	NOUN
admet-2013	191	6	-	-	PUNCT
admet-2013	191	7	polymer	polymer	NOUN
admet-2013	191	8	hybrid	hybrid	NOUN
admet-2013	191	9	doxorubicin	doxorubicin	NOUN
admet-2013	191	10	and	and	CCONJ
admet-2013	191	11	gallic	gallic	NOUN
admet-2013	191	12	acid	acid	NOUN
admet-2013	191	13	in	in	ADP
admet-2013	191	14	vivo	vivo	NOUN
admet-2013	191	15	and	and	CCONJ
admet-2013	191	16	in	in	ADP
admet-2013	191	17	vitro	vitro	X
admet-2013	191	18	they	they	PRON
admet-2013	191	19	reduced	reduce	VERB
admet-2013	191	20	the	the	DET
admet-2013	191	21	size	size	NOUN
admet-2013	191	22	of	of	ADP
admet-2013	191	23	tumor	tumor	NOUN
admet-2013	191	24	growth	growth	NOUN
admet-2013	191	25	in	in	ADP
admet-2013	191	26	k562	k562	PROPN
admet-2013	191	27	cells	cell	NOUN
admet-2013	191	28	from	from	ADP
admet-2013	191	29	956	956	NUM
admet-2013	191	30	mm3	mm3	NOUN
admet-2013	191	31	to	to	ADP
admet-2013	191	32	213	213	NUM
admet-2013	191	33	mm3	mm3	NOUN
admet-2013	191	34	.	.	PUNCT
admet-2013	192	1	[	[	X
admet-2013	192	2	85	85	NUM
admet-2013	192	3	]	]	SYM
admet-2013	192	4	7	7	NUM
admet-2013	192	5	polylactic	polylactic	ADJ
admet-2013	192	6	acid	acid	NOUN
admet-2013	192	7	nanoparticle	nanoparticle	NOUN
admet-2013	192	8	daunorubicin	daunorubicin	PROPN
admet-2013	192	9	and	and	CCONJ
admet-2013	192	10	glycyrrhizic	glycyrrhizic	NOUN
admet-2013	192	11	acid	acid	NOUN
admet-2013	192	12	in	in	ADP
admet-2013	192	13	vitro	vitro	X
admet-2013	192	14	the	the	DET
admet-2013	192	15	drug	drug	NOUN
admet-2013	192	16	caused	cause	VERB
admet-2013	192	17	apoptosis	apoptosis	NOUN
admet-2013	192	18	of	of	ADP
admet-2013	192	19	k562	k562	PROPN
admet-2013	192	20	cells	cell	NOUN
admet-2013	192	21	.	.	PUNCT
admet-2013	193	1	[	[	X
admet-2013	193	2	86	86	NUM
admet-2013	193	3	]	]	PUNCT
admet-2013	193	4	https://doi.org/10.5599/admet.2013	https://doi.org/10.5599/admet.2013	NOUN
admet-2013	193	5	g.	g.	PROPN
admet-2013	193	6	janani	janani	PROPN
admet-2013	193	7	et	et	PROPN
admet-2013	193	8	al	al	PROPN
admet-2013	193	9	.	.	PROPN
admet-2013	193	10	admet	admet	PROPN
admet-2013	193	11	&	&	CCONJ
admet-2013	193	12	dmpk	dmpk	PROPN
admet-2013	193	13	11(4	11(4	NUM
admet-2013	193	14	)	)	PUNCT
admet-2013	193	15	(	(	PUNCT
admet-2013	193	16	2023	2023	NUM
admet-2013	193	17	)	)	PUNCT
admet-2013	193	18	499	499	NUM
admet-2013	193	19	-	-	SYM
admet-2013	193	20	511	511	NUM
admet-2013	193	21	506	506	NUM
admet-2013	193	22	conclusion	conclusion	NOUN
admet-2013	193	23	recent	recent	ADJ
admet-2013	193	24	advances	advance	NOUN
admet-2013	193	25	in	in	ADP
admet-2013	193	26	nanotechnology	nanotechnology	NOUN
admet-2013	193	27	have	have	AUX
admet-2013	193	28	sparked	spark	VERB
admet-2013	193	29	the	the	DET
admet-2013	193	30	creation	creation	NOUN
admet-2013	193	31	of	of	ADP
admet-2013	193	32	numerous	numerous	ADJ
admet-2013	193	33	improvised	improvised	ADJ
admet-2013	193	34	nanoparticles	nanoparticle	NOUN
admet-2013	193	35	for	for	ADP
admet-2013	193	36	diagnostic	diagnostic	ADJ
admet-2013	193	37	and	and	CCONJ
admet-2013	193	38	therapeutic	therapeutic	ADJ
admet-2013	193	39	uses	use	NOUN
admet-2013	193	40	.	.	PUNCT
admet-2013	194	1	of	of	ADP
admet-2013	194	2	all	all	DET
admet-2013	194	3	newly	newly	ADV
admet-2013	194	4	reported	report	VERB
admet-2013	194	5	cancer	cancer	NOUN
admet-2013	194	6	cases	case	NOUN
admet-2013	194	7	in	in	ADP
admet-2013	194	8	india	india	PROPN
admet-2013	194	9	,	,	PUNCT
admet-2013	194	10	8	8	NUM
admet-2013	194	11	%	%	NOUN
admet-2013	194	12	are	be	AUX
admet-2013	194	13	blood	blood	NOUN
admet-2013	194	14	cancer	cancer	NOUN
admet-2013	194	15	cases	case	NOUN
admet-2013	194	16	.	.	PUNCT
admet-2013	195	1	blood	blood	NOUN
admet-2013	195	2	cancers	cancer	NOUN
admet-2013	195	3	like	like	ADP
admet-2013	195	4	leukemia	leukemia	NOUN
admet-2013	195	5	,	,	PUNCT
admet-2013	195	6	lymphoma	lymphoma	NOUN
admet-2013	195	7	,	,	PUNCT
admet-2013	195	8	and	and	CCONJ
admet-2013	195	9	myeloma	myeloma	NOUN
admet-2013	195	10	are	be	AUX
admet-2013	195	11	more	more	ADV
admet-2013	195	12	prevalent	prevalent	ADJ
admet-2013	195	13	in	in	ADP
admet-2013	195	14	men	man	NOUN
admet-2013	195	15	than	than	ADP
admet-2013	195	16	women	woman	NOUN
admet-2013	195	17	.	.	PUNCT
admet-2013	196	1	several	several	ADJ
admet-2013	196	2	improvements	improvement	NOUN
admet-2013	196	3	in	in	ADP
admet-2013	196	4	treating	treat	VERB
admet-2013	196	5	cml	cml	PROPN
admet-2013	196	6	patients	patient	NOUN
admet-2013	196	7	have	have	AUX
admet-2013	196	8	improved	improve	VERB
admet-2013	196	9	.	.	PUNCT
admet-2013	197	1	an	an	DET
admet-2013	197	2	effective	effective	ADJ
admet-2013	197	3	tool	tool	NOUN
admet-2013	197	4	for	for	ADP
admet-2013	197	5	treating	treat	VERB
admet-2013	197	6	is	be	AUX
admet-2013	197	7	provided	provide	VERB
admet-2013	197	8	by	by	ADP
admet-2013	197	9	nanotechnology	nanotechnology	PROPN
admet-2013	197	10	.	.	PUNCT
admet-2013	198	1	nanomedicines	nanomedicine	NOUN
admet-2013	198	2	can	can	AUX
admet-2013	198	3	target	target	VERB
admet-2013	198	4	and	and	CCONJ
admet-2013	198	5	regulate	regulate	VERB
admet-2013	198	6	the	the	DET
admet-2013	198	7	release	release	NOUN
admet-2013	198	8	of	of	ADP
admet-2013	198	9	drugs	drug	NOUN
admet-2013	198	10	in	in	ADP
admet-2013	198	11	diseased	diseased	ADJ
admet-2013	198	12	areas	area	NOUN
admet-2013	198	13	and	and	CCONJ
admet-2013	198	14	protect	protect	VERB
admet-2013	198	15	the	the	DET
admet-2013	198	16	body	body	NOUN
admet-2013	198	17	from	from	ADP
admet-2013	198	18	deadly	deadly	ADJ
admet-2013	198	19	off	off	ADP
admet-2013	198	20	-	-	PUNCT
admet-2013	198	21	target	target	VERB
admet-2013	198	22	adverse	adverse	ADJ
admet-2013	198	23	effects	effect	NOUN
admet-2013	198	24	.	.	PUNCT
admet-2013	199	1	nanomedicines	nanomedicine	NOUN
admet-2013	199	2	employed	employ	VERB
admet-2013	199	3	in	in	ADP
admet-2013	199	4	cml	cml	PROPN
admet-2013	199	5	target	target	PROPN
admet-2013	199	6	tyrosine	tyrosine	PROPN
admet-2013	199	7	kinase	kinase	PROPN
admet-2013	199	8	pathway	pathway	NOUN
admet-2013	199	9	,	,	PUNCT
admet-2013	199	10	apoptosis	apoptosis	NOUN
admet-2013	199	11	,	,	PUNCT
admet-2013	199	12	and	and	CCONJ
admet-2013	199	13	multidrug	multidrug	NOUN
admet-2013	199	14	-	-	PUNCT
admet-2013	199	15	resistant	resistant	ADJ
admet-2013	199	16	gene	gene	NOUN
admet-2013	199	17	mdr1	mdr1	PROPN
admet-2013	199	18	.	.	PUNCT
admet-2013	200	1	due	due	ADP
admet-2013	200	2	to	to	ADP
admet-2013	200	3	their	their	PRON
admet-2013	200	4	large	large	ADJ
admet-2013	200	5	surface	surface	NOUN
admet-2013	200	6	area	area	NOUN
admet-2013	200	7	,	,	PUNCT
admet-2013	200	8	they	they	PRON
admet-2013	200	9	are	be	AUX
admet-2013	200	10	coated	coat	VERB
admet-2013	200	11	on	on	ADP
admet-2013	200	12	the	the	DET
admet-2013	200	13	biosensors	biosensor	NOUN
admet-2013	200	14	to	to	PART
admet-2013	200	15	detect	detect	VERB
admet-2013	200	16	the	the	DET
admet-2013	200	17	malignant	malignant	ADJ
admet-2013	200	18	cells	cell	NOUN
admet-2013	200	19	precisely	precisely	ADV
admet-2013	200	20	with	with	ADP
admet-2013	200	21	high	high	ADJ
admet-2013	200	22	sensitivity	sensitivity	NOUN
admet-2013	200	23	and	and	CCONJ
admet-2013	200	24	specificity	specificity	NOUN
admet-2013	200	25	,	,	PUNCT
admet-2013	200	26	enabling	enable	VERB
admet-2013	200	27	early	early	ADJ
admet-2013	200	28	-	-	PUNCT
admet-2013	200	29	stage	stage	NOUN
admet-2013	200	30	cancer	cancer	NOUN
admet-2013	200	31	detection	detection	NOUN
admet-2013	200	32	.	.	PUNCT
admet-2013	201	1	acknowledgements	acknowledgement	NOUN
admet-2013	201	2	:	:	PUNCT
admet-2013	202	1	we	we	PRON
admet-2013	202	2	are	be	AUX
admet-2013	202	3	grateful	grateful	ADJ
admet-2013	202	4	to	to	ADP
admet-2013	202	5	chettinad	chettinad	PROPN
admet-2013	202	6	academy	academy	PROPN
admet-2013	202	7	of	of	ADP
admet-2013	202	8	research	research	NOUN
admet-2013	202	9	and	and	CCONJ
admet-2013	202	10	education	education	NOUN
admet-2013	202	11	for	for	ADP
admet-2013	202	12	providing	provide	VERB
admet-2013	202	13	the	the	DET
admet-2013	202	14	infrastructure	infrastructure	NOUN
admet-2013	202	15	.	.	PUNCT
admet-2013	203	1	gj	gj	NOUN
admet-2013	203	2	is	be	AUX
admet-2013	203	3	thankful	thankful	ADJ
admet-2013	203	4	to	to	ADP
admet-2013	203	5	chettinad	chettinad	PROPN
admet-2013	203	6	academy	academy	PROPN
admet-2013	203	7	of	of	ADP
admet-2013	203	8	research	research	NOUN
admet-2013	203	9	and	and	CCONJ
admet-2013	203	10	education	education	NOUN
admet-2013	203	11	for	for	ADP
admet-2013	203	12	providing	provide	VERB
admet-2013	203	13	her	she	PRON
admet-2013	203	14	with	with	ADP
admet-2013	203	15	the	the	DET
admet-2013	203	16	phd	phd	NOUN
admet-2013	203	17	fellowship	fellowship	NOUN
admet-2013	203	18	.	.	PUNCT
admet-2013	204	1	conflict	conflict	NOUN
admet-2013	204	2	of	of	ADP
admet-2013	204	3	interest	interest	NOUN
admet-2013	204	4	:	:	PUNCT
admet-2013	204	5	the	the	DET
admet-2013	204	6	authors	author	NOUN
admet-2013	204	7	declare	declare	VERB
admet-2013	204	8	no	no	DET
admet-2013	204	9	conflicts	conflict	NOUN
admet-2013	204	10	of	of	ADP
admet-2013	204	11	interest	interest	NOUN
admet-2013	204	12	.	.	PUNCT
admet-2013	205	1	references	reference	NOUN
admet-2013	205	2	[	[	X
admet-2013	205	3	1	1	X
admet-2013	205	4	]	]	PUNCT
admet-2013	205	5	d.	d.	PROPN
admet-2013	205	6	findakly	findakly	PROPN
admet-2013	205	7	,	,	PUNCT
admet-2013	205	8	w.	w.	PROPN
admet-2013	205	9	arslan	arslan	PROPN
admet-2013	205	10	,	,	PUNCT
admet-2013	205	11	d.	d.	PROPN
admet-2013	205	12	findakly	findakly	ADV
admet-2013	205	13	.	.	PUNCT
admet-2013	206	1	clinical	clinical	ADJ
admet-2013	206	2	features	feature	NOUN
admet-2013	206	3	and	and	CCONJ
admet-2013	206	4	outcomes	outcome	NOUN
admet-2013	206	5	of	of	ADP
admet-2013	206	6	patients	patient	NOUN
admet-2013	206	7	with	with	ADP
admet-2013	206	8	chronic	chronic	ADJ
admet-2013	206	9	myeloid	myeloid	NOUN
admet-2013	206	10	leukemia	leukemia	NOUN
admet-2013	206	11	presenting	present	VERB
admet-2013	206	12	with	with	ADP
admet-2013	206	13	isolated	isolated	ADJ
admet-2013	206	14	thrombocytosis	thrombocytosis	NOUN
admet-2013	206	15	:	:	PUNCT
admet-2013	206	16	a	a	DET
admet-2013	206	17	systematic	systematic	ADJ
admet-2013	206	18	review	review	NOUN
admet-2013	206	19	and	and	CCONJ
admet-2013	206	20	a	a	DET
admet-2013	206	21	case	case	NOUN
admet-2013	206	22	from	from	ADP
admet-2013	206	23	our	our	PRON
admet-2013	206	24	institution	institution	NOUN
admet-2013	206	25	.	.	PUNCT
admet-2013	207	1	cureus	cureus	NOUN
admet-2013	207	2	12	12	NUM
admet-2013	207	3	(	(	PUNCT
admet-2013	207	4	2020	2020	NUM
admet-2013	207	5	)	)	PUNCT
admet-2013	207	6	.	.	PUNCT
admet-2013	208	1	https://doi.org/10.7759/cureus.8788	https://doi.org/10.7759/cureus.8788	PROPN
admet-2013	208	2	.	.	PUNCT
admet-2013	209	1	[	[	X
admet-2013	209	2	2	2	NUM
admet-2013	209	3	]	]	X
admet-2013	209	4	e.h	e.h	PROPN
admet-2013	209	5	.	.	PROPN
admet-2013	209	6	powsner	powsner	PROPN
admet-2013	209	7	,	,	PUNCT
admet-2013	209	8	j.c	j.c	PROPN
admet-2013	209	9	.	.	PROPN
admet-2013	209	10	harris	harris	PROPN
admet-2013	209	11	,	,	PUNCT
admet-2013	209	12	e.s	e.s	PROPN
admet-2013	209	13	.	.	PROPN
admet-2013	209	14	day	day	NOUN
admet-2013	209	15	.	.	PUNCT
admet-2013	210	1	biomimetic	biomimetic	ADJ
admet-2013	210	2	nanoparticles	nanoparticle	NOUN
admet-2013	210	3	for	for	ADP
admet-2013	210	4	the	the	DET
admet-2013	210	5	treatment	treatment	NOUN
admet-2013	210	6	of	of	ADP
admet-2013	210	7	hematologic	hematologic	NOUN
admet-2013	210	8	malignancies	malignancy	NOUN
admet-2013	210	9	.	.	PUNCT
admet-2013	211	1	advanced	advanced	PROPN
admet-2013	211	2	nanobiomed	nanobiome	VERB
admet-2013	211	3	research	research	NOUN
admet-2013	211	4	1	1	NUM
admet-2013	211	5	(	(	PUNCT
admet-2013	211	6	2021	2021	NUM
admet-2013	211	7	)	)	PUNCT
admet-2013	211	8	2000047	2000047	NUM
admet-2013	211	9	.	.	PUNCT
admet-2013	212	1	https://doi.org/10.1002/anbr.202000047	https://doi.org/10.1002/anbr.202000047	NOUN
admet-2013	212	2	.	.	PUNCT
admet-2013	213	1	[	[	X
admet-2013	213	2	3	3	X
admet-2013	213	3	]	]	PUNCT
admet-2013	213	4	j.	j.	PROPN
admet-2013	213	5	wang	wang	PROPN
admet-2013	213	6	,	,	PUNCT
admet-2013	213	7	l.	l.	PROPN
admet-2013	213	8	sheng	sheng	PROPN
admet-2013	213	9	,	,	PUNCT
admet-2013	213	10	y.	y.	PROPN
admet-2013	213	11	lai	lai	PROPN
admet-2013	213	12	,	,	PUNCT
admet-2013	213	13	z.	z.	PROPN
admet-2013	213	14	xu	xu	PROPN
admet-2013	213	15	.	.	PUNCT
admet-2013	214	1	an	an	DET
admet-2013	214	2	overview	overview	NOUN
admet-2013	214	3	on	on	ADP
admet-2013	214	4	therapeutic	therapeutic	ADJ
admet-2013	214	5	efficacy	efficacy	NOUN
admet-2013	214	6	and	and	CCONJ
admet-2013	214	7	challenges	challenge	NOUN
admet-2013	214	8	of	of	ADP
admet-2013	214	9	nanoparticles	nanoparticle	NOUN
admet-2013	214	10	in	in	ADP
admet-2013	214	11	blood	blood	NOUN
admet-2013	214	12	cancer	cancer	NOUN
admet-2013	214	13	therapy	therapy	NOUN
admet-2013	214	14	.	.	PUNCT
admet-2013	215	1	journal	journal	PROPN
admet-2013	215	2	of	of	ADP
admet-2013	215	3	king	king	PROPN
admet-2013	215	4	saud	saud	PROPN
admet-2013	215	5	university	university	PROPN
admet-2013	215	6	-	-	PUNCT
admet-2013	215	7	science	science	NOUN
admet-2013	215	8	34	34	NUM
admet-2013	215	9	(	(	PUNCT
admet-2013	215	10	2022	2022	NUM
admet-2013	215	11	)	)	PUNCT
admet-2013	215	12	102182	102182	NUM
admet-2013	215	13	.	.	PUNCT
admet-2013	216	1	https://doi.org/10.1016/j.jksus.2022.102182	https://doi.org/10.1016/j.jksus.2022.102182	NOUN
admet-2013	216	2	.	.	PUNCT
admet-2013	217	1	[	[	X
admet-2013	217	2	4	4	X
admet-2013	217	3	]	]	X
admet-2013	217	4	d.	d.	PROPN
admet-2013	217	5	vetrie	vetrie	PROPN
admet-2013	217	6	,	,	PUNCT
admet-2013	217	7	g.v	g.v	PROPN
admet-2013	217	8	.	.	PROPN
admet-2013	217	9	helgason	helgason	PROPN
admet-2013	217	10	,	,	PUNCT
admet-2013	217	11	m.	m.	NOUN
admet-2013	217	12	copland	copland	PROPN
admet-2013	217	13	.	.	PUNCT
admet-2013	218	1	the	the	DET
admet-2013	218	2	leukaemia	leukaemia	NOUN
admet-2013	218	3	stem	stem	NOUN
admet-2013	218	4	cell	cell	NOUN
admet-2013	218	5	:	:	PUNCT
admet-2013	218	6	similarities	similarity	NOUN
admet-2013	218	7	,	,	PUNCT
admet-2013	218	8	differences	difference	NOUN
admet-2013	218	9	and	and	CCONJ
admet-2013	218	10	clinical	clinical	ADJ
admet-2013	218	11	prospects	prospect	NOUN
admet-2013	218	12	in	in	ADP
admet-2013	218	13	cml	cml	PROPN
admet-2013	218	14	and	and	CCONJ
admet-2013	218	15	aml	aml	PROPN
admet-2013	218	16	.	.	PUNCT
admet-2013	219	1	nature	nature	NOUN
admet-2013	219	2	reviews	review	VERB
admet-2013	219	3	cancer	cancer	NOUN
admet-2013	219	4	20	20	NUM
admet-2013	219	5	(	(	PUNCT
admet-2013	219	6	2020	2020	NUM
admet-2013	219	7	)	)	PUNCT
admet-2013	219	8	158	158	NUM
admet-2013	219	9	-	-	SYM
admet-2013	219	10	173	173	NUM
admet-2013	219	11	.	.	PUNCT
admet-2013	220	1	https://doi.org/10.1038/s41568-019-0230-9	https://doi.org/10.1038/s41568-019-0230-9	NUM
admet-2013	220	2	.	.	PUNCT
admet-2013	221	1	[	[	X
admet-2013	221	2	5	5	X
admet-2013	221	3	]	]	X
admet-2013	221	4	j.r	j.r	PROPN
admet-2013	221	5	.	.	PROPN
admet-2013	221	6	mcwhirter	mcwhirter	PROPN
admet-2013	221	7	,	,	PUNCT
admet-2013	221	8	d.l	d.l	PROPN
admet-2013	221	9	.	.	PROPN
admet-2013	221	10	galasso	galasso	PROPN
admet-2013	221	11	,	,	PUNCT
admet-2013	221	12	j.y	j.y	PROPN
admet-2013	221	13	.	.	PROPN
admet-2013	221	14	wang	wang	PROPN
admet-2013	221	15	.	.	PUNCT
admet-2013	222	1	a	a	DET
admet-2013	222	2	coiled	coil	VERB
admet-2013	222	3	-	-	PUNCT
admet-2013	222	4	coil	coil	NOUN
admet-2013	222	5	oligomerization	oligomerization	NOUN
admet-2013	222	6	domain	domain	NOUN
admet-2013	222	7	of	of	ADP
admet-2013	222	8	bcr	bcr	PROPN
admet-2013	222	9	is	be	AUX
admet-2013	222	10	essential	essential	ADJ
admet-2013	222	11	for	for	ADP
admet-2013	222	12	the	the	DET
admet-2013	222	13	transforming	transform	VERB
admet-2013	222	14	function	function	NOUN
admet-2013	222	15	of	of	ADP
admet-2013	222	16	bcr	bcr	PROPN
admet-2013	222	17	-	-	ADJ
admet-2013	222	18	abl	abl	NOUN
admet-2013	222	19	oncoproteins	oncoprotein	NOUN
admet-2013	222	20	.	.	PUNCT
admet-2013	223	1	molecular	molecular	ADJ
admet-2013	223	2	and	and	CCONJ
admet-2013	223	3	cellular	cellular	ADJ
admet-2013	223	4	biology	biology	NOUN
admet-2013	223	5	13	13	NUM
admet-2013	223	6	(	(	PUNCT
admet-2013	223	7	1993	1993	NUM
admet-2013	223	8	)	)	PUNCT
admet-2013	223	9	75877595	75877595	NUM
admet-2013	223	10	.	.	PUNCT
admet-2013	224	1	https://doi.org/10.1128/mcb.13.12.7587-7595.1993	https://doi.org/10.1128/mcb.13.12.7587-7595.1993	X
admet-2013	224	2	.	.	PUNCT
admet-2013	225	1	[	[	X
admet-2013	225	2	6	6	NUM
admet-2013	225	3	]	]	X
admet-2013	225	4	y.	y.	PROPN
admet-2013	225	5	ghosn	ghosn	PROPN
admet-2013	225	6	,	,	PUNCT
admet-2013	225	7	m.h	m.h	PROPN
admet-2013	225	8	.	.	PROPN
admet-2013	225	9	kamareddine	kamareddine	PROPN
admet-2013	225	10	,	,	PUNCT
admet-2013	225	11	a.	a.	NOUN
admet-2013	225	12	tawk	tawk	PROPN
admet-2013	225	13	,	,	PUNCT
admet-2013	225	14	c.	c.	PROPN
admet-2013	225	15	elia	elia	PROPN
admet-2013	225	16	,	,	PUNCT
admet-2013	225	17	a.	a.	PROPN
admet-2013	225	18	el	el	PROPN
admet-2013	225	19	mahmoud	mahmoud	PROPN
admet-2013	225	20	,	,	PUNCT
admet-2013	225	21	k.	k.	PROPN
admet-2013	225	22	terro	terro	PROPN
admet-2013	225	23	,	,	PUNCT
admet-2013	225	24	n.	n.	PROPN
admet-2013	225	25	el	el	PROPN
admet-2013	225	26	harake	harake	PROPN
admet-2013	225	27	,	,	PUNCT
admet-2013	225	28	b.	b.	PROPN
admet-2013	225	29	el	el	PROPN
admet-2013	225	30	-	-	PROPN
admet-2013	225	31	baba	baba	PROPN
admet-2013	225	32	,	,	PUNCT
admet-2013	225	33	j.	j.	PROPN
admet-2013	225	34	makdessi	makdessi	PROPN
admet-2013	225	35	,	,	PUNCT
admet-2013	225	36	s.	s.	PROPN
admet-2013	225	37	farhat	farhat	PROPN
admet-2013	225	38	.	.	PUNCT
admet-2013	226	1	inorganic	inorganic	ADJ
admet-2013	226	2	nanoparticles	nanoparticle	NOUN
admet-2013	226	3	as	as	ADP
admet-2013	226	4	drug	drug	NOUN
admet-2013	226	5	delivery	delivery	NOUN
admet-2013	226	6	systems	system	NOUN
admet-2013	226	7	and	and	CCONJ
admet-2013	226	8	their	their	PRON
admet-2013	226	9	potential	potential	ADJ
admet-2013	226	10	role	role	NOUN
admet-2013	226	11	in	in	ADP
admet-2013	226	12	the	the	DET
admet-2013	226	13	treatment	treatment	NOUN
admet-2013	226	14	of	of	ADP
admet-2013	226	15	chronic	chronic	ADJ
admet-2013	226	16	myelogenous	myelogenous	ADJ
admet-2013	226	17	leukaemia	leukaemia	NOUN
admet-2013	226	18	.	.	PUNCT
admet-2013	227	1	technology	technology	NOUN
admet-2013	227	2	in	in	ADP
admet-2013	227	3	cancer	cancer	NOUN
admet-2013	227	4	research	research	PROPN
admet-2013	227	5	&	&	CCONJ
admet-2013	227	6	treatment	treatment	PROPN
admet-2013	227	7	18	18	NUM
admet-2013	227	8	(	(	PUNCT
admet-2013	227	9	2019	2019	NUM
admet-2013	227	10	)	)	PUNCT
admet-2013	227	11	1533033819853241	1533033819853241	NUM
admet-2013	227	12	.	.	PUNCT
admet-2013	228	1	https://doi.org/10.1177/1533033819853	https://doi.org/10.1177/1533033819853	NOUN
admet-2013	228	2	.	.	PUNCT
admet-2013	229	1	[	[	X
admet-2013	229	2	7	7	X
admet-2013	229	3	]	]	X
admet-2013	229	4	y.	y.	PROPN
admet-2013	229	5	zhang	zhang	PROPN
admet-2013	229	6	,	,	PUNCT
admet-2013	229	7	m.	m.	PROPN
admet-2013	229	8	li	li	PROPN
admet-2013	229	9	,	,	PUNCT
admet-2013	229	10	x.	x.	PROPN
admet-2013	229	11	gao	gao	PROPN
admet-2013	229	12	,	,	PUNCT
admet-2013	229	13	y.	y.	PROPN
admet-2013	229	14	chen	chen	PROPN
admet-2013	229	15	,	,	PUNCT
admet-2013	229	16	t.	t.	PROPN
admet-2013	229	17	liu	liu	PROPN
admet-2013	229	18	.	.	PUNCT
admet-2013	229	19	nanotechnology	nanotechnology	PROPN
admet-2013	229	20	in	in	ADP
admet-2013	229	21	cancer	cancer	NOUN
admet-2013	229	22	diagnosis	diagnosis	NOUN
admet-2013	229	23	:	:	PUNCT
admet-2013	229	24	progress	progress	NOUN
admet-2013	229	25	,	,	PUNCT
admet-2013	229	26	challenges	challenge	NOUN
admet-2013	229	27	and	and	CCONJ
admet-2013	229	28	opportunities	opportunity	NOUN
admet-2013	229	29	.	.	PUNCT
admet-2013	230	1	journal	journal	NOUN
admet-2013	230	2	of	of	ADP
admet-2013	230	3	hematology	hematology	PROPN
admet-2013	230	4	&	&	CCONJ
admet-2013	230	5	oncology	oncology	NOUN
admet-2013	230	6	12	12	NUM
admet-2013	230	7	(	(	PUNCT
admet-2013	230	8	2019	2019	NUM
admet-2013	230	9	)	)	PUNCT
admet-2013	230	10	1	1	NUM
admet-2013	230	11	-	-	SYM
admet-2013	230	12	13	13	NUM
admet-2013	230	13	.	.	PUNCT
admet-2013	231	1	https://doi.org/10.1186/s13045019-0833-3	https://doi.org/10.1186/s13045019-0833-3	NOUN
admet-2013	231	2	.	.	PUNCT
admet-2013	232	1	[	[	X
admet-2013	232	2	8	8	NUM
admet-2013	232	3	]	]	PUNCT
admet-2013	232	4	p.	p.	NOUN
admet-2013	232	5	sharmiladevi	sharmiladevi	NOUN
admet-2013	232	6	,	,	PUNCT
admet-2013	232	7	k.	k.	PROPN
admet-2013	232	8	girigoswami	girigoswami	PROPN
admet-2013	232	9	,	,	PUNCT
admet-2013	232	10	v.	v.	PROPN
admet-2013	232	11	haribabu	haribabu	PROPN
admet-2013	232	12	,	,	PUNCT
admet-2013	232	13	a.	a.	PROPN
admet-2013	232	14	girigoswami	girigoswami	PROPN
admet-2013	232	15	.	.	PUNCT
admet-2013	233	1	nano	nano	NOUN
admet-2013	233	2	-	-	PUNCT
admet-2013	233	3	enabled	enable	VERB
admet-2013	233	4	theranostics	theranostic	NOUN
admet-2013	233	5	for	for	ADP
admet-2013	233	6	cancer	cancer	NOUN
admet-2013	233	7	.	.	PUNCT
admet-2013	234	1	materials	material	NOUN
admet-2013	234	2	advances	advance	VERB
admet-2013	234	3	2	2	NUM
admet-2013	234	4	(	(	PUNCT
admet-2013	234	5	2021	2021	NUM
admet-2013	234	6	)	)	PUNCT
admet-2013	234	7	2876	2876	NUM
admet-2013	234	8	-	-	SYM
admet-2013	234	9	2891	2891	NUM
admet-2013	234	10	.	.	PUNCT
admet-2013	235	1	https://doi.org/10.1039/d1ma00069a	https://doi.org/10.1039/d1ma00069a	PROPN
admet-2013	235	2	.	.	PUNCT
admet-2013	236	1	[	[	X
admet-2013	236	2	9	9	NUM
admet-2013	236	3	]	]	X
admet-2013	236	4	s.k	s.k	PROPN
admet-2013	236	5	.	.	PROPN
admet-2013	236	6	metkar	metkar	PROPN
admet-2013	236	7	,	,	PUNCT
admet-2013	236	8	k.	k.	PROPN
admet-2013	236	9	girigoswami	girigoswami	PROPN
admet-2013	236	10	.	.	PUNCT
admet-2013	237	1	diagnostic	diagnostic	ADJ
admet-2013	237	2	biosensors	biosensor	NOUN
admet-2013	237	3	in	in	ADP
admet-2013	237	4	medicine	medicine	NOUN
admet-2013	237	5	–	–	PUNCT
admet-2013	237	6	a	a	DET
admet-2013	237	7	review	review	NOUN
admet-2013	237	8	.	.	PUNCT
admet-2013	238	1	biocatalysis	biocatalysis	NOUN
admet-2013	238	2	and	and	CCONJ
admet-2013	238	3	agricultural	agricultural	ADJ
admet-2013	238	4	biotechnology	biotechnology	NOUN
admet-2013	238	5	17	17	NUM
admet-2013	238	6	(	(	PUNCT
admet-2013	238	7	2019	2019	NUM
admet-2013	238	8	)	)	PUNCT
admet-2013	238	9	271	271	NUM
admet-2013	238	10	-	-	SYM
admet-2013	238	11	283	283	NUM
admet-2013	238	12	.	.	PUNCT
admet-2013	239	1	https://doi.org/10.1016/j.bcab.2018.11.029	https://doi.org/10.1016/j.bcab.2018.11.029	PROPN
admet-2013	239	2	.	.	PUNCT
admet-2013	240	1	[	[	X
admet-2013	240	2	10	10	NUM
admet-2013	240	3	]	]	X
admet-2013	240	4	n.	n.	NOUN
admet-2013	240	5	akhtar	akhtar	PROPN
admet-2013	240	6	,	,	PUNCT
admet-2013	240	7	s.k	s.k	PROPN
admet-2013	240	8	.	.	PROPN
admet-2013	240	9	metkar	metkar	PROPN
admet-2013	240	10	,	,	PUNCT
admet-2013	240	11	a.	a.	PROPN
admet-2013	240	12	girigoswami	girigoswami	PROPN
admet-2013	240	13	,	,	PUNCT
admet-2013	240	14	k.	k.	PROPN
admet-2013	240	15	girigoswami	girigoswami	PROPN
admet-2013	240	16	.	.	PUNCT
admet-2013	241	1	zno	zno	PROPN
admet-2013	241	2	nanoflower	nanoflower	PROPN
admet-2013	241	3	based	base	VERB
admet-2013	241	4	sensitive	sensitive	ADJ
admet-2013	241	5	nanobiosensor	nanobiosensor	NOUN
admet-2013	241	6	for	for	ADP
admet-2013	241	7	amyloid	amyloid	NOUN
admet-2013	241	8	detection	detection	NOUN
admet-2013	241	9	.	.	PUNCT
admet-2013	242	1	materials	material	NOUN
admet-2013	242	2	science	science	NOUN
admet-2013	242	3	and	and	CCONJ
admet-2013	242	4	engineering	engineering	NOUN
admet-2013	242	5	c	c	PROPN
admet-2013	242	6	78	78	NUM
admet-2013	242	7	(	(	PUNCT
admet-2013	242	8	2017	2017	NUM
admet-2013	242	9	)	)	PUNCT
admet-2013	242	10	960	960	NUM
admet-2013	242	11	-	-	SYM
admet-2013	242	12	968	968	NUM
admet-2013	242	13	.	.	PUNCT
admet-2013	243	1	https://doi.org/j.msec.2017.04.118	https://doi.org/j.msec.2017.04.118	X
admet-2013	243	2	.	.	PUNCT
admet-2013	244	1	[	[	X
admet-2013	244	2	11	11	NUM
admet-2013	244	3	]	]	X
admet-2013	244	4	r.k	r.k	PROPN
admet-2013	244	5	.	.	PROPN
admet-2013	244	6	satvekar	satvekar	PROPN
admet-2013	244	7	.	.	PUNCT
admet-2013	244	8	electrochemical	electrochemical	PROPN
admet-2013	244	9	nanobiosensors	nanobiosensor	NOUN
admet-2013	244	10	perspectives	perspective	NOUN
admet-2013	244	11	for	for	ADP
admet-2013	244	12	covid	covid	PROPN
admet-2013	244	13	19	19	NUM
admet-2013	244	14	pandemic	pandemic	ADJ
admet-2013	244	15	.	.	PUNCT
admet-2013	245	1	journal	journal	PROPN
admet-2013	245	2	of	of	ADP
admet-2013	245	3	electrochemical	electrochemical	ADJ
admet-2013	245	4	science	science	NOUN
admet-2013	245	5	and	and	CCONJ
admet-2013	245	6	engineering	engineering	NOUN
admet-2013	245	7	12	12	NUM
admet-2013	245	8	(	(	PUNCT
admet-2013	245	9	2022	2022	NUM
admet-2013	245	10	)	)	PUNCT
admet-2013	245	11	25	25	NUM
admet-2013	245	12	-	-	SYM
admet-2013	245	13	35	35	NUM
admet-2013	245	14	.	.	PUNCT
admet-2013	246	1	https://doi.org/10.5599/jese.1116	https://doi.org/10.5599/jese.1116	PROPN
admet-2013	246	2	.	.	PUNCT
admet-2013	247	1	https://doi.org/10.7759/cureus.8788	https://doi.org/10.7759/cureus.8788	AUX
admet-2013	247	2	https://doi.org/10.1002/anbr.202000047	https://doi.org/10.1002/anbr.202000047	NOUN
admet-2013	247	3	https://doi.org/10.1016/j.jksus.2022.102182	https://doi.org/10.1016/j.jksus.2022.102182	NOUN
admet-2013	247	4	https://doi.org/10.1038/s41568-019-0230-9	https://doi.org/10.1038/s41568-019-0230-9	NUM
admet-2013	247	5	https://doi.org/10.1128/mcb.13.12.7587-7595.1993	https://doi.org/10.1128/mcb.13.12.7587-7595.1993	PROPN
admet-2013	247	6	https://doi.org/10.1177/1533033819853	https://doi.org/10.1177/1533033819853	NOUN
admet-2013	247	7	https://doi.org/10.1186/s13045-019-0833-3	https://doi.org/10.1186/s13045-019-0833-3	NUM
admet-2013	247	8	https://doi.org/10.1186/s13045-019-0833-3	https://doi.org/10.1186/s13045-019-0833-3	NUM
admet-2013	248	1	https://doi.org/10.1039/d1ma00069a	https://doi.org/10.1039/d1ma00069a	PROPN
admet-2013	248	2	https://doi.org/10.1016/j.bcab.2018.11.029	https://doi.org/10.1016/j.bcab.2018.11.029	PROPN
admet-2013	248	3	https://doi.org/j.msec.2017.04.118	https://doi.org/j.msec.2017.04.118	PROPN
admet-2013	248	4	https://doi.org/10.5599/jese.1116	https://doi.org/10.5599/jese.1116	ADV
admet-2013	248	5	admet	admet	PROPN
admet-2013	248	6	&	&	CCONJ
admet-2013	248	7	dmpk	dmpk	PROPN
admet-2013	248	8	11(4	11(4	NUM
admet-2013	248	9	)	)	PUNCT
admet-2013	248	10	(	(	PUNCT
admet-2013	248	11	2023	2023	NUM
admet-2013	248	12	)	)	PUNCT
admet-2013	248	13	499	499	NUM
admet-2013	248	14	-	-	SYM
admet-2013	248	15	511	511	NUM
admet-2013	248	16	nanoparticles	nanoparticle	NOUN
admet-2013	248	17	in	in	ADP
admet-2013	248	18	the	the	DET
admet-2013	248	19	therapy	therapy	NOUN
admet-2013	248	20	of	of	ADP
admet-2013	248	21	chronic	chronic	ADJ
admet-2013	248	22	myelogenous	myelogenous	ADJ
admet-2013	248	23	leukemia	leukemia	PROPN
admet-2013	248	24	doi	doi	PROPN
admet-2013	248	25	:	:	PUNCT
admet-2013	248	26	https://doi.org/10.5599/adme	https://doi.org/10.5599/adme	NOUN
admet-2013	248	27	t.2013	t.2013	PROPN
admet-2013	248	28	507	507	NUM
admet-2013	249	1	[	[	X
admet-2013	249	2	12	12	NUM
admet-2013	249	3	]	]	X
admet-2013	249	4	a.k	a.k	PROPN
admet-2013	249	5	.	.	PROPN
admet-2013	249	6	sari	sari	PROPN
admet-2013	249	7	,	,	PUNCT
admet-2013	249	8	y.w	y.w	PROPN
admet-2013	249	9	.	.	PROPN
admet-2013	249	10	hartati	hartati	PROPN
admet-2013	249	11	,	,	PUNCT
admet-2013	249	12	s.	s.	PROPN
admet-2013	249	13	gaffar	gaffar	PROPN
admet-2013	249	14	,	,	PUNCT
admet-2013	249	15	i.	i.	PROPN
admet-2013	249	16	anshori	anshori	PROPN
admet-2013	249	17	,	,	PUNCT
admet-2013	249	18	d.	d.	PROPN
admet-2013	249	19	hidayat	hidayat	PROPN
admet-2013	249	20	,	,	PUNCT
admet-2013	249	21	h.l	h.l	PROPN
admet-2013	249	22	.	.	PROPN
admet-2013	249	23	wiraswati	wiraswati	PROPN
admet-2013	249	24	.	.	PUNCT
admet-2013	250	1	the	the	DET
admet-2013	250	2	optimization	optimization	NOUN
admet-2013	250	3	of	of	ADP
admet-2013	250	4	an	an	DET
admet-2013	250	5	electrochemical	electrochemical	ADJ
admet-2013	250	6	aptasensor	aptasensor	NOUN
admet-2013	250	7	to	to	PART
admet-2013	250	8	detect	detect	VERB
admet-2013	250	9	rbd	rbd	NOUN
admet-2013	250	10	protein	protein	NOUN
admet-2013	250	11	s	s	PART
admet-2013	250	12	sars	sar	NOUN
admet-2013	250	13	-	-	PUNCT
admet-2013	250	14	cov-2	cov-2	NOUN
admet-2013	250	15	as	as	ADP
admet-2013	250	16	a	a	DET
admet-2013	250	17	biomarker	biomarker	NOUN
admet-2013	250	18	of	of	ADP
admet-2013	250	19	covid-19	covid-19	PROPN
admet-2013	250	20	using	use	VERB
admet-2013	250	21	screen	screen	NOUN
admet-2013	250	22	-	-	PUNCT
admet-2013	250	23	printed	print	VERB
admet-2013	250	24	carbon	carbon	NOUN
admet-2013	250	25	electrode	electrode	NOUN
admet-2013	250	26	/	/	SYM
admet-2013	250	27	aunp	aunp	ADJ
admet-2013	250	28	.	.	PUNCT
admet-2013	251	1	journal	journal	NOUN
admet-2013	251	2	of	of	ADP
admet-2013	251	3	electrochemical	electrochemical	ADJ
admet-2013	251	4	science	science	NOUN
admet-2013	251	5	and	and	CCONJ
admet-2013	251	6	engineering	engineering	NOUN
admet-2013	251	7	12	12	NUM
admet-2013	251	8	(	(	PUNCT
admet-2013	251	9	2022	2022	NUM
admet-2013	251	10	)	)	PUNCT
admet-2013	251	11	219	219	NUM
admet-2013	251	12	-	-	SYM
admet-2013	251	13	235	235	NUM
admet-2013	251	14	.	.	PUNCT
admet-2013	252	1	https://doi.org/10.5599/jese.1206	https://doi.org/10.5599/jese.1206	X
admet-2013	252	2	.	.	PUNCT
admet-2013	253	1	[	[	X
admet-2013	253	2	13	13	NUM
admet-2013	253	3	]	]	PUNCT
admet-2013	253	4	s.	s.	PROPN
admet-2013	253	5	chatterjee	chatterjee	PROPN
admet-2013	253	6	,	,	PUNCT
admet-2013	253	7	k.	k.	PROPN
admet-2013	253	8	harini	harini	PROPN
admet-2013	253	9	,	,	PUNCT
admet-2013	253	10	a.	a.	PROPN
admet-2013	253	11	girigoswami	girigoswami	PROPN
admet-2013	253	12	,	,	PUNCT
admet-2013	253	13	m.	m.	NOUN
admet-2013	253	14	nag	nag	PROPN
admet-2013	253	15	,	,	PUNCT
admet-2013	253	16	d.	d.	PROPN
admet-2013	253	17	lahiri	lahiri	PROPN
admet-2013	253	18	,	,	PUNCT
admet-2013	253	19	k.	k.	PROPN
admet-2013	253	20	girigoswami	girigoswami	PROPN
admet-2013	253	21	.	.	PUNCT
admet-2013	254	1	nanodecoys	nanodecoy	NOUN
admet-2013	254	2	:	:	PUNCT
admet-2013	254	3	a	a	DET
admet-2013	254	4	quintessential	quintessential	ADJ
admet-2013	254	5	candidate	candidate	NOUN
admet-2013	254	6	to	to	PART
admet-2013	254	7	augment	augment	VERB
admet-2013	254	8	theranostic	theranostic	ADJ
admet-2013	254	9	applications	application	NOUN
admet-2013	254	10	for	for	ADP
admet-2013	254	11	a	a	DET
admet-2013	254	12	plethora	plethora	NOUN
admet-2013	254	13	of	of	ADP
admet-2013	254	14	diseases	disease	NOUN
admet-2013	254	15	.	.	PUNCT
admet-2013	255	1	pharmaceutics	pharmaceutic	NOUN
admet-2013	255	2	15	15	NUM
admet-2013	255	3	(	(	PUNCT
admet-2013	255	4	2022	2022	NUM
admet-2013	255	5	)	)	PUNCT
admet-2013	255	6	73	73	NUM
admet-2013	255	7	.	.	PUNCT
admet-2013	256	1	https://doi.org/10.3390/pharmaceutics15010073	https://doi.org/10.3390/pharmaceutics15010073	PROPN
admet-2013	256	2	.	.	PUNCT
admet-2013	257	1	[	[	X
admet-2013	257	2	14	14	NUM
admet-2013	257	3	]	]	X
admet-2013	257	4	g.	g.	PROPN
admet-2013	257	5	amsaveni	amsaveni	PROPN
admet-2013	257	6	,	,	PUNCT
admet-2013	257	7	a.s	a.s	PROPN
admet-2013	257	8	.	.	PROPN
admet-2013	257	9	farook	farook	NOUN
admet-2013	257	10	,	,	PUNCT
admet-2013	257	11	v.	v.	PROPN
admet-2013	257	12	haribabu	haribabu	PROPN
admet-2013	257	13	,	,	PUNCT
admet-2013	257	14	r.	r.	PROPN
admet-2013	257	15	murugesan	murugesan	PROPN
admet-2013	257	16	,	,	PUNCT
admet-2013	257	17	a.	a.	PROPN
admet-2013	257	18	girigoswami	girigoswami	PROPN
admet-2013	257	19	.	.	PUNCT
admet-2013	258	1	engineered	engineer	VERB
admet-2013	258	2	multifunctional	multifunctional	ADJ
admet-2013	258	3	nanoparticles	nanoparticle	NOUN
admet-2013	258	4	for	for	ADP
admet-2013	258	5	dla	dla	NOUN
admet-2013	258	6	cancer	cancer	NOUN
admet-2013	258	7	cells	cell	NOUN
admet-2013	258	8	targeting	target	VERB
admet-2013	258	9	,	,	PUNCT
admet-2013	258	10	sorting	sorting	NOUN
admet-2013	258	11	,	,	PUNCT
admet-2013	258	12	mr	mr	PROPN
admet-2013	258	13	imaging	imaging	NOUN
admet-2013	258	14	and	and	CCONJ
admet-2013	258	15	drug	drug	NOUN
admet-2013	258	16	delivery	delivery	NOUN
admet-2013	258	17	.	.	PUNCT
admet-2013	259	1	advanced	advanced	ADJ
admet-2013	259	2	science	science	NOUN
admet-2013	259	3	,	,	PUNCT
admet-2013	259	4	engineering	engineering	NOUN
admet-2013	259	5	and	and	CCONJ
admet-2013	259	6	medicine	medicine	NOUN
admet-2013	259	7	5	5	NUM
admet-2013	259	8	(	(	PUNCT
admet-2013	259	9	2013	2013	NUM
admet-2013	259	10	)	)	PUNCT
admet-2013	259	11	1340	1340	NUM
admet-2013	259	12	-	-	SYM
admet-2013	259	13	1348	1348	NUM
admet-2013	259	14	.	.	PUNCT
admet-2013	260	1	https://doi.org/10.1166/asem.2013.1425	https://doi.org/10.1166/asem.2013.1425	PROPN
admet-2013	260	2	.	.	PUNCT
admet-2013	261	1	[	[	X
admet-2013	261	2	15	15	NUM
admet-2013	261	3	]	]	X
admet-2013	261	4	m.	m.	NOUN
admet-2013	261	5	ozdal	ozdal	NOUN
admet-2013	261	6	,	,	PUNCT
admet-2013	261	7	s.	s.	PROPN
admet-2013	261	8	gurkok	gurkok	PROPN
admet-2013	261	9	.	.	PUNCT
admet-2013	262	1	recent	recent	ADJ
admet-2013	262	2	advances	advance	NOUN
admet-2013	262	3	in	in	ADP
admet-2013	262	4	nanoparticles	nanoparticle	NOUN
admet-2013	262	5	as	as	ADP
admet-2013	262	6	antibacterial	antibacterial	ADJ
admet-2013	262	7	agent	agent	NOUN
admet-2013	262	8	.	.	PUNCT
admet-2013	263	1	admet	admet	PROPN
admet-2013	263	2	and	and	CCONJ
admet-2013	263	3	dmpk	dmpk	PROPN
admet-2013	263	4	10	10	NUM
admet-2013	263	5	(	(	PUNCT
admet-2013	263	6	2022	2022	NUM
admet-2013	263	7	)	)	PUNCT
admet-2013	263	8	115	115	NUM
admet-2013	263	9	-	-	SYM
admet-2013	263	10	129	129	NUM
admet-2013	263	11	.	.	PUNCT
admet-2013	264	1	https://doi.org/10.5599/admet.1172	https://doi.org/10.5599/admet.1172	NOUN
admet-2013	264	2	.	.	PUNCT
admet-2013	265	1	[	[	X
admet-2013	265	2	16	16	NUM
admet-2013	265	3	]	]	PUNCT
admet-2013	265	4	a.	a.	NOUN
admet-2013	265	5	girigoswami	girigoswami	PROPN
admet-2013	265	6	,	,	PUNCT
admet-2013	265	7	w.	w.	PROPN
admet-2013	265	8	yassine	yassine	PROPN
admet-2013	265	9	,	,	PUNCT
admet-2013	265	10	p.	p.	PROPN
admet-2013	265	11	sharmiladevi	sharmiladevi	NOUN
admet-2013	265	12	,	,	PUNCT
admet-2013	265	13	v.	v.	PROPN
admet-2013	265	14	haribabu	haribabu	PROPN
admet-2013	265	15	,	,	PUNCT
admet-2013	265	16	k.	k.	PROPN
admet-2013	265	17	girigoswami	girigoswami	PROPN
admet-2013	265	18	.	.	PUNCT
admet-2013	266	1	camouflaged	camouflage	VERB
admet-2013	266	2	nanosilver	nanosilver	ADV
admet-2013	266	3	with	with	ADP
admet-2013	266	4	excitation	excitation	NOUN
admet-2013	266	5	wavelength	wavelength	NOUN
admet-2013	266	6	dependent	dependent	ADJ
admet-2013	266	7	high	high	ADJ
admet-2013	266	8	quantum	quantum	NOUN
admet-2013	266	9	yield	yield	NOUN
admet-2013	266	10	for	for	ADP
admet-2013	266	11	targeted	target	VERB
admet-2013	266	12	theranostic	theranostic	ADJ
admet-2013	266	13	.	.	PUNCT
admet-2013	267	1	scientific	scientific	ADJ
admet-2013	267	2	reports	report	NOUN
admet-2013	267	3	8	8	NUM
admet-2013	267	4	(	(	PUNCT
admet-2013	267	5	2018	2018	NUM
admet-2013	267	6	)	)	PUNCT
admet-2013	267	7	16459	16459	NUM
admet-2013	267	8	.	.	PUNCT
admet-2013	268	1	https://doi.org/10.1038/s41598-018-34843-4	https://doi.org/10.1038/s41598-018-34843-4	PROPN
admet-2013	268	2	.	.	PUNCT
admet-2013	269	1	[	[	X
admet-2013	269	2	17	17	NUM
admet-2013	269	3	]	]	X
admet-2013	269	4	r.	r.	PROPN
admet-2013	269	5	sakthi	sakthi	PROPN
admet-2013	269	6	devi	devi	PROPN
admet-2013	269	7	,	,	PUNCT
admet-2013	269	8	a.	a.	PROPN
admet-2013	269	9	girigoswami	girigoswami	PROPN
admet-2013	269	10	,	,	PUNCT
admet-2013	269	11	m.	m.	PROPN
admet-2013	269	12	siddharth	siddharth	PROPN
admet-2013	269	13	,	,	PUNCT
admet-2013	269	14	k.	k.	PROPN
admet-2013	269	15	girigoswami	girigoswami	PROPN
admet-2013	269	16	.	.	PUNCT
admet-2013	270	1	applications	application	NOUN
admet-2013	270	2	of	of	ADP
admet-2013	270	3	gold	gold	NOUN
admet-2013	270	4	and	and	CCONJ
admet-2013	270	5	silver	silver	ADJ
admet-2013	270	6	nanoparticles	nanoparticle	NOUN
admet-2013	270	7	in	in	ADP
admet-2013	270	8	theranostics	theranostic	NOUN
admet-2013	270	9	.	.	PUNCT
admet-2013	271	1	applied	apply	VERB
admet-2013	271	2	biochemistry	biochemistry	NOUN
admet-2013	271	3	and	and	CCONJ
admet-2013	271	4	biotechnology	biotechnology	NOUN
admet-2013	271	5	194	194	NUM
admet-2013	271	6	(	(	PUNCT
admet-2013	271	7	2022	2022	NUM
admet-2013	271	8	)	)	PUNCT
admet-2013	271	9	4187	4187	NUM
admet-2013	271	10	-	-	SYM
admet-2013	271	11	4219	4219	NUM
admet-2013	271	12	.	.	PUNCT
admet-2013	272	1	https://doi.org/10.1007/s12010-022-03963-z	https://doi.org/10.1007/s12010-022-03963-z	NOUN
admet-2013	272	2	.	.	PUNCT
admet-2013	273	1	[	[	X
admet-2013	273	2	18	18	NUM
admet-2013	273	3	]	]	X
admet-2013	273	4	p.	p.	NOUN
admet-2013	273	5	pallavi	pallavi	PROPN
admet-2013	273	6	,	,	PUNCT
admet-2013	273	7	p.	p.	PROPN
admet-2013	273	8	sharmiladevi	sharmiladevi	NOUN
admet-2013	273	9	,	,	PUNCT
admet-2013	273	10	v.	v.	PROPN
admet-2013	273	11	haribabu	haribabu	PROPN
admet-2013	273	12	,	,	PUNCT
admet-2013	273	13	k.	k.	PROPN
admet-2013	273	14	girigoswami	girigoswami	PROPN
admet-2013	273	15	,	,	PUNCT
admet-2013	273	16	a.	a.	PROPN
admet-2013	273	17	girigoswami	girigoswami	PROPN
admet-2013	273	18	.	.	PUNCT
admet-2013	274	1	a	a	DET
admet-2013	274	2	nano	nano	NOUN
admet-2013	274	3	approach	approach	NOUN
admet-2013	274	4	to	to	AUX
admet-2013	274	5	formulate	formulate	VERB
admet-2013	274	6	photosensitizers	photosensitizer	NOUN
admet-2013	274	7	for	for	ADP
admet-2013	274	8	photodynamic	photodynamic	ADJ
admet-2013	274	9	therapy	therapy	NOUN
admet-2013	274	10	.	.	PUNCT
admet-2013	275	1	current	current	ADJ
admet-2013	275	2	nanoscience	nanoscience	NOUN
admet-2013	275	3	18	18	NUM
admet-2013	275	4	(	(	PUNCT
admet-2013	275	5	2022	2022	NUM
admet-2013	275	6	)	)	PUNCT
admet-2013	275	7	675	675	NUM
admet-2013	275	8	-	-	SYM
admet-2013	275	9	689	689	NUM
admet-2013	275	10	.	.	PUNCT
admet-2013	275	11	https://doi.org/10.2174/1573413718666211222162041	https://doi.org/10.2174/1573413718666211222162041	NOUN
admet-2013	275	12	.	.	PUNCT
admet-2013	276	1	[	[	X
admet-2013	276	2	19	19	NUM
admet-2013	276	3	]	]	X
admet-2013	276	4	d.	d.	PROPN
admet-2013	276	5	balasubramanian	balasubramanian	PROPN
admet-2013	276	6	,	,	PUNCT
admet-2013	276	7	a.	a.	PROPN
admet-2013	276	8	girigoswami	girigoswami	PROPN
admet-2013	276	9	,	,	PUNCT
admet-2013	276	10	k.	k.	PROPN
admet-2013	276	11	girigoswami	girigoswami	PROPN
admet-2013	276	12	.	.	PUNCT
admet-2013	277	1	nano	nano	NOUN
admet-2013	277	2	resveratrol	resveratrol	NOUN
admet-2013	277	3	and	and	CCONJ
admet-2013	277	4	its	its	PRON
admet-2013	277	5	anticancer	anticancer	NOUN
admet-2013	277	6	activity	activity	NOUN
admet-2013	277	7	.	.	PUNCT
admet-2013	278	1	current	current	ADJ
admet-2013	278	2	applied	apply	VERB
admet-2013	278	3	science	science	NOUN
admet-2013	278	4	and	and	CCONJ
admet-2013	278	5	technology	technology	NOUN
admet-2013	278	6	23(3	23(3	NOUN
admet-2013	278	7	)	)	PUNCT
admet-2013	278	8	(	(	PUNCT
admet-2013	278	9	2023	2023	NUM
admet-2013	278	10	)	)	PUNCT
admet-2013	278	11	.	.	PUNCT
admet-2013	279	1	https://doi.org/10.55003/cast.2022.03.23.010	https://doi.org/10.55003/cast.2022.03.23.010	NOUN
admet-2013	279	2	.	.	PUNCT
admet-2013	280	1	[	[	X
admet-2013	280	2	20	20	NUM
admet-2013	280	3	]	]	X
admet-2013	280	4	d.	d.	PROPN
admet-2013	280	5	balasubramanian	balasubramanian	PROPN
admet-2013	280	6	,	,	PUNCT
admet-2013	280	7	a.	a.	PROPN
admet-2013	280	8	girigoswami	girigoswami	PROPN
admet-2013	280	9	,	,	PUNCT
admet-2013	280	10	k.	k.	PROPN
admet-2013	280	11	girigoswami	girigoswami	PROPN
admet-2013	280	12	.	.	PUNCT
admet-2013	281	1	antimicrobial	antimicrobial	ADJ
admet-2013	281	2	,	,	PUNCT
admet-2013	281	3	pesticidal	pesticidal	NOUN
admet-2013	281	4	and	and	CCONJ
admet-2013	281	5	food	food	NOUN
admet-2013	281	6	preservative	preservative	ADJ
admet-2013	281	7	applications	application	NOUN
admet-2013	281	8	of	of	ADP
admet-2013	281	9	lemongrass	lemongrass	NOUN
admet-2013	281	10	oil	oil	NOUN
admet-2013	281	11	nanoemulsion	nanoemulsion	NOUN
admet-2013	281	12	:	:	PUNCT
admet-2013	281	13	a	a	DET
admet-2013	281	14	mini	mini	NOUN
admet-2013	281	15	-	-	NOUN
admet-2013	281	16	review	review	NOUN
admet-2013	281	17	.	.	PUNCT
admet-2013	282	1	recent	recent	ADJ
admet-2013	282	2	advances	advance	NOUN
admet-2013	282	3	in	in	ADP
admet-2013	282	4	food	food	NOUN
admet-2013	282	5	nutrition	nutrition	NOUN
admet-2013	282	6	&	&	CCONJ
admet-2013	282	7	agriculture	agriculture	PROPN
admet-2013	282	8	13	13	NUM
admet-2013	282	9	(	(	PUNCT
admet-2013	282	10	2022	2022	NUM
admet-2013	282	11	)	)	PUNCT
admet-2013	282	12	51	51	NUM
admet-2013	282	13	-	-	SYM
admet-2013	282	14	58	58	NUM
admet-2013	282	15	.	.	PUNCT
admet-2013	283	1	https://doi.org/10.2174/2212798412666220527154707	https://doi.org/10.2174/2212798412666220527154707	NOUN
admet-2013	283	2	.	.	PUNCT
admet-2013	284	1	[	[	X
admet-2013	284	2	21	21	NUM
admet-2013	284	3	]	]	X
admet-2013	284	4	s.	s.	PROPN
admet-2013	284	5	staroverov	staroverov	PROPN
admet-2013	284	6	,	,	PUNCT
admet-2013	284	7	s.	s.	PROPN
admet-2013	284	8	kozlov	kozlov	PROPN
admet-2013	284	9	,	,	PUNCT
admet-2013	284	10	a.	a.	NOUN
admet-2013	284	11	fomin	fomin	PROPN
admet-2013	284	12	,	,	PUNCT
admet-2013	284	13	k.	k.	PROPN
admet-2013	284	14	gabalov	gabalov	PROPN
admet-2013	284	15	,	,	PUNCT
admet-2013	284	16	v.	v.	PROPN
admet-2013	284	17	khanadeev	khanadeev	PROPN
admet-2013	284	18	,	,	PUNCT
admet-2013	284	19	d.	d.	PROPN
admet-2013	284	20	soldatov	soldatov	PROPN
admet-2013	284	21	,	,	PUNCT
admet-2013	284	22	i.	i.	PROPN
admet-2013	284	23	domnitsky	domnitsky	PROPN
admet-2013	284	24	,	,	PUNCT
admet-2013	284	25	l.	l.	PROPN
admet-2013	284	26	dykman	dykman	PROPN
admet-2013	284	27	,	,	PUNCT
admet-2013	284	28	s.v	s.v	PROPN
admet-2013	284	29	.	.	PROPN
admet-2013	284	30	akchurin	akchurin	PROPN
admet-2013	284	31	,	,	PUNCT
admet-2013	284	32	o.	o.	PROPN
admet-2013	284	33	guliy	guliy	PROPN
admet-2013	284	34	.	.	PUNCT
admet-2013	285	1	synthesis	synthesis	NOUN
admet-2013	285	2	of	of	ADP
admet-2013	285	3	silymarin−	silymarin−	NOUN
admet-2013	285	4	selenium	selenium	NOUN
admet-2013	285	5	nanoparticle	nanoparticle	NOUN
admet-2013	285	6	conjugate	conjugate	NOUN
admet-2013	285	7	and	and	CCONJ
admet-2013	285	8	examination	examination	NOUN
admet-2013	285	9	of	of	ADP
admet-2013	285	10	its	its	PRON
admet-2013	285	11	biological	biological	ADJ
admet-2013	285	12	activity	activity	NOUN
admet-2013	285	13	in	in	ADP
admet-2013	285	14	vitro	vitro	X
admet-2013	285	15	.	.	PUNCT
admet-2013	286	1	admet	admet	PROPN
admet-2013	286	2	and	and	CCONJ
admet-2013	286	3	dmpk	dmpk	X
admet-2013	286	4	9	9	NUM
admet-2013	286	5	(	(	PUNCT
admet-2013	286	6	2021	2021	NUM
admet-2013	286	7	)	)	PUNCT
admet-2013	286	8	255	255	NUM
admet-2013	286	9	-	-	SYM
admet-2013	286	10	266	266	NUM
admet-2013	286	11	.	.	PUNCT
admet-2013	286	12	https://doi.org/10.5599/admet.1023	https://doi.org/10.5599/admet.1023	PROPN
admet-2013	286	13	.	.	PUNCT
admet-2013	287	1	[	[	X
admet-2013	287	2	22	22	NUM
admet-2013	287	3	]	]	X
admet-2013	287	4	b.	b.	PROPN
admet-2013	287	5	deepika	deepika	PROPN
admet-2013	287	6	,	,	PUNCT
admet-2013	287	7	a.	a.	NOUN
admet-2013	287	8	gopikrishna	gopikrishna	PROPN
admet-2013	287	9	,	,	PUNCT
admet-2013	287	10	a.	a.	PROPN
admet-2013	287	11	girigoswami	girigoswami	PROPN
admet-2013	287	12	,	,	PUNCT
admet-2013	287	13	m.n	m.n	PROPN
admet-2013	287	14	.	.	PROPN
admet-2013	287	15	banu	banu	PROPN
admet-2013	287	16	,	,	PUNCT
admet-2013	287	17	k.	k.	PROPN
admet-2013	287	18	girigoswami	girigoswami	PROPN
admet-2013	287	19	.	.	PUNCT
admet-2013	288	1	applications	application	NOUN
admet-2013	288	2	of	of	ADP
admet-2013	288	3	nanoscaffolds	nanoscaffold	NOUN
admet-2013	288	4	in	in	ADP
admet-2013	288	5	tissue	tissue	NOUN
admet-2013	288	6	engineering	engineering	NOUN
admet-2013	288	7	.	.	PUNCT
admet-2013	289	1	current	current	ADJ
admet-2013	289	2	pharmacology	pharmacology	NOUN
admet-2013	289	3	reports	report	VERB
admet-2013	289	4	8	8	NUM
admet-2013	289	5	(	(	PUNCT
admet-2013	289	6	2022	2022	NUM
admet-2013	289	7	)	)	PUNCT
admet-2013	289	8	171	171	NUM
admet-2013	289	9	-	-	SYM
admet-2013	289	10	187	187	NUM
admet-2013	289	11	.	.	PUNCT
admet-2013	290	1	https://doi.org/10.1007/s40495-022-00284-x	https://doi.org/10.1007/s40495-022-00284-x	PROPN
admet-2013	290	2	.	.	PUNCT
admet-2013	291	1	[	[	X
admet-2013	291	2	23	23	NUM
admet-2013	291	3	]	]	PUNCT
admet-2013	291	4	p.	p.	NOUN
admet-2013	291	5	gowtham	gowtham	PROPN
admet-2013	291	6	,	,	PUNCT
admet-2013	291	7	p.	p.	PROPN
admet-2013	291	8	pallavi	pallavi	PROPN
admet-2013	291	9	,	,	PUNCT
admet-2013	291	10	k.	k.	PROPN
admet-2013	291	11	harini	harini	PROPN
admet-2013	291	12	,	,	PUNCT
admet-2013	291	13	k.	k.	PROPN
admet-2013	291	14	girigoswami	girigoswami	PROPN
admet-2013	291	15	,	,	PUNCT
admet-2013	291	16	a.	a.	PROPN
admet-2013	291	17	girigoswami	girigoswami	PROPN
admet-2013	291	18	.	.	PUNCT
admet-2013	292	1	hydrogelated	hydrogelate	VERB
admet-2013	292	2	virus	virus	NOUN
admet-2013	292	3	nanoparticles	nanoparticle	NOUN
admet-2013	292	4	in	in	ADP
admet-2013	292	5	tissue	tissue	NOUN
admet-2013	292	6	engineering	engineering	NOUN
admet-2013	292	7	.	.	PUNCT
admet-2013	293	1	current	current	ADJ
admet-2013	293	2	nanoscience	nanoscience	NOUN
admet-2013	293	3	19	19	NUM
admet-2013	293	4	(	(	PUNCT
admet-2013	293	5	2023	2023	NUM
admet-2013	293	6	)	)	PUNCT
admet-2013	293	7	258	258	NUM
admet-2013	293	8	-	-	SYM
admet-2013	293	9	269	269	NUM
admet-2013	293	10	.	.	PUNCT
admet-2013	293	11	https://doi.org/10.2174/1573413718666220520094933	https://doi.org/10.2174/1573413718666220520094933	NUM
admet-2013	293	12	.	.	PUNCT
admet-2013	294	1	[	[	X
admet-2013	294	2	24	24	NUM
admet-2013	294	3	]	]	PUNCT
admet-2013	294	4	p.	p.	NOUN
admet-2013	294	5	gowtham	gowtham	PROPN
admet-2013	294	6	,	,	PUNCT
admet-2013	294	7	k.	k.	PROPN
admet-2013	294	8	girigoswami	girigoswami	PROPN
admet-2013	294	9	,	,	PUNCT
admet-2013	294	10	p.	p.	PROPN
admet-2013	294	11	pallavi	pallavi	PROPN
admet-2013	294	12	,	,	PUNCT
admet-2013	294	13	k.	k.	PROPN
admet-2013	294	14	harini	harini	PROPN
admet-2013	294	15	,	,	PUNCT
admet-2013	294	16	i.	i.	PROPN
admet-2013	294	17	gurubharath	gurubharath	PROPN
admet-2013	294	18	,	,	PUNCT
admet-2013	294	19	a.	a.	NOUN
admet-2013	294	20	girigoswami	girigoswami	PROPN
admet-2013	294	21	.	.	PUNCT
admet-2013	295	1	alginate	alginate	NOUN
admet-2013	295	2	-derivative	-derivative	PROPN
admet-2013	295	3	encapsulated	encapsulate	VERB
admet-2013	295	4	carbon	carbon	NOUN
admet-2013	295	5	coated	coat	VERB
admet-2013	295	6	manganese	manganese	ADJ
admet-2013	295	7	-	-	PUNCT
admet-2013	295	8	ferrite	ferrite	NOUN
admet-2013	295	9	nanodots	nanodot	NOUN
admet-2013	295	10	for	for	ADP
admet-2013	295	11	multimodal	multimodal	ADJ
admet-2013	295	12	medical	medical	ADJ
admet-2013	295	13	imaging	imaging	NOUN
admet-2013	295	14	.	.	PUNCT
admet-2013	296	1	pharmaceutics	pharmaceutic	NOUN
admet-2013	296	2	14	14	NUM
admet-2013	296	3	(	(	PUNCT
admet-2013	296	4	2022	2022	NUM
admet-2013	296	5	)	)	PUNCT
admet-2013	296	6	2550	2550	NUM
admet-2013	296	7	.	.	PUNCT
admet-2013	297	1	https://doi.org/10.3390/pharmaceutics14122550	https://doi.org/10.3390/pharmaceutics14122550	PROPN
admet-2013	297	2	.	.	PUNCT
admet-2013	298	1	[	[	X
admet-2013	298	2	25	25	NUM
admet-2013	298	3	]	]	X
admet-2013	298	4	v.	v.	CCONJ
admet-2013	298	5	haribabu	haribabu	PROPN
admet-2013	298	6	,	,	PUNCT
admet-2013	298	7	p.	p.	PROPN
admet-2013	298	8	sharmiladevi	sharmiladevi	NOUN
admet-2013	298	9	,	,	PUNCT
admet-2013	298	10	n.	n.	PROPN
admet-2013	298	11	akhtar	akhtar	PROPN
admet-2013	298	12	,	,	PUNCT
admet-2013	298	13	a.s	a.s	PROPN
admet-2013	298	14	.	.	PROPN
admet-2013	298	15	farook	farook	PROPN
admet-2013	298	16	,	,	PUNCT
admet-2013	298	17	k.	k.	PROPN
admet-2013	298	18	girigoswami	girigoswami	PROPN
admet-2013	298	19	,	,	PUNCT
admet-2013	298	20	a.	a.	PROPN
admet-2013	298	21	girigoswami	girigoswami	PROPN
admet-2013	298	22	.	.	PUNCT
admet-2013	299	1	label	label	NOUN
admet-2013	299	2	free	free	ADJ
admet-2013	299	3	ultrasmall	ultrasmall	ADJ
admet-2013	299	4	fluoromagnetic	fluoromagnetic	ADJ
admet-2013	299	5	ferrite	ferrite	NOUN
admet-2013	299	6	-	-	PUNCT
admet-2013	299	7	clusters	cluster	NOUN
admet-2013	299	8	for	for	ADP
admet-2013	299	9	targeted	target	VERB
admet-2013	299	10	cancer	cancer	NOUN
admet-2013	299	11	imaging	imaging	NOUN
admet-2013	299	12	and	and	CCONJ
admet-2013	299	13	drug	drug	NOUN
admet-2013	299	14	delivery	delivery	NOUN
admet-2013	299	15	.	.	PUNCT
admet-2013	300	1	current	current	ADJ
admet-2013	300	2	drug	drug	NOUN
admet-2013	300	3	delivery	delivery	NOUN
admet-2013	300	4	16	16	NUM
admet-2013	300	5	(	(	PUNCT
admet-2013	300	6	2019	2019	NUM
admet-2013	300	7	)	)	PUNCT
admet-2013	300	8	233	233	NUM
admet-2013	300	9	-	-	SYM
admet-2013	300	10	241	241	NUM
admet-2013	300	11	.	.	PUNCT
admet-2013	301	1	https://doi.org/10.2174/1567201816666181119112410	https://doi.org/10.2174/1567201816666181119112410	PROPN
admet-2013	301	2	.	.	PUNCT
admet-2013	302	1	[	[	X
admet-2013	302	2	26	26	NUM
admet-2013	302	3	]	]	PUNCT
admet-2013	302	4	j.	j.	PROPN
admet-2013	302	5	kavya	kavya	PROPN
admet-2013	302	6	,	,	PUNCT
admet-2013	302	7	g.	g.	PROPN
admet-2013	302	8	amsaveni	amsaveni	PROPN
admet-2013	302	9	,	,	PUNCT
admet-2013	302	10	m.	m.	NOUN
admet-2013	302	11	nagalakshmi	nagalakshmi	PROPN
admet-2013	302	12	,	,	PUNCT
admet-2013	302	13	k.	k.	PROPN
admet-2013	302	14	girigoswami	girigoswami	PROPN
admet-2013	302	15	,	,	PUNCT
admet-2013	302	16	r.	r.	PROPN
admet-2013	302	17	murugesan	murugesan	PROPN
admet-2013	302	18	,	,	PUNCT
admet-2013	302	19	a.	a.	NOUN
admet-2013	302	20	girigoswami	girigoswami	PROPN
admet-2013	302	21	.	.	PUNCT
admet-2013	303	1	silver	silver	ADJ
admet-2013	303	2	nanoparticles	nanoparticle	NOUN
admet-2013	303	3	induced	induce	VERB
admet-2013	303	4	lowering	lower	VERB
admet-2013	303	5	of	of	ADP
admet-2013	303	6	bcl2	bcl2	PROPN
admet-2013	303	7	/	/	SYM
admet-2013	303	8	bax	bax	PROPN
admet-2013	303	9	causes	cause	VERB
admet-2013	303	10	dalton	dalton	PROPN
admet-2013	303	11	's	's	PART
admet-2013	303	12	lymphoma	lymphoma	NOUN
admet-2013	303	13	tumour	tumour	NOUN
admet-2013	303	14	cell	cell	NOUN
admet-2013	303	15	death	death	NOUN
admet-2013	303	16	in	in	ADP
admet-2013	303	17	mice	mouse	NOUN
admet-2013	303	18	.	.	PUNCT
admet-2013	304	1	journal	journal	PROPN
admet-2013	304	2	of	of	ADP
admet-2013	304	3	bionanoscience	bionanoscience	NOUN
admet-2013	304	4	7	7	NUM
admet-2013	304	5	(	(	PUNCT
admet-2013	304	6	2013	2013	NUM
admet-2013	304	7	)	)	PUNCT
admet-2013	304	8	276	276	NUM
admet-2013	304	9	-	-	SYM
admet-2013	304	10	281	281	NUM
admet-2013	304	11	.	.	PUNCT
admet-2013	305	1	https://doi.org/10.1166/jbns.2013.1135	https://doi.org/10.1166/jbns.2013.1135	NOUN
admet-2013	305	2	.	.	PUNCT
admet-2013	306	1	[	[	X
admet-2013	306	2	27	27	NUM
admet-2013	306	3	]	]	X
admet-2013	306	4	s.	s.	PROPN
admet-2013	306	5	kulkarni	kulkarni	PROPN
admet-2013	306	6	,	,	PUNCT
admet-2013	306	7	a.	a.	PROPN
admet-2013	306	8	pandey	pandey	PROPN
admet-2013	306	9	,	,	PUNCT
admet-2013	306	10	s.	s.	PROPN
admet-2013	306	11	mutalik	mutalik	PROPN
admet-2013	306	12	.	.	PUNCT
admet-2013	307	1	heterogeneous	heterogeneous	ADJ
admet-2013	307	2	surface	surface	NOUN
admet-2013	307	3	-	-	PUNCT
admet-2013	307	4	modified	modify	VERB
admet-2013	307	5	nanoplatforms	nanoplatform	NOUN
admet-2013	307	6	for	for	ADP
admet-2013	307	7	the	the	DET
admet-2013	307	8	targeted	target	VERB
admet-2013	307	9	therapy	therapy	NOUN
admet-2013	307	10	of	of	ADP
admet-2013	307	11	haematological	haematological	ADJ
admet-2013	307	12	malignancies	malignancy	NOUN
admet-2013	307	13	.	.	PUNCT
admet-2013	308	1	drug	drug	NOUN
admet-2013	308	2	discovery	discovery	PROPN
admet-2013	308	3	today	today	NOUN
admet-2013	308	4	25	25	NUM
admet-2013	308	5	(	(	PUNCT
admet-2013	308	6	2020	2020	NUM
admet-2013	308	7	)	)	PUNCT
admet-2013	308	8	160	160	NUM
admet-2013	308	9	-	-	SYM
admet-2013	308	10	167	167	NUM
admet-2013	308	11	.	.	PUNCT
admet-2013	309	1	https://doi.org/10.1016/j.drudis.2019.10.001	https://doi.org/10.1016/j.drudis.2019.10.001	VERB
admet-2013	309	2	.	.	PUNCT
admet-2013	310	1	[	[	X
admet-2013	310	2	28	28	NUM
admet-2013	310	3	]	]	X
admet-2013	310	4	v.	v.	CCONJ
admet-2013	310	5	dutta	dutta	PROPN
admet-2013	310	6	,	,	PUNCT
admet-2013	310	7	r.	r.	PROPN
admet-2013	310	8	verma	verma	PROPN
admet-2013	310	9	,	,	PUNCT
admet-2013	310	10	c.	c.	PROPN
admet-2013	310	11	gopalkrishnan	gopalkrishnan	PROPN
admet-2013	310	12	,	,	PUNCT
admet-2013	310	13	m.-h	m.-h	NOUN
admet-2013	310	14	.	.	PUNCT
admet-2013	311	1	yuan	yuan	PROPN
admet-2013	311	2	,	,	PUNCT
admet-2013	311	3	k.m	k.m	PROPN
admet-2013	311	4	.	.	PROPN
admet-2013	311	5	batoo	batoo	PROPN
admet-2013	311	6	,	,	PUNCT
admet-2013	311	7	r.	r.	PROPN
admet-2013	311	8	jayavel	jayavel	PROPN
admet-2013	311	9	,	,	PUNCT
admet-2013	311	10	a.	a.	NOUN
admet-2013	311	11	chauhan	chauhan	PROPN
admet-2013	311	12	,	,	PUNCT
admet-2013	311	13	k.-y.a	k.-y.a	PROPN
admet-2013	311	14	.	.	PUNCT
admet-2013	312	1	lin	lin	PROPN
admet-2013	312	2	,	,	PUNCT
admet-2013	312	3	r.	r.	PROPN
admet-2013	312	4	balasubramani	balasubramani	PROPN
admet-2013	312	5	,	,	PUNCT
admet-2013	312	6	s.	s.	PROPN
admet-2013	312	7	ghotekar	ghotekar	PROPN
admet-2013	312	8	.	.	PUNCT
admet-2013	313	1	bio	bio	ADJ
admet-2013	313	2	-	-	PUNCT
admet-2013	313	3	inspired	inspire	VERB
admet-2013	313	4	synthesis	synthesis	NOUN
admet-2013	313	5	of	of	ADP
admet-2013	313	6	carbon	carbon	NOUN
admet-2013	313	7	-	-	PUNCT
admet-2013	313	8	based	base	VERB
admet-2013	313	9	nanomaterials	nanomaterial	NOUN
admet-2013	313	10	and	and	CCONJ
admet-2013	313	11	their	their	PRON
admet-2013	313	12	https://doi.org/10.5599/admet.2013	https://doi.org/10.5599/admet.2013	NOUN
admet-2013	313	13	https://doi.org/10.5599/jese.1206	https://doi.org/10.5599/jese.1206	DET
admet-2013	313	14	https://doi.org/10.3390/pharmaceutics15010073	https://doi.org/10.3390/pharmaceutics15010073	NOUN
admet-2013	313	15	https://doi.org/10.1166/asem.2013.1425	https://doi.org/10.1166/asem.2013.1425	PROPN
admet-2013	313	16	https://doi.org/10.5599/admet.1172	https://doi.org/10.5599/admet.1172	VERB
admet-2013	313	17	https://doi.org/10.1038/s41598-018-34843-4	https://doi.org/10.1038/s41598-018-34843-4	NUM
admet-2013	313	18	https://doi.org/10.1007/s12010-022-03963-z	https://doi.org/10.1007/s12010-022-03963-z	PROPN
admet-2013	313	19	https://doi.org/10.2174/1573413718666211222162041	https://doi.org/10.2174/1573413718666211222162041	NOUN
admet-2013	313	20	https://doi.org/10.55003/cast.2022.03.23.010	https://doi.org/10.55003/cast.2022.03.23.010	PROPN
admet-2013	313	21	https://doi.org/10.2174/2212798412666220527154707	https://doi.org/10.2174/2212798412666220527154707	NOUN
admet-2013	313	22	https://doi.org/10.5599/admet.1023	https://doi.org/10.5599/admet.1023	PROPN
admet-2013	313	23	https://doi.org/10.1007/s40495-022-00284-x	https://doi.org/10.1007/s40495-022-00284-x	X
admet-2013	313	24	https://doi.org/10.2174/1573413718666220520094933	https://doi.org/10.2174/1573413718666220520094933	PROPN
admet-2013	313	25	https://doi.org/10.3390/pharmaceutics14122550	https://doi.org/10.3390/pharmaceutics14122550	NOUN
admet-2013	313	26	https://doi.org/10.2174/1567201816666181119112410	https://doi.org/10.2174/1567201816666181119112410	VERB
admet-2013	314	1	https://doi.org/10.1166/jbns.2013.1135	https://doi.org/10.1166/jbns.2013.1135	PROPN
admet-2013	314	2	https://doi.org/10.1016/j.drudis.2019.10.001	https://doi.org/10.1016/j.drudis.2019.10.001	VERB
admet-2013	314	3	g.	g.	PROPN
admet-2013	314	4	janani	janani	PROPN
admet-2013	314	5	et	et	PROPN
admet-2013	314	6	al	al	PROPN
admet-2013	314	7	.	.	PROPN
admet-2013	314	8	admet	admet	PROPN
admet-2013	314	9	&	&	CCONJ
admet-2013	314	10	dmpk	dmpk	PROPN
admet-2013	314	11	11(4	11(4	NUM
admet-2013	314	12	)	)	PUNCT
admet-2013	314	13	(	(	PUNCT
admet-2013	314	14	2023	2023	NUM
admet-2013	314	15	)	)	PUNCT
admet-2013	314	16	499	499	NUM
admet-2013	314	17	-	-	SYM
admet-2013	314	18	511	511	NUM
admet-2013	314	19	508	508	NUM
admet-2013	314	20	potential	potential	ADJ
admet-2013	314	21	environmental	environmental	ADJ
admet-2013	314	22	applications	application	NOUN
admet-2013	314	23	:	:	PUNCT
admet-2013	314	24	a	a	DET
admet-2013	314	25	state	state	NOUN
admet-2013	314	26	-	-	PUNCT
admet-2013	314	27	of	of	ADP
admet-2013	314	28	-	-	PUNCT
admet-2013	314	29	the	the	DET
admet-2013	314	30	-	-	PUNCT
admet-2013	314	31	art	art	NOUN
admet-2013	314	32	review	review	NOUN
admet-2013	314	33	.	.	PUNCT
admet-2013	315	1	inorganics	inorganic	NOUN
admet-2013	315	2	10	10	NUM
admet-2013	315	3	(	(	PUNCT
admet-2013	315	4	2022	2022	NUM
admet-2013	315	5	)	)	PUNCT
admet-2013	315	6	169	169	NUM
admet-2013	315	7	.	.	PUNCT
admet-2013	316	1	https://doi.org/10.3390/inorganics10100169	https://doi.org/10.3390/inorganics10100169	PROPN
admet-2013	316	2	.	.	PUNCT
admet-2013	317	1	[	[	X
admet-2013	317	2	29	29	NUM
admet-2013	317	3	]	]	PUNCT
admet-2013	317	4	a.	a.	NOUN
admet-2013	317	5	hochhaus	hochhaus	PROPN
admet-2013	317	6	,	,	PUNCT
admet-2013	317	7	s.	s.	PROPN
admet-2013	317	8	saussele	saussele	PROPN
admet-2013	317	9	,	,	PUNCT
admet-2013	317	10	g.	g.	PROPN
admet-2013	317	11	rosti	rosti	PROPN
admet-2013	317	12	,	,	PUNCT
admet-2013	317	13	f.-x	f.-x	PROPN
admet-2013	317	14	.	.	PUNCT
admet-2013	318	1	mahon	mahon	PROPN
admet-2013	318	2	,	,	PUNCT
admet-2013	318	3	j.j	j.j	PROPN
admet-2013	318	4	.	.	PROPN
admet-2013	318	5	janssen	janssen	PROPN
admet-2013	318	6	,	,	PUNCT
admet-2013	318	7	h.	h.	PROPN
admet-2013	318	8	hjorth	hjorth	PROPN
admet-2013	318	9	-	-	PUNCT
admet-2013	318	10	hansen	hansen	PROPN
admet-2013	318	11	,	,	PUNCT
admet-2013	318	12	j.	j.	PROPN
admet-2013	318	13	richter	richter	PROPN
admet-2013	318	14	,	,	PUNCT
admet-2013	318	15	c.	c.	PROPN
admet-2013	318	16	buske	buske	PROPN
admet-2013	318	17	.	.	PROPN
admet-2013	319	1	chronic	chronic	ADJ
admet-2013	319	2	myeloid	myeloid	NOUN
admet-2013	319	3	leukaemia	leukaemia	NOUN
admet-2013	319	4	:	:	PUNCT
admet-2013	319	5	esmo	esmo	VERB
admet-2013	319	6	clinical	clinical	ADJ
admet-2013	319	7	practice	practice	NOUN
admet-2013	319	8	guidelines	guideline	NOUN
admet-2013	319	9	for	for	ADP
admet-2013	319	10	diagnosis	diagnosis	NOUN
admet-2013	319	11	,	,	PUNCT
admet-2013	319	12	treatment	treatment	NOUN
admet-2013	319	13	and	and	CCONJ
admet-2013	319	14	follow	follow	NOUN
admet-2013	319	15	-	-	PUNCT
admet-2013	319	16	up	up	NOUN
admet-2013	319	17	.	.	PUNCT
admet-2013	320	1	annals	annal	NOUN
admet-2013	320	2	of	of	ADP
admet-2013	320	3	oncology	oncology	NOUN
admet-2013	320	4	28	28	NUM
admet-2013	320	5	(	(	PUNCT
admet-2013	320	6	2017	2017	NUM
admet-2013	320	7	)	)	PUNCT
admet-2013	321	1	iv41	iv41	PROPN
admet-2013	321	2	-	-	PUNCT
admet-2013	321	3	iv51	iv51	PROPN
admet-2013	321	4	.	.	PUNCT
admet-2013	322	1	https://doi.org/10.1093/annonc/mdx219	https://doi.org/10.1093/annonc/mdx219	PROPN
admet-2013	322	2	.	.	PUNCT
admet-2013	323	1	[	[	X
admet-2013	323	2	30	30	NUM
admet-2013	323	3	]	]	X
admet-2013	323	4	f.-x	f.-x	PROPN
admet-2013	323	5	.	.	PUNCT
admet-2013	324	1	mahon	mahon	PROPN
admet-2013	324	2	,	,	PUNCT
admet-2013	324	3	f.	f.	PROPN
admet-2013	324	4	belloc	belloc	PROPN
admet-2013	324	5	,	,	PUNCT
admet-2013	324	6	v.	v.	PROPN
admet-2013	324	7	lagarde	lagarde	PROPN
admet-2013	324	8	,	,	PUNCT
admet-2013	324	9	c.	c.	PROPN
admet-2013	324	10	chollet	chollet	PROPN
admet-2013	324	11	,	,	PUNCT
admet-2013	324	12	f.	f.	PROPN
admet-2013	324	13	moreau	moreau	PROPN
admet-2013	324	14	-	-	PUNCT
admet-2013	324	15	gaudry	gaudry	PROPN
admet-2013	324	16	,	,	PUNCT
admet-2013	324	17	j.	j.	PROPN
admet-2013	324	18	reiffers	reiffers	PROPN
admet-2013	324	19	,	,	PUNCT
admet-2013	324	20	j.m	j.m	PROPN
admet-2013	324	21	.	.	PROPN
admet-2013	324	22	goldman	goldman	PROPN
admet-2013	324	23	,	,	PUNCT
admet-2013	324	24	j.v	j.v	PROPN
admet-2013	324	25	.	.	PUNCT
admet-2013	324	26	melo	melo	PROPN
admet-2013	324	27	.	.	PUNCT
admet-2013	325	1	mdr1	mdr1	PROPN
admet-2013	325	2	gene	gene	NOUN
admet-2013	325	3	overexpression	overexpression	NOUN
admet-2013	325	4	confers	confer	NOUN
admet-2013	325	5	resistance	resistance	NOUN
admet-2013	325	6	to	to	ADP
admet-2013	325	7	imatinib	imatinib	NOUN
admet-2013	325	8	mesylate	mesylate	VERB
admet-2013	325	9	in	in	ADP
admet-2013	325	10	leukemia	leukemia	NOUN
admet-2013	325	11	cell	cell	NOUN
admet-2013	325	12	line	line	NOUN
admet-2013	325	13	models	model	NOUN
admet-2013	325	14	.	.	PUNCT
admet-2013	326	1	blood	blood	NOUN
admet-2013	326	2	,	,	PUNCT
admet-2013	326	3	the	the	DET
admet-2013	326	4	journal	journal	NOUN
admet-2013	326	5	of	of	ADP
admet-2013	326	6	the	the	DET
admet-2013	326	7	american	american	ADJ
admet-2013	326	8	society	society	NOUN
admet-2013	326	9	of	of	ADP
admet-2013	326	10	hematology	hematology	NOUN
admet-2013	326	11	101	101	NUM
admet-2013	326	12	(	(	PUNCT
admet-2013	326	13	2003	2003	NUM
admet-2013	326	14	)	)	PUNCT
admet-2013	326	15	2368	2368	NUM
admet-2013	326	16	-	-	SYM
admet-2013	326	17	2373	2373	NUM
admet-2013	326	18	.	.	PUNCT
admet-2013	327	1	https://doi.org/10.1182/blood.v101.6.2368	https://doi.org/10.1182/blood.v101.6.2368	X
admet-2013	327	2	.	.	PUNCT
admet-2013	328	1	[	[	X
admet-2013	328	2	31	31	NUM
admet-2013	328	3	]	]	PUNCT
admet-2013	328	4	b.-r	b.-r	NOUN
admet-2013	328	5	.	.	PUNCT
admet-2013	329	1	oh	oh	INTJ
admet-2013	329	2	,	,	PUNCT
admet-2013	329	3	n.-t	n.-t	PROPN
admet-2013	329	4	.	.	PUNCT
admet-2013	330	1	huang	huang	PROPN
admet-2013	330	2	,	,	PUNCT
admet-2013	330	3	w.	w.	PROPN
admet-2013	330	4	chen	chen	PROPN
admet-2013	330	5	,	,	PUNCT
admet-2013	330	6	j.h	j.h	PROPN
admet-2013	330	7	.	.	PROPN
admet-2013	330	8	seo	seo	PROPN
admet-2013	330	9	,	,	PUNCT
admet-2013	330	10	p.	p.	NOUN
admet-2013	330	11	chen	chen	PROPN
admet-2013	330	12	,	,	PUNCT
admet-2013	330	13	t.t	t.t	PROPN
admet-2013	330	14	.	.	PROPN
admet-2013	330	15	cornell	cornell	PROPN
admet-2013	330	16	,	,	PUNCT
admet-2013	330	17	t.p	t.p	PROPN
admet-2013	330	18	.	.	PROPN
admet-2013	330	19	shanley	shanley	PROPN
admet-2013	330	20	,	,	PUNCT
admet-2013	330	21	j.	j.	PROPN
admet-2013	330	22	fu	fu	PROPN
admet-2013	330	23	,	,	PUNCT
admet-2013	330	24	k.	k.	PROPN
admet-2013	330	25	kurabayashi	kurabayashi	PROPN
admet-2013	330	26	.	.	PUNCT
admet-2013	331	1	integrated	integrate	VERB
admet-2013	331	2	nanoplasmonic	nanoplasmonic	ADJ
admet-2013	331	3	sensing	sensing	NOUN
admet-2013	331	4	for	for	ADP
admet-2013	331	5	cellular	cellular	ADJ
admet-2013	331	6	functional	functional	ADJ
admet-2013	331	7	immunoanalysis	immunoanalysis	NOUN
admet-2013	331	8	using	use	VERB
admet-2013	331	9	human	human	ADJ
admet-2013	331	10	blood	blood	NOUN
admet-2013	331	11	.	.	PUNCT
admet-2013	332	1	acs	acs	PROPN
admet-2013	332	2	nano	nano	VERB
admet-2013	332	3	8	8	NUM
admet-2013	332	4	(	(	PUNCT
admet-2013	332	5	2014	2014	NUM
admet-2013	332	6	)	)	PUNCT
admet-2013	332	7	2667	2667	NUM
admet-2013	332	8	-	-	SYM
admet-2013	332	9	2676	2676	NUM
admet-2013	332	10	.	.	PUNCT
admet-2013	333	1	https://doi.org/10.1021/nn406370u	https://doi.org/10.1021/nn406370u	PROPN
admet-2013	333	2	.	.	PUNCT
admet-2013	334	1	[	[	X
admet-2013	334	2	32	32	NUM
admet-2013	334	3	]	]	PUNCT
admet-2013	334	4	g.	g.	PROPN
admet-2013	334	5	lentini	lentini	PROPN
admet-2013	334	6	,	,	PUNCT
admet-2013	334	7	e.	e.	PROPN
admet-2013	334	8	fazio	fazio	PROPN
admet-2013	334	9	,	,	PUNCT
admet-2013	334	10	f.	f.	PROPN
admet-2013	334	11	calabrese	calabrese	PROPN
admet-2013	334	12	,	,	PUNCT
admet-2013	334	13	l.m	l.m	PROPN
admet-2013	334	14	.	.	PROPN
admet-2013	334	15	de	de	PROPN
admet-2013	334	16	plano	plano	PROPN
admet-2013	334	17	,	,	PUNCT
admet-2013	334	18	m.	m.	NOUN
admet-2013	334	19	puliafico	puliafico	PROPN
admet-2013	334	20	,	,	PUNCT
admet-2013	334	21	d.	d.	PROPN
admet-2013	334	22	franco	franco	PROPN
admet-2013	334	23	,	,	PUNCT
admet-2013	334	24	m.s	m.s	PROPN
admet-2013	334	25	.	.	PROPN
admet-2013	334	26	nicolò	nicolò	PROPN
admet-2013	334	27	,	,	PUNCT
admet-2013	334	28	s.	s.	PROPN
admet-2013	334	29	carnazza	carnazza	PROPN
admet-2013	334	30	,	,	PUNCT
admet-2013	334	31	s.	s.	PROPN
admet-2013	334	32	trusso	trusso	PROPN
admet-2013	334	33	,	,	PUNCT
admet-2013	334	34	a.	a.	NOUN
admet-2013	334	35	allegra	allegra	PROPN
admet-2013	334	36	.	.	PUNCT
admet-2013	335	1	phage	phage	NOUN
admet-2013	335	2	–	–	PUNCT
admet-2013	335	3	agnps	agnps	ADJ
admet-2013	335	4	complex	complex	NOUN
admet-2013	335	5	as	as	SCONJ
admet-2013	335	6	sers	ser	NOUN
admet-2013	335	7	probe	probe	VERB
admet-2013	335	8	for	for	ADP
admet-2013	335	9	u937	u937	PROPN
admet-2013	335	10	cell	cell	NOUN
admet-2013	335	11	identification	identification	NOUN
admet-2013	335	12	.	.	PUNCT
admet-2013	336	1	biosensors	biosensor	NOUN
admet-2013	336	2	and	and	CCONJ
admet-2013	336	3	bioelectronics	bioelectronic	NOUN
admet-2013	336	4	74	74	NUM
admet-2013	336	5	(	(	PUNCT
admet-2013	336	6	2015	2015	NUM
admet-2013	336	7	)	)	PUNCT
admet-2013	336	8	398	398	NUM
admet-2013	336	9	-	-	SYM
admet-2013	336	10	405	405	NUM
admet-2013	336	11	.	.	PUNCT
admet-2013	336	12	https://doi.org/10.1016/j.bios.2015.05.073	https://doi.org/10.1016/j.bios.2015.05.073	NOUN
admet-2013	336	13	.	.	PUNCT
admet-2013	337	1	[	[	X
admet-2013	337	2	33	33	NUM
admet-2013	337	3	]	]	PUNCT
admet-2013	337	4	x.	x.	PROPN
admet-2013	337	5	chen	chen	PROPN
admet-2013	337	6	,	,	PUNCT
admet-2013	337	7	j.	j.	PROPN
admet-2013	337	8	zhou	zhou	PROPN
admet-2013	337	9	,	,	PUNCT
admet-2013	337	10	x.	x.	PROPN
admet-2013	337	11	yue	yue	PROPN
admet-2013	337	12	,	,	PUNCT
admet-2013	337	13	s.	s.	PROPN
admet-2013	337	14	wang	wang	PROPN
admet-2013	337	15	,	,	PUNCT
admet-2013	337	16	b.	b.	PROPN
admet-2013	337	17	yu	yu	PROPN
admet-2013	337	18	,	,	PUNCT
admet-2013	337	19	y.	y.	PROPN
admet-2013	337	20	luo	luo	PROPN
admet-2013	337	21	,	,	PUNCT
admet-2013	337	22	x.	x.	PROPN
admet-2013	337	23	huang	huang	PROPN
admet-2013	337	24	.	.	PROPN
admet-2013	337	25	selective	selective	PROPN
admet-2013	337	26	bio	bio	PROPN
admet-2013	337	27	-	-	ADJ
admet-2013	337	28	labeling	labeling	ADJ
admet-2013	337	29	and	and	CCONJ
admet-2013	337	30	induced	induced	ADJ
admet-2013	337	31	apoptosis	apoptosis	NOUN
admet-2013	337	32	of	of	ADP
admet-2013	337	33	hematopoietic	hematopoietic	ADJ
admet-2013	337	34	cancer	cancer	NOUN
admet-2013	337	35	cells	cell	NOUN
admet-2013	337	36	using	use	VERB
admet-2013	337	37	dual	dual	ADJ
admet-2013	337	38	-	-	PUNCT
admet-2013	337	39	functional	functional	ADJ
admet-2013	337	40	polyethylenimine	polyethylenimine	NOUN
admet-2013	337	41	-	-	PUNCT
admet-2013	337	42	caged	cage	VERB
admet-2013	337	43	platinum	platinum	NOUN
admet-2013	337	44	nanoclusters	nanocluster	NOUN
admet-2013	337	45	.	.	PUNCT
admet-2013	338	1	biochemical	biochemical	ADJ
admet-2013	338	2	and	and	CCONJ
admet-2013	338	3	biophysical	biophysical	ADJ
admet-2013	338	4	research	research	NOUN
admet-2013	338	5	communications	communication	NOUN
admet-2013	338	6	503	503	NUM
admet-2013	338	7	(	(	PUNCT
admet-2013	338	8	2018	2018	NUM
admet-2013	338	9	)	)	PUNCT
admet-2013	338	10	1465	1465	NUM
admet-2013	338	11	-	-	SYM
admet-2013	338	12	1470	1470	NUM
admet-2013	338	13	.	.	PUNCT
admet-2013	339	1	https://doi.org/10.1016/j.bbrc.2018.07.064	https://doi.org/10.1016/j.bbrc.2018.07.064	NOUN
admet-2013	339	2	.	.	PUNCT
admet-2013	340	1	[	[	X
admet-2013	340	2	34	34	NUM
admet-2013	340	3	]	]	PUNCT
admet-2013	340	4	t.	t.	PROPN
admet-2013	340	5	limongi	limongi	PROPN
admet-2013	340	6	,	,	PUNCT
admet-2013	340	7	f.	f.	PROPN
admet-2013	340	8	susa	susa	PROPN
admet-2013	340	9	,	,	PUNCT
admet-2013	340	10	v.	v.	ADP
admet-2013	340	11	cauda	cauda	NOUN
admet-2013	340	12	.	.	PUNCT
admet-2013	341	1	nanoparticles	nanoparticle	NOUN
admet-2013	341	2	for	for	ADP
admet-2013	341	3	hematologic	hematologic	NOUN
admet-2013	341	4	diseases	disease	NOUN
admet-2013	341	5	detection	detection	NOUN
admet-2013	341	6	and	and	CCONJ
admet-2013	341	7	treatment	treatment	NOUN
admet-2013	341	8	.	.	PUNCT
admet-2013	342	1	hematology	hematology	PROPN
admet-2013	342	2	&	&	CCONJ
admet-2013	342	3	medical	medical	ADJ
admet-2013	342	4	oncology	oncology	NOUN
admet-2013	342	5	4	4	NUM
admet-2013	342	6	(	(	PUNCT
admet-2013	342	7	2019	2019	NUM
admet-2013	342	8	)	)	PUNCT
admet-2013	342	9	.	.	PUNCT
admet-2013	343	1	https://doi.org/10.15761/hmo.1000183	https://doi.org/10.15761/hmo.1000183	NOUN
admet-2013	343	2	.	.	PUNCT
admet-2013	344	1	[	[	X
admet-2013	344	2	35	35	NUM
admet-2013	344	3	]	]	X
admet-2013	344	4	s.	s.	PROPN
admet-2013	344	5	dilruba	dilruba	PROPN
admet-2013	344	6	,	,	PUNCT
admet-2013	344	7	g.v	g.v	PROPN
admet-2013	344	8	.	.	PROPN
admet-2013	344	9	kalayda	kalayda	PROPN
admet-2013	344	10	.	.	PUNCT
admet-2013	345	1	platinum	platinum	NOUN
admet-2013	345	2	-	-	PUNCT
admet-2013	345	3	based	base	VERB
admet-2013	345	4	drugs	drug	NOUN
admet-2013	345	5	:	:	PUNCT
admet-2013	345	6	past	past	ADJ
admet-2013	345	7	,	,	PUNCT
admet-2013	345	8	present	present	ADJ
admet-2013	345	9	and	and	CCONJ
admet-2013	345	10	future	future	NOUN
admet-2013	345	11	.	.	PUNCT
admet-2013	346	1	cancer	cancer	NOUN
admet-2013	346	2	chemotherapy	chemotherapy	NOUN
admet-2013	346	3	and	and	CCONJ
admet-2013	346	4	pharmacology	pharmacology	NOUN
admet-2013	346	5	77	77	NUM
admet-2013	346	6	(	(	PUNCT
admet-2013	346	7	2016	2016	NUM
admet-2013	346	8	)	)	PUNCT
admet-2013	346	9	1103	1103	NUM
admet-2013	346	10	-	-	SYM
admet-2013	346	11	1124	1124	NUM
admet-2013	346	12	.	.	PUNCT
admet-2013	347	1	https://doi.org/10.1007/s00280-016-2976-z	https://doi.org/10.1007/s00280-016-2976-z	NOUN
admet-2013	347	2	.	.	PUNCT
admet-2013	348	1	[	[	X
admet-2013	348	2	36	36	NUM
admet-2013	348	3	]	]	X
admet-2013	348	4	p.	p.	NOUN
admet-2013	348	5	pallavi	pallavi	PROPN
admet-2013	348	6	,	,	PUNCT
admet-2013	348	7	k.	k.	PROPN
admet-2013	348	8	harini	harini	PROPN
admet-2013	348	9	,	,	PUNCT
admet-2013	348	10	s.	s.	PROPN
admet-2013	348	11	crowder	crowder	PROPN
admet-2013	348	12	,	,	PUNCT
admet-2013	348	13	d.	d.	PROPN
admet-2013	348	14	ghosh	ghosh	PROPN
admet-2013	348	15	,	,	PUNCT
admet-2013	348	16	p.	p.	PROPN
admet-2013	348	17	gowtham	gowtham	PROPN
admet-2013	348	18	,	,	PUNCT
admet-2013	348	19	k.	k.	PROPN
admet-2013	348	20	girigoswami	girigoswami	PROPN
admet-2013	348	21	,	,	PUNCT
admet-2013	348	22	a.	a.	PROPN
admet-2013	348	23	girigoswami	girigoswami	PROPN
admet-2013	348	24	.	.	PUNCT
admet-2013	349	1	rhodamine	rhodamine	PROPN
admet-2013	349	2	conjugated	conjugate	VERB
admet-2013	349	3	anti	anti	ADJ
admet-2013	349	4	-	-	ADJ
admet-2013	349	5	stokes	stokes	ADJ
admet-2013	349	6	gold	gold	NOUN
admet-2013	349	7	nanoparticles	nanoparticle	NOUN
admet-2013	349	8	with	with	ADP
admet-2013	349	9	higher	high	ADJ
admet-2013	349	10	ros	ros	PROPN
admet-2013	349	11	quantum	quantum	NOUN
admet-2013	349	12	yield	yield	NOUN
admet-2013	349	13	as	as	ADP
admet-2013	349	14	theranostic	theranostic	ADJ
admet-2013	349	15	probe	probe	NOUN
admet-2013	349	16	to	to	PART
admet-2013	349	17	arrest	arrest	VERB
admet-2013	349	18	cancer	cancer	NOUN
admet-2013	349	19	and	and	CCONJ
admet-2013	349	20	mdr	mdr	PROPN
admet-2013	349	21	bacteria	bacteria	NOUN
admet-2013	349	22	.	.	PUNCT
admet-2013	350	1	applied	apply	VERB
admet-2013	350	2	biochemistry	biochemistry	NOUN
admet-2013	350	3	and	and	CCONJ
admet-2013	350	4	biotechnology	biotechnology	NOUN
admet-2013	350	5	(	(	PUNCT
admet-2013	350	6	2023	2023	NUM
admet-2013	350	7	)	)	PUNCT
admet-2013	350	8	.	.	PUNCT
admet-2013	351	1	https://doi.org/10.1007/s12010-023-04475-0	https://doi.org/10.1007/s12010-023-04475-0	X
admet-2013	351	2	.	.	PUNCT
admet-2013	352	1	[	[	X
admet-2013	352	2	37	37	NUM
admet-2013	352	3	]	]	PUNCT
admet-2013	352	4	x.	x.	PROPN
admet-2013	352	5	huang	huang	PROPN
admet-2013	352	6	,	,	PUNCT
admet-2013	352	7	h.m	h.m	PROPN
admet-2013	352	8	.	.	PROPN
admet-2013	352	9	mahmudul	mahmudul	NOUN
admet-2013	352	10	,	,	PUNCT
admet-2013	352	11	z.	z.	PROPN
admet-2013	352	12	li	li	PROPN
admet-2013	352	13	,	,	PUNCT
admet-2013	352	14	x.	x.	PROPN
admet-2013	352	15	deng	deng	PROPN
admet-2013	352	16	,	,	PUNCT
admet-2013	352	17	x.	x.	PROPN
admet-2013	352	18	su	su	PROPN
admet-2013	352	19	,	,	PUNCT
admet-2013	352	20	z.	z.	PROPN
admet-2013	352	21	xiao	xiao	PROPN
admet-2013	352	22	,	,	PUNCT
admet-2013	352	23	l.	l.	PROPN
admet-2013	352	24	zhao	zhao	PROPN
admet-2013	352	25	,	,	PUNCT
admet-2013	352	26	t.	t.	PROPN
admet-2013	352	27	liu	liu	PROPN
admet-2013	352	28	,	,	PUNCT
admet-2013	352	29	h.	h.	PROPN
admet-2013	352	30	li	li	PROPN
admet-2013	352	31	.	.	PUNCT
admet-2013	352	32	noble	noble	ADJ
admet-2013	352	33	metal	metal	NOUN
admet-2013	352	34	nanomaterials	nanomaterial	NOUN
admet-2013	352	35	for	for	ADP
admet-2013	352	36	the	the	DET
admet-2013	352	37	diagnosis	diagnosis	NOUN
admet-2013	352	38	and	and	CCONJ
admet-2013	352	39	treatment	treatment	NOUN
admet-2013	352	40	of	of	ADP
admet-2013	352	41	hematological	hematological	ADJ
admet-2013	352	42	malignancies	malignancy	NOUN
admet-2013	352	43	.	.	PUNCT
admet-2013	353	1	frontiers	frontier	NOUN
admet-2013	353	2	in	in	ADP
admet-2013	353	3	bioscience	bioscience	NOUN
admet-2013	353	4	-	-	PUNCT
admet-2013	353	5	landmark	landmark	NOUN
admet-2013	353	6	27	27	NUM
admet-2013	353	7	(	(	PUNCT
admet-2013	353	8	2022	2022	NUM
admet-2013	353	9	)	)	PUNCT
admet-2013	353	10	40	40	NUM
admet-2013	353	11	.	.	PUNCT
admet-2013	353	12	https://doi.org/10.31083/j.fbl2702040	https://doi.org/10.31083/j.fbl2702040	PROPN
admet-2013	353	13	.	.	PUNCT
admet-2013	354	1	[	[	X
admet-2013	354	2	38	38	NUM
admet-2013	354	3	]	]	PUNCT
admet-2013	354	4	g.	g.	PROPN
admet-2013	354	5	soni	soni	PROPN
admet-2013	354	6	,	,	PUNCT
admet-2013	354	7	k.s	k.s	PROPN
admet-2013	354	8	.	.	PROPN
admet-2013	354	9	yadav	yadav	PROPN
admet-2013	354	10	.	.	PUNCT
admet-2013	355	1	applications	application	NOUN
admet-2013	355	2	of	of	ADP
admet-2013	355	3	nanoparticles	nanoparticle	NOUN
admet-2013	355	4	in	in	ADP
admet-2013	355	5	treatment	treatment	NOUN
admet-2013	355	6	and	and	CCONJ
admet-2013	355	7	diagnosis	diagnosis	NOUN
admet-2013	355	8	of	of	ADP
admet-2013	355	9	leukemia	leukemia	NOUN
admet-2013	355	10	.	.	PUNCT
admet-2013	356	1	materials	material	NOUN
admet-2013	356	2	science	science	NOUN
admet-2013	356	3	and	and	CCONJ
admet-2013	356	4	engineering	engineering	NOUN
admet-2013	356	5	c	c	PROPN
admet-2013	356	6	47	47	NUM
admet-2013	356	7	(	(	PUNCT
admet-2013	356	8	2015	2015	NUM
admet-2013	356	9	)	)	PUNCT
admet-2013	356	10	156	156	NUM
admet-2013	356	11	-	-	SYM
admet-2013	356	12	164	164	NUM
admet-2013	356	13	.	.	PUNCT
admet-2013	357	1	https://doi.org/10.1016/j.msec.2014.10.043	https://doi.org/10.1016/j.msec.2014.10.043	PROPN
admet-2013	357	2	.	.	PUNCT
admet-2013	358	1	[	[	X
admet-2013	358	2	39	39	NUM
admet-2013	358	3	]	]	X
admet-2013	358	4	o.s	o.s	PROPN
admet-2013	358	5	.	.	PROPN
admet-2013	358	6	muddineti	muddineti	PROPN
admet-2013	358	7	,	,	PUNCT
admet-2013	358	8	b.	b.	PROPN
admet-2013	358	9	ghosh	ghosh	PROPN
admet-2013	358	10	,	,	PUNCT
admet-2013	358	11	s.	s.	PROPN
admet-2013	358	12	biswas	biswas	PROPN
admet-2013	358	13	.	.	PUNCT
admet-2013	359	1	current	current	ADJ
admet-2013	359	2	trends	trend	NOUN
admet-2013	359	3	in	in	ADP
admet-2013	359	4	using	use	VERB
admet-2013	359	5	polymer	polymer	NOUN
admet-2013	359	6	coated	coat	VERB
admet-2013	359	7	gold	gold	NOUN
admet-2013	359	8	nanoparticles	nanoparticle	NOUN
admet-2013	359	9	for	for	ADP
admet-2013	359	10	cancer	cancer	NOUN
admet-2013	359	11	therapy	therapy	NOUN
admet-2013	359	12	.	.	PUNCT
admet-2013	360	1	international	international	ADJ
admet-2013	360	2	journal	journal	PROPN
admet-2013	360	3	of	of	ADP
admet-2013	360	4	pharmaceutics	pharmaceutic	NOUN
admet-2013	360	5	484	484	NUM
admet-2013	360	6	(	(	PUNCT
admet-2013	360	7	2015	2015	NUM
admet-2013	360	8	)	)	PUNCT
admet-2013	360	9	252	252	NUM
admet-2013	360	10	-	-	SYM
admet-2013	360	11	267	267	NUM
admet-2013	360	12	.	.	PUNCT
admet-2013	361	1	https://doi.org/10.1016/j.ijpharm.2015.02.038	https://doi.org/10.1016/j.ijpharm.2015.02.038	NOUN
admet-2013	361	2	.	.	PUNCT
admet-2013	362	1	[	[	X
admet-2013	362	2	40	40	NUM
admet-2013	362	3	]	]	PUNCT
admet-2013	362	4	l.	l.	PROPN
admet-2013	362	5	huang	huang	PROPN
admet-2013	362	6	,	,	PUNCT
admet-2013	362	7	j.	j.	PROPN
admet-2013	362	8	huang	huang	PROPN
admet-2013	362	9	,	,	PUNCT
admet-2013	362	10	j.	j.	PROPN
admet-2013	362	11	huang	huang	PROPN
admet-2013	362	12	,	,	PUNCT
admet-2013	362	13	h.	h.	PROPN
admet-2013	362	14	xue	xue	PROPN
admet-2013	362	15	,	,	PUNCT
admet-2013	362	16	z.	z.	PROPN
admet-2013	362	17	liang	liang	PROPN
admet-2013	362	18	,	,	PUNCT
admet-2013	362	19	j.	j.	PROPN
admet-2013	362	20	wu	wu	PROPN
admet-2013	362	21	,	,	PUNCT
admet-2013	362	22	c.	c.	PROPN
admet-2013	362	23	chen	chen	PROPN
admet-2013	362	24	.	.	PUNCT
admet-2013	363	1	nanomedicine	nanomedicine	PROPN
admet-2013	363	2	–	–	PUNCT
admet-2013	363	3	a	a	DET
admet-2013	363	4	promising	promising	ADJ
admet-2013	363	5	therapy	therapy	NOUN
admet-2013	363	6	for	for	ADP
admet-2013	363	7	hematological	hematological	ADJ
admet-2013	363	8	malignancies	malignancy	NOUN
admet-2013	363	9	.	.	PUNCT
admet-2013	364	1	biomaterials	biomaterial	NOUN
admet-2013	364	2	science	science	NOUN
admet-2013	364	3	8	8	NUM
admet-2013	364	4	(	(	PUNCT
admet-2013	364	5	2020	2020	NUM
admet-2013	364	6	)	)	PUNCT
admet-2013	364	7	2376	2376	NUM
admet-2013	364	8	-	-	SYM
admet-2013	364	9	2393	2393	NUM
admet-2013	364	10	.	.	PUNCT
admet-2013	365	1	https://doi.org/10.1039/d0bm00129e	https://doi.org/10.1039/d0bm00129e	PROPN
admet-2013	365	2	.	.	PUNCT
admet-2013	366	1	[	[	X
admet-2013	366	2	41	41	NUM
admet-2013	366	3	]	]	X
admet-2013	366	4	r.	r.	PROPN
admet-2013	366	5	tietze	tietze	PROPN
admet-2013	366	6	,	,	PUNCT
admet-2013	366	7	j.	j.	PROPN
admet-2013	366	8	zaloga	zaloga	PROPN
admet-2013	366	9	,	,	PUNCT
admet-2013	366	10	h.	h.	PROPN
admet-2013	366	11	unterweger	unterweger	PROPN
admet-2013	366	12	,	,	PUNCT
admet-2013	366	13	s.	s.	PROPN
admet-2013	366	14	lyer	lyer	PROPN
admet-2013	366	15	,	,	PUNCT
admet-2013	366	16	r.p	r.p	PROPN
admet-2013	366	17	.	.	PROPN
admet-2013	366	18	friedrich	friedrich	PROPN
admet-2013	366	19	,	,	PUNCT
admet-2013	366	20	c.	c.	PROPN
admet-2013	366	21	janko	janko	PROPN
admet-2013	366	22	,	,	PUNCT
admet-2013	366	23	m.	m.	NOUN
admet-2013	366	24	pöttler	pöttler	PROPN
admet-2013	366	25	,	,	PUNCT
admet-2013	366	26	s.	s.	PROPN
admet-2013	366	27	dürr	dürr	PROPN
admet-2013	366	28	,	,	PUNCT
admet-2013	366	29	c.	c.	PROPN
admet-2013	366	30	alexiou	alexiou	NOUN
admet-2013	366	31	.	.	PUNCT
admet-2013	367	1	magnetic	magnetic	ADJ
admet-2013	367	2	nanoparticle	nanoparticle	NOUN
admet-2013	367	3	-	-	PUNCT
admet-2013	367	4	based	base	VERB
admet-2013	367	5	drug	drug	NOUN
admet-2013	367	6	delivery	delivery	NOUN
admet-2013	367	7	for	for	ADP
admet-2013	367	8	cancer	cancer	NOUN
admet-2013	367	9	therapy	therapy	NOUN
admet-2013	367	10	.	.	PUNCT
admet-2013	368	1	biochemical	biochemical	ADJ
admet-2013	368	2	and	and	CCONJ
admet-2013	368	3	biophysical	biophysical	ADJ
admet-2013	368	4	research	research	NOUN
admet-2013	368	5	communications	communication	NOUN
admet-2013	368	6	468	468	NUM
admet-2013	368	7	(	(	PUNCT
admet-2013	368	8	2015	2015	NUM
admet-2013	368	9	)	)	PUNCT
admet-2013	368	10	463	463	NUM
admet-2013	368	11	-	-	SYM
admet-2013	368	12	470	470	NUM
admet-2013	368	13	.	.	PUNCT
admet-2013	369	1	https://doi.org/10.1016/j.bbrc.2015.08.022	https://doi.org/10.1016/j.bbrc.2015.08.022	NOUN
admet-2013	369	2	.	.	PUNCT
admet-2013	370	1	[	[	X
admet-2013	370	2	42	42	NUM
admet-2013	370	3	]	]	X
admet-2013	370	4	f.	f.	PROPN
admet-2013	370	5	ali	ali	PROPN
admet-2013	370	6	,	,	PUNCT
admet-2013	370	7	s.b	s.b	PROPN
admet-2013	370	8	.	.	PROPN
admet-2013	370	9	khan	khan	PROPN
admet-2013	370	10	,	,	PUNCT
admet-2013	370	11	t.	t.	PROPN
admet-2013	370	12	kamal	kamal	PROPN
admet-2013	370	13	,	,	PUNCT
admet-2013	370	14	k.a	k.a	PROPN
admet-2013	370	15	.	.	PROPN
admet-2013	370	16	alamry	alamry	PROPN
admet-2013	370	17	,	,	PUNCT
admet-2013	370	18	a.m.	a.m.	NOUN
admet-2013	370	19	asiri	asiri	PROPN
admet-2013	370	20	.	.	PUNCT
admet-2013	371	1	chitosan	chitosan	ADJ
admet-2013	371	2	-	-	PUNCT
admet-2013	371	3	titanium	titanium	NOUN
admet-2013	371	4	oxide	oxide	NOUN
admet-2013	371	5	fibers	fiber	NOUN
admet-2013	371	6	supported	support	VERB
admet-2013	371	7	zerovalent	zerovalent	NOUN
admet-2013	371	8	nanoparticles	nanoparticle	NOUN
admet-2013	371	9	:	:	PUNCT
admet-2013	371	10	highly	highly	ADV
admet-2013	371	11	efficient	efficient	ADJ
admet-2013	371	12	and	and	CCONJ
admet-2013	371	13	easily	easily	ADV
admet-2013	371	14	retrievable	retrievable	ADJ
admet-2013	371	15	catalyst	catalyst	NOUN
admet-2013	371	16	for	for	ADP
admet-2013	371	17	the	the	DET
admet-2013	371	18	removal	removal	NOUN
admet-2013	371	19	of	of	ADP
admet-2013	371	20	organic	organic	ADJ
admet-2013	371	21	pollutants	pollutant	NOUN
admet-2013	371	22	.	.	PUNCT
admet-2013	372	1	scientific	scientific	ADJ
admet-2013	372	2	reports	report	NOUN
admet-2013	372	3	8	8	NUM
admet-2013	372	4	(	(	PUNCT
admet-2013	372	5	2018	2018	NUM
admet-2013	372	6	)	)	PUNCT
admet-2013	372	7	6260	6260	NUM
admet-2013	372	8	.	.	PUNCT
admet-2013	373	1	https://doi.org/10.1038/s41598-018-24311-4	https://doi.org/10.1038/s41598-018-24311-4	PRON
admet-2013	373	2	.	.	PUNCT
admet-2013	374	1	[	[	X
admet-2013	374	2	43	43	NUM
admet-2013	374	3	]	]	X
admet-2013	374	4	m.	m.	NOUN
admet-2013	374	5	mineo	mineo	PROPN
admet-2013	374	6	,	,	PUNCT
admet-2013	374	7	s.h	s.h	PROPN
admet-2013	374	8	.	.	PROPN
admet-2013	374	9	garfield	garfield	PROPN
admet-2013	374	10	,	,	PUNCT
admet-2013	374	11	s.	s.	PROPN
admet-2013	374	12	taverna	taverna	PROPN
admet-2013	374	13	,	,	PUNCT
admet-2013	374	14	a.	a.	NOUN
admet-2013	374	15	flugy	flugy	PROPN
admet-2013	374	16	,	,	PUNCT
admet-2013	374	17	g.	g.	PROPN
admet-2013	374	18	de	de	PROPN
admet-2013	374	19	leo	leo	PROPN
admet-2013	374	20	,	,	PUNCT
admet-2013	374	21	r.	r.	PROPN
admet-2013	374	22	alessandro	alessandro	PROPN
admet-2013	374	23	,	,	PUNCT
admet-2013	374	24	e.c	e.c	PROPN
admet-2013	374	25	.	.	PROPN
admet-2013	374	26	kohn	kohn	PROPN
admet-2013	374	27	.	.	PUNCT
admet-2013	375	1	exosomes	exosome	NOUN
admet-2013	375	2	released	release	VERB
admet-2013	375	3	by	by	ADP
admet-2013	375	4	k562	k562	PROPN
admet-2013	375	5	chronic	chronic	ADJ
admet-2013	375	6	myeloid	myeloid	NOUN
admet-2013	375	7	leukemia	leukemia	NOUN
admet-2013	375	8	cells	cell	NOUN
admet-2013	375	9	promote	promote	VERB
admet-2013	375	10	angiogenesis	angiogenesis	NOUN
admet-2013	375	11	in	in	ADP
admet-2013	375	12	a	a	DET
admet-2013	375	13	src	src	NOUN
admet-2013	375	14	-	-	PUNCT
admet-2013	375	15	dependent	dependent	ADJ
admet-2013	375	16	fashion	fashion	NOUN
admet-2013	375	17	.	.	PUNCT
admet-2013	376	1	angiogenesis	angiogenesis	NOUN
admet-2013	376	2	15	15	NUM
admet-2013	376	3	(	(	PUNCT
admet-2013	376	4	2012	2012	NUM
admet-2013	376	5	)	)	PUNCT
admet-2013	376	6	33	33	NUM
admet-2013	376	7	-	-	SYM
admet-2013	376	8	45	45	NUM
admet-2013	376	9	.	.	PUNCT
admet-2013	377	1	https://doi.org/10.1007/s10456-011-9241-1	https://doi.org/10.1007/s10456-011-9241-1	NOUN
admet-2013	377	2	.	.	PUNCT
admet-2013	378	1	[	[	X
admet-2013	378	2	44	44	NUM
admet-2013	378	3	]	]	X
admet-2013	378	4	c.	c.	PROPN
admet-2013	378	5	roma	roma	PROPN
admet-2013	378	6	-	-	PUNCT
admet-2013	378	7	rodrigues	rodrigues	PROPN
admet-2013	378	8	,	,	PUNCT
admet-2013	378	9	a.r	a.r	PROPN
admet-2013	378	10	.	.	PROPN
admet-2013	378	11	fernandes	fernandes	PROPN
admet-2013	378	12	,	,	PUNCT
admet-2013	378	13	p.v	p.v	PROPN
admet-2013	378	14	.	.	PROPN
admet-2013	378	15	baptista	baptista	PROPN
admet-2013	378	16	.	.	PUNCT
admet-2013	379	1	counteracting	counteract	VERB
admet-2013	379	2	the	the	DET
admet-2013	379	3	effect	effect	NOUN
admet-2013	379	4	of	of	ADP
admet-2013	379	5	leukemia	leukemia	NOUN
admet-2013	379	6	exosomes	exosome	NOUN
admet-2013	379	7	by	by	ADP
admet-2013	379	8	antiangiogenic	antiangiogenic	ADJ
admet-2013	379	9	gold	gold	NOUN
admet-2013	379	10	nanoparticles	nanoparticle	NOUN
admet-2013	379	11	.	.	PUNCT
admet-2013	380	1	international	international	ADJ
admet-2013	380	2	journal	journal	NOUN
admet-2013	380	3	of	of	ADP
admet-2013	380	4	nanomedicine	nanomedicine	PROPN
admet-2013	380	5	2019:14	2019:14	NUM
admet-2013	380	6	(	(	PUNCT
admet-2013	380	7	2019	2019	NUM
admet-2013	380	8	)	)	PUNCT
admet-2013	380	9	6843	6843	NUM
admet-2013	380	10	-	-	SYM
admet-2013	380	11	6854	6854	NUM
admet-2013	380	12	.	.	PUNCT
admet-2013	381	1	https://doi.org/10.2147/ijn.s215711	https://doi.org/10.2147/ijn.s215711	NOUN
admet-2013	381	2	.	.	PUNCT
admet-2013	382	1	https://doi.org/10.3390/inorganics10100169	https://doi.org/10.3390/inorganics10100169	PROPN
admet-2013	382	2	https://doi.org/10.1093/annonc/mdx219	https://doi.org/10.1093/annonc/mdx219	PROPN
admet-2013	382	3	https://doi.org/10.1182/blood.v101.6.2368	https://doi.org/10.1182/blood.v101.6.2368	PUNCT
admet-2013	383	1	https://doi.org/10.1021/nn406370u	https://doi.org/10.1021/nn406370u	PROPN
admet-2013	383	2	https://doi.org/https:/doi.org/10.1016/j.bios.2015.05.073	https://doi.org/https:/doi.org/10.1016/j.bios.2015.05.073	PROPN
admet-2013	383	3	https://doi.org/10.1016/j.bbrc.2018.07.064	https://doi.org/10.1016/j.bbrc.2018.07.064	PROPN
admet-2013	383	4	https://doi.org/10.15761/hmo.1000183	https://doi.org/10.15761/hmo.1000183	PROPN
admet-2013	383	5	https://doi.org/10.1007/s00280-016-2976-z	https://doi.org/10.1007/s00280-016-2976-z	PROPN
admet-2013	383	6	https://doi.org/10.1007/s12010-023-04475-0	https://doi.org/10.1007/s12010-023-04475-0	NUM
admet-2013	383	7	https://doi.org/10.31083/j.fbl2702040	https://doi.org/10.31083/j.fbl2702040	NOUN
admet-2013	383	8	https://doi.org/10.1016/j.msec.2014.10.043	https://doi.org/10.1016/j.msec.2014.10.043	PROPN
admet-2013	383	9	https://doi.org/10.1016/j.ijpharm.2015.02.038	https://doi.org/10.1016/j.ijpharm.2015.02.038	NOUN
admet-2013	383	10	https://doi.org/10.1039/d0bm00129e	https://doi.org/10.1039/d0bm00129e	PROPN
admet-2013	383	11	https://doi.org/10.1016/j.bbrc.2015.08.022	https://doi.org/10.1016/j.bbrc.2015.08.022	PROPN
admet-2013	383	12	https://doi.org/10.1038/s41598-018-24311-4	https://doi.org/10.1038/s41598-018-24311-4	NUM
admet-2013	383	13	https://doi.org/10.1007/s10456-011-9241-1	https://doi.org/10.1007/s10456-011-9241-1	NOUN
admet-2013	383	14	https://doi.org/10.2147/ijn.s215711	https://doi.org/10.2147/ijn.s215711	NOUN
admet-2013	383	15	admet	admet	PROPN
admet-2013	383	16	&	&	CCONJ
admet-2013	383	17	dmpk	dmpk	PROPN
admet-2013	383	18	11(4	11(4	NUM
admet-2013	383	19	)	)	PUNCT
admet-2013	383	20	(	(	PUNCT
admet-2013	383	21	2023	2023	NUM
admet-2013	383	22	)	)	PUNCT
admet-2013	383	23	499	499	NUM
admet-2013	383	24	-	-	SYM
admet-2013	383	25	511	511	NUM
admet-2013	383	26	nanoparticles	nanoparticle	NOUN
admet-2013	383	27	in	in	ADP
admet-2013	383	28	the	the	DET
admet-2013	383	29	therapy	therapy	NOUN
admet-2013	383	30	of	of	ADP
admet-2013	383	31	chronic	chronic	ADJ
admet-2013	383	32	myelogenous	myelogenous	ADJ
admet-2013	383	33	leukemia	leukemia	PROPN
admet-2013	383	34	doi	doi	PROPN
admet-2013	383	35	:	:	PUNCT
admet-2013	383	36	https://doi.org/10.5599/adme	https://doi.org/10.5599/adme	NOUN
admet-2013	383	37	t.2013	t.2013	PROPN
admet-2013	383	38	509	509	NUM
admet-2013	384	1	[	[	X
admet-2013	384	2	45	45	NUM
admet-2013	384	3	]	]	X
admet-2013	384	4	a.y	a.y	PROPN
admet-2013	384	5	.	.	PROPN
admet-2013	384	6	elderdery	elderdery	PROPN
admet-2013	384	7	,	,	PUNCT
admet-2013	384	8	b.	b.	PROPN
admet-2013	384	9	alzahrani	alzahrani	PROPN
admet-2013	384	10	,	,	PUNCT
admet-2013	384	11	s.m	s.m	PROPN
admet-2013	384	12	.	.	PROPN
admet-2013	384	13	hamza	hamza	PROPN
admet-2013	384	14	,	,	PUNCT
admet-2013	384	15	g.	g.	PROPN
admet-2013	384	16	mostafa	mostafa	PROPN
admet-2013	384	17	-	-	PUNCT
admet-2013	384	18	hedeab	hedeab	PROPN
admet-2013	384	19	,	,	PUNCT
admet-2013	384	20	p.l	p.l	PROPN
admet-2013	384	21	.	.	PROPN
admet-2013	384	22	mok	mok	PROPN
admet-2013	384	23	,	,	PUNCT
admet-2013	384	24	s.k	s.k	PROPN
admet-2013	384	25	.	.	PROPN
admet-2013	384	26	subbiah	subbiah	PROPN
admet-2013	384	27	.	.	PUNCT
admet-2013	385	1	cuo	cuo	PROPN
admet-2013	385	2	-	-	PUNCT
admet-2013	385	3	tio2chitosan	tio2chitosan	PROPN
admet-2013	385	4	-	-	PUNCT
admet-2013	385	5	berbamine	berbamine	NOUN
admet-2013	385	6	nanocomposites	nanocomposite	NOUN
admet-2013	385	7	induce	induce	VERB
admet-2013	385	8	apoptosis	apoptosis	NOUN
admet-2013	385	9	through	through	ADP
admet-2013	385	10	the	the	DET
admet-2013	385	11	mitochondrial	mitochondrial	ADJ
admet-2013	385	12	pathway	pathway	NOUN
admet-2013	385	13	with	with	ADP
admet-2013	385	14	the	the	DET
admet-2013	385	15	expression	expression	NOUN
admet-2013	385	16	of	of	ADP
admet-2013	385	17	p53	p53	NOUN
admet-2013	385	18	,	,	PUNCT
admet-2013	385	19	bax	bax	PROPN
admet-2013	385	20	,	,	PUNCT
admet-2013	385	21	and	and	CCONJ
admet-2013	385	22	bcl-2	bcl-2	VERB
admet-2013	385	23	in	in	ADP
admet-2013	385	24	the	the	DET
admet-2013	385	25	human	human	ADJ
admet-2013	385	26	k562	k562	PROPN
admet-2013	385	27	cancer	cancer	NOUN
admet-2013	385	28	cell	cell	NOUN
admet-2013	385	29	line	line	NOUN
admet-2013	385	30	.	.	PUNCT
admet-2013	386	1	bioinorganic	bioinorganic	ADJ
admet-2013	386	2	chemistry	chemistry	NOUN
admet-2013	386	3	and	and	CCONJ
admet-2013	386	4	applications	application	NOUN
admet-2013	386	5	(	(	PUNCT
admet-2013	386	6	2022	2022	NUM
admet-2013	386	7	)	)	PUNCT
admet-2013	386	8	9602725	9602725	NUM
admet-2013	386	9	.	.	PUNCT
admet-2013	387	1	https://doi.org/10.1155/2022/9602725	https://doi.org/10.1155/2022/9602725	PROPN
admet-2013	387	2	.	.	PUNCT
admet-2013	388	1	[	[	X
admet-2013	388	2	46	46	NUM
admet-2013	388	3	]	]	X
admet-2013	388	4	s.k.r	s.k.r	NOUN
admet-2013	388	5	.	.	PUNCT
admet-2013	388	6	adena	adena	PROPN
admet-2013	388	7	,	,	PUNCT
admet-2013	388	8	m.	m.	NOUN
admet-2013	388	9	upadhyay	upadhyay	PROPN
admet-2013	388	10	,	,	PUNCT
admet-2013	388	11	h.	h.	PROPN
admet-2013	388	12	vardhan	vardhan	PROPN
admet-2013	388	13	,	,	PUNCT
admet-2013	388	14	b.	b.	PROPN
admet-2013	388	15	mishra	mishra	PROPN
admet-2013	388	16	.	.	PROPN
admet-2013	388	17	gold	gold	ADJ
admet-2013	388	18	nanoparticles	nanoparticle	NOUN
admet-2013	388	19	for	for	ADP
admet-2013	388	20	sustained	sustained	ADJ
admet-2013	388	21	antileukemia	antileukemia	NOUN
admet-2013	388	22	drug	drug	NOUN
admet-2013	388	23	release	release	NOUN
admet-2013	388	24	:	:	PUNCT
admet-2013	388	25	development	development	NOUN
admet-2013	388	26	,	,	PUNCT
admet-2013	388	27	optimization	optimization	NOUN
admet-2013	388	28	and	and	CCONJ
admet-2013	388	29	evaluation	evaluation	NOUN
admet-2013	388	30	by	by	ADP
admet-2013	388	31	quality	quality	NOUN
admet-2013	388	32	-	-	PUNCT
admet-2013	388	33	by	by	ADP
admet-2013	388	34	-	-	PUNCT
admet-2013	388	35	design	design	NOUN
admet-2013	388	36	approach	approach	NOUN
admet-2013	388	37	.	.	PUNCT
admet-2013	389	1	nanomedicine	nanomedicine	NOUN
admet-2013	389	2	14	14	NUM
admet-2013	389	3	(	(	PUNCT
admet-2013	389	4	2019	2019	NUM
admet-2013	389	5	)	)	PUNCT
admet-2013	389	6	851	851	NUM
admet-2013	389	7	.	.	PUNCT
admet-2013	389	8	https://doi.org/10.2217/nnm-2018-0306	https://doi.org/10.2217/nnm-2018-0306	PROPN
admet-2013	389	9	.	.	PUNCT
admet-2013	390	1	[	[	X
admet-2013	390	2	47	47	NUM
admet-2013	390	3	]	]	X
admet-2013	390	4	s.a	s.a	PROPN
admet-2013	390	5	.	.	PROPN
admet-2013	390	6	alsagaby	alsagaby	PROPN
admet-2013	390	7	,	,	PUNCT
admet-2013	390	8	r.	r.	PROPN
admet-2013	390	9	vijayakumar	vijayakumar	PROPN
admet-2013	390	10	,	,	PUNCT
admet-2013	390	11	m.	m.	NOUN
admet-2013	390	12	premanathan	premanathan	PROPN
admet-2013	390	13	,	,	PUNCT
admet-2013	390	14	s.	s.	PROPN
admet-2013	390	15	mickymaray	mickymaray	PROPN
admet-2013	390	16	,	,	PUNCT
admet-2013	390	17	w.	w.	PROPN
admet-2013	390	18	alturaiki	alturaiki	PROPN
admet-2013	390	19	,	,	PUNCT
admet-2013	390	20	r.s	r.s	PROPN
admet-2013	390	21	.	.	PROPN
admet-2013	391	1	al	al	PROPN
admet-2013	391	2	-	-	PUNCT
admet-2013	391	3	baradie	baradie	NOUN
admet-2013	391	4	,	,	PUNCT
admet-2013	391	5	s.	s.	PROPN
admet-2013	391	6	alghamdi	alghamdi	PROPN
admet-2013	391	7	,	,	PUNCT
admet-2013	391	8	m.a	m.a	PROPN
admet-2013	391	9	.	.	PROPN
admet-2013	391	10	aziz	aziz	PROPN
admet-2013	391	11	,	,	PUNCT
admet-2013	391	12	f.a	f.a	PROPN
admet-2013	391	13	.	.	PROPN
admet-2013	391	14	alhumaydhi	alhumaydhi	PROPN
admet-2013	391	15	,	,	PUNCT
admet-2013	391	16	f.a	f.a	PROPN
admet-2013	391	17	.	.	PROPN
admet-2013	391	18	alzahrani	alzahrani	PROPN
admet-2013	391	19	.	.	PUNCT
admet-2013	392	1	transcriptomics	transcriptomic	NOUN
admet-2013	392	2	-	-	PUNCT
admet-2013	392	3	based	base	VERB
admet-2013	392	4	characterization	characterization	NOUN
admet-2013	392	5	of	of	ADP
admet-2013	392	6	the	the	DET
admet-2013	392	7	toxicity	toxicity	NOUN
admet-2013	392	8	of	of	ADP
admet-2013	392	9	zno	zno	NOUN
admet-2013	392	10	nanoparticles	nanoparticle	NOUN
admet-2013	392	11	against	against	ADP
admet-2013	392	12	chronic	chronic	ADJ
admet-2013	392	13	myeloid	myeloid	NOUN
admet-2013	392	14	leukemia	leukemia	NOUN
admet-2013	392	15	cells	cell	NOUN
admet-2013	392	16	.	.	PUNCT
admet-2013	393	1	international	international	ADJ
admet-2013	393	2	journal	journal	NOUN
admet-2013	393	3	of	of	ADP
admet-2013	393	4	nanomedicine	nanomedicine	ADJ
admet-2013	393	5	2020:15	2020:15	NUM
admet-2013	393	6	(	(	PUNCT
admet-2013	393	7	2020	2020	NUM
admet-2013	393	8	)	)	PUNCT
admet-2013	393	9	7901	7901	NUM
admet-2013	393	10	-	-	SYM
admet-2013	393	11	7921	7921	NUM
admet-2013	393	12	.	.	PUNCT
admet-2013	394	1	https://doi.org/10.2147/ijn.s261636	https://doi.org/10.2147/ijn.s261636	NOUN
admet-2013	394	2	.	.	PUNCT
admet-2013	395	1	[	[	X
admet-2013	395	2	48	48	NUM
admet-2013	395	3	]	]	PUNCT
admet-2013	395	4	c.	c.	PROPN
admet-2013	395	5	amgoth	amgoth	PROPN
admet-2013	395	6	,	,	PUNCT
admet-2013	395	7	r.	r.	PROPN
admet-2013	395	8	santhosh	santhosh	PROPN
admet-2013	395	9	,	,	PUNCT
admet-2013	395	10	t.	t.	NOUN
admet-2013	395	11	malavath	malavath	NOUN
admet-2013	395	12	,	,	PUNCT
admet-2013	395	13	a.	a.	NOUN
admet-2013	395	14	singh	singh	PROPN
admet-2013	395	15	,	,	PUNCT
admet-2013	395	16	b.	b.	PROPN
admet-2013	395	17	murali	murali	PROPN
admet-2013	395	18	,	,	PUNCT
admet-2013	395	19	g	g	PROPN
admet-2013	395	20	.	.	PUNCT
admet-2013	395	21	tang	tang	PROPN
admet-2013	395	22	.	.	PUNCT
admet-2013	395	23	solvent‐assisted	solvent‐assiste	VERB
admet-2013	395	24	[	[	PUNCT
admet-2013	395	25	(	(	PUNCT
admet-2013	395	26	glycine)‐(mp‐	glycine)‐(mp‐	PUNCT
admet-2013	395	27	sio2nps	sio2nps	PROPN
admet-2013	395	28	)	)	PUNCT
admet-2013	395	29	]	]	PUNCT
admet-2013	395	30	aggregate	aggregate	NOUN
admet-2013	395	31	for	for	ADP
admet-2013	395	32	drug	drug	NOUN
admet-2013	395	33	loading	loading	NOUN
admet-2013	395	34	and	and	CCONJ
admet-2013	395	35	cancer	cancer	NOUN
admet-2013	395	36	therapy	therapy	NOUN
admet-2013	395	37	.	.	PUNCT
admet-2013	396	1	chemistry	chemistry	NOUN
admet-2013	396	2	select	select	VERB
admet-2013	396	3	5	5	NUM
admet-2013	396	4	(	(	PUNCT
admet-2013	396	5	2020	2020	NUM
admet-2013	396	6	)	)	PUNCT
admet-2013	396	7	8221	8221	NUM
admet-2013	396	8	-	-	SYM
admet-2013	396	9	8232	8232	NUM
admet-2013	396	10	.	.	PUNCT
admet-2013	397	1	https://doi.org/10.1002/slct.202001905	https://doi.org/10.1002/slct.202001905	PROPN
admet-2013	397	2	.	.	PUNCT
admet-2013	398	1	[	[	X
admet-2013	398	2	49	49	NUM
admet-2013	398	3	]	]	X
admet-2013	398	4	h.m	h.m	PROPN
admet-2013	398	5	.	.	PROPN
admet-2013	398	6	dizman	dizman	PROPN
admet-2013	398	7	,	,	PUNCT
admet-2013	398	8	g.o	g.o	PROPN
admet-2013	398	9	.	.	PROPN
admet-2013	398	10	eroglu	eroglu	PROPN
admet-2013	398	11	,	,	PUNCT
admet-2013	398	12	s.e	s.e	PROPN
admet-2013	398	13	.	.	PROPN
admet-2013	398	14	kuruca	kuruca	PROPN
admet-2013	398	15	,	,	PUNCT
admet-2013	398	16	n.	n.	PROPN
admet-2013	398	17	arsu	arsu	PROPN
admet-2013	398	18	.	.	PUNCT
admet-2013	399	1	photochemically	photochemically	ADV
admet-2013	399	2	prepared	prepare	VERB
admet-2013	399	3	monodisperse	monodisperse	NOUN
admet-2013	399	4	gold	gold	NOUN
admet-2013	399	5	nanoparticles	nanoparticle	NOUN
admet-2013	399	6	as	as	ADP
admet-2013	399	7	doxorubicin	doxorubicin	PROPN
admet-2013	399	8	carrier	carrier	NOUN
admet-2013	399	9	and	and	CCONJ
admet-2013	399	10	its	its	PRON
admet-2013	399	11	cytotoxicity	cytotoxicity	NOUN
admet-2013	399	12	on	on	ADP
admet-2013	399	13	leukemia	leukemia	NOUN
admet-2013	399	14	cancer	cancer	NOUN
admet-2013	399	15	cells	cell	NOUN
admet-2013	399	16	.	.	PUNCT
admet-2013	400	1	applied	apply	VERB
admet-2013	400	2	nanoscience	nanoscience	NOUN
admet-2013	400	3	11	11	NUM
admet-2013	400	4	(	(	PUNCT
admet-2013	400	5	2021	2021	NUM
admet-2013	400	6	)	)	PUNCT
admet-2013	400	7	309	309	NUM
admet-2013	400	8	-	-	SYM
admet-2013	400	9	320	320	NUM
admet-2013	400	10	.	.	PUNCT
admet-2013	400	11	https://doi.org/10.1007/s13204-020-01589-3	https://doi.org/10.1007/s13204-020-01589-3	NOUN
admet-2013	400	12	.	.	PUNCT
admet-2013	401	1	[	[	X
admet-2013	401	2	50	50	NUM
admet-2013	401	3	]	]	PUNCT
admet-2013	401	4	r.	r.	PROPN
admet-2013	401	5	deng	deng	PROPN
admet-2013	401	6	,	,	PUNCT
admet-2013	401	7	b.	b.	PROPN
admet-2013	402	1	ji	ji	PROPN
admet-2013	402	2	,	,	PUNCT
admet-2013	402	3	h.	h.	PROPN
admet-2013	402	4	yu	yu	PROPN
admet-2013	402	5	,	,	PUNCT
admet-2013	402	6	w.	w.	PROPN
admet-2013	402	7	bao	bao	PROPN
admet-2013	402	8	,	,	PUNCT
admet-2013	402	9	z.	z.	PROPN
admet-2013	402	10	yang	yang	PROPN
admet-2013	402	11	,	,	PUNCT
admet-2013	402	12	y.	y.	PROPN
admet-2013	402	13	yu	yu	PROPN
admet-2013	402	14	,	,	PUNCT
admet-2013	402	15	y.	y.	PROPN
admet-2013	402	16	cui	cui	PROPN
admet-2013	402	17	,	,	PUNCT
admet-2013	402	18	y.	y.	PROPN
admet-2013	402	19	du	du	PROPN
admet-2013	402	20	,	,	PUNCT
admet-2013	402	21	m.	m.	NOUN
admet-2013	402	22	song	song	NOUN
admet-2013	402	23	,	,	PUNCT
admet-2013	402	24	s.	s.	PROPN
admet-2013	402	25	liu	liu	PROPN
admet-2013	402	26	.	.	PUNCT
admet-2013	403	1	multifunctional	multifunctional	ADJ
admet-2013	403	2	gold	gold	ADJ
admet-2013	403	3	nanoparticles	nanoparticle	NOUN
admet-2013	403	4	overcome	overcome	VERB
admet-2013	403	5	microrna	microrna	PROPN
admet-2013	403	6	regulatory	regulatory	ADJ
admet-2013	403	7	network	network	NOUN
admet-2013	403	8	mediated	mediate	VERB
admet-2013	403	9	-	-	PUNCT
admet-2013	403	10	multidrug	multidrug	NOUN
admet-2013	403	11	resistant	resistant	ADJ
admet-2013	403	12	leukemia	leukemia	NOUN
admet-2013	403	13	.	.	PUNCT
admet-2013	404	1	scientific	scientific	ADJ
admet-2013	404	2	reports	report	NOUN
admet-2013	404	3	9	9	NUM
admet-2013	404	4	(	(	PUNCT
admet-2013	404	5	2019	2019	NUM
admet-2013	404	6	)	)	PUNCT
admet-2013	404	7	5348	5348	NUM
admet-2013	404	8	.	.	PUNCT
admet-2013	405	1	https://doi.org/10.1038/s41598-019-41866-y	https://doi.org/10.1038/s41598-019-41866-y	NOUN
admet-2013	405	2	.	.	PUNCT
admet-2013	406	1	[	[	X
admet-2013	406	2	51	51	NUM
admet-2013	406	3	]	]	PUNCT
admet-2013	406	4	l.	l.	PROPN
admet-2013	406	5	kafi	kafi	PROPN
admet-2013	406	6	-	-	PUNCT
admet-2013	406	7	ahmadi	ahmadi	PROPN
admet-2013	406	8	,	,	PUNCT
admet-2013	406	9	s.	s.	PROPN
admet-2013	406	10	khademinia	khademinia	PROPN
admet-2013	406	11	,	,	PUNCT
admet-2013	406	12	m.	m.	PROPN
admet-2013	406	13	najafzadeh	najafzadeh	PROPN
admet-2013	406	14	nansa	nansa	PROPN
admet-2013	406	15	,	,	PUNCT
admet-2013	406	16	a.a	a.a	PROPN
admet-2013	406	17	.	.	PROPN
admet-2013	406	18	alemi	alemi	PROPN
admet-2013	406	19	,	,	PUNCT
admet-2013	406	20	m.	m.	NOUN
admet-2013	406	21	mahdavi	mahdavi	PROPN
admet-2013	406	22	,	,	PUNCT
admet-2013	406	23	a.	a.	NOUN
admet-2013	406	24	poursattar	poursattar	NOUN
admet-2013	406	25	marjani	marjani	NOUN
admet-2013	406	26	.	.	PUNCT
admet-2013	407	1	co	co	VERB
admet-2013	407	2	-	-	NOUN
admet-2013	407	3	precipitation	precipitation	ADJ
admet-2013	407	4	synthesis	synthesis	NOUN
admet-2013	407	5	,	,	PUNCT
admet-2013	407	6	characterization	characterization	NOUN
admet-2013	407	7	of	of	ADP
admet-2013	407	8	cofe2o4	cofe2o4	NOUN
admet-2013	407	9	nanomaterial	nanomaterial	NOUN
admet-2013	407	10	and	and	CCONJ
admet-2013	407	11	evaluation	evaluation	NOUN
admet-2013	407	12	of	of	ADP
admet-2013	407	13	its	its	PRON
admet-2013	407	14	toxicity	toxicity	NOUN
admet-2013	407	15	behavior	behavior	NOUN
admet-2013	407	16	on	on	ADP
admet-2013	407	17	human	human	ADJ
admet-2013	407	18	leukemia	leukemia	NOUN
admet-2013	407	19	cancer	cancer	NOUN
admet-2013	407	20	k562	k562	PROPN
admet-2013	407	21	cell	cell	NOUN
admet-2013	407	22	line	line	NOUN
admet-2013	407	23	.	.	PUNCT
admet-2013	408	1	journal	journal	NOUN
admet-2013	408	2	of	of	ADP
admet-2013	408	3	the	the	DET
admet-2013	408	4	chilean	chilean	PROPN
admet-2013	408	5	chemical	chemical	PROPN
admet-2013	408	6	society	society	PROPN
admet-2013	408	7	65	65	NUM
admet-2013	408	8	(	(	PUNCT
admet-2013	408	9	2020	2020	NUM
admet-2013	408	10	)	)	PUNCT
admet-2013	408	11	4845	4845	NUM
admet-2013	408	12	-	-	SYM
admet-2013	408	13	4848	4848	NUM
admet-2013	408	14	.	.	PUNCT
admet-2013	409	1	http://dx.doi.org/10.4067/s0717-97072020000204845	http://dx.doi.org/10.4067/s0717-97072020000204845	PROPN
admet-2013	410	1	[	[	X
admet-2013	410	2	52	52	NUM
admet-2013	410	3	]	]	PUNCT
admet-2013	410	4	l.	l.	PROPN
admet-2013	410	5	fan	fan	PROPN
admet-2013	410	6	,	,	PUNCT
admet-2013	410	7	c.	c.	PROPN
admet-2013	410	8	liu	liu	PROPN
admet-2013	410	9	,	,	PUNCT
admet-2013	410	10	a.	a.	PROPN
admet-2013	410	11	hu	hu	PROPN
admet-2013	410	12	,	,	PUNCT
admet-2013	410	13	j.	j.	PROPN
admet-2013	410	14	liang	liang	PROPN
admet-2013	410	15	,	,	PUNCT
admet-2013	410	16	f.	f.	PROPN
admet-2013	410	17	li	li	PROPN
admet-2013	410	18	,	,	PUNCT
admet-2013	410	19	y.	y.	PROPN
admet-2013	410	20	xiong	xiong	PROPN
admet-2013	410	21	,	,	PUNCT
admet-2013	410	22	c.-f	c.-f	NOUN
admet-2013	410	23	.	.	PUNCT
admet-2013	411	1	mu	mu	NOUN
admet-2013	411	2	.	.	PUNCT
admet-2013	412	1	dual	dual	ADJ
admet-2013	412	2	oligopeptides	oligopeptide	NOUN
admet-2013	412	3	modification	modification	NOUN
admet-2013	412	4	mediates	mediate	NOUN
admet-2013	412	5	arsenic	arsenic	ADJ
admet-2013	412	6	trioxide	trioxide	NOUN
admet-2013	412	7	containing	contain	VERB
admet-2013	412	8	nanoparticles	nanoparticle	NOUN
admet-2013	412	9	to	to	PART
admet-2013	412	10	eliminate	eliminate	VERB
admet-2013	412	11	primitive	primitive	ADJ
admet-2013	412	12	chronic	chronic	ADJ
admet-2013	412	13	myeloid	myeloid	NOUN
admet-2013	412	14	leukemia	leukemia	NOUN
admet-2013	412	15	cells	cell	NOUN
admet-2013	412	16	inside	inside	ADP
admet-2013	412	17	bone	bone	NOUN
admet-2013	412	18	marrow	marrow	NOUN
admet-2013	412	19	niches	niche	NOUN
admet-2013	412	20	.	.	PUNCT
admet-2013	413	1	international	international	ADJ
admet-2013	413	2	journal	journal	PROPN
admet-2013	413	3	of	of	ADP
admet-2013	413	4	pharmaceutics	pharmaceutic	NOUN
admet-2013	413	5	579	579	NUM
admet-2013	413	6	(	(	PUNCT
admet-2013	413	7	2020	2020	NUM
admet-2013	413	8	)	)	PUNCT
admet-2013	413	9	119179	119179	NUM
admet-2013	413	10	.	.	PUNCT
admet-2013	414	1	https://doi.org/10.1016/j.ijpharm.2020.119179	https://doi.org/10.1016/j.ijpharm.2020.119179	NOUN
admet-2013	414	2	.	.	PUNCT
admet-2013	415	1	[	[	X
admet-2013	415	2	53	53	NUM
admet-2013	415	3	]	]	PUNCT
admet-2013	415	4	s.	s.	PROPN
admet-2013	415	5	wang	wang	PROPN
admet-2013	415	6	,	,	PUNCT
admet-2013	415	7	x.	x.	PROPN
admet-2013	415	8	liu	liu	PROPN
admet-2013	415	9	,	,	PUNCT
admet-2013	415	10	s.	s.	PROPN
admet-2013	415	11	wang	wang	PROPN
admet-2013	415	12	,	,	PUNCT
admet-2013	415	13	l.	l.	PROPN
admet-2013	415	14	ouyang	ouyang	PROPN
admet-2013	415	15	,	,	PUNCT
admet-2013	415	16	h.	h.	PROPN
admet-2013	415	17	li	li	PROPN
admet-2013	415	18	,	,	PUNCT
admet-2013	415	19	j.	j.	PROPN
admet-2013	415	20	ding	ding	PROPN
admet-2013	415	21	,	,	PUNCT
admet-2013	415	22	g.	g.	PROPN
admet-2013	415	23	deng	deng	PROPN
admet-2013	415	24	,	,	PUNCT
admet-2013	415	25	w.	w.	PROPN
admet-2013	415	26	zhou	zhou	PROPN
admet-2013	415	27	.	.	PUNCT
admet-2013	416	1	imatinib	imatinib	NOUN
admet-2013	416	2	co	co	VERB
admet-2013	416	3	-	-	VERB
admet-2013	416	4	loaded	load	VERB
admet-2013	416	5	targeted	target	VERB
admet-2013	416	6	realgar	realgar	NOUN
admet-2013	416	7	nanocrystal	nanocrystal	NOUN
admet-2013	416	8	for	for	ADP
admet-2013	416	9	synergistic	synergistic	ADJ
admet-2013	416	10	therapy	therapy	NOUN
admet-2013	416	11	of	of	ADP
admet-2013	416	12	chronic	chronic	ADJ
admet-2013	416	13	myeloid	myeloid	NOUN
admet-2013	416	14	leukemia	leukemia	NOUN
admet-2013	416	15	.	.	PUNCT
admet-2013	417	1	journal	journal	PROPN
admet-2013	417	2	of	of	ADP
admet-2013	417	3	controlled	control	VERB
admet-2013	417	4	release	release	NOUN
admet-2013	417	5	338	338	NUM
admet-2013	417	6	(	(	PUNCT
admet-2013	417	7	2021	2021	NUM
admet-2013	417	8	)	)	PUNCT
admet-2013	417	9	190	190	NUM
admet-2013	417	10	-	-	SYM
admet-2013	417	11	200	200	NUM
admet-2013	417	12	.	.	PUNCT
admet-2013	418	1	https://doi.org/10.1016/j.jconrel.2021.08.035	https://doi.org/10.1016/j.jconrel.2021.08.035	NOUN
admet-2013	418	2	.	.	PUNCT
admet-2013	419	1	[	[	X
admet-2013	419	2	54	54	NUM
admet-2013	419	3	]	]	PUNCT
admet-2013	419	4	t.	t.	PROPN
admet-2013	419	5	wang	wang	PROPN
admet-2013	419	6	,	,	PUNCT
admet-2013	419	7	t.	t.	PROPN
admet-2013	419	8	wen	wen	PROPN
admet-2013	419	9	,	,	PUNCT
admet-2013	419	10	h.	h.	PROPN
admet-2013	419	11	li	li	PROPN
admet-2013	419	12	,	,	PUNCT
admet-2013	419	13	b.	b.	PROPN
admet-2013	419	14	han	han	PROPN
admet-2013	419	15	,	,	PUNCT
admet-2013	419	16	s.	s.	PROPN
admet-2013	419	17	hao	hao	PROPN
admet-2013	419	18	,	,	PUNCT
admet-2013	419	19	c.	c.	PROPN
admet-2013	419	20	wang	wang	PROPN
admet-2013	419	21	,	,	PUNCT
admet-2013	419	22	q.	q.	PROPN
admet-2013	419	23	ma	ma	PROPN
admet-2013	419	24	,	,	PUNCT
admet-2013	419	25	j.	j.	PROPN
admet-2013	419	26	meng	meng	PROPN
admet-2013	419	27	,	,	PUNCT
admet-2013	419	28	j.	j.	PROPN
admet-2013	419	29	liu	liu	PROPN
admet-2013	419	30	,	,	PUNCT
admet-2013	419	31	h.	h.	PROPN
admet-2013	419	32	xu	xu	PROPN
admet-2013	419	33	.	.	PUNCT
admet-2013	420	1	arsenic	arsenic	ADJ
admet-2013	420	2	sulfide	sulfide	NOUN
admet-2013	420	3	nanoformulation	nanoformulation	NOUN
admet-2013	420	4	induces	induce	VERB
admet-2013	420	5	erythroid	erythroid	ADJ
admet-2013	420	6	differentiation	differentiation	NOUN
admet-2013	420	7	in	in	ADP
admet-2013	420	8	chronic	chronic	ADJ
admet-2013	420	9	myeloid	myeloid	NOUN
admet-2013	420	10	leukemia	leukemia	NOUN
admet-2013	420	11	cells	cell	NOUN
admet-2013	420	12	through	through	ADP
admet-2013	420	13	degradation	degradation	NOUN
admet-2013	420	14	of	of	ADP
admet-2013	420	15	bcr	bcr	PROPN
admet-2013	420	16	-	-	PUNCT
admet-2013	420	17	abl	abl	PROPN
admet-2013	420	18	.	.	PROPN
admet-2013	420	19	international	international	PROPN
admet-2013	420	20	journal	journal	PROPN
admet-2013	420	21	of	of	ADP
admet-2013	420	22	nanomedicine	nanomedicine	NOUN
admet-2013	420	23	(	(	PUNCT
admet-2013	420	24	2019	2019	NUM
admet-2013	420	25	)	)	PUNCT
admet-2013	420	26	5581	5581	NUM
admet-2013	420	27	-	-	SYM
admet-2013	420	28	5594	5594	NUM
admet-2013	420	29	.	.	PUNCT
admet-2013	421	1	https://doi.org/10.2147/ijn.s207298	https://doi.org/10.2147/ijn.s207298	X
admet-2013	421	2	.	.	PUNCT
admet-2013	422	1	[	[	X
admet-2013	422	2	55	55	NUM
admet-2013	422	3	]	]	X
admet-2013	422	4	a.-m	a.-m	NOUN
admet-2013	422	5	.	.	PUNCT
admet-2013	423	1	yousefi	yousefi	PROPN
admet-2013	423	2	,	,	PUNCT
admet-2013	423	3	a.	a.	PROPN
admet-2013	423	4	safaroghli	safaroghli	PROPN
admet-2013	423	5	-	-	PUNCT
admet-2013	423	6	azar	azar	PROPN
admet-2013	423	7	,	,	PUNCT
admet-2013	423	8	z.	z.	PROPN
admet-2013	423	9	fakhroueian	fakhroueian	PROPN
admet-2013	423	10	,	,	PUNCT
admet-2013	423	11	d.	d.	PROPN
admet-2013	423	12	bashash	bashash	PROPN
admet-2013	423	13	.	.	PUNCT
admet-2013	424	1	zno	zno	PROPN
admet-2013	424	2	/	/	SYM
admet-2013	424	3	cnt@	cnt@	PROPN
admet-2013	424	4	fe3o4	fe3o4	PROPN
admet-2013	424	5	induces	induce	NOUN
admet-2013	424	6	rosmediated	rosmediate	VERB
admet-2013	424	7	apoptosis	apoptosis	NOUN
admet-2013	424	8	in	in	ADP
admet-2013	424	9	chronic	chronic	ADJ
admet-2013	424	10	myeloid	myeloid	NOUN
admet-2013	424	11	leukemia	leukemia	NOUN
admet-2013	424	12	(	(	PUNCT
admet-2013	424	13	cml	cml	PROPN
admet-2013	424	14	)	)	PUNCT
admet-2013	424	15	cells	cell	NOUN
admet-2013	424	16	:	:	PUNCT
admet-2013	424	17	an	an	DET
admet-2013	424	18	emerging	emerge	VERB
admet-2013	424	19	prospective	prospective	ADJ
admet-2013	424	20	for	for	ADP
admet-2013	424	21	nanoparticles	nanoparticle	NOUN
admet-2013	424	22	in	in	ADP
admet-2013	424	23	leukemia	leukemia	NOUN
admet-2013	424	24	treatment	treatment	NOUN
admet-2013	424	25	.	.	PUNCT
admet-2013	425	1	artificial	artificial	ADJ
admet-2013	425	2	cells	cell	NOUN
admet-2013	425	3	,	,	PUNCT
admet-2013	425	4	nanomedicine	nanomedicine	NOUN
admet-2013	425	5	and	and	CCONJ
admet-2013	425	6	biotechnology	biotechnology	NOUN
admet-2013	425	7	48	48	NUM
admet-2013	425	8	(	(	PUNCT
admet-2013	425	9	2020	2020	NUM
admet-2013	425	10	)	)	PUNCT
admet-2013	425	11	735745	735745	NUM
admet-2013	425	12	.	.	PUNCT
admet-2013	426	1	https://doi.org/10.1080/21691401.2020.1748885	https://doi.org/10.1080/21691401.2020.1748885	PROPN
admet-2013	426	2	.	.	PUNCT
admet-2013	427	1	[	[	X
admet-2013	427	2	56	56	NUM
admet-2013	427	3	]	]	PUNCT
admet-2013	427	4	z.	z.	PROPN
admet-2013	427	5	kiani	kiani	PROPN
admet-2013	427	6	,	,	PUNCT
admet-2013	427	7	h.	h.	PROPN
admet-2013	427	8	aramjoo	aramjoo	PROPN
admet-2013	427	9	,	,	PUNCT
admet-2013	427	10	e.	e.	PROPN
admet-2013	427	11	chamani	chamani	PROPN
admet-2013	427	12	,	,	PUNCT
admet-2013	427	13	m.	m.	NOUN
admet-2013	427	14	siami	siami	NOUN
admet-2013	427	15	-	-	PUNCT
admet-2013	427	16	aliabad	aliabad	PROPN
admet-2013	427	17	,	,	PUNCT
admet-2013	427	18	s.	s.	PROPN
admet-2013	427	19	mortazavi	mortazavi	PROPN
admet-2013	427	20	-	-	PUNCT
admet-2013	427	21	derazkola	derazkola	NOUN
admet-2013	427	22	.	.	PUNCT
admet-2013	428	1	in	in	ADP
admet-2013	428	2	vitro	vitro	X
admet-2013	428	3	cytotoxicity	cytotoxicity	NOUN
admet-2013	428	4	against	against	ADP
admet-2013	428	5	k562	k562	PROPN
admet-2013	428	6	tumor	tumor	NOUN
admet-2013	428	7	cell	cell	NOUN
admet-2013	428	8	line	line	NOUN
admet-2013	428	9	,	,	PUNCT
admet-2013	428	10	antibacterial	antibacterial	ADJ
admet-2013	428	11	,	,	PUNCT
admet-2013	428	12	antioxidant	antioxidant	ADJ
admet-2013	428	13	,	,	PUNCT
admet-2013	428	14	antifungal	antifungal	ADJ
admet-2013	428	15	and	and	CCONJ
admet-2013	428	16	catalytic	catalytic	ADJ
admet-2013	428	17	activities	activity	NOUN
admet-2013	428	18	of	of	ADP
admet-2013	428	19	biosynthesized	biosynthesize	VERB
admet-2013	428	20	silver	silver	ADJ
admet-2013	428	21	nanoparticles	nanoparticle	NOUN
admet-2013	428	22	using	use	VERB
admet-2013	428	23	sophora	sophora	NOUN
admet-2013	428	24	pachycarpa	pachycarpa	NOUN
admet-2013	428	25	extract	extract	NOUN
admet-2013	428	26	.	.	PUNCT
admet-2013	429	1	arabian	arabian	ADJ
admet-2013	429	2	journal	journal	PROPN
admet-2013	429	3	of	of	ADP
admet-2013	429	4	chemistry	chemistry	NOUN
admet-2013	429	5	15	15	NUM
admet-2013	429	6	(	(	PUNCT
admet-2013	429	7	2022	2022	NUM
admet-2013	429	8	)	)	PUNCT
admet-2013	429	9	103677	103677	NUM
admet-2013	429	10	.	.	PUNCT
admet-2013	430	1	https://doi.org/10.1016/j.arabjc.2021.103677	https://doi.org/10.1016/j.arabjc.2021.103677	PROPN
admet-2013	430	2	.	.	PUNCT
admet-2013	431	1	[	[	X
admet-2013	431	2	57	57	NUM
admet-2013	431	3	]	]	PUNCT
admet-2013	431	4	t.	t.	PROPN
admet-2013	431	5	wen	wen	PROPN
admet-2013	431	6	,	,	PUNCT
admet-2013	431	7	a.	a.	PROPN
admet-2013	431	8	yang	yang	PROPN
admet-2013	431	9	,	,	PUNCT
admet-2013	431	10	t.	t.	PROPN
admet-2013	431	11	wang	wang	PROPN
admet-2013	431	12	,	,	PUNCT
admet-2013	431	13	m.	m.	PROPN
admet-2013	431	14	jia	jia	PROPN
admet-2013	431	15	,	,	PUNCT
admet-2013	431	16	x.	x.	PROPN
admet-2013	431	17	lai	lai	PROPN
admet-2013	431	18	,	,	PUNCT
admet-2013	431	19	j.	j.	PROPN
admet-2013	431	20	meng	meng	PROPN
admet-2013	431	21	,	,	PUNCT
admet-2013	431	22	j.	j.	PROPN
admet-2013	431	23	liu	liu	PROPN
admet-2013	431	24	,	,	PUNCT
admet-2013	431	25	b.	b.	PROPN
admet-2013	431	26	han	han	PROPN
admet-2013	431	27	,	,	PUNCT
admet-2013	431	28	h.	h.	PROPN
admet-2013	431	29	xu	xu	PROPN
admet-2013	431	30	.	.	PUNCT
admet-2013	432	1	ultra	ultra	ADJ
admet-2013	432	2	-	-	ADJ
admet-2013	432	3	small	small	ADJ
admet-2013	432	4	platinum	platinum	NOUN
admet-2013	432	5	nanoparticles	nanoparticle	NOUN
admet-2013	432	6	on	on	ADP
admet-2013	432	7	gold	gold	NOUN
admet-2013	432	8	nanorods	nanorod	NOUN
admet-2013	432	9	induced	induce	VERB
admet-2013	432	10	intracellular	intracellular	ADJ
admet-2013	432	11	ros	ros	PROPN
admet-2013	432	12	fluctuation	fluctuation	NOUN
admet-2013	432	13	to	to	PART
admet-2013	432	14	drive	drive	VERB
admet-2013	432	15	megakaryocytic	megakaryocytic	ADJ
admet-2013	432	16	differentiation	differentiation	NOUN
admet-2013	432	17	of	of	ADP
admet-2013	432	18	leukemia	leukemia	NOUN
admet-2013	432	19	cells	cell	NOUN
admet-2013	432	20	.	.	PUNCT
admet-2013	433	1	biomaterials	biomaterial	NOUN
admet-2013	433	2	science	science	NOUN
admet-2013	433	3	8	8	NUM
admet-2013	433	4	(	(	PUNCT
admet-2013	433	5	2020	2020	NUM
admet-2013	433	6	)	)	PUNCT
admet-2013	433	7	6204	6204	NUM
admet-2013	433	8	-	-	SYM
admet-2013	433	9	6211	6211	NUM
admet-2013	433	10	.	.	PUNCT
admet-2013	434	1	https://doi.org/10.1039/d0bm01547d	https://doi.org/10.1039/d0bm01547d	NOUN
admet-2013	434	2	.	.	PUNCT
admet-2013	435	1	[	[	X
admet-2013	435	2	58	58	NUM
admet-2013	435	3	]	]	PUNCT
admet-2013	435	4	l.	l.	PROPN
admet-2013	435	5	caldemeyer	caldemeyer	PROPN
admet-2013	435	6	,	,	PUNCT
admet-2013	435	7	m.	m.	NOUN
admet-2013	435	8	dugan	dugan	PROPN
admet-2013	435	9	,	,	PUNCT
admet-2013	435	10	j.	j.	PROPN
admet-2013	435	11	edwards	edwards	PROPN
admet-2013	435	12	,	,	PUNCT
admet-2013	435	13	l.	l.	PROPN
admet-2013	435	14	akard	akard	PROPN
admet-2013	435	15	.	.	PUNCT
admet-2013	436	1	long	long	ADJ
admet-2013	436	2	-	-	PUNCT
admet-2013	436	3	term	term	NOUN
admet-2013	436	4	side	side	NOUN
admet-2013	436	5	effects	effect	NOUN
admet-2013	436	6	of	of	ADP
admet-2013	436	7	tyrosine	tyrosine	NOUN
admet-2013	436	8	kinase	kinase	PROPN
admet-2013	436	9	inhibitors	inhibitor	NOUN
admet-2013	436	10	in	in	ADP
admet-2013	436	11	chronic	chronic	ADJ
admet-2013	436	12	myeloid	myeloid	NOUN
admet-2013	436	13	leukemia	leukemia	NOUN
admet-2013	436	14	.	.	PUNCT
admet-2013	437	1	current	current	ADJ
admet-2013	437	2	hematologic	hematologic	NOUN
admet-2013	437	3	malignancy	malignancy	NOUN
admet-2013	437	4	reports	report	VERB
admet-2013	437	5	11	11	NUM
admet-2013	437	6	(	(	PUNCT
admet-2013	437	7	2016	2016	NUM
admet-2013	437	8	)	)	PUNCT
admet-2013	437	9	71	71	NUM
admet-2013	437	10	-	-	SYM
admet-2013	437	11	79	79	NUM
admet-2013	437	12	.	.	PUNCT
admet-2013	438	1	https://doi.org/10.1007/s11899-016-0309-2	https://doi.org/10.1007/s11899-016-0309-2	NOUN
admet-2013	438	2	.	.	PUNCT
admet-2013	439	1	https://doi.org/10.5599/admet.2013	https://doi.org/10.5599/admet.2013	PROPN
admet-2013	439	2	https://doi.org/10.1155/2022/9602725	https://doi.org/10.1155/2022/9602725	PROPN
admet-2013	439	3	https://doi.org/10.2217/nnm-2018-0306	https://doi.org/10.2217/nnm-2018-0306	NOUN
admet-2013	439	4	.	.	PUNCT
admet-2013	440	1	https://doi.org/10.2147/ijn.s261636	https://doi.org/10.2147/ijn.s261636	X
admet-2013	440	2	https://doi.org/10.1002/slct.202001905	https://doi.org/10.1002/slct.202001905	VERB
admet-2013	440	3	https://doi.org/10.1007/s13204-020-01589-3	https://doi.org/10.1007/s13204-020-01589-3	NUM
admet-2013	440	4	https://doi.org/10.1038/s41598-019-41866-y	https://doi.org/10.1038/s41598-019-41866-y	NOUN
admet-2013	440	5	http://dx.doi.org/10.4067/s0717-97072020000204845	http://dx.doi.org/10.4067/s0717-97072020000204845	PROPN
admet-2013	440	6	https://doi.org/10.1016/j.ijpharm.2020.119179	https://doi.org/10.1016/j.ijpharm.2020.119179	PROPN
admet-2013	440	7	https://doi.org/10.1016/j.jconrel.2021.08.035	https://doi.org/10.1016/j.jconrel.2021.08.035	VERB
admet-2013	440	8	https://doi.org/10.2147/ijn.s207298	https://doi.org/10.2147/ijn.s207298	PRON
admet-2013	440	9	https://doi.org/10.1080/21691401.2020.1748885	https://doi.org/10.1080/21691401.2020.1748885	NOUN
admet-2013	441	1	https://doi.org/10.1016/j.arabjc.2021.103677	https://doi.org/10.1016/j.arabjc.2021.103677	PROPN
admet-2013	441	2	https://doi.org/10.1039/d0bm01547d	https://doi.org/10.1039/d0bm01547d	PROPN
admet-2013	441	3	https://doi.org/10.1007/s11899-016-0309-2	https://doi.org/10.1007/s11899-016-0309-2	PROPN
admet-2013	441	4	g.	g.	PROPN
admet-2013	441	5	janani	janani	PROPN
admet-2013	441	6	et	et	PROPN
admet-2013	441	7	al	al	PROPN
admet-2013	441	8	.	.	PROPN
admet-2013	441	9	admet	admet	PROPN
admet-2013	441	10	&	&	CCONJ
admet-2013	441	11	dmpk	dmpk	PROPN
admet-2013	441	12	11(4	11(4	NUM
admet-2013	441	13	)	)	PUNCT
admet-2013	441	14	(	(	PUNCT
admet-2013	441	15	2023	2023	NUM
admet-2013	441	16	)	)	PUNCT
admet-2013	441	17	499	499	NUM
admet-2013	441	18	-	-	SYM
admet-2013	441	19	511	511	NUM
admet-2013	441	20	510	510	NUM
admet-2013	441	21	[	[	X
admet-2013	441	22	59	59	NUM
admet-2013	441	23	]	]	PUNCT
admet-2013	441	24	g.	g.	PROPN
admet-2013	441	25	vlahovic	vlahovic	PROPN
admet-2013	441	26	,	,	PUNCT
admet-2013	441	27	j.	j.	PROPN
admet-2013	441	28	crawford	crawford	PROPN
admet-2013	441	29	.	.	PUNCT
admet-2013	442	1	activation	activation	NOUN
admet-2013	442	2	of	of	ADP
admet-2013	442	3	tyrosine	tyrosine	NOUN
admet-2013	442	4	kinases	kinase	NOUN
admet-2013	442	5	in	in	ADP
admet-2013	442	6	cancer	cancer	NOUN
admet-2013	442	7	.	.	PUNCT
admet-2013	443	1	the	the	DET
admet-2013	443	2	oncologist	oncologist	NOUN
admet-2013	443	3	8	8	NUM
admet-2013	443	4	(	(	PUNCT
admet-2013	443	5	2003	2003	NUM
admet-2013	443	6	)	)	PUNCT
admet-2013	443	7	531	531	NUM
admet-2013	443	8	-	-	SYM
admet-2013	443	9	538	538	NUM
admet-2013	443	10	.	.	PUNCT
admet-2013	444	1	https://doi.org/10.1634/theoncologist.8-6-531	https://doi.org/10.1634/theoncologist.8-6-531	PROPN
admet-2013	444	2	.	.	PUNCT
admet-2013	445	1	[	[	X
admet-2013	445	2	60	60	NUM
admet-2013	445	3	]	]	X
admet-2013	445	4	c.-d	c.-d	PROPN
admet-2013	445	5	.	.	PUNCT
admet-2013	445	6	kang	kang	PROPN
admet-2013	445	7	,	,	PUNCT
admet-2013	445	8	s.-d	s.-d	PROPN
admet-2013	445	9	.	.	PUNCT
admet-2013	446	1	yoo	yoo	PROPN
admet-2013	446	2	,	,	PUNCT
admet-2013	446	3	b.-w	b.-w	PROPN
admet-2013	446	4	.	.	PUNCT
admet-2013	447	1	hwang	hwang	PROPN
admet-2013	447	2	,	,	PUNCT
admet-2013	447	3	k.-w	k.-w	PROPN
admet-2013	447	4	.	.	PUNCT
admet-2013	448	1	kim	kim	PROPN
admet-2013	448	2	,	,	PUNCT
admet-2013	448	3	d.-w	d.-w	PROPN
admet-2013	448	4	.	.	PUNCT
admet-2013	449	1	kim	kim	PROPN
admet-2013	449	2	,	,	PUNCT
admet-2013	449	3	c.-m	c.-m	NOUN
admet-2013	449	4	.	.	PUNCT
admet-2013	450	1	kim	kim	PROPN
admet-2013	450	2	,	,	PUNCT
admet-2013	450	3	s.-h	s.-h	NOUN
admet-2013	450	4	.	.	PUNCT
admet-2013	451	1	kim	kim	PROPN
admet-2013	451	2	,	,	PUNCT
admet-2013	451	3	b.-s	b.-s	PROPN
admet-2013	451	4	.	.	PUNCT
admet-2013	452	1	chung	chung	PROPN
admet-2013	452	2	.	.	PUNCT
admet-2013	453	1	the	the	DET
admet-2013	453	2	inhibition	inhibition	NOUN
admet-2013	453	3	of	of	ADP
admet-2013	453	4	erk	erk	NOUN
admet-2013	453	5	/	/	SYM
admet-2013	453	6	mapk	mapk	NOUN
admet-2013	453	7	not	not	PART
admet-2013	453	8	the	the	DET
admet-2013	453	9	activation	activation	NOUN
admet-2013	453	10	of	of	ADP
admet-2013	453	11	jnk	jnk	PROPN
admet-2013	453	12	/	/	SYM
admet-2013	453	13	sapk	sapk	NOUN
admet-2013	453	14	is	be	AUX
admet-2013	453	15	primarily	primarily	ADV
admet-2013	453	16	required	require	VERB
admet-2013	453	17	to	to	PART
admet-2013	453	18	induce	induce	VERB
admet-2013	453	19	apoptosis	apoptosis	NOUN
admet-2013	453	20	in	in	ADP
admet-2013	453	21	chronic	chronic	ADJ
admet-2013	453	22	myelogenous	myelogenous	ADJ
admet-2013	453	23	leukemic	leukemic	ADJ
admet-2013	453	24	k562	k562	PROPN
admet-2013	453	25	cells	cell	NOUN
admet-2013	453	26	.	.	PUNCT
admet-2013	454	1	leukemia	leukemia	NOUN
admet-2013	454	2	research	research	NOUN
admet-2013	454	3	24	24	NUM
admet-2013	454	4	(	(	PUNCT
admet-2013	454	5	2000	2000	NUM
admet-2013	454	6	)	)	PUNCT
admet-2013	454	7	527	527	NUM
admet-2013	454	8	-	-	SYM
admet-2013	454	9	534	534	NUM
admet-2013	454	10	.	.	PUNCT
admet-2013	455	1	https://doi.org/10.1016/s0145-2126(00)00010-2	https://doi.org/10.1016/s0145-2126(00)00010-2	VERB
admet-2013	455	2	.	.	PUNCT
admet-2013	456	1	[	[	X
admet-2013	456	2	61	61	NUM
admet-2013	456	3	]	]	PUNCT
admet-2013	456	4	a.m.	a.m.	NOUN
admet-2013	456	5	pendergast	pendergast	PROPN
admet-2013	456	6	,	,	PUNCT
admet-2013	456	7	l.a	l.a	PROPN
admet-2013	456	8	.	.	PROPN
admet-2013	456	9	quilliam	quilliam	PROPN
admet-2013	456	10	,	,	PUNCT
admet-2013	456	11	l.d	l.d	PROPN
admet-2013	456	12	.	.	PROPN
admet-2013	456	13	cripe	cripe	PROPN
admet-2013	456	14	,	,	PUNCT
admet-2013	456	15	c.h	c.h	PROPN
admet-2013	456	16	.	.	PROPN
admet-2013	457	1	bassing	bassing	PROPN
admet-2013	457	2	,	,	PUNCT
admet-2013	457	3	z.	z.	PROPN
admet-2013	457	4	dai	dai	PROPN
admet-2013	457	5	,	,	PUNCT
admet-2013	457	6	n.	n.	PROPN
admet-2013	457	7	li	li	PROPN
admet-2013	457	8	,	,	PUNCT
admet-2013	457	9	a.	a.	NOUN
admet-2013	457	10	batzer	batzer	NOUN
admet-2013	457	11	,	,	PUNCT
admet-2013	457	12	k.m	k.m	PROPN
admet-2013	457	13	.	.	PROPN
admet-2013	457	14	rabun	rabun	PROPN
admet-2013	457	15	,	,	PUNCT
admet-2013	457	16	c.j	c.j	PROPN
admet-2013	457	17	.	.	PROPN
admet-2013	457	18	der	der	PROPN
admet-2013	457	19	,	,	PUNCT
admet-2013	457	20	j.	j.	PROPN
admet-2013	457	21	schlessinger	schlessinger	PROPN
admet-2013	457	22	.	.	PUNCT
admet-2013	458	1	bcr	bcr	PROPN
admet-2013	458	2	-	-	PUNCT
admet-2013	458	3	abl	abl	NOUN
admet-2013	458	4	-	-	PUNCT
admet-2013	458	5	induced	induce	VERB
admet-2013	458	6	oncogenesis	oncogenesis	NOUN
admet-2013	458	7	is	be	AUX
admet-2013	458	8	mediated	mediate	VERB
admet-2013	458	9	by	by	ADP
admet-2013	458	10	direct	direct	ADJ
admet-2013	458	11	interaction	interaction	NOUN
admet-2013	458	12	with	with	ADP
admet-2013	458	13	the	the	DET
admet-2013	458	14	sh2	sh2	PROPN
admet-2013	458	15	domain	domain	NOUN
admet-2013	458	16	of	of	ADP
admet-2013	458	17	the	the	DET
admet-2013	458	18	grb-2	grb-2	NOUN
admet-2013	458	19	adaptor	adaptor	NOUN
admet-2013	458	20	protein	protein	NOUN
admet-2013	458	21	.	.	PUNCT
admet-2013	459	1	cell	cell	NOUN
admet-2013	459	2	75	75	NUM
admet-2013	459	3	(	(	PUNCT
admet-2013	459	4	1993	1993	NUM
admet-2013	459	5	)	)	PUNCT
admet-2013	459	6	175	175	NUM
admet-2013	459	7	-	-	SYM
admet-2013	459	8	185	185	NUM
admet-2013	459	9	.	.	PUNCT
admet-2013	460	1	https://doi.org/10.1016/s0092-8674(05)80094-7	https://doi.org/10.1016/s0092-8674(05)80094-7	NOUN
admet-2013	460	2	.	.	PUNCT
admet-2013	461	1	[	[	X
admet-2013	461	2	62	62	NUM
admet-2013	461	3	]	]	PUNCT
admet-2013	461	4	c.	c.	PROPN
admet-2013	461	5	boni	boni	PROPN
admet-2013	461	6	,	,	PUNCT
admet-2013	461	7	c.	c.	PROPN
admet-2013	461	8	sorio	sorio	PROPN
admet-2013	461	9	.	.	PUNCT
admet-2013	462	1	current	current	ADJ
admet-2013	462	2	views	view	NOUN
admet-2013	462	3	on	on	ADP
admet-2013	462	4	the	the	DET
admet-2013	462	5	interplay	interplay	NOUN
admet-2013	462	6	between	between	ADP
admet-2013	462	7	tyrosine	tyrosine	NOUN
admet-2013	462	8	kinases	kinase	NOUN
admet-2013	462	9	and	and	CCONJ
admet-2013	462	10	phosphatases	phosphatase	NOUN
admet-2013	462	11	in	in	ADP
admet-2013	462	12	chronic	chronic	ADJ
admet-2013	462	13	myeloid	myeloid	NOUN
admet-2013	462	14	leukemia	leukemia	NOUN
admet-2013	462	15	.	.	PUNCT
admet-2013	463	1	cancers	cancer	NOUN
admet-2013	463	2	13	13	NUM
admet-2013	463	3	(	(	PUNCT
admet-2013	463	4	2021	2021	NUM
admet-2013	463	5	)	)	PUNCT
admet-2013	463	6	2311	2311	NUM
admet-2013	463	7	.	.	PUNCT
admet-2013	464	1	https://doi.org/10.3390/cancers13102311	https://doi.org/10.3390/cancers13102311	NOUN
admet-2013	464	2	.	.	PUNCT
admet-2013	465	1	[	[	X
admet-2013	465	2	63	63	NUM
admet-2013	465	3	]	]	PUNCT
admet-2013	465	4	t.	t.	NOUN
admet-2013	465	5	skorski	skorski	NOUN
admet-2013	465	6	,	,	PUNCT
admet-2013	465	7	p.	p.	PROPN
admet-2013	465	8	kanakaraj	kanakaraj	PROPN
admet-2013	465	9	,	,	PUNCT
admet-2013	465	10	m.	m.	NOUN
admet-2013	465	11	nieborowska	nieborowska	PROPN
admet-2013	465	12	-	-	PUNCT
admet-2013	465	13	skorska	skorska	PROPN
admet-2013	465	14	,	,	PUNCT
admet-2013	465	15	m.z	m.z	PROPN
admet-2013	465	16	.	.	PROPN
admet-2013	465	17	ratajczak	ratajczak	PROPN
admet-2013	465	18	,	,	PUNCT
admet-2013	465	19	s.-c	s.-c	PROPN
admet-2013	465	20	.	.	PUNCT
admet-2013	466	1	wen	wen	PROPN
admet-2013	466	2	,	,	PUNCT
admet-2013	466	3	g.	g.	PROPN
admet-2013	466	4	zon	zon	PROPN
admet-2013	466	5	,	,	PUNCT
admet-2013	466	6	a.m.	a.m.	PROPN
admet-2013	466	7	gewirtz	gewirtz	PROPN
admet-2013	466	8	,	,	PUNCT
admet-2013	466	9	b.	b.	PROPN
admet-2013	466	10	perussia	perussia	PROPN
admet-2013	466	11	,	,	PUNCT
admet-2013	466	12	b.	b.	PROPN
admet-2013	466	13	calabretta	calabretta	PROPN
admet-2013	466	14	.	.	PUNCT
admet-2013	467	1	phosphatidylinositol-3	phosphatidylinositol-3	NUM
admet-2013	467	2	kinase	kinase	NOUN
admet-2013	467	3	activity	activity	NOUN
admet-2013	467	4	is	be	AUX
admet-2013	467	5	regulated	regulate	VERB
admet-2013	467	6	by	by	ADP
admet-2013	467	7	bcr	bcr	PROPN
admet-2013	467	8	/	/	SYM
admet-2013	467	9	abl	abl	PROPN
admet-2013	467	10	and	and	CCONJ
admet-2013	467	11	is	be	AUX
admet-2013	467	12	required	require	VERB
admet-2013	467	13	for	for	ADP
admet-2013	467	14	the	the	DET
admet-2013	467	15	growth	growth	NOUN
admet-2013	467	16	of	of	ADP
admet-2013	467	17	philadelphia	philadelphia	PROPN
admet-2013	467	18	chromosome	chromosome	NOUN
admet-2013	467	19	-	-	PUNCT
admet-2013	467	20	positive	positive	ADJ
admet-2013	467	21	cells	cell	NOUN
admet-2013	467	22	.	.	PUNCT
admet-2013	468	1	blood	blood	NOUN
admet-2013	468	2	86(2	86(2	PROPN
admet-2013	468	3	)	)	PUNCT
admet-2013	468	4	(	(	PUNCT
admet-2013	468	5	1995	1995	NUM
admet-2013	468	6	)	)	PUNCT
admet-2013	469	1	726–736	726–736	NUM
admet-2013	469	2	.	.	PUNCT
admet-2013	470	1	https://doi.org/10.1182/blood.v86.2.726.bloodjournal862726	https://doi.org/10.1182/blood.v86.2.726.bloodjournal862726	X
admet-2013	470	2	.	.	PUNCT
admet-2013	471	1	[	[	X
admet-2013	471	2	64	64	NUM
admet-2013	471	3	]	]	PUNCT
admet-2013	471	4	a.	a.	NOUN
admet-2013	471	5	zinger	zinger	NOUN
admet-2013	471	6	,	,	PUNCT
admet-2013	471	7	g.	g.	PROPN
admet-2013	471	8	baudo	baudo	PROPN
admet-2013	471	9	,	,	PUNCT
admet-2013	471	10	t.	t.	PROPN
admet-2013	471	11	naoi	naoi	PROPN
admet-2013	471	12	,	,	PUNCT
admet-2013	471	13	f.	f.	PROPN
admet-2013	471	14	giordano	giordano	PROPN
admet-2013	471	15	,	,	PUNCT
admet-2013	471	16	s.	s.	PROPN
admet-2013	471	17	lenna	lenna	PROPN
admet-2013	471	18	,	,	PUNCT
admet-2013	471	19	m.	m.	NOUN
admet-2013	471	20	massaro	massaro	PROPN
admet-2013	471	21	,	,	PUNCT
admet-2013	471	22	a.	a.	PROPN
admet-2013	471	23	ewing	ewing	PROPN
admet-2013	471	24	,	,	PUNCT
admet-2013	471	25	h.r	h.r	PROPN
admet-2013	471	26	.	.	PROPN
admet-2013	471	27	kim	kim	PROPN
admet-2013	471	28	,	,	PUNCT
admet-2013	471	29	e.	e.	PROPN
admet-2013	471	30	tasciotti	tasciotti	PROPN
admet-2013	471	31	,	,	PUNCT
admet-2013	471	32	j.t	j.t	PROPN
admet-2013	471	33	.	.	PROPN
admet-2013	471	34	yustein	yustein	PROPN
admet-2013	471	35	.	.	PUNCT
admet-2013	471	36	reproducible	reproducible	VERB
admet-2013	471	37	and	and	CCONJ
admet-2013	471	38	characterized	characterize	VERB
admet-2013	471	39	method	method	NOUN
admet-2013	471	40	for	for	ADP
admet-2013	471	41	ponatinib	ponatinib	NOUN
admet-2013	471	42	encapsulation	encapsulation	NOUN
admet-2013	471	43	into	into	ADP
admet-2013	471	44	biomimetic	biomimetic	ADJ
admet-2013	471	45	lipid	lipid	NOUN
admet-2013	471	46	nanoparticles	nanoparticle	NOUN
admet-2013	471	47	as	as	ADP
admet-2013	471	48	a	a	DET
admet-2013	471	49	platform	platform	NOUN
admet-2013	471	50	for	for	ADP
admet-2013	471	51	multi	multi	ADJ
admet-2013	471	52	-	-	ADJ
admet-2013	471	53	tyrosine	tyrosine	ADJ
admet-2013	471	54	kinase	kinase	NOUN
admet-2013	471	55	-	-	PUNCT
admet-2013	471	56	targeted	target	VERB
admet-2013	471	57	therapy	therapy	NOUN
admet-2013	471	58	.	.	PUNCT
admet-2013	472	1	acs	acs	PROPN
admet-2013	472	2	applied	apply	VERB
admet-2013	472	3	bio	bio	NOUN
admet-2013	472	4	materials	material	NOUN
admet-2013	472	5	3	3	NUM
admet-2013	472	6	(	(	PUNCT
admet-2013	472	7	2020	2020	NUM
admet-2013	472	8	)	)	PUNCT
admet-2013	472	9	6737	6737	NUM
admet-2013	472	10	-	-	SYM
admet-2013	472	11	6745	6745	NUM
admet-2013	472	12	.	.	PUNCT
admet-2013	473	1	https://doi.org/10.1021/acsabm.0c00685	https://doi.org/10.1021/acsabm.0c00685	PROPN
admet-2013	473	2	.	.	PUNCT
admet-2013	474	1	[	[	X
admet-2013	474	2	65	65	NUM
admet-2013	474	3	]	]	X
admet-2013	474	4	p.	p.	NOUN
admet-2013	474	5	dehghankelishadi	dehghankelishadi	NOUN
admet-2013	474	6	,	,	PUNCT
admet-2013	474	7	p.	p.	PROPN
admet-2013	474	8	badiee	badiee	PROPN
admet-2013	474	9	,	,	PUNCT
admet-2013	474	10	m.f	m.f	PROPN
admet-2013	474	11	.	.	PROPN
admet-2013	474	12	maritz	maritz	PROPN
admet-2013	474	13	,	,	PUNCT
admet-2013	474	14	n.	n.	NOUN
admet-2013	474	15	dmochowska	dmochowska	PROPN
admet-2013	474	16	,	,	PUNCT
admet-2013	474	17	b.	b.	PROPN
admet-2013	474	18	thierry	thierry	PROPN
admet-2013	474	19	.	.	PUNCT
admet-2013	475	1	bosutinib	bosutinib	NOUN
admet-2013	475	2	high	high	ADJ
admet-2013	475	3	density	density	NOUN
admet-2013	475	4	lipoprotein	lipoprotein	ADJ
admet-2013	475	5	nanoformulation	nanoformulation	NOUN
admet-2013	475	6	has	have	AUX
admet-2013	475	7	potent	potent	VERB
admet-2013	475	8	tumour	tumour	NOUN
admet-2013	475	9	radiosensitisation	radiosensitisation	NOUN
admet-2013	475	10	effects	effect	NOUN
admet-2013	475	11	.	.	PUNCT
admet-2013	476	1	journal	journal	NOUN
admet-2013	476	2	of	of	ADP
admet-2013	476	3	nanobiotechnology	nanobiotechnology	NOUN
admet-2013	476	4	21	21	NUM
admet-2013	476	5	(	(	PUNCT
admet-2013	476	6	2023	2023	NUM
admet-2013	476	7	)	)	PUNCT
admet-2013	476	8	102	102	NUM
admet-2013	476	9	.	.	PUNCT
admet-2013	477	1	https://doi.org/10.1186/s12951-023-01848-9	https://doi.org/10.1186/s12951-023-01848-9	NUM
admet-2013	477	2	.	.	PUNCT
admet-2013	478	1	[	[	X
admet-2013	478	2	66	66	NUM
admet-2013	478	3	]	]	X
admet-2013	478	4	a.e	a.e	PROPN
admet-2013	478	5	.	.	PROPN
admet-2013	478	6	el‐sisi	el‐sisi	PROPN
admet-2013	478	7	,	,	PUNCT
admet-2013	478	8	s.s	s.s	PROPN
admet-2013	478	9	.	.	PROPN
admet-2013	478	10	sokkar	sokkar	PROPN
admet-2013	478	11	,	,	PUNCT
admet-2013	478	12	h.a	h.a	PROPN
admet-2013	478	13	.	.	PROPN
admet-2013	478	14	ibrahim	ibrahim	PROPN
admet-2013	478	15	,	,	PUNCT
admet-2013	478	16	m.f	m.f	PROPN
admet-2013	478	17	.	.	PROPN
admet-2013	478	18	hamed	hamed	PROPN
admet-2013	478	19	,	,	PUNCT
admet-2013	478	20	s.e	s.e	PROPN
admet-2013	478	21	.	.	PROPN
admet-2013	478	22	abu‐risha	abu‐risha	PROPN
admet-2013	478	23	.	.	PUNCT
admet-2013	479	1	targeting	target	VERB
admet-2013	479	2	mdr‐1	mdr‐1	NOUN
admet-2013	479	3	gene	gene	NOUN
admet-2013	479	4	expression	expression	NOUN
admet-2013	479	5	,	,	PUNCT
admet-2013	479	6	bax	bax	PROPN
admet-2013	479	7	/	/	SYM
admet-2013	479	8	bcl2	bcl2	PROPN
admet-2013	479	9	,	,	PUNCT
admet-2013	479	10	caspase‐3	caspase‐3	X
admet-2013	479	11	,	,	PUNCT
admet-2013	479	12	and	and	CCONJ
admet-2013	479	13	ki‐67	ki‐67	NOUN
admet-2013	479	14	by	by	ADP
admet-2013	479	15	nanoencapsulated	nanoencapsulate	VERB
admet-2013	479	16	imatinib	imatinib	NOUN
admet-2013	479	17	and	and	CCONJ
admet-2013	479	18	hesperidin	hesperidin	VERB
admet-2013	479	19	to	to	PART
admet-2013	479	20	enhance	enhance	VERB
admet-2013	479	21	anticancer	anticancer	NOUN
admet-2013	479	22	activity	activity	NOUN
admet-2013	479	23	and	and	CCONJ
admet-2013	479	24	ameliorate	ameliorate	VERB
admet-2013	479	25	cardiotoxicity	cardiotoxicity	NOUN
admet-2013	479	26	.	.	PUNCT
admet-2013	480	1	fundamental	fundamental	ADJ
admet-2013	480	2	&	&	CCONJ
admet-2013	480	3	clinical	clinical	ADJ
admet-2013	480	4	pharmacology	pharmacology	NOUN
admet-2013	480	5	34	34	NUM
admet-2013	480	6	(	(	PUNCT
admet-2013	480	7	2020	2020	NUM
admet-2013	480	8	)	)	PUNCT
admet-2013	480	9	458	458	NUM
admet-2013	480	10	-	-	SYM
admet-2013	480	11	475	475	NUM
admet-2013	480	12	.	.	PUNCT
admet-2013	481	1	https://doi.org/10.1111/fcp.12549	https://doi.org/10.1111/fcp.12549	PROPN
admet-2013	481	2	.	.	PUNCT
admet-2013	482	1	[	[	X
admet-2013	482	2	67	67	NUM
admet-2013	482	3	]	]	PUNCT
admet-2013	482	4	m.	m.	NOUN
admet-2013	482	5	antonios	antonios	PROPN
admet-2013	482	6	tawk	tawk	PROPN
admet-2013	482	7	,	,	PUNCT
admet-2013	482	8	m.	m.	NOUN
admet-2013	482	9	carlos	carlos	PROPN
admet-2013	482	10	elia	elia	PROPN
admet-2013	482	11	,	,	PUNCT
admet-2013	482	12	m.	m.	PROPN
admet-2013	482	13	walid	walid	PROPN
admet-2013	482	14	alam	alam	PROPN
admet-2013	482	15	,	,	PUNCT
admet-2013	482	16	m.	m.	PROPN
admet-2013	482	17	joseph	joseph	PROPN
admet-2013	482	18	makdessi	makdessi	PROPN
admet-2013	482	19	,	,	PUNCT
admet-2013	482	20	m.	m.	PROPN
admet-2013	482	21	said	say	VERB
admet-2013	482	22	farhat	farhat	PROPN
admet-2013	482	23	.	.	PUNCT
admet-2013	483	1	organic	organic	ADJ
admet-2013	483	2	nanoparticles	nanoparticle	NOUN
admet-2013	483	3	as	as	ADP
admet-2013	483	4	drug	drug	NOUN
admet-2013	483	5	delivery	delivery	NOUN
admet-2013	483	6	systems	system	NOUN
admet-2013	483	7	and	and	CCONJ
admet-2013	483	8	their	their	PRON
admet-2013	483	9	potential	potential	ADJ
admet-2013	483	10	role	role	NOUN
admet-2013	483	11	in	in	ADP
admet-2013	483	12	the	the	DET
admet-2013	483	13	treatment	treatment	NOUN
admet-2013	483	14	of	of	ADP
admet-2013	483	15	chronic	chronic	ADJ
admet-2013	483	16	myeloid	myeloid	NOUN
admet-2013	483	17	leukemia	leukemia	NOUN
admet-2013	483	18	.	.	PUNCT
admet-2013	484	1	technology	technology	NOUN
admet-2013	484	2	in	in	ADP
admet-2013	484	3	cancer	cancer	NOUN
admet-2013	484	4	research	research	PROPN
admet-2013	484	5	&	&	CCONJ
admet-2013	484	6	treatment	treatment	PROPN
admet-2013	484	7	18	18	NUM
admet-2013	484	8	(	(	PUNCT
admet-2013	484	9	2019	2019	NUM
admet-2013	484	10	)	)	PUNCT
admet-2013	484	11	1533033819853241	1533033819853241	NUM
admet-2013	484	12	.	.	PUNCT
admet-2013	485	1	https://doi.org/10.1177/1533033819879902	https://doi.org/10.1177/1533033819879902	NOUN
admet-2013	485	2	.	.	PUNCT
admet-2013	486	1	[	[	X
admet-2013	486	2	68	68	NUM
admet-2013	486	3	]	]	PUNCT
admet-2013	486	4	r.	r.	PROPN
admet-2013	486	5	misra	misra	PROPN
admet-2013	486	6	,	,	PUNCT
admet-2013	486	7	s.k	s.k	PROPN
admet-2013	486	8	.	.	PROPN
admet-2013	486	9	sahoo	sahoo	PROPN
admet-2013	486	10	.	.	PUNCT
admet-2013	486	11	intracellular	intracellular	ADJ
admet-2013	486	12	trafficking	trafficking	NOUN
admet-2013	486	13	of	of	ADP
admet-2013	486	14	nuclear	nuclear	ADJ
admet-2013	486	15	localization	localization	NOUN
admet-2013	486	16	signal	signal	VERB
admet-2013	486	17	conjugated	conjugate	VERB
admet-2013	486	18	nanoparticles	nanoparticle	NOUN
admet-2013	486	19	for	for	ADP
admet-2013	486	20	cancer	cancer	NOUN
admet-2013	486	21	therapy	therapy	NOUN
admet-2013	486	22	.	.	PUNCT
admet-2013	487	1	european	european	PROPN
admet-2013	487	2	journal	journal	PROPN
admet-2013	487	3	of	of	ADP
admet-2013	487	4	pharmaceutical	pharmaceutical	PROPN
admet-2013	487	5	sciences	science	NOUN
admet-2013	487	6	39	39	NUM
admet-2013	487	7	(	(	PUNCT
admet-2013	487	8	2010	2010	NUM
admet-2013	487	9	)	)	PUNCT
admet-2013	487	10	152	152	NUM
admet-2013	487	11	-	-	SYM
admet-2013	487	12	163	163	NUM
admet-2013	487	13	.	.	PUNCT
admet-2013	488	1	https://doi.org/10.1016/j.ejps.2009.11.010	https://doi.org/10.1016/j.ejps.2009.11.010	NOUN
admet-2013	488	2	.	.	PUNCT
admet-2013	489	1	[	[	X
admet-2013	489	2	69	69	NUM
admet-2013	489	3	]	]	X
admet-2013	489	4	w.	w.	PROPN
admet-2013	489	5	xia	xia	PROPN
admet-2013	489	6	,	,	PUNCT
admet-2013	489	7	z.	z.	PROPN
admet-2013	489	8	tao	tao	PROPN
admet-2013	489	9	,	,	PUNCT
admet-2013	489	10	b.	b.	PROPN
admet-2013	489	11	zhu	zhu	PROPN
admet-2013	489	12	,	,	PUNCT
admet-2013	489	13	w.	w.	PROPN
admet-2013	489	14	zhang	zhang	PROPN
admet-2013	489	15	,	,	PUNCT
admet-2013	489	16	c.	c.	PROPN
admet-2013	489	17	liu	liu	PROPN
admet-2013	489	18	,	,	PUNCT
admet-2013	489	19	s.	s.	PROPN
admet-2013	489	20	chen	chen	PROPN
admet-2013	489	21	,	,	PUNCT
admet-2013	489	22	m.	m.	NOUN
admet-2013	489	23	song	song	NOUN
admet-2013	489	24	.	.	PUNCT
admet-2013	490	1	targeted	target	VERB
admet-2013	490	2	delivery	delivery	NOUN
admet-2013	490	3	of	of	ADP
admet-2013	490	4	drugs	drug	NOUN
admet-2013	490	5	and	and	CCONJ
admet-2013	490	6	genes	gene	NOUN
admet-2013	490	7	using	use	VERB
admet-2013	490	8	polymer	polymer	NOUN
admet-2013	490	9	nanocarriers	nanocarrier	NOUN
admet-2013	490	10	for	for	ADP
admet-2013	490	11	cancer	cancer	NOUN
admet-2013	490	12	therapy	therapy	NOUN
admet-2013	490	13	.	.	PUNCT
admet-2013	491	1	international	international	ADJ
admet-2013	491	2	journal	journal	NOUN
admet-2013	491	3	of	of	ADP
admet-2013	491	4	molecular	molecular	ADJ
admet-2013	491	5	sciences	science	NOUN
admet-2013	491	6	22	22	NUM
admet-2013	491	7	(	(	PUNCT
admet-2013	491	8	2021	2021	NUM
admet-2013	491	9	)	)	PUNCT
admet-2013	491	10	9118	9118	NUM
admet-2013	491	11	.	.	PUNCT
admet-2013	492	1	https://doi.org/10.3390/ijms22179118	https://doi.org/10.3390/ijms22179118	PROPN
admet-2013	492	2	.	.	PUNCT
admet-2013	493	1	[	[	X
admet-2013	493	2	70	70	NUM
admet-2013	493	3	]	]	X
admet-2013	493	4	e.	e.	PROPN
admet-2013	493	5	abbasi	abbasi	PROPN
admet-2013	493	6	,	,	PUNCT
admet-2013	493	7	s.f	s.f	PROPN
admet-2013	493	8	.	.	PROPN
admet-2013	493	9	aval	aval	PROPN
admet-2013	493	10	,	,	PUNCT
admet-2013	493	11	a.	a.	NOUN
admet-2013	493	12	akbarzadeh	akbarzadeh	PROPN
admet-2013	493	13	,	,	PUNCT
admet-2013	493	14	m.	m.	PROPN
admet-2013	493	15	milani	milani	PROPN
admet-2013	493	16	,	,	PUNCT
admet-2013	493	17	h.t	h.t	PROPN
admet-2013	493	18	.	.	PROPN
admet-2013	493	19	nasrabadi	nasrabadi	PROPN
admet-2013	493	20	,	,	PUNCT
admet-2013	493	21	s.w	s.w	PROPN
admet-2013	493	22	.	.	PROPN
admet-2013	493	23	joo	joo	PROPN
admet-2013	493	24	,	,	PUNCT
admet-2013	493	25	y.	y.	PROPN
admet-2013	493	26	hanifehpour	hanifehpour	PROPN
admet-2013	493	27	,	,	PUNCT
admet-2013	493	28	k.	k.	PROPN
admet-2013	493	29	nejatikoshki	nejatikoshki	PROPN
admet-2013	493	30	,	,	PUNCT
admet-2013	493	31	r.	r.	PROPN
admet-2013	493	32	pashaei	pashaei	PROPN
admet-2013	493	33	-	-	PUNCT
admet-2013	493	34	asl	asl	NOUN
admet-2013	493	35	.	.	PUNCT
admet-2013	494	1	dendrimers	dendrimer	NOUN
admet-2013	494	2	:	:	PUNCT
admet-2013	494	3	synthesis	synthesis	NOUN
admet-2013	494	4	,	,	PUNCT
admet-2013	494	5	applications	application	NOUN
admet-2013	494	6	,	,	PUNCT
admet-2013	494	7	and	and	CCONJ
admet-2013	494	8	properties	property	NOUN
admet-2013	494	9	.	.	PUNCT
admet-2013	495	1	nanoscale	nanoscale	NOUN
admet-2013	495	2	research	research	NOUN
admet-2013	495	3	letters	letter	NOUN
admet-2013	495	4	9	9	NUM
admet-2013	495	5	(	(	PUNCT
admet-2013	495	6	2014	2014	NUM
admet-2013	495	7	)	)	PUNCT
admet-2013	495	8	247	247	NUM
admet-2013	495	9	.	.	PUNCT
admet-2013	496	1	https://doi.org/10.1186/1556-276x-9-247	https://doi.org/10.1186/1556-276x-9-247	PROPN
admet-2013	496	2	.	.	PUNCT
admet-2013	497	1	[	[	X
admet-2013	497	2	71	71	NUM
admet-2013	497	3	]	]	PUNCT
admet-2013	497	4	v.	v.	CCONJ
admet-2013	497	5	haribabu	haribabu	PROPN
admet-2013	497	6	,	,	PUNCT
admet-2013	497	7	a.s	a.s	PROPN
admet-2013	497	8	.	.	PROPN
admet-2013	497	9	farook	farook	PROPN
admet-2013	497	10	,	,	PUNCT
admet-2013	497	11	n.	n.	PROPN
admet-2013	497	12	goswami	goswami	PROPN
admet-2013	497	13	,	,	PUNCT
admet-2013	497	14	r.	r.	PROPN
admet-2013	497	15	murugesan	murugesan	PROPN
admet-2013	497	16	,	,	PUNCT
admet-2013	497	17	a.	a.	PROPN
admet-2013	497	18	girigoswami	girigoswami	PROPN
admet-2013	497	19	.	.	PUNCT
admet-2013	498	1	optimized	optimize	VERB
admet-2013	498	2	mn‐doped	mn‐dope	VERB
admet-2013	498	3	iron	iron	NOUN
admet-2013	498	4	oxide	oxide	NOUN
admet-2013	498	5	nanoparticles	nanoparticle	NOUN
admet-2013	498	6	entrapped	entrap	VERB
admet-2013	498	7	in	in	ADP
admet-2013	498	8	dendrimer	dendrimer	NOUN
admet-2013	498	9	for	for	ADP
admet-2013	498	10	dual	dual	ADJ
admet-2013	498	11	contrasting	contrast	VERB
admet-2013	498	12	role	role	NOUN
admet-2013	498	13	in	in	ADP
admet-2013	498	14	mri	mri	PROPN
admet-2013	498	15	.	.	PUNCT
admet-2013	499	1	journal	journal	PROPN
admet-2013	499	2	of	of	ADP
admet-2013	499	3	biomedical	biomedical	ADJ
admet-2013	499	4	materials	material	NOUN
admet-2013	499	5	research	research	NOUN
admet-2013	499	6	b	b	NOUN
admet-2013	499	7	104	104	NUM
admet-2013	499	8	(	(	PUNCT
admet-2013	499	9	2016	2016	NUM
admet-2013	499	10	)	)	PUNCT
admet-2013	499	11	817	817	NUM
admet-2013	499	12	-	-	SYM
admet-2013	499	13	824	824	NUM
admet-2013	499	14	.	.	PUNCT
admet-2013	500	1	https://doi.org/10.1002/jbm.b.33550	https://doi.org/10.1002/jbm.b.33550	X
admet-2013	500	2	.	.	PUNCT
admet-2013	501	1	[	[	X
admet-2013	501	2	72	72	NUM
admet-2013	501	3	]	]	SYM
admet-2013	501	4	a.a	a.a	PROPN
admet-2013	501	5	.	.	PROPN
admet-2013	501	6	abdellatif	abdellatif	PROPN
admet-2013	501	7	,	,	PUNCT
admet-2013	501	8	r.	r.	PROPN
admet-2013	501	9	hennig	hennig	PROPN
admet-2013	501	10	,	,	PUNCT
admet-2013	501	11	k.	k.	PROPN
admet-2013	501	12	pollinger	pollinger	PROPN
admet-2013	501	13	,	,	PUNCT
admet-2013	501	14	h.m	h.m	PROPN
admet-2013	501	15	.	.	PROPN
admet-2013	501	16	tawfeek	tawfeek	PROPN
admet-2013	501	17	,	,	PUNCT
admet-2013	501	18	a.	a.	PROPN
admet-2013	501	19	bouazzaoui	bouazzaoui	PROPN
admet-2013	501	20	,	,	PUNCT
admet-2013	501	21	a.	a.	NOUN
admet-2013	501	22	goepferich	goepferich	NOUN
admet-2013	501	23	.	.	PUNCT
admet-2013	502	1	fluorescent	fluorescent	ADJ
admet-2013	502	2	nanoparticles	nanoparticle	NOUN
admet-2013	502	3	coated	coat	VERB
admet-2013	502	4	with	with	ADP
admet-2013	502	5	a	a	DET
admet-2013	502	6	somatostatin	somatostatin	NOUN
admet-2013	502	7	analogue	analogue	NOUN
admet-2013	502	8	target	target	NOUN
admet-2013	502	9	blood	blood	NOUN
admet-2013	502	10	monocyte	monocyte	NOUN
admet-2013	502	11	for	for	ADP
admet-2013	502	12	efficient	efficient	ADJ
admet-2013	502	13	leukaemia	leukaemia	NOUN
admet-2013	502	14	treatment	treatment	NOUN
admet-2013	502	15	.	.	PUNCT
admet-2013	503	1	pharmaceutical	pharmaceutical	PROPN
admet-2013	503	2	research	research	NOUN
admet-2013	503	3	37	37	NUM
admet-2013	503	4	(	(	PUNCT
admet-2013	503	5	2020	2020	NUM
admet-2013	503	6	)	)	PUNCT
admet-2013	503	7	217	217	NUM
admet-2013	503	8	.	.	PUNCT
admet-2013	504	1	https://doi.org/10.1007/s11095-020-02938-1	https://doi.org/10.1007/s11095-020-02938-1	NUM
admet-2013	504	2	.	.	PUNCT
admet-2013	505	1	[	[	X
admet-2013	505	2	73	73	NUM
admet-2013	505	3	]	]	X
admet-2013	505	4	g.	g.	PROPN
admet-2013	505	5	asgaritarghi	asgaritarghi	PROPN
admet-2013	505	6	,	,	PUNCT
admet-2013	505	7	s.s.m	s.s.m	PROPN
admet-2013	505	8	.	.	PROPN
admet-2013	505	9	farsani	farsani	PROPN
admet-2013	505	10	,	,	PUNCT
admet-2013	505	11	d.	d.	PROPN
admet-2013	505	12	sadeghizadeh	sadeghizadeh	PROPN
admet-2013	505	13	,	,	PUNCT
admet-2013	505	14	m.	m.	NOUN
admet-2013	505	15	sadeghizadeh	sadeghizadeh	PROPN
admet-2013	505	16	.	.	PUNCT
admet-2013	506	1	anti	anti	ADJ
admet-2013	506	2	-	-	ADJ
admet-2013	506	3	cancer	cancer	ADJ
admet-2013	506	4	role	role	NOUN
admet-2013	506	5	of	of	ADP
admet-2013	506	6	dendrosomal	dendrosomal	ADJ
admet-2013	506	7	nano	nano	NOUN
admet-2013	506	8	solanine	solanine	NOUN
admet-2013	506	9	in	in	ADP
admet-2013	506	10	chronic	chronic	ADJ
admet-2013	506	11	myelogenous	myelogenous	ADJ
admet-2013	506	12	leukemia	leukemia	NOUN
admet-2013	506	13	cell	cell	NOUN
admet-2013	506	14	line	line	NOUN
admet-2013	506	15	through	through	ADP
admet-2013	506	16	attenuation	attenuation	NOUN
admet-2013	506	17	of	of	ADP
admet-2013	506	18	pi3k	pi3k	PROPN
admet-2013	506	19	/	/	SYM
admet-2013	506	20	akt	akt	PROPN
admet-2013	506	21	/	/	SYM
admet-2013	506	22	mtor	mtor	PROPN
admet-2013	506	23	signaling	signal	VERB
admet-2013	506	24	pathway	pathway	NOUN
admet-2013	506	25	and	and	CCONJ
admet-2013	506	26	inhibition	inhibition	NOUN
admet-2013	506	27	of	of	ADP
admet-2013	506	28	htert	htert	NOUN
admet-2013	506	29	expression	expression	NOUN
admet-2013	506	30	.	.	PUNCT
admet-2013	507	1	current	current	ADJ
admet-2013	507	2	molecular	molecular	ADJ
admet-2013	507	3	pharmacology	pharmacology	NOUN
admet-2013	507	4	16	16	NUM
admet-2013	507	5	(	(	PUNCT
admet-2013	507	6	2023	2023	NUM
admet-2013	507	7	)	)	PUNCT
admet-2013	507	8	592	592	NUM
admet-2013	507	9	-	-	NUM
admet-2013	507	10	608	608	NUM
admet-2013	507	11	.	.	PUNCT
admet-2013	508	1	https://doi.org/10.2174/1874467215666220516143155	https://doi.org/10.2174/1874467215666220516143155	VERB
admet-2013	508	2	.	.	PUNCT
admet-2013	509	1	https://doi.org/10.1634/theoncologist.8-6-531	https://doi.org/10.1634/theoncologist.8-6-531	PROPN
admet-2013	509	2	https://doi.org/10.1016/s0145-2126(00)00010-2	https://doi.org/10.1016/s0145-2126(00)00010-2	NOUN
admet-2013	509	3	https://doi.org/10.1016/s0092-8674(05)80094-7	https://doi.org/10.1016/s0092-8674(05)80094-7	NOUN
admet-2013	509	4	https://doi.org/10.3390/cancers13102311	https://doi.org/10.3390/cancers13102311	PROPN
admet-2013	509	5	https://doi.org/10.1182/blood.v86.2.726.bloodjournal862726	https://doi.org/10.1182/blood.v86.2.726.bloodjournal862726	PROPN
admet-2013	509	6	https://doi.org/10.1021/acsabm.0c00685	https://doi.org/10.1021/acsabm.0c00685	PROPN
admet-2013	509	7	https://doi.org/10.1186/s12951-023-01848-9	https://doi.org/10.1186/s12951-023-01848-9	NUM
admet-2013	509	8	https://doi.org/10.1111/fcp.12549	https://doi.org/10.1111/fcp.12549	PROPN
admet-2013	509	9	https://doi.org/10.1177/1533033819879902	https://doi.org/10.1177/1533033819879902	PROPN
admet-2013	509	10	https://doi.org/10.1016/j.ejps.2009.11.010	https://doi.org/10.1016/j.ejps.2009.11.010	PROPN
admet-2013	510	1	https://doi.org/10.3390/ijms22179118	https://doi.org/10.3390/ijms22179118	PROPN
admet-2013	510	2	https://doi.org/10.1186/1556-276x-9-247	https://doi.org/10.1186/1556-276x-9-247	PROPN
admet-2013	510	3	https://doi.org/10.1002/jbm.b.33550	https://doi.org/10.1002/jbm.b.33550	NOUN
admet-2013	510	4	https://doi.org/10.1007/s11095-020-02938-1	https://doi.org/10.1007/s11095-020-02938-1	NUM
admet-2013	510	5	https://doi.org/10.2174/1874467215666220516143155	https://doi.org/10.2174/1874467215666220516143155	NOUN
admet-2013	510	6	admet	admet	PROPN
admet-2013	510	7	&	&	CCONJ
admet-2013	510	8	dmpk	dmpk	PROPN
admet-2013	510	9	11(4	11(4	NUM
admet-2013	510	10	)	)	PUNCT
admet-2013	510	11	(	(	PUNCT
admet-2013	510	12	2023	2023	NUM
admet-2013	510	13	)	)	PUNCT
admet-2013	510	14	499	499	NUM
admet-2013	510	15	-	-	SYM
admet-2013	510	16	511	511	NUM
admet-2013	510	17	nanoparticles	nanoparticle	NOUN
admet-2013	510	18	in	in	ADP
admet-2013	510	19	the	the	DET
admet-2013	510	20	therapy	therapy	NOUN
admet-2013	510	21	of	of	ADP
admet-2013	510	22	chronic	chronic	ADJ
admet-2013	510	23	myelogenous	myelogenous	ADJ
admet-2013	510	24	leukemia	leukemia	PROPN
admet-2013	510	25	doi	doi	PROPN
admet-2013	510	26	:	:	PUNCT
admet-2013	510	27	https://doi.org/10.5599/adme	https://doi.org/10.5599/adme	NOUN
admet-2013	510	28	t.2013	t.2013	PROPN
admet-2013	510	29	511	511	NUM
admet-2013	511	1	[	[	X
admet-2013	511	2	74	74	NUM
admet-2013	511	3	]	]	PUNCT
admet-2013	511	4	k.	k.	PROPN
admet-2013	511	5	amerigos	amerigos	PROPN
admet-2013	511	6	daddy	daddy	PROPN
admet-2013	511	7	jc	jc	PROPN
admet-2013	511	8	,	,	PUNCT
admet-2013	511	9	m.	m.	PROPN
admet-2013	511	10	chen	chen	PROPN
admet-2013	511	11	,	,	PUNCT
admet-2013	511	12	f.	f.	PROPN
admet-2013	511	13	raza	raza	PROPN
admet-2013	511	14	,	,	PUNCT
admet-2013	511	15	y.	y.	PROPN
admet-2013	511	16	xiao	xiao	PROPN
admet-2013	511	17	,	,	PUNCT
admet-2013	511	18	z.	z.	PROPN
admet-2013	511	19	su	su	PROPN
admet-2013	511	20	,	,	PUNCT
admet-2013	511	21	q.	q.	PROPN
admet-2013	511	22	ping	ping	PROPN
admet-2013	511	23	.	.	PUNCT
admet-2013	512	1	co	co	NOUN
admet-2013	512	2	-	-	NOUN
admet-2013	512	3	encapsulation	encapsulation	NOUN
admet-2013	512	4	of	of	ADP
admet-2013	512	5	mitoxantrone	mitoxantrone	NOUN
admet-2013	512	6	and	and	CCONJ
admet-2013	512	7	β	β	NOUN
admet-2013	512	8	-	-	NOUN
admet-2013	512	9	elemene	elemene	NOUN
admet-2013	512	10	in	in	ADP
admet-2013	512	11	solid	solid	ADJ
admet-2013	512	12	lipid	lipid	NOUN
admet-2013	512	13	nanoparticles	nanoparticle	NOUN
admet-2013	512	14	to	to	PART
admet-2013	512	15	overcome	overcome	VERB
admet-2013	512	16	multidrug	multidrug	NOUN
admet-2013	512	17	resistance	resistance	NOUN
admet-2013	512	18	in	in	ADP
admet-2013	512	19	leukemia	leukemia	NOUN
admet-2013	512	20	.	.	PUNCT
admet-2013	513	1	pharmaceutics	pharmaceutic	NOUN
admet-2013	513	2	12	12	NUM
admet-2013	513	3	(	(	PUNCT
admet-2013	513	4	2020	2020	NUM
admet-2013	513	5	)	)	PUNCT
admet-2013	513	6	191	191	NUM
admet-2013	513	7	.	.	PUNCT
admet-2013	513	8	https://doi.org/10.3390/pharmaceutics12020191	https://doi.org/10.3390/pharmaceutics12020191	NOUN
admet-2013	513	9	.	.	PUNCT
admet-2013	514	1	[	[	X
admet-2013	514	2	75	75	NUM
admet-2013	514	3	]	]	PUNCT
admet-2013	514	4	p.	p.	PROPN
admet-2013	514	5	ernst	ernst	PROPN
admet-2013	514	6	,	,	PUNCT
admet-2013	514	7	a.t	a.t	PROPN
admet-2013	514	8	.	.	PROPN
admet-2013	514	9	press	press	PROPN
admet-2013	514	10	,	,	PUNCT
admet-2013	514	11	m.	m.	NOUN
admet-2013	514	12	fischer	fischer	PROPN
admet-2013	514	13	,	,	PUNCT
admet-2013	514	14	v.	v.	ADP
admet-2013	514	15	günther	günther	NOUN
admet-2013	514	16	,	,	PUNCT
admet-2013	514	17	c.	c.	PROPN
admet-2013	514	18	gräfe	gräfe	PROPN
admet-2013	514	19	,	,	PUNCT
admet-2013	514	20	j.h	j.h	PROPN
admet-2013	514	21	.	.	PROPN
admet-2013	514	22	clement	clement	PROPN
admet-2013	514	23	,	,	PUNCT
admet-2013	514	24	t.	t.	PROPN
admet-2013	514	25	ernst	ernst	PROPN
admet-2013	514	26	,	,	PUNCT
admet-2013	514	27	u.s	u.s	PROPN
admet-2013	514	28	.	.	PROPN
admet-2013	514	29	schubert	schubert	PROPN
admet-2013	514	30	,	,	PUNCT
admet-2013	514	31	j.	j.	PROPN
admet-2013	514	32	wotschadlo	wotschadlo	PROPN
admet-2013	514	33	,	,	PUNCT
admet-2013	514	34	m.	m.	NOUN
admet-2013	514	35	lehmann	lehmann	PROPN
admet-2013	514	36	.	.	PROPN
admet-2013	515	1	polymethine	polymethine	PROPN
admet-2013	515	2	dye	dye	NOUN
admet-2013	515	3	-	-	PUNCT
admet-2013	515	4	functionalized	functionalize	VERB
admet-2013	515	5	nanoparticles	nanoparticle	NOUN
admet-2013	515	6	for	for	ADP
admet-2013	515	7	targeting	target	VERB
admet-2013	515	8	cml	cml	PROPN
admet-2013	515	9	stem	stem	NOUN
admet-2013	515	10	cells	cell	NOUN
admet-2013	515	11	.	.	PUNCT
admet-2013	516	1	molecular	molecular	ADJ
admet-2013	516	2	therapy	therapy	NOUN
admet-2013	516	3	-	-	PUNCT
admet-2013	516	4	oncolytics	oncolytic	NOUN
admet-2013	516	5	18	18	NUM
admet-2013	516	6	(	(	PUNCT
admet-2013	516	7	2020	2020	NUM
admet-2013	516	8	)	)	PUNCT
admet-2013	516	9	372	372	NUM
admet-2013	516	10	-	-	SYM
admet-2013	516	11	381	381	NUM
admet-2013	516	12	.	.	PUNCT
admet-2013	517	1	https://doi.org/10.1016/j.omto.2020.07.007	https://doi.org/10.1016/j.omto.2020.07.007	PROPN
admet-2013	517	2	.	.	PUNCT
admet-2013	518	1	[	[	X
admet-2013	518	2	76	76	NUM
admet-2013	518	3	]	]	X
admet-2013	518	4	l.	l.	PROPN
admet-2013	518	5	fu	fu	PROPN
admet-2013	518	6	,	,	PUNCT
admet-2013	518	7	f.	f.	PROPN
admet-2013	518	8	zou	zou	PROPN
admet-2013	518	9	,	,	PUNCT
admet-2013	518	10	q.	q.	PROPN
admet-2013	518	11	liu	liu	PROPN
admet-2013	518	12	,	,	PUNCT
admet-2013	518	13	b.	b.	PROPN
admet-2013	518	14	wang	wang	PROPN
admet-2013	518	15	,	,	PUNCT
admet-2013	518	16	j.	j.	PROPN
admet-2013	518	17	wang	wang	PROPN
admet-2013	518	18	,	,	PUNCT
admet-2013	518	19	h.	h.	PROPN
admet-2013	518	20	liang	liang	PROPN
admet-2013	518	21	,	,	PUNCT
admet-2013	518	22	x.	x.	PROPN
admet-2013	518	23	liang	liang	PROPN
admet-2013	518	24	,	,	PUNCT
admet-2013	518	25	j.	j.	PROPN
admet-2013	518	26	liu	liu	PROPN
admet-2013	518	27	,	,	PUNCT
admet-2013	518	28	j.	j.	PROPN
admet-2013	518	29	shi	shi	PROPN
admet-2013	518	30	,	,	PUNCT
admet-2013	518	31	q.	q.	PROPN
admet-2013	518	32	liu	liu	PROPN
admet-2013	518	33	.	.	PUNCT
admet-2013	519	1	an	an	DET
admet-2013	519	2	ultra	ultra	ADJ
admet-2013	519	3	-	-	ADJ
admet-2013	519	4	long	long	ADJ
admet-2013	519	5	circulating	circulate	VERB
admet-2013	519	6	nanoparticle	nanoparticle	NOUN
admet-2013	519	7	for	for	ADP
admet-2013	519	8	reviving	revive	VERB
admet-2013	519	9	a	a	DET
admet-2013	519	10	highly	highly	ADV
admet-2013	519	11	selective	selective	ADJ
admet-2013	519	12	bcr	bcr	ADJ
admet-2013	519	13	-	-	ADJ
admet-2013	519	14	abl	abl	NOUN
admet-2013	519	15	inhibitor	inhibitor	NOUN
admet-2013	519	16	in	in	ADP
admet-2013	519	17	long	long	ADJ
admet-2013	519	18	-	-	PUNCT
admet-2013	519	19	term	term	NOUN
admet-2013	519	20	effective	effective	ADJ
admet-2013	519	21	and	and	CCONJ
admet-2013	519	22	safe	safe	ADJ
admet-2013	519	23	treatment	treatment	NOUN
admet-2013	519	24	of	of	ADP
admet-2013	519	25	chronic	chronic	ADJ
admet-2013	519	26	myeloid	myeloid	NOUN
admet-2013	519	27	leukemia	leukemia	NOUN
admet-2013	519	28	.	.	PUNCT
admet-2013	520	1	nanomedicine	nanomedicine	NOUN
admet-2013	520	2	:	:	PUNCT
admet-2013	520	3	nanotechnology	nanotechnology	NOUN
admet-2013	520	4	,	,	PUNCT
admet-2013	520	5	biology	biology	NOUN
admet-2013	520	6	and	and	CCONJ
admet-2013	520	7	medicine	medicine	NOUN
admet-2013	520	8	29	29	NUM
admet-2013	520	9	(	(	PUNCT
admet-2013	520	10	2020	2020	NUM
admet-2013	520	11	)	)	PUNCT
admet-2013	520	12	102283	102283	NUM
admet-2013	520	13	.	.	PUNCT
admet-2013	521	1	https://doi.org/10.1016/j.nano.2020.102283	https://doi.org/10.1016/j.nano.2020.102283	PROPN
admet-2013	521	2	.	.	PUNCT
admet-2013	522	1	[	[	X
admet-2013	522	2	77	77	NUM
admet-2013	522	3	]	]	X
admet-2013	522	4	w.	w.	PROPN
admet-2013	522	5	guo	guo	PROPN
admet-2013	522	6	,	,	PUNCT
admet-2013	522	7	x.	x.	PROPN
admet-2013	522	8	liu	liu	PROPN
admet-2013	522	9	,	,	PUNCT
admet-2013	522	10	l.	l.	PROPN
admet-2013	522	11	ye	ye	PROPN
admet-2013	522	12	,	,	PUNCT
admet-2013	522	13	j.	j.	PROPN
admet-2013	522	14	liu	liu	PROPN
admet-2013	522	15	,	,	PUNCT
admet-2013	522	16	k.	k.	PROPN
admet-2013	522	17	larwubah	larwubah	PROPN
admet-2013	522	18	,	,	PUNCT
admet-2013	522	19	g.	g.	PROPN
admet-2013	522	20	meng	meng	PROPN
admet-2013	522	21	,	,	PUNCT
admet-2013	522	22	w.	w.	PROPN
admet-2013	522	23	shen	shen	PROPN
admet-2013	522	24	,	,	PUNCT
admet-2013	522	25	x.	x.	PROPN
admet-2013	522	26	ying	ying	PROPN
admet-2013	522	27	,	,	PUNCT
admet-2013	522	28	j.	j.	PROPN
admet-2013	522	29	zhu	zhu	PROPN
admet-2013	522	30	,	,	PUNCT
admet-2013	522	31	s.	s.	PROPN
admet-2013	522	32	yang	yang	PROPN
admet-2013	522	33	.	.	PUNCT
admet-2013	523	1	the	the	DET
admet-2013	523	2	effect	effect	NOUN
admet-2013	523	3	of	of	ADP
admet-2013	523	4	polyhydroxy	polyhydroxy	ADJ
admet-2013	523	5	fullerene	fullerene	ADJ
admet-2013	523	6	derivative	derivative	NOUN
admet-2013	523	7	on	on	ADP
admet-2013	523	8	human	human	ADJ
admet-2013	523	9	myeloid	myeloid	NOUN
admet-2013	523	10	leukemia	leukemia	NOUN
admet-2013	523	11	k562	k562	PROPN
admet-2013	523	12	cells	cell	NOUN
admet-2013	523	13	.	.	PUNCT
admet-2013	524	1	materials	material	NOUN
admet-2013	524	2	15	15	NUM
admet-2013	524	3	(	(	PUNCT
admet-2013	524	4	2022	2022	NUM
admet-2013	524	5	)	)	PUNCT
admet-2013	524	6	1349	1349	NUM
admet-2013	524	7	.	.	PUNCT
admet-2013	525	1	https://doi.org/10.3390/ma15041349	https://doi.org/10.3390/ma15041349	X
admet-2013	525	2	.	.	PUNCT
admet-2013	526	1	[	[	X
admet-2013	526	2	78	78	NUM
admet-2013	526	3	]	]	PUNCT
admet-2013	526	4	m.	m.	NOUN
admet-2013	526	5	houshmand	houshmand	PROPN
admet-2013	526	6	,	,	PUNCT
admet-2013	526	7	f.	f.	PROPN
admet-2013	526	8	garello	garello	PROPN
admet-2013	526	9	,	,	PUNCT
admet-2013	526	10	r.	r.	PROPN
admet-2013	526	11	stefania	stefania	PROPN
admet-2013	526	12	,	,	PUNCT
admet-2013	526	13	v.	v.	CCONJ
admet-2013	526	14	gaidano	gaidano	ADJ
admet-2013	526	15	,	,	PUNCT
admet-2013	526	16	a.	a.	PROPN
admet-2013	526	17	cignetti	cignetti	PROPN
admet-2013	526	18	,	,	PUNCT
admet-2013	526	19	m.	m.	NOUN
admet-2013	526	20	spinelli	spinelli	PROPN
admet-2013	526	21	,	,	PUNCT
admet-2013	526	22	c.	c.	PROPN
admet-2013	526	23	fava	fava	PROPN
admet-2013	526	24	,	,	PUNCT
admet-2013	526	25	m.	m.	NOUN
admet-2013	526	26	nikougoftar	nikougoftar	PROPN
admet-2013	526	27	zarif	zarif	PROPN
admet-2013	526	28	,	,	PUNCT
admet-2013	526	29	s.	s.	PROPN
admet-2013	526	30	galimberti	galimberti	PROPN
admet-2013	526	31	,	,	PUNCT
admet-2013	526	32	e.	e.	PROPN
admet-2013	526	33	pungolino	pungolino	PROPN
admet-2013	526	34	.	.	PUNCT
admet-2013	527	1	targeting	target	VERB
admet-2013	527	2	chronic	chronic	ADJ
admet-2013	527	3	myeloid	myeloid	NOUN
admet-2013	527	4	leukemia	leukemia	NOUN
admet-2013	527	5	stem	stem	NOUN
admet-2013	527	6	/	/	SYM
admet-2013	527	7	progenitor	progenitor	NOUN
admet-2013	527	8	cells	cell	NOUN
admet-2013	527	9	using	use	VERB
admet-2013	527	10	venetoclax	venetoclax	NOUN
admet-2013	527	11	-	-	PUNCT
admet-2013	527	12	loaded	load	VERB
admet-2013	527	13	immunoliposome	immunoliposome	NOUN
admet-2013	527	14	.	.	PUNCT
admet-2013	528	1	cancers	cancer	NOUN
admet-2013	528	2	13	13	NUM
admet-2013	528	3	(	(	PUNCT
admet-2013	528	4	2021	2021	NUM
admet-2013	528	5	)	)	PUNCT
admet-2013	528	6	1311	1311	NUM
admet-2013	528	7	.	.	PUNCT
admet-2013	529	1	https://doi.org/10.3390/cancers13061311	https://doi.org/10.3390/cancers13061311	NOUN
admet-2013	529	2	.	.	PUNCT
admet-2013	530	1	[	[	X
admet-2013	530	2	79	79	NUM
admet-2013	530	3	]	]	X
admet-2013	530	4	g.	g.	PROPN
admet-2013	530	5	jiang	jiang	PROPN
admet-2013	530	6	,	,	PUNCT
admet-2013	530	7	z.	z.	PROPN
admet-2013	530	8	huang	huang	PROPN
admet-2013	530	9	,	,	PUNCT
admet-2013	530	10	y.	y.	PROPN
admet-2013	530	11	yuan	yuan	PROPN
admet-2013	530	12	,	,	PUNCT
admet-2013	530	13	k.	k.	PROPN
admet-2013	530	14	tao	tao	PROPN
admet-2013	530	15	,	,	PUNCT
admet-2013	530	16	w.	w.	PROPN
admet-2013	530	17	feng	feng	PROPN
admet-2013	530	18	.	.	PUNCT
admet-2013	531	1	intracellular	intracellular	ADJ
admet-2013	531	2	delivery	delivery	NOUN
admet-2013	531	3	of	of	ADP
admet-2013	531	4	anti	anti	ADJ
admet-2013	531	5	-	-	ADJ
admet-2013	531	6	bcr	bcr	ADJ
admet-2013	531	7	/	/	SYM
admet-2013	531	8	abl	abl	NOUN
admet-2013	531	9	antibody	antibody	NOUN
admet-2013	531	10	by	by	ADP
admet-2013	531	11	plga	plga	NOUN
admet-2013	531	12	nanoparticles	nanoparticle	NOUN
admet-2013	531	13	suppresses	suppress	VERB
admet-2013	531	14	the	the	DET
admet-2013	531	15	oncogenesis	oncogenesis	NOUN
admet-2013	531	16	of	of	ADP
admet-2013	531	17	chronic	chronic	ADJ
admet-2013	531	18	myeloid	myeloid	NOUN
admet-2013	531	19	leukemia	leukemia	NOUN
admet-2013	531	20	cells	cell	NOUN
admet-2013	531	21	.	.	PUNCT
admet-2013	532	1	journal	journal	NOUN
admet-2013	532	2	of	of	ADP
admet-2013	532	3	hematology	hematology	PROPN
admet-2013	532	4	&	&	CCONJ
admet-2013	532	5	oncology	oncology	NOUN
admet-2013	532	6	14	14	NUM
admet-2013	532	7	(	(	PUNCT
admet-2013	532	8	2021	2021	NUM
admet-2013	532	9	)	)	PUNCT
admet-2013	532	10	139	139	NUM
admet-2013	532	11	.	.	PUNCT
admet-2013	533	1	https://doi.org/10.1186/s13045-021-01150-x	https://doi.org/10.1186/s13045-021-01150-x	NOUN
admet-2013	533	2	.	.	PUNCT
admet-2013	534	1	[	[	X
admet-2013	534	2	80	80	NUM
admet-2013	534	3	]	]	X
admet-2013	534	4	n.	n.	NOUN
admet-2013	534	5	jyotsana	jyotsana	PROPN
admet-2013	534	6	,	,	PUNCT
admet-2013	534	7	a.	a.	PROPN
admet-2013	534	8	sharma	sharma	PROPN
admet-2013	534	9	,	,	PUNCT
admet-2013	534	10	a.	a.	PROPN
admet-2013	534	11	chaturvedi	chaturvedi	PROPN
admet-2013	534	12	,	,	PUNCT
admet-2013	534	13	r.	r.	PROPN
admet-2013	534	14	budida	budida	PROPN
admet-2013	534	15	,	,	PUNCT
admet-2013	534	16	m.	m.	NOUN
admet-2013	534	17	scherr	scherr	PROPN
admet-2013	534	18	,	,	PUNCT
admet-2013	534	19	f.	f.	PROPN
admet-2013	534	20	kuchenbauer	kuchenbauer	PROPN
admet-2013	534	21	,	,	PUNCT
admet-2013	534	22	r.	r.	PROPN
admet-2013	534	23	lindner	lindner	PROPN
admet-2013	534	24	,	,	PUNCT
admet-2013	534	25	f.	f.	PROPN
admet-2013	534	26	noyan	noyan	PROPN
admet-2013	534	27	,	,	PUNCT
admet-2013	534	28	k.-w	k.-w	PROPN
admet-2013	534	29	.	.	PUNCT
admet-2013	535	1	sühs	sühs	PROPN
admet-2013	535	2	,	,	PUNCT
admet-2013	535	3	m.	m.	NOUN
admet-2013	535	4	stangel	stangel	PROPN
admet-2013	535	5	.	.	PUNCT
admet-2013	536	1	lipid	lipid	PROPN
admet-2013	536	2	nanoparticle	nanoparticle	NOUN
admet-2013	536	3	-	-	PUNCT
admet-2013	536	4	mediated	mediate	VERB
admet-2013	536	5	sirna	sirna	PROPN
admet-2013	536	6	delivery	delivery	NOUN
admet-2013	536	7	for	for	ADP
admet-2013	536	8	safe	safe	ADJ
admet-2013	536	9	targeting	targeting	NOUN
admet-2013	536	10	of	of	ADP
admet-2013	536	11	human	human	PROPN
admet-2013	536	12	cml	cml	PROPN
admet-2013	536	13	in	in	ADP
admet-2013	536	14	vivo	vivo	NOUN
admet-2013	536	15	.	.	PUNCT
admet-2013	537	1	annals	annal	NOUN
admet-2013	537	2	of	of	ADP
admet-2013	537	3	hematology	hematology	NOUN
admet-2013	537	4	98	98	NUM
admet-2013	537	5	(	(	PUNCT
admet-2013	537	6	2019	2019	NUM
admet-2013	537	7	)	)	PUNCT
admet-2013	537	8	1905	1905	NUM
admet-2013	537	9	-	-	SYM
admet-2013	537	10	1918	1918	NUM
admet-2013	537	11	.	.	PUNCT
admet-2013	538	1	https://doi.org/10.1007/s00277-019-03713-y	https://doi.org/10.1007/s00277-019-03713-y	NOUN
admet-2013	538	2	.	.	PUNCT
admet-2013	539	1	[	[	X
admet-2013	539	2	81	81	NUM
admet-2013	539	3	]	]	PUNCT
admet-2013	539	4	h.	h.	PROPN
admet-2013	539	5	liang	liang	PROPN
admet-2013	539	6	,	,	PUNCT
admet-2013	539	7	f.	f.	PROPN
admet-2013	539	8	zou	zou	PROPN
admet-2013	539	9	,	,	PUNCT
admet-2013	539	10	l.	l.	PROPN
admet-2013	539	11	fu	fu	PROPN
admet-2013	539	12	,	,	PUNCT
admet-2013	539	13	q.	q.	PROPN
admet-2013	539	14	liu	liu	PROPN
admet-2013	539	15	,	,	PUNCT
admet-2013	539	16	b.	b.	PROPN
admet-2013	539	17	wang	wang	PROPN
admet-2013	539	18	,	,	PUNCT
admet-2013	539	19	x.	x.	PROPN
admet-2013	539	20	liang	liang	PROPN
admet-2013	539	21	,	,	PUNCT
admet-2013	539	22	j.	j.	PROPN
admet-2013	539	23	liu	liu	PROPN
admet-2013	539	24	,	,	PUNCT
admet-2013	539	25	q.	q.	PROPN
admet-2013	539	26	liu	liu	PROPN
admet-2013	539	27	.	.	PUNCT
admet-2013	539	28	peg	peg	NOUN
admet-2013	539	29	-	-	PUNCT
admet-2013	539	30	bottlebrush	bottlebrush	NOUN
admet-2013	539	31	stabilizer	stabilizer	NOUN
admet-2013	539	32	-	-	PUNCT
admet-2013	539	33	based	base	VERB
admet-2013	539	34	wormlike	wormlike	PROPN
admet-2013	539	35	nanocrystal	nanocrystal	ADJ
admet-2013	539	36	micelles	micelle	NOUN
admet-2013	539	37	with	with	ADP
admet-2013	539	38	long	long	ADV
admet-2013	539	39	-	-	PUNCT
admet-2013	539	40	circulating	circulate	VERB
admet-2013	539	41	and	and	CCONJ
admet-2013	539	42	controlled	control	VERB
admet-2013	539	43	release	release	NOUN
admet-2013	539	44	for	for	ADP
admet-2013	539	45	delivery	delivery	NOUN
admet-2013	539	46	of	of	ADP
admet-2013	539	47	a	a	DET
admet-2013	539	48	bcr	bcr	ADJ
admet-2013	539	49	-	-	ADJ
admet-2013	539	50	abl	abl	NOUN
admet-2013	539	51	inhibitor	inhibitor	NOUN
admet-2013	539	52	against	against	ADP
admet-2013	539	53	chronic	chronic	ADJ
admet-2013	539	54	myeloid	myeloid	NOUN
admet-2013	539	55	leukemia	leukemia	NOUN
admet-2013	539	56	(	(	PUNCT
admet-2013	539	57	cml	cml	PROPN
admet-2013	539	58	)	)	PUNCT
admet-2013	539	59	.	.	PUNCT
admet-2013	540	1	pharmaceutics	pharmaceutic	NOUN
admet-2013	540	2	14	14	NUM
admet-2013	540	3	(	(	PUNCT
admet-2013	540	4	2022	2022	NUM
admet-2013	540	5	)	)	PUNCT
admet-2013	540	6	1662	1662	NUM
admet-2013	540	7	.	.	PUNCT
admet-2013	541	1	https://doi.org/10.3390/pharmaceutics14081662	https://doi.org/10.3390/pharmaceutics14081662	NOUN
admet-2013	541	2	.	.	PUNCT
admet-2013	542	1	[	[	X
admet-2013	542	2	82	82	X
admet-2013	542	3	]	]	X
admet-2013	542	4	b.	b.	PROPN
admet-2013	542	5	ma	ma	PROPN
admet-2013	542	6	,	,	PUNCT
admet-2013	542	7	f.	f.	PROPN
admet-2013	542	8	niu	niu	PROPN
admet-2013	542	9	,	,	PUNCT
admet-2013	542	10	x.	x.	PROPN
admet-2013	542	11	qu	qu	PROPN
admet-2013	542	12	,	,	PUNCT
admet-2013	542	13	w.	w.	PROPN
admet-2013	542	14	he	he	PROPN
admet-2013	542	15	,	,	PUNCT
admet-2013	542	16	c.	c.	PROPN
admet-2013	542	17	feng	feng	PROPN
admet-2013	542	18	,	,	PUNCT
admet-2013	542	19	s.	s.	PROPN
admet-2013	542	20	wang	wang	PROPN
admet-2013	542	21	,	,	PUNCT
admet-2013	542	22	z.	z.	PROPN
admet-2013	542	23	ouyang	ouyang	PROPN
admet-2013	542	24	,	,	PUNCT
admet-2013	542	25	j.	j.	PROPN
admet-2013	542	26	yan	yan	PROPN
admet-2013	542	27	,	,	PUNCT
admet-2013	542	28	y.	y.	PROPN
admet-2013	542	29	wen	wen	PROPN
admet-2013	542	30	,	,	PUNCT
admet-2013	542	31	d.	d.	PROPN
admet-2013	542	32	xu	xu	PROPN
admet-2013	542	33	.	.	PUNCT
admet-2013	543	1	a	a	DET
admet-2013	543	2	tetrameric	tetrameric	ADJ
admet-2013	543	3	protein	protein	NOUN
admet-2013	543	4	scaffold	scaffold	NOUN
admet-2013	543	5	as	as	ADP
admet-2013	543	6	a	a	DET
admet-2013	543	7	nano	nano	NOUN
admet-2013	543	8	-	-	PUNCT
admet-2013	543	9	carrier	carrier	NOUN
admet-2013	543	10	of	of	ADP
admet-2013	543	11	antitumor	antitumor	PROPN
admet-2013	543	12	peptides	peptide	NOUN
admet-2013	543	13	for	for	ADP
admet-2013	543	14	cancer	cancer	NOUN
admet-2013	543	15	therapy	therapy	NOUN
admet-2013	543	16	.	.	PUNCT
admet-2013	544	1	biomaterials	biomaterial	NOUN
admet-2013	544	2	204	204	NUM
admet-2013	544	3	(	(	PUNCT
admet-2013	544	4	2019	2019	NUM
admet-2013	544	5	)	)	PUNCT
admet-2013	544	6	1	1	NUM
admet-2013	544	7	-	-	SYM
admet-2013	544	8	12	12	NUM
admet-2013	544	9	.	.	PUNCT
admet-2013	545	1	https://doi.org/10.1016/j.biomaterials.2019.03.004	https://doi.org/10.1016/j.biomaterials.2019.03.004	NOUN
admet-2013	545	2	.	.	PUNCT
admet-2013	546	1	[	[	X
admet-2013	546	2	83	83	NUM
admet-2013	546	3	]	]	X
admet-2013	546	4	f.	f.	PROPN
admet-2013	546	5	palombarini	palombarini	PROPN
admet-2013	546	6	,	,	PUNCT
admet-2013	546	7	s.	s.	PROPN
admet-2013	546	8	masciarelli	masciarelli	PROPN
admet-2013	546	9	,	,	PUNCT
admet-2013	546	10	a.	a.	NOUN
admet-2013	546	11	incocciati	incocciati	PROPN
admet-2013	546	12	,	,	PUNCT
admet-2013	546	13	f.	f.	PROPN
admet-2013	546	14	liccardo	liccardo	PROPN
admet-2013	546	15	,	,	PUNCT
admet-2013	546	16	e.	e.	PROPN
admet-2013	546	17	di	di	PROPN
admet-2013	546	18	fabio	fabio	PROPN
admet-2013	546	19	,	,	PUNCT
admet-2013	546	20	a.	a.	PROPN
admet-2013	546	21	iazzetti	iazzetti	PROPN
admet-2013	546	22	,	,	PUNCT
admet-2013	546	23	g.	g.	PROPN
admet-2013	546	24	fabrizi	fabrizi	PROPN
admet-2013	546	25	,	,	PUNCT
admet-2013	546	26	f.	f.	PROPN
admet-2013	546	27	fazi	fazi	PROPN
admet-2013	546	28	,	,	PUNCT
admet-2013	546	29	a.	a.	NOUN
admet-2013	546	30	macone	macone	PROPN
admet-2013	546	31	,	,	PUNCT
admet-2013	546	32	a.	a.	NOUN
admet-2013	546	33	bonamore	bonamore	NOUN
admet-2013	546	34	.	.	PUNCT
admet-2013	547	1	self	self	NOUN
admet-2013	547	2	-	-	PUNCT
admet-2013	547	3	assembling	assemble	VERB
admet-2013	547	4	ferritin	ferritin	ADJ
admet-2013	547	5	-	-	PUNCT
admet-2013	547	6	dendrimer	dendrimer	NOUN
admet-2013	547	7	nanoparticles	nanoparticle	NOUN
admet-2013	547	8	for	for	ADP
admet-2013	547	9	targeted	target	VERB
admet-2013	547	10	delivery	delivery	NOUN
admet-2013	547	11	of	of	ADP
admet-2013	547	12	nucleic	nucleic	ADJ
admet-2013	547	13	acids	acid	NOUN
admet-2013	547	14	to	to	ADP
admet-2013	547	15	myeloid	myeloid	VERB
admet-2013	547	16	leukemia	leukemia	NOUN
admet-2013	547	17	cells	cell	NOUN
admet-2013	547	18	.	.	PUNCT
admet-2013	548	1	journal	journal	NOUN
admet-2013	548	2	of	of	ADP
admet-2013	548	3	nanobiotechnology	nanobiotechnology	NOUN
admet-2013	548	4	19	19	NUM
admet-2013	548	5	(	(	PUNCT
admet-2013	548	6	2021	2021	NUM
admet-2013	548	7	)	)	PUNCT
admet-2013	548	8	172	172	NUM
admet-2013	548	9	.	.	PUNCT
admet-2013	548	10	https://doi.org/10.1186/s12951-021-00921-5	https://doi.org/10.1186/s12951-021-00921-5	NUM
admet-2013	548	11	.	.	PUNCT
admet-2013	549	1	[	[	X
admet-2013	549	2	84	84	NUM
admet-2013	549	3	]	]	PUNCT
admet-2013	549	4	k.	k.	PROPN
admet-2013	549	5	remant	remant	PROPN
admet-2013	549	6	,	,	PUNCT
admet-2013	549	7	b.	b.	PROPN
admet-2013	549	8	thapa	thapa	PROPN
admet-2013	549	9	,	,	PUNCT
admet-2013	549	10	j.	j.	PROPN
admet-2013	549	11	valencia‐serna	valencia‐serna	PROPN
admet-2013	549	12	,	,	PUNCT
admet-2013	549	13	s.s	s.s	PROPN
admet-2013	549	14	.	.	PROPN
admet-2013	549	15	domun	domun	PROPN
admet-2013	549	16	,	,	PUNCT
admet-2013	549	17	c.	c.	PROPN
admet-2013	549	18	dimitroff	dimitroff	PROPN
admet-2013	549	19	,	,	PUNCT
admet-2013	549	20	x.	x.	PROPN
admet-2013	549	21	jiang	jiang	PROPN
admet-2013	549	22	,	,	PUNCT
admet-2013	549	23	h.	h.	PROPN
admet-2013	549	24	uludağ	uludağ	PROPN
admet-2013	549	25	.	.	PUNCT
admet-2013	550	1	cholesterol	cholesterol	NOUN
admet-2013	550	2	grafted	graft	VERB
admet-2013	550	3	cationic	cationic	ADJ
admet-2013	550	4	lipopolymers	lipopolymer	NOUN
admet-2013	550	5	:	:	PUNCT
admet-2013	550	6	potential	potential	ADJ
admet-2013	550	7	sirna	sirna	PROPN
admet-2013	550	8	carriers	carrier	NOUN
admet-2013	550	9	for	for	ADP
admet-2013	550	10	selective	selective	ADJ
admet-2013	550	11	chronic	chronic	ADJ
admet-2013	550	12	myeloid	myeloid	NOUN
admet-2013	550	13	leukemia	leukemia	NOUN
admet-2013	550	14	therapy	therapy	NOUN
admet-2013	550	15	.	.	PUNCT
admet-2013	551	1	journal	journal	PROPN
admet-2013	551	2	of	of	ADP
admet-2013	551	3	biomedical	biomedical	ADJ
admet-2013	551	4	materials	material	NOUN
admet-2013	551	5	research	research	VERB
admet-2013	551	6	a	a	DET
admet-2013	551	7	108	108	NUM
admet-2013	551	8	(	(	PUNCT
admet-2013	551	9	2020	2020	NUM
admet-2013	551	10	)	)	PUNCT
admet-2013	551	11	565	565	NUM
admet-2013	551	12	-	-	SYM
admet-2013	551	13	580	580	NUM
admet-2013	551	14	.	.	PUNCT
admet-2013	552	1	https://doi.org/10.1002/jbm.a.36837	https://doi.org/10.1002/jbm.a.36837	PROPN
admet-2013	552	2	.	.	PUNCT
admet-2013	553	1	[	[	X
admet-2013	553	2	85	85	NUM
admet-2013	553	3	]	]	X
admet-2013	553	4	y.	y.	PROPN
admet-2013	553	5	shao	shao	PROPN
admet-2013	553	6	,	,	PUNCT
admet-2013	553	7	w.	w.	PROPN
admet-2013	553	8	luo	luo	PROPN
admet-2013	553	9	,	,	PUNCT
admet-2013	553	10	q.	q.	PROPN
admet-2013	553	11	guo	guo	PROPN
admet-2013	553	12	,	,	PUNCT
admet-2013	553	13	x.	x.	PROPN
admet-2013	553	14	li	li	PROPN
admet-2013	553	15	,	,	PUNCT
admet-2013	553	16	q.	q.	PROPN
admet-2013	553	17	zhang	zhang	PROPN
admet-2013	553	18	,	,	PUNCT
admet-2013	553	19	j.	j.	PROPN
admet-2013	553	20	li	li	PROPN
admet-2013	553	21	.	.	PROPN
admet-2013	553	22	in	in	ADP
admet-2013	553	23	vitro	vitro	X
admet-2013	553	24	and	and	CCONJ
admet-2013	553	25	in	in	ADP
admet-2013	553	26	vivo	vivo	ADJ
admet-2013	553	27	effect	effect	NOUN
admet-2013	553	28	of	of	ADP
admet-2013	553	29	hyaluronic	hyaluronic	ADJ
admet-2013	553	30	acid	acid	NOUN
admet-2013	553	31	modified	modify	VERB
admet-2013	553	32	,	,	PUNCT
admet-2013	553	33	doxorubicin	doxorubicin	PROPN
admet-2013	553	34	and	and	CCONJ
admet-2013	553	35	gallic	gallic	PROPN
admet-2013	553	36	acid	acid	PROPN
admet-2013	553	37	co	co	VERB
admet-2013	553	38	-	-	VERB
admet-2013	553	39	delivered	deliver	VERB
admet-2013	553	40	lipid	lipid	NOUN
admet-2013	553	41	-	-	PUNCT
admet-2013	553	42	polymeric	polymeric	ADJ
admet-2013	553	43	hybrid	hybrid	ADJ
admet-2013	553	44	nano	nano	NOUN
admet-2013	553	45	-	-	PUNCT
admet-2013	553	46	system	system	NOUN
admet-2013	553	47	for	for	ADP
admet-2013	553	48	leukemia	leukemia	NOUN
admet-2013	553	49	therapy	therapy	NOUN
admet-2013	553	50	.	.	PUNCT
admet-2013	554	1	drug	drug	NOUN
admet-2013	554	2	design	design	NOUN
admet-2013	554	3	,	,	PUNCT
admet-2013	554	4	development	development	NOUN
admet-2013	554	5	and	and	CCONJ
admet-2013	554	6	therapy	therapy	NOUN
admet-2013	554	7	2019:13	2019:13	NUM
admet-2013	554	8	(	(	PUNCT
admet-2013	554	9	2019	2019	NUM
admet-2013	554	10	)	)	PUNCT
admet-2013	554	11	2043	2043	NUM
admet-2013	554	12	-	-	SYM
admet-2013	554	13	2055	2055	NUM
admet-2013	554	14	.	.	PUNCT
admet-2013	555	1	https://doi.org/10.2147/dddt.s202818	https://doi.org/10.2147/dddt.s202818	INTJ
admet-2013	555	2	.	.	PUNCT
admet-2013	556	1	[	[	X
admet-2013	556	2	86	86	NUM
admet-2013	556	3	]	]	PUNCT
admet-2013	556	4	l.	l.	PROPN
admet-2013	556	5	zhang	zhang	PROPN
admet-2013	556	6	,	,	PUNCT
admet-2013	556	7	h.	h.	PROPN
admet-2013	556	8	zhu	zhu	PROPN
admet-2013	556	9	,	,	PUNCT
admet-2013	556	10	y.	y.	PROPN
admet-2013	556	11	gu	gu	PROPN
admet-2013	556	12	,	,	PUNCT
admet-2013	556	13	x.	x.	PROPN
admet-2013	556	14	wang	wang	PROPN
admet-2013	556	15	,	,	PUNCT
admet-2013	556	16	p.	p.	PROPN
admet-2013	556	17	wu	wu	PROPN
admet-2013	556	18	.	.	PUNCT
admet-2013	557	1	dual	dual	ADJ
admet-2013	557	2	drug	drug	NOUN
admet-2013	557	3	-	-	PUNCT
admet-2013	557	4	loaded	load	VERB
admet-2013	557	5	pla	pla	NOUN
admet-2013	557	6	nanoparticles	nanoparticle	NOUN
admet-2013	557	7	bypassing	bypass	VERB
admet-2013	557	8	drug	drug	NOUN
admet-2013	557	9	resistance	resistance	NOUN
admet-2013	557	10	for	for	ADP
admet-2013	557	11	improved	improved	ADJ
admet-2013	557	12	leukemia	leukemia	NOUN
admet-2013	557	13	therapy	therapy	NOUN
admet-2013	557	14	.	.	PUNCT
admet-2013	558	1	journal	journal	PROPN
admet-2013	558	2	of	of	ADP
admet-2013	558	3	nanoparticle	nanoparticle	PROPN
admet-2013	558	4	research	research	NOUN
admet-2013	558	5	21	21	NUM
admet-2013	558	6	(	(	PUNCT
admet-2013	558	7	2019	2019	NUM
admet-2013	558	8	)	)	PUNCT
admet-2013	558	9	83	83	NUM
admet-2013	558	10	.	.	PUNCT
admet-2013	559	1	https://doi.org/10.1007/s11051-018-4430-0	https://doi.org/10.1007/s11051-018-4430-0	PROPN
admet-2013	559	2	.	.	PUNCT
admet-2013	560	1	©	©	PROPN
admet-2013	560	2	2023	2023	NUM
admet-2013	560	3	by	by	ADP
admet-2013	560	4	the	the	DET
admet-2013	560	5	authors	author	NOUN
admet-2013	560	6	;	;	PUNCT
admet-2013	560	7	licensee	licensee	PROPN
admet-2013	560	8	iapc	iapc	PROPN
admet-2013	560	9	,	,	PUNCT
admet-2013	560	10	zagreb	zagreb	PROPN
admet-2013	560	11	,	,	PUNCT
admet-2013	560	12	croatia	croatia	PROPN
admet-2013	560	13	.	.	PUNCT
admet-2013	561	1	this	this	DET
admet-2013	561	2	article	article	NOUN
admet-2013	561	3	is	be	AUX
admet-2013	561	4	an	an	DET
admet-2013	561	5	open	open	ADJ
admet-2013	561	6	-	-	PUNCT
admet-2013	561	7	access	access	NOUN
admet-2013	561	8	article	article	NOUN
admet-2013	561	9	distributed	distribute	VERB
admet-2013	561	10	under	under	ADP
admet-2013	561	11	the	the	DET
admet-2013	561	12	terms	term	NOUN
admet-2013	561	13	and	and	CCONJ
admet-2013	561	14	conditions	condition	NOUN
admet-2013	561	15	of	of	ADP
admet-2013	561	16	the	the	DET
admet-2013	561	17	creative	creative	ADJ
admet-2013	561	18	commons	common	NOUN
admet-2013	561	19	attribution	attribution	NOUN
admet-2013	561	20	license	license	NOUN
admet-2013	561	21	(	(	PUNCT
admet-2013	561	22	http://creativecommons.org/licenses/by/3.0/	http://creativecommons.org/licenses/by/3.0/	PROPN
admet-2013	561	23	)	)	PUNCT
admet-2013	561	24	https://doi.org/10.5599/admet.2013	https://doi.org/10.5599/admet.2013	NOUN
admet-2013	561	25	https://doi.org/10.3390/pharmaceutics12020191	https://doi.org/10.3390/pharmaceutics12020191	PROPN
admet-2013	561	26	https://doi.org/10.1016/j.omto.2020.07.007	https://doi.org/10.1016/j.omto.2020.07.007	PROPN
admet-2013	561	27	https://doi.org/10.1016/j.nano.2020.102283	https://doi.org/10.1016/j.nano.2020.102283	PROPN
admet-2013	561	28	https://doi.org/10.3390/ma15041349	https://doi.org/10.3390/ma15041349	ADJ
admet-2013	561	29	https://doi.org/10.3390/cancers13061311	https://doi.org/10.3390/cancers13061311	NOUN
admet-2013	561	30	https://doi.org/10.1186/s13045-021-01150-x	https://doi.org/10.1186/s13045-021-01150-x	PROPN
admet-2013	561	31	https://doi.org/10.1007/s00277-019-03713-y	https://doi.org/10.1007/s00277-019-03713-y	VERB
admet-2013	561	32	https://doi.org/10.3390/pharmaceutics14081662	https://doi.org/10.3390/pharmaceutics14081662	NOUN
admet-2013	561	33	https://doi.org/10.1016/j.biomaterials.2019.03.004	https://doi.org/10.1016/j.biomaterials.2019.03.004	PROPN
admet-2013	561	34	https://doi.org/10.1186/s12951-021-00921-5	https://doi.org/10.1186/s12951-021-00921-5	NUM
admet-2013	561	35	https://doi.org/10.1002/jbm.a.36837	https://doi.org/10.1002/jbm.a.36837	NOUN
admet-2013	562	1	https://doi.org/https:/doi.org/10.2147/dddt.s202818	https://doi.org/https:/doi.org/10.2147/dddt.s202818	PRON
admet-2013	562	2	https://doi.org/10.1007/s11051-018-4430-0	https://doi.org/10.1007/s11051-018-4430-0	PROPN
admet-2013	562	3	http://creativecommons.org/licenses/by/3.0/	http://creativecommons.org/licenses/by/3.0/	PROPN